Quarterlytics / Industrials / Industrial - Machinery / Bodycote / FY2023 Annual Report

Bodycote
Annual Report 2023

BOY · LSE Industrials
Claim this profile
Ticker BOY
Exchange LSE
Sector Industrials
Industry Industrial - Machinery
Employees 5001-10,000
← All annual reports
FY2023 Annual Report · Bodycote
Loading PDF…
Annual 
Report
2023

Bodycote plc

Contents

Strategic report

Governance

1

2

3

4

6

8

Understanding Bodycote

54 Board of Directors

Our markets

Our technologies

Our global network

Highlights

56 Corporate governance statement

65 Directors’ report

67 Report of the Nomination Committee

72 Report of the Audit Committee

The investment proposition

77 Directors’ report on remuneration

10 Chair’s statement

11 Chief Executive’s review

14 Strategy and objectives

15 Our business model

16 Measuring progress; our KPIs

18 Our stakeholders

19 A component journey  
On solid foundations – 
Transmission shafts

20 Compliance with Directors’ duties 

Section 172 statement

21 Section 172 cross-reference

22 Business review

24 A component journey 

Rock solid – Drill bits

25 Chief Financial Officer’s report

28 Principal risks and uncertainties

33 Viability statement

34 A component journey 

Touch down – Landing gear

35 Sustainability report

43 TCFD report

53 Non-financial and sustainability 

information statement

92 Directors’ responsibilities statement

Financial statements

93 Independent auditors’ report

100 Consolidated income statement

100 Consolidated statement of 
comprehensive income

101 Consolidated balance sheet

102 Consolidated cash flow statement

103 Consolidated statement of  

changes in equity

104 Group accounting policies

111 Notes to the consolidated 
financial statements

142 Company balance sheet

143 Company statement of changes 

in equity

144 Company accounting policies

147 Notes to the Company 
financial statements

Additional information

151 Five-year summary (unaudited)

152  Alternative performance measures 

(APMs) – unaudited

155 Subsidiary undertakings

158 Shareholder enquiries

160 Company information

www.bodycote.com/investors 
for more information 

In preparing this Strategic report,  
the Directors have complied with  
s414C of the Companies Act 2006.

This Strategic report has been prepared 
for the Group as a whole and therefore 
gives greater emphasis to those matters 
which are significant to Bodycote plc 
and its subsidiary undertakings when 
viewed as a whole.

Strategic reportGovernanceFinancial statementsAdditional informationUnderstanding Bodycote

Bodycote is the world’s leading 
provider of thermal processing 
services. As the partner of choice  
for many of the world’s most 
respected manufacturing companies, 
our purpose is to provide a vital link  
in the manufacturing process that 
makes the products our customers 
manufacture fit for purpose. 

Our breadth of solutions across 
multiple technologies creates  
value through superior customer 
service for our customers across 
aerospace, defence, energy, 
automotive and general industrial 
markets. Our unique business model,  
expertise and global infrastructure 
mean we can adapt to our customers’ 
needs and continue to deliver long-
term success for our shareholders  
and other stakeholders.

Driving performance  
with our Core Values

Honesty and Transparency

We cultivate a culture of transparency, where honesty and integrity 
are the foundation of our business and our relationships. Trust is at 
the heart of everything we do.

Respect and Responsibility

We behave individually and collectively with respect for each other, 
our stakeholders and the environment, conducting business 
responsibly, taking ownership of our actions.

Creating Value

We create value for our employees, customers and shareholders, 
and this is the very essence of Bodycote.

Page 35 for more information

1

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 Understanding Bodycote
 Our markets 

Bodycote offers materials solutions for virtually every market sector, providing 
expertise across classical heat treatment and specialist thermal processes. 
Bodycote supports many market sectors; however, we categorise our business 
into three major groups:

Aerospace and Defence

Automotive

General Industrial  
(including Energy)

The aerospace market is highly complex 
and requires significant technical expertise. 
Within this market we primarily provide 
thermal processing solutions for engine 
components, which often undergo extremely 
challenging operating conditions, as well as 
landing gear and other aircraft components. 
We provide these solutions across various 
applications, including commercial, business 
and military aircraft.

Bodycote operates an international network 
of quality accredited facilities supporting 
prime aerospace manufacturers and their 
supply chains.

Focused on key components in the car, 
light truck, heavy truck and bus markets, 
thermal processing delivers greater strength 
and durability. 

Bodycote has developed strategic 
partnerships with major automotive Original 
Equipment Manufacturers (OEMs) and their 
supply chains by offering comprehensive 
thermal processing support on a global basis.

We serve a vast range of customers across 
multiple industry segments in our General 
Industrial business. These customers span 
markets including power generation, tooling, 
industrial gas turbines, medical equipment, 
electronics, agriculture, industrial machinery, 
construction and oil & gas components. 

Our success in these markets is due to 
the breadth of processes available within 
Bodycote and our extensive technical 
resources, combined with our local plant 
network and superior customer service, 
allowing for the development of cost-effective 
solutions for our customers.

2

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 Our technologies 

Bodycote’s purpose is to support our customers in producing superior 
components. Our thermal processing services encompass a variety of  
heat treatment techniques and specialist technologies that extend the life  
of components. Bodycote addresses the markets we serve with our 
exceptional service levels and unmatched ability to satisfy customers’ needs.

Classical Heat Treatment

Specialist Technologies

Classical Heat Treatment is the process 
of controlled heating and cooling of metals 
to obtain the desired mechanical, chemical 
and metallurgical properties during the 
manufacturing of a product.

Product life is extended by 
accurately treating products, 
carried out in precisely controlled 
industrial furnaces that can heat 
to temperatures above 1000°C 
and use quenchants like oil, 
water or nitrogen gas to cool 
the heated material. During the 
process, the microstructure of 
the metal transforms, resulting 
in the hardening or softening 
of the material depending on the 
process. Engineers can design 
thinner, lighter, but stronger 
components with the help 
of Classical Heat Treatment. 
The extended life of our 
customers’ products positively 
impacts the environment by 
reducing their carbon footprint.

We provide an indispensable 
set of processes within the 
manufacturing chain of most of 
the products used in daily life. 
By providing wear resistance, 
strength or toughness, 
depending on the application, 
the components we treat last 
longer, reduce downtime, 
increase the lifespan of the 
products our customers 
manufacture and improve the 
sustainability of their products. 
Surface hardness can be 
controlled by diffusing elements 
such as carbon and nitrogen into 
the metal during the heating 
stages of the process. The heat 
treatment of products impacts 
daily life, whether it’s a vehicle 
seatbelt buckle to ensure that  
it keeps the passenger safe 
during an accident or a turbine 
blade bringing power to your  
neighbourhood. 

Our Specialist Technologies business is a 
selection of highly differentiated, early-stage 
processes with high margins, significant market 
opportunities and appealing growth prospects. 
Our Specialist Technologies generally emit lower 
carbon emissions and, therefore, are better for 
the environment. Bodycote is either the clear 
market leader or one of the top players among 
a small number of competitors.

Hot Isostatic Pressing 
(HIP) Services
Improves component integrity 
and strength by application of 
extreme pressure and heat. 

HIP PF including Powdermet®
Additive manufacturing of 
often complex components 
by combining with HIP. 

Specialty Stainless Steel 
Processes (S³P)
Improves the strength, hardness 
and wear resistance of stainless 
steel. Standard heat treatments 
negatively impact the corrosion 
resistance of stainless steel,  
but our proprietary S³P processes 
can provide dramatically improved 
material properties while 
maintaining corrosion resistance. 

Surface Technology
Enhances component life using 
ceramic and metal coatings.

Low Pressure Carburising (LPC) 
Obtains a hardened surface 
and a tough core under  
vacuum using a cleaner process 
than atmospheric carburising, 
providing improved wear 
resistance and fatigue life 
with less distortion.

Corr-I-Dur® (CiD)
Improves corrosion resistance 
and wear properties and is 
primarily used as a sustainable 
substitute for hard chrome. 

3

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Understanding Bodycote
Our global network

Delivering quality through our international network of facilities.

Bodycote offers significant advantages to our customers  
as the only global thermal processing service provider.  
Through an international network of facilities, Bodycote can 
effectively utilise a wealth of knowledge, experience and 
specialist expertise to deliver quality service when and  
where it is needed.

The network operates from more than 165 facilities, with customers benefitting from 
Bodycote’s comprehensive range of services across multiple locations. Customers know 
that if their business expands, Bodycote will have the capability to meet their needs. 
They recognise that if they broaden their manufacturing footprint, Bodycote will assist 
them. They know that they can obtain the same process at the same quality standards 
from multiple locations. Customers understand that Bodycote can operate its facilities 
more efficiently and reduce their overall impact on the environment, assisting them in 
achieving climate impact targets. 

Such an extensive network brings economies of scale, with technology developed at 
one location being available globally if the market requires it. Similarly, network utilisation 
is enhanced by using logistics to put customers’ work into the most effective facility to 
meet their requirements. Moreover, the network allows Bodycote to specialise in fewer 
technologies per location, reducing complexity, increasing efficiency and reducing the 
carbon footprint of our operations.

The Bodycote network has a wealth of technical accreditations, some industry-  
or customer-specific, others more general. Individual operations concentrate on the 
accreditations suited to their market.

Revenue by geography

£802.5m

North America

Western Europe

Emerging Markets  

36%

52%

12%

Revenue by market sector

>40,000

customers

4,833¹

employees

£802.5m

>165

facilities

22

countries

Aerospace and Defence

Automotive

General Industrial (including energy)

27%

24%

49%

1  At year end 2023.

4

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
 
North America

Western Europe

Emerging Markets

Bodycote is the largest provider of thermal 
processing services in North America  
with comprehensive network coverage. 
This network offers more than 55 facilities 
convenient to customers in all areas where 
manufacturing and technical industries  
are concentrated.

Bodycote operates facilities across Western 
Europe and is the number one provider of 
thermal processing services, with the largest 
network and comprehensive service offering 
with facilities near major industrial hubs.

Bodycote has facilities across our Emerging 
Markets, covering Eastern Europe, China and 
Mexico. Bodycote is the number one thermal 
processing provider in Eastern Europe and is 
the leading Western provider in China.

£287.5m

£417.4m

£97.6m

Revenue by market sector

 Aerospace and Defence

 Automotive

General Industrial (including energy)

44%

19%

37%

 Aerospace and Defence

 Automotive

General Industrial (including energy)

18%

20%

62%

 Aerospace and Defence

 Automotive

General Industrial (including energy)

10%

57%

33%

>55
facilities

 1,545
employees

>80
facilities

2,284
employees

>25
facilities

 1,004
employees

5

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
 
 
Understanding Bodycote
Highlights

Highlights

Financial summary

Revenue
Headline operating profit1
Headline operating margin1
Headline operating margin excluding surcharges1
Free cash flow1
Basic headline earnings per share1,2
Full year dividend per share
Return on capital employed1

Additional statutory measures

Operating profit
Operating profit margin
Profit after tax
Net cash generated from operating activities
Basic earnings per share

Financial performance 

2023
£802.5m 
£127.6m 
15.9% 
17.3%
£122.5m 
48.4p 
22.7p
14.8% 

2023
£119.2m 
14.9%
£86.8m 
£191.6m 
45.1p 

2022
£743.6m
£112.2m
15.1%
16.1%
£84.0m
42.7p
21.3p
13.3%

2022
£102.0m
13.7%
£74.3m
£142.9m
38.6p

 – Revenue up 8% to £802.5m. Growth of 6% excluding energy-related surcharges 

 –  Headline operating profit of £127.6m, 17% higher at constant currency

 –  Headline operating margin of 15.9%, up 80bps; 17.3% excluding surcharge revenue, up 120bps

 –  Headline EPS1,2 growth of 13% to 48.4p

 –  Return on capital employed1 up 150bps to 14.8%

 –  Free cash flow improved by £38.5m to £122.5m1  

 – Full year dividend per share of 22.7p, up 7%, 36-year record of growing or maintaining the dividend

Key achievements 
 – Revenue growth led by Specialist Technologies, up 12% excluding surcharges3 

 –  Strong performance in aerospace, oil & gas and medical markets

 –  4% reduction in absolute energy consumption, notwithstanding 8% revenue growth

 –  Significant margin improvement; on track to achieve margins in excess of 20% over the medium term

 –  Returned to historical levels of free cash flow conversion1 of over 90%

 –  Disciplined capital allocation resulting in the £52m acquisition of Lake City in January 2024 and  

a £60m share buyback commencing 15 March 2024 

 – Delivering successfully on all strategic focus areas

1  The headline performance measures represent the statutory results excluding certain items. These are deemed alternative performance measures under the European Securities and Markets 

Authority guidelines. Please refer to page 152 for a reconciliation to the nearest IFRS equivalent.

2  A detailed EPS reconciliation is provided in note 8 of the consolidated financial statements.

3  At constant currency.

6

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Financial highlights

Revenue 
£m

5
.
2
0
8

6
.
3
4
7

7
.
9
1
7

0
.
8
9
5

8
.
5
1
6

Full year dividend per share
pence

7
.
2
2

3
.
1
2

0
.
0
2

3
.
9
1

4
.
9
1

£802.5m

22.7p

’19

’20

’21

’22

’23

’19

’20

’21

’22

’23

Headline operating profit 
£m

Basic headline earnings per share 
pence

9
.
4
3
1

3
.
5
7

6
.
7
2
1

2
.
2
1
1

8
.
4
9

£127.6m

4
.
8
4

7
.
2
4

1
.
2
5

8
.
5
3

8
.
7
2

48.4p

’19

’20

’21

’22

’23

’19

’20

’21

’22

’23

Free cash flow 
£m

Return on capital employed 
%

.

1
3
2
1

.

1
6
0
1

.

0
5
0
01
4
8

.

.

5
2
2
1

£122.5m

.

7
7
1

.

8
4
1

.

3
3
1

.

0
2
1

8
9

.

14.8%

’19

’20

’21

’22

’23

’19

’20

’21

’22

’23

7

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
 
 
 
Understanding Bodycote
The investment proposition

We provide expertise in heat treatment and specialist thermal 
processes across a wide variety of markets. We aim to create 
sustainable value for all our stakeholders, whether investors, 
customers, employees or the communities where we operate. 

Scale and expertise as the 
world’s number one service 
provider of heat treatment and 
specialist thermal processing

Business resilience to a 
downturn derived from flexibility 
of the workforce, diversity 
of end-markets, continuous 
improvements in business 
quality and geographic spread

Significant barriers to entry  
in Specialist Technologies, 
Emerging Markets and 
civil aerospace

Consistently strong margins 
and excellent free cash 
flow generation

Highly cash-  
generative business  
funding both investment  
and cash returns 
to shareholders

Superior growth  
opportunities 
in Emerging Markets and  
secular growth markets 
of civil aerospace, 
electric vehicles, and 
medical products

Disciplined  
capital allocation  
focused on investing in the 
business and returning capital 
to shareholders

Plentiful investment 
opportunities to drive 
margins and returns

 Strong balance sheet 
providing options to  
drive shareholder value

Specialist Technologies 
with high margins and high 
growth rates will become  
a larger portion of the Group

Low-carbon 
market opportunity  
a major enabler of 
Scope 4 avoided 
emissions for customers 
through outsourcing

8

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Key investment strengths
A strategy in place to further enhance margins 
and growth through:

 – Increasing the size of our Specialist 

Technologies business with its superior 
margins, higher growth characteristics 
and lower emissions

 – Investment in development and localisation 

opportunities in Emerging Markets

 – Investment in secular growth end-markets  

of civil aerospace and electric vehicles
 – Improving the mix of the Classical Heat 

Treatment business

 – Proactive approach to ESG and sustainability
 – Investment in acquisitions and 

greenfield sites

 – Strategy that can accommodate widely 

differing market outcomes

>£310m

invested in capacity growth 
in last five years

>£225m

returned to shareholders 
in last five years

What you can expect

Higher growth markets of Specialist 
Technologies, Emerging Markets and 
civil aerospace already constitute 
more than half of the Group 
revenues and more than 60% of the 
Group’s headline operating profit

 – These higher margin and growth 

opportunities are expected to continue 
to outperform the Classical Heat 
Treatment business

Classical Heat Treatment should 
perform ahead of markets, driven by:

 – Increasing demand for improved 

materials and quality

 – Additional outsourcing as customers 
understand that Bodycote is part of 
the solution to reducing their 
carbon emissions

Continued selected acquisitions

 – Four key acquisitions in the last 

five years

All on top of underlying industrial 
production growth

9

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Chair’s statement

 Bodycote is a service business, 

reliant on its people at all levels.  
The Group has exceptional people  
who understand the needs of our 
customers and are committed to 
delivering outstanding performance  
for them and for our shareholders.

D. Dayan
Chair

Overview
I am pleased with Bodycote’s performance in 2023, which delivered 
further strong growth in revenue, profitability and cash flow. 
Our Executive team has made significant strides in delivering our 
strategic objectives and generating value for all our stakeholders. 
Since the year end, we successfully closed the acquisition of Lake City, 
strengthening further our Specialist Technologies offering. Appointing a 
new Group Chief Executive to succeed Stephen Harris after his 
successful 15 years leading Bodycote was a very significant step, and 
the Board is delighted Jim Fairbairn has joined us in March 2024 to 
continue the positive developments that have marked Stephen’s tenure.

Dividend and shareholder returns
The Board is proposing a final dividend of 16.0 pence per share, an 
increase of 7%, to be paid on 6 June 2024 subject to shareholder 
approval at the 2024 Annual General Meeting (AGM). Combined with 
the interim dividend of 6.7 pence, this takes the full year dividend to  
22.7 pence per share for the year, a 7% increase, returning £43m  
to shareholders. 

In addition to the regular dividend, the Group announced in January 
2024 the intention to launch a £60m share buyback. This will commence 
on 15 March 2024. Taken together with the dividend, this underlines  
the Board’s commitment to delivering returns to our shareholders and 
pursuing a balanced and flexible approach to capital allocation.

Board and governance
In May 2023, when Stephen Harris announced his plan to retire  
from Bodycote at the 2024 AGM, the Board launched an extensive 
search to find his successor, considering both internal and external 
candidates. Jim Fairbairn joined the Board in March 2024 and  
following a comprehensive induction programme, will be ready to  
take up the position of Group Chief Executive on Stephen’s departure. 
We welcome Jim to the Company. 

Bodycote has been transformed since Stephen was appointed  
Group Chief Executive in 2009. His legacy and impact on Bodycote will 
be enduring and we thank him deeply and sincerely for his work and 
dedication. With Jim Fairbairn’s succession as Group Chief Executive  
we are well-positioned for the next chapter of Bodycote’s evolution. 

We welcomed Beatriz García-Cos Muntañola to the Board in September 
2023. Her experience within the industrial manufacturing and metals 
industry and as a serving Chief Financial Officer makes her a further 
well-qualified Non-Executive Director.

Governance remains a focal point for me as Chair and for the Board as a 
whole. As a Board, we continually keep our governance approach under 

10

review to ensure it remains effective and in-line with best practice as  
it evolves; this is discussed in detail in the corporate governance report  
on page 56. 

People 
I would like to thank all our colleagues across Bodycote for their hard 
work and commitment on behalf of stakeholders during 2023. As a 
service business, it is their dedication to delivering outstanding service 
levels that sets us apart, and we are fortunate to have an impressive 
team of experienced people across all levels of the organisation who 
deliver against demanding expectations. 

Sustainability
During 2023 the Board has been actively involved in oversight of the 
execution of our sustainability strategy. Our Sustainability report,  
on page 35, highlights the efforts and progress the Group has made. 
In particular, given the energy-intensity and relatively simple supply 
chains of Bodycote’s businesses, carbon emissions remain our 
sustainability priority. Our operations continued to successfully  
execute on a range of carbon reduction plans which put us on a path  
to deliver against the Science Based Target initiative (SBTi) targets. 
Our commitment to sustainability is an active part of the Group’s 
strategy and is incorporated into our leadership team’s core objectives. 
We are well placed to meet our goals underpinned by a set of clear 
action plans which are laid out for the entire organisation and approved 
by the Board. 

Shareholders 
Throughout 2023, I had the privilege of engaging with many of our 
shareholders to understand their various points of view, especially  
when considering the appointment of our new Group Chief Executive. 
The Board appreciates the support of our shareholders and takes  
their views into account as part of our decision-making processes.  
I look forward to further opportunities to meet with shareholders 
through 2024.

Summary 
Overall, the Group has made good progress in 2023, remains in a  
strong financial position and has the capability to take advantage of 
many opportunities ahead. I am confident that Bodycote will continue  
to perform well and deliver value to our customers, shareholders 
and employees.

D. Dayan
Chair  
15 March 2024

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Chief Executive’s review

 In 2023, we once again 
delivered good revenue growth  
and improved financial performance,  
as well as making progress against 
our strategic priorities.

S.C. Harris
Group Chief Executive

Full year commentary
Overview
Group revenue increased 8% to £802.5m in 2023. 
Excluding surcharges which have continued to be applied in order to 
recover high energy prices, revenue was up 6% at constant currency. 
This growth reflected significant progress in the Group’s strategic 
focus areas, and was despite a mixed end-market picture, particularly 
in the second half of the year. Bodycote delivered continued 
outperformance in Specialist Technologies, up 12% at constant 
currency and excluding surcharges, compared with Classical Heat 
Treatment which grew by 4% at constant currency. Good revenue 
progress was delivered with strong performance, in particular, in civil 
aerospace (+12%), medical (+24%) and energy (+27%). 

Headline operating profit increased 14% to £127.6m, from £112.2m 
in 2022 (+17% at constant currency). Headline operating margin 
improved to 15.9% (2022: 15.1%). Adjusting for the revenue impact  
of energy surcharges, headline operating margin increased by  
120bps to 17.3%. Cost inflation was successfully covered through 
price increases. Margin improvement was led by the ADE business, 
where headline operating margins rose by 410bps to 21%, driven by 
strong revenue growth in Aerospace and Defence, in addition to the 
successful actions to improve pricing and operational performance  
in Surface Technology.

Statutory operating profit increased from £102.0m to £119.2m. 

Basic headline earnings per share increased by 13% to 48.4p 
(2022: 42.7p). Basic earnings per share rose 17% to 45.1p 
(2022: 38.6p), reflecting the increase in statutory operating profit.

The Group delivered a significant improvement in free cash flow, 
which increased £39m to £123m (2022: £84m). This reflected higher 
operating profit, as well as a significant improvement in working 
capital control, through better receivables collection. Investment in 
maintenance capital expenditure increased by £6m reflecting ongoing 
steps to drive improvements in equipment uptime performance.

As a result of the cash flow performance, the balance sheet further 
strengthened, with a closing net cash position excluding lease 
liabilities of £12.6m (2022: £33.4m net debt excluding lease liabilities). 

Disciplined and balanced capital allocation to drive 
shareholder value
The Group’s strong financial position provides flexibility for disciplined 
and balanced capital allocation, with a number of actions taken during 
2023 and in early 2024.

In 2023, the Group invested £85.5m (2022: £74.3m) in capital 
expenditure, including expansionary capital expenditure of £27.8m 
(2022: £22.1m). Over 80% of the expansionary spend was deployed  
in our strategic focus areas of Specialist Technologies, Emerging 
Markets, civil aerospace and electric vehicles.

Full year DPS was increased by 7% to 22.7p, continuing a 36-year 
track record of growing or maintaining the dividend. The total cash 
returned to shareholders through dividends in 2023 was £40.6m 
(2022: £38.5m).

In January 2024, the Group announced completion of the  
acquisition of Lake City Heat Treating for a total gross consideration  
of £52m (£46m net of expected tax benefits). Lake City is a leading 
hot isostatic pressing (HIP) and vacuum heat treatment business in 
Warsaw, Indiana, serving the orthopaedic implant market as well  
as civil aerospace. It fits well with the strategic focus on growing  
further the Group’s Specialist Technologies revenue in addition  
to significantly expanding the Group’s presence in the structurally 
attractive medical market.

In addition, a £60m share buyback programme was announced in 
January, which will commence on 15 March 2024. Further details 
are provided in a separate announcement.

Business focus
The following commentary reflects constant currency growth rates 
versus the comparable period last year, unless stated otherwise.

11

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Strategic report

Governance

Financial statements

Additional information

Chief Executive’s review continued

Specialist Technologies
Specialist Technologies are differentiated, early-stage processes with 
high margins, large market opportunities and good growth prospects, 
where Bodycote is either the clear leader or one of the top players 
among few competitors. A key part of the Group’s strategy is to grow 
these businesses and, over time, to increase their relative weight 
within our portfolio. Over the past six years, Specialist Technologies 
has now outgrown Classical Heat Treatment by on average c.10% per 
year (at constant currency and excluding surcharges). 

In 2023, revenue from Specialist Technologies grew by 12%, 
supported by existing customer growth and ongoing sales and 
marketing efforts to drive higher rates of new adoption of these 
processes. To service this growth there was also investment in 
additional capacity, with 58% of expansionary capital expenditure in 
2023 (£16m) invested in Specialist Technologies. In 2023 this included 
HIP capacity expansion in the US on the East Coast and in the 
Midwest, growth in our S3P businesses in Mooresville, North Carolina 
and in Vellinge, Sweden, as well as additional LPC capacity in Hungary 
to support electric vehicle production. In 2024 we expect to drive 
further expansion, including new Corr-I-Dur® capability in China and 
additional HIP capacity at several sites in the US. 

Market sectors
Aerospace & Defence revenue of £214m was 15% higher than the 
prior year, 11% higher excluding the impact of energy surcharges. 
Civil aerospace revenue was 12% higher excluding surcharges, as 
production rates for commercial aircraft and engines continued to 
recover, and there was a considerable step-up in air traffic and related 
aftermarket and servicing activity. Further growth in OEM production 
volumes and aftermarket activity is expected in 2024, which the  
Group is well positioned to capture through strong exposure on  
newer engine programmes like the CFM LEAP engine. Supply chain 
issues continue to temper growth in civil aerospace, although there 
was some improvement in the second half of 2023. Outside civil 
aerospace, we also saw good growth in defence (up 10%), notably  
in France and the US, and in the space sector. 

Automotive revenue was £195m, 6% higher in the year, 5% growth 
excluding the impact of energy surcharges. Growth was led by 
Emerging Markets, which saw strong performance in Eastern Europe 
(up 24%), partly offset by weakness in China and Mexico. There was 
modest growth in Western Europe, where heavy truck and bus sales 
grew strongly but light vehicle sales were flat. Automotive revenue in 
North America grew by a low single digit percentage. There was 
considerable order activity in electric vehicles (EVs), including battery 
electric vehicles and hybrids. We secured further major new OEM 
contracts for EV components in Emerging Markets, North America  
and Europe, which will progressively ramp-up in the coming years. 

General Industrial (including energy) revenue increased 6% to 
£394m, which represented 4% growth excluding surcharges. 
There was significant variation across end markets, with energy  
sales increasing 27%, and with continued strong growth delivered in 
medical, up 24%. There were more challenging conditions in the 
manufacturing, industrial machinery, tooling, and electronics markets, 
which saw declines in the second half of the year.  

Sustainability
We are proud of the work we do to improve sustainability through our 
innovative range of metallurgy services across a multitude of markets 
and applications. Our services deliver a wide range of sustainability 
benefits to customers: extending the lifespan of components, 
reducing carbon emissions, supporting the development of low-carbon 
industries, and enabling lighter and thinner components to be adopted 
for more sustainable manufacturing. With increasing pressure on 
companies to decarbonise their activities to meet emissions targets 
and align with emerging legislation, Bodycote’s role in helping 
customers reduce emissions has never been more important.

As part of our sales and marketing agenda, in 2023 we accelerated  
our work to develop digital tools that automate the quantification of 
carbon savings for customers. Emissions are up to 60% lower when 
parts are processed in our facilities, compared with customers’ own 
in-house processing. Our tools will enable us to demonstrate the 
positive impact of outsourcing to Bodycote, enabling our customers to 
reduce their operational emissions, and avoid some emissions entirely.

Our work to transition customers to lower carbon technologies also 
gained momentum in 2023. Encouraging accelerated conversion to 
these technologies plays a role in reducing emissions, while driving 
growth at the same time. We secured several new contracts in the 
year where avoided carbon emissions (Scope 4) were a critical factor 
for our customers.  

The pace of investment in our own carbon reduction programme 
continues to accelerate. This also yields a financial payback through 
lowering the cost of energy, driving higher margins. The Group’s 
energy consumption reduced by 4% in 2023 as a result of our 
initiatives, notwithstanding the 8% growth in Group revenue. We are 
well on track to achieve our Science Based Target1 for emissions 
reduction, having now reduced emissions by 24% since 2019.

Summary and outlook
In 2023 we once again delivered strong revenue growth and  
improved financial performance, as well as making progress against 
our strategic focus areas. 

We delivered significant headline operating profit margin 
improvement, notably in the ADE business, helping to drive Group 
margins to 17.3%, excluding surcharges. Headline EPS increased  
by 13% to 48.4p. Bodycote returned to the strong levels of cash 
conversion which are more typical for the business, with free  
cash flow of £123m, up 46%, reflecting improved working 
capital management.

We will continue to deliver on our strategic focus areas in 2024, 
including driving growth in Specialist Technologies, capitalising on  
the growth opportunities from delivering carbon reductions for our 
customers, and integrating the newly acquired Lake City business.

Despite macroeconomic uncertainty we expect to deliver further 
progress in 2024. We anticipate a reduction in the level of energy 
surcharges, reflecting further normalisation of energy prices. 

2024 should see us take another step towards our medium term 
margin target of more than 20%.

The Board remains confident in the Group’s prospects for continued 
profitable growth.

S.C. Harris
Group Chief Executive  
15 March 2024

1  Bodycote has signed up to emissions reductions in line with the Science Based Targets 

initiative (SBTi).

12
12

Bodycote plc Annual Report 2023

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Strategic report

Governance

Financial statements

Additional information

Case study: A real world example
Driving the green energy transition with  
Specialist Technologies

In 2023, Bodycote began work on a major new multi-year contract to 
provide efficient processing of automotive parts destined for hybrid 
vehicles, using low pressure carburising (one of our Specialist 
Technologies). The win marked another key milestone in the Group’s 
efforts to transition customers into adopting newer, lower-carbon  
heat treatment processes. 

Bodycote won the contract with a key supplier to a leading global 
automaker and is providing heat treatment services for a number  
of parts in the vehicles’ driveline system. 

Instead of quoting for services using traditional processing methods, 
as the customer had requested, Bodycote proposed low pressure 
carburising (LPC) for the customers’ parts. The LPC process enables  
a significant reduction in the amount of energy required to achieve  
the same metallurgical properties for a product. It cuts processing 
time by around 20% and the amount of energy required by 50%. 
Process gas – needed to achieve carburisation – is also reduced by 
99% in LPC technology.

As the LPC process uses electricity, as opposed to gas, it also  
enables a continuous reduction in products’ carbon footprints as  
the grid becomes increasingly decarbonised over time.

Through the application of our specialist knowledge and expertise, 
Bodycote successfully transitioned the customer to a process that  
will enable them to achieve significant emissions avoidance and 
provide low carbon revenue growth at high margins for Bodycote  
at the same time.

20% less

processing time using  
Bodycote’s LPC process

50% saving

in energy using LPC versus  
traditional processing methods

99% reduction

in process gas used

Bodycote plc Annual Report 2023

13
13

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Strategy and objectives

Bodycote’s objective is to create superior shareholder returns through 
the provision of selected thermal processing services that are highly 
valued by our customers, giving full regard to a safe working environment 
for our employees and with minimal environmental impact.

m

Strategic priorities

Objectives

1

2

3

4

5

6

Safety and  
Climate Change

We have a strategic commitment to ensuring the safety of 
our employees and reducing our direct environmental impact, 
specifically on climate change.

Capitalising on and investing 
in our Specialist Technologies

Delivering unique solutions that provide customers with 
innovative, high-value-added products to meet the changing 
needs within component manufacturing, as well as helping 
them reduce their impact on the environment.

Investing in  
Emerging Markets

Expanding alongside our customers, with an emphasis in 
markets delivering higher growth in Eastern Europe, Mexico 
and China.

Investing in structural  
growth opportunities

We invest in structural growth markets of civil aerospace  
and electric vehicles.

Driving operational  
improvement

Continuous improvement of business processes and systems 
makes us more efficient and responsive.

Acquisitions

Adding bolt-on acquisitions to improve our plant network in 
Classical Heat Treatment and investing in larger acquisitions 
and adjacent technologies to grow Specialist Technologies. 

In addition to the strategic icons above, we also link our markets and values  
via the following icons throughout the report.

We cultivate a culture of transparency where honesty  
and integrity are at the foundation of our business and our 
relationships. Trust is at the heart of everything we do.

Core markets

Aerospace and Defence

Creating  
Value

We create value for our employees, customers and 
shareholders, and this is the very essence of Bodycote.

Automotive

We behave individually and collectively with respect for each 
other, our stakeholders and the environment, conducting 
business responsibly and taking ownership of our actions.

General Industrial  
(including Energy)

Core values

Honesty and  
Transparency

Respect and  
Responsibility

14

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023m

Our business model

Our business model ensures we are the supplier of choice 
for our customers’ thermal processing needs.

We provide essential 
solutions to customers

Our thermal processing services simplify customer manufacturing by reducing 
their non-core activities. Bodycote adds value while reducing the impact 
on the environment by operating more efficiently and offering substitute 
Specialist Technologies processes, which are inherently lower emissions 
processes. Our global network of engineers and metallurgists collaborates 
with customers to solve complex challenges, enhance operational efficiencies 
and help improve product performance. Our services allow our customers’ 
parts to last longer and reduce their environmental impact,  
supporting a more sustainable future.

A global network
 – A global network of more than 165 market-

focused facilities in 22 countries. We have global 
expertise but are located near our customers.

  See our global network on pages 4–5.

Unmatched expertise
 – Recognised as the leader in the industry with 

the best metallurgists, engineers and technicians, 
Bodycote is ideally placed to provide solutions 
for customers, whatever their market or wherever 
in the world they may be.

  See managing our people on pages 36–38.

 – Unique opportunities for transferring knowledge, 

skills and technology across the network.
  See our customer component journeys throughout  

the Strategic report.

Utilising our 
strategic 
competitive 
 advantages

We focus on  
service and quality 

Scale and investment
 – Bodycote’s scale enables continuous yet focused 
investment in the latest processes and the most 
efficient and environmentally friendly equipment.

  See Chief Executive’s review on pages 11–12.

Customer focus
 – Building strong customer relationships through local 
service expertise; the scope of Bodycote’s network 
enables us to specialise at individual locations and 
provide comprehensive backup for our customers 
more effectively than competitors.

 – We secure service-specific agreements with our 

customers, giving protection from supply disruption 
and leveraging Bodycote’s unique facility network.

  See business review on pages 22–23.

Service and expertise
 – We provide highly efficient, cost-effective services to 

the highest quality standards through strategic investment 
in people and the latest technology, equipment and 
quality systems.

Quality
 – Bodycote’s quality management systems, validated by 
major engineering OEMs, have been developed to  
meet the requirements of both international and national 
accrediting bodies.

 – Bodycote’s extensive expertise means that projects can 

 – Our facilities hold industry and customer approvals 

improve beyond customers’ in-house capabilities, 
combining identification and provision of technical solutions 
to deliver value-adding material properties with a lower 
environmental impact and often at a lower cost.

appropriate to the services they offer and the markets  
they serve.

We create value for customers, Bodycote and our investors.

For our customers
 – Value-adding services
 – Global supplier meeting multiple 

processing needs

 – Carbon reduction versus in-house 
operations, reducing the overall 
emissions from their value chain
 – Cost reduction benefits versus 

in-house operations

 – Access to the entire Bodycote 
knowledge base and expertise

For Bodycote
 – Mutually beneficial 

customer relationships

 – Vast customer base means Bodycote 
is not reliant on any one customer 
or market

 – Ideally positioned to promote 

growth in targeted markets and 
selected technologies

For our investors
 – Financially stable and 
sustainable business
 – Solid growth drivers
 – Superior return on investment
 – Strong margins and cash flows
 – Proactive approach to sustainability 

and climate change

15

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Measuring progress
Our key performance indicators

Performance
Return on capital employed increased by 1.5 percentage points during the year, 
up from 13.3% to 14.8%.

Definition
Headline operating profit1 as a percentage of the average of the opening and  
closing capital employed.

Capital employed is defined as net assets adjusted for net cash/(debt).

Return on capital employed
(%)

7
.
7
1

8
.
4
1

3
.
3
1

0
.
2
1

8
.
9

’19

’20

’21

’22

’23

Basic headline earnings per share 
(pence)

Performance
Basic headline earnings per share increased by 5.7p (13.3%) from 42.7p to 48.4p.

Definition
Basic headline earnings per share is defined on page 26.

Performance
Headline operating margin increased by 0.8 percentage points during the year,  
from 15.1% to 15.9%. Headline operating profit increased by 14% from £112.2m to £127.6m, 
while revenue increased by 8% from £743.6m to £802.5m.

Definition
Headline operating profit as a percentage of revenue.

4
.
8
4

7
.
2
4

1
.
2
5

8
.
5
3

8
.
7
2

’19

’20

’21

’22

’23

Headline operating margin
(%)

7
.
8
1

.

6
2
1

.

4
5
1

1
.
5
1

9
.
5
1

’19

’20

’21

’22

’23

1  Defined on page 152.

16

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
Performance 
Free cash flow for the Group was £122.5m (2022: £84.0m).  
This was 96% of headline operating profit (2022: 75%).

Definition
Free cash flow is defined on page 26.

Performance
Bodycote works hard to improve safety and reduce workplace incidents and is committed to 
providing a safe environment for everyone who works at or visits our locations. The TRIR rate 
increased to 2.8 (2022: 2.5). Further details are included in the Sustainability section on 
page 37.

Definition
TRIR is defined as the number of lost time incidents, restricted work cases and medical 
treatment cases x 200,000 hours, divided by the total number of employee hours worked.

Performance
The Group’s carbon footprint, absolute Scope 1 and Scope 2 CO2e emissions,  
reduced by 2% year-on-year, from 270.7 to 265.3 ktCO2e. Further details are included  
in the Sustainability report.

Definition
Carbon footprint is defined as the kilotonnes of CO2 equivalent emissions.  
CO2 equivalent emissions are calculated by taking electricity, fuel and process  
gas consumption data and multiplying by relevant conversion factors.  
Further details are included in the Sustainability report.

Free cash flow
(£m)

1
.
3
2
1

5
.
2
2
1

1
.
6
0
1

0
.
5
0
1

0
.
4
8

’19

’20

’21

’22

’23

Total Reportable
Incident Rate (TRIR)

0
9
.
2

2
8
.
2

2
5
.
2

7
7
.
2

0
3
.
2

’19

’20

’21

’22

’23

Carbon footprint1 
(ktCO2e)

6
.
6
5
3

.

5
4
9
2

9

.

4
8
2

7

.

0
7
2

.

3
5
6
2

’19

’20

’21

’22

’23

1  CO2e emissions for 2019–2022 have been 
restated in line with the Group’s emissions 
calculation methodology and using 
appropriate CO2e conversion factors for  
the years presented here. See page 40  
for details.

17

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
Our stakeholders
How and why we engage

Building strong, positive relationships with Bodycote’s key stakeholders 
is essential to achieving long-term success.

Employees

Their interests
 – Health and safety at work
 – Employee development/engagement 
 – Wages, benefits and social packages 
 – Career opportunities 
 – Training opportunities 
 – Reputation of the organisation
 – Sustainability 
 – Diversity and inclusion

Customers

Their interests
 – Value-enhancing services and satisfaction of 

their needs

 – Service performance, efficiency and quality 
 – Commitment to sustainability and 

emissions reduction

 – Supply chain transparency

Reason for engagement
Employee engagement is vital for our success. 
We work to create a diverse and inclusive 
workplace where every employee can reach their 
full potential. We engage with our people to ensure 
we meet their expectations and make the right 
business decisions. This helps us to retain and 
develop the best talent.

How we engage
 – Employee Engagement Groups and  

Town Hall meetings 

 – Annual individual performance reviews 
 – Works councils and their representatives 
 – Intranet and communications, suggestion boxes 

and grievance mechanisms 
 – Annual Report and Accounts 
 – Environment, health and safety briefings 

and trainings

 – Social media communications

Reason for engagement
We collaborate with our customers to improve our 
customers’ product characteristics and to develop 
a project pipeline.

Investors

Their interests
 – Financial performance and financial returns 
 – Effective capital allocations and dividends 
 – Commitment to sustainability and climate change
 – Mergers and acquisitions 
 – Health and safety performance 
 – Governance and transparency 
 – Sustainability of performance

Reason for engagement
Continued access to capital is important to 
the long-term performance of our business. 
We work to ensure that our investors and analysts 
understand our strategy and performance well.

How we engage
 – Through ongoing customer 
relationship management

 – Participation in industry forums and trade events 
 – Surveys of customer satisfaction
 – Customer marketing communication programme, 

including utilisation of our corporate website 

 – Engaging with our customers helps us to 

understand their needs and identify opportunities 
and challenges

How we engage
 – Annual General Meeting 
 – Annual Report and Accounts
 – Results presentations and regular engagement 

with top shareholders 

 – Investor communications and our 

corporate website

 – Meetings throughout the year with existing and 
prospective shareholders and banking partners

 – Press releases  

(including regulatory announcements)

 – Addressing enquiries regularly

Reason for engagement
Bodycote operates in a very large number of local 
communities across the world, and we aim to 
ensure that the business is seen as something that 
contributes positively to these communities and 
their inhabitants.

How we engage
 – Employee engagement activities 

involving families 

 – Employee volunteering in local communities
 – Local site community activities
 – Our corporate website

Society/Communities

Their interests
 – Positive social impact 
 – Employment opportunities
 – Future talent pipeline 
 – Minimised environmental impact in the locations 
where we operate and on the global community 

 – Safety, health and environmental performance
 – Individual employee volunteering 
 – Corporate website 
 – Local site community activities

18

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Strategic report

Governance

Financial statements

Additional information

A component journey
On solid foundations – Transmission shafts

Transmission shafts form part of the drivetrain of all vehicles. In this example, we will look at how these hard 
working components are given a longer lifetime as part of powerful construction vehicles, such as excavators, 
through heat treatment and metal joining processes. Transmission shafts are an excellent example of thermal 
processing’s contribution to value engineering. The Electron Beam Welding (EBW) process, in particular, 
allows the fabrication of a high performance component from two pieces, thereby avoiding machining from 
solid which is both wasteful and expensive. 

The shafts begin life as 
high grade steel alloy forgings.

The forged steel part 
is then machined into its 
near net shaft shape and 
sent for heat treatment. 

The shafts require carburising 
to increase their wear resistance 
and impart high hardness properties. 
They are then quenched and tempered 
to remove internal stresses. 

Shafts requiring an EBW operation 
after heat treatment are first 
selectively chemically coated to 
prevent carbon penetration; this 
will ensure a clean electron beam 
weld at a later stage. 

The parts undergo automatic 
shaft straightening to correct 
any distortion caused by high 
processing temperatures. 

 The shafts are machined  
again to achieve final 
engineering dimensions.

End application, 
construction vehicles 
such as an excavator.

The shafts need assembly with their 
gear or drum using EBW. The parts are 
ultrasonically cleaned and measured to 
ensure no contamination of the parts 
during the EBW vacuum process 
which fuses the parent metal of the 
parts together. 

 Denotes the parts of the component journey undertaken by Bodycote

Bodycote plc Annual Report 2023

19
19

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
 
 
 
 
Compliance with Directors’ duties
Section 172 statement

Strategy

Performance

People

Governance

In determining the Group’s strategic 
direction, and the sustainability 
of our business model, the Board 
is conscious of its collective 
responsibilities to all stakeholders, 
seeking to ensure that corporate 
and management structures are 
in place for our strategy to be 
implemented effectively.

At each Board meeting, progress 
against our strategic priorities 
and the changing shape of the 
business portfolio is reviewed. 
This approach, together with the 
Board’s approval of the Company 
strategy, helps the Board to promote 
the long-term success of the Group. 
Board decisions are ultimately taken 
against the backdrop of what it 
considers to be in the best interest 
of the long-term financial success of 
the Company and each of the Group’s 
stakeholders. The Company’s strong 
underlying financial position enables 
us to pursue new opportunities for 
the Group within our disciplined 
financial framework.

A core pillar of the Group’s strategy 
is growth via selected acquisitions.

As an organisation, we endeavour 
to drive performance through the 
communication of clear objectives and 
skills development.

We are committed to continuous 
improvement and the Board regularly 
reviews and monitors the Group’s 
safety, reliability and environmental 
performance, with the aim of making 
Bodycote safer for our entire workforce 
and minimising our impact on 
climate change.

In 2023, the Group recorded a TRIR of 
2.8 (2022: 2.5). There was an increase 
in the number of incidents relating to 
the manual handling of parts, slips, 
trips and falls, and lifting operations. 
We remain focused on delivering 
targeted and timely employee 
engagement to tackle the occurrence 
of these sorts of incidents. The safety, 
health and wellbeing of our employees 
will always be our highest priority. 
This is important to our workforce 
and local communities, while strong 
operational availability and reliability is 
crucial to our partners and customers.

The Board’s oversight ensures 
the Group continues to focus on 
maintaining financial discipline and 
delivering strong earnings, cash flow 
and returns to shareholders. 

As a service business, it is our 
people, their attitude, capabilities 
and skills, who are the key to 
our success. Our people help us 
maintain our strong reputation 
for high standards of business 
conduct, which is fundamental in 
delivering our purpose to support 
our customers in producing superior 
components. We are committed to 
ensuring we have safe and effective 
working environments, which 
enable everyone to perform to their 
true potential.

Bodycote operates divisional 
Employee Engagement Groups 
which are chaired by a Non-Executive 
Director. The feedback from these 
forums is reported to the Board, with 
Executive Directors charged with 
addressing any particular items that 
arise. In 2023 these forums were 
held virtually. Feedback was generally 
positive with no material concerns 
expressed by employees during 
the year.

The Board believes that strong 
governance is essential to the success 
of our business and recognises 
that the Group’s long-term success 
depends on a commitment to good 
governance standards. The Board sets 
the tone of the Company with regard 
to our governance framework.

Our governance framework 
underpins good governance practices 
and enables the Board to provide 
effective stewardship of the Company. 
It drives the highest levels of business 
standards and best practices, aligning 
these with Bodycote’s business 
purpose, values, strategy and culture.

The Board assesses and monitors 
culture and looks to obtain useful 
insight through effective dialogue with 
our key stakeholders, taking feedback 
into account in the Board’s decision-
making processes.

The Board understands the benefits  
of annual performance evaluations  
and, in 2023, undertook an internal 
evaluation process. The Board 
discussed the findings of this review, 
with recommendations including the 
review of longer-term strategy,  
applying greater focus to ESG topics 
and their potential role in strategy and 
additional emphasis on succession 
planning. An external evaluation 
process will be conducted during 2024.

Relevant section 172 factors

Decision-making

The Board
(including delegation of authority) 

Decision-making

Engagement

Employees

Customers

Investors

Society/Communities

The knowledge, capabilities, 
expertise and skills of our employees 
are a major part of the Group’s 
intangible value. We work to attract, 
develop and retain the best talent, 
equipped with the right skills for the 
future. Our people have a crucial role 
in delivering against our strategy and 
creating value. Our remuneration 
policies have been designed to 
support the Group’s strategy, in 
alignment with the Company’s 
purpose, values and culture to 
promote the long-term success 
of the organisation.

We provide our services to the 
aerospace and defence, automotive 
and general industrial markets. 
Working closely with our customers, 
and seeking their feedback, we 
are better able to understand their 
evolving needs so we can continually 
improve and adapt to meet them, 
finding solutions to create value and 
improve their overall experience.

Delivering an attractive return 
is a core priority for the Board. 
Our investment proposition builds 
upon our strengths to create value for 
shareholders, with capital rewarded 
through dividends and share price 
increases. We communicate progress 
on our financial and non-financial 
plans to cultivate the support of our 
investors, analysts, banks and proxy 
voting agencies.

We are committed to building 
positive relationships with the 
communities where we operate.

We consult through our plant 
network to better understand 
and manage the social impacts 
of our business and gain valuable 
perspectives on the ways in which 
our activities could impact the local 
community or environment.

£308m

in annual staff costs

>40,000

customers worldwide

£41m

in dividends paid in the year

>165

facilities in 22 countries

20

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Section 172 cross-reference

The Board, in line with its  
duties under section 172 of the 
Companies Act 2006, must act 
in the way it considers, in good 
faith, would most likely promote 
the success of the Company 
for the benefit of shareholders. 
Our Directors must also have 
regard to the likely long-term 
consequences of their decisions, 
and the impact that these may 
have on the Company’s  
key stakeholders.

We believe that by understanding 
what matters to our key 
stakeholders, we are better able 
to secure long-term success 
for the Group. We place a 
strong emphasis on proactive, 
transparent, and open 
engagement with our key 
stakeholder groups, which in 
turn promotes mutually beneficial 
relationships and value.

Further information about how 
these duties have been applied 
can be found throughout this 
Annual Report.

Section 172 duties 

Key examples

Consequences of decisions in the long-term

Interests of employees

Fostering business relationships with suppliers, 
customers and others

Impact of operations on the community  
and the environment
Maintaining high standards of business conduct 

Acting fairly between members 

Strategic progress
Board activities in the year
Financial report
Going concern and viability statements
Principal risks
Chair and Chief Executive statements
Our stakeholders
Sustainability report
Board activities in the year
Our stakeholders
Sustainability report
Board activities in the year
Sustainability report (including TCFD report)

Sustainability report
Corporate governance statement
Shareholder engagement

Page

13, 15-17
20, 57, 59
25-27
27, 33
28-32
10-12
18
35-42
18, 20, 62
10-12, 18
35-42
58-61
35-52

35-42
56
18-20

The table on page 18 sets out our key stakeholder groups and how they were engaged with directly and indirectly by the Board throughout 
the year.

21

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Business review

Bodycote has more than 165  
facilities around the world, which are 
organised into two customer-focused 
businesses: the ADE business 
and the AGI business. 

Our ADE business focuses on aerospace, defence and energy 
customers, who typically operate globally. Our AGI business  
focuses on automotive and general industrial customers. 
These include many multinational companies that tend to typically 
operate on a regionally focused basis and numerous medium-sized 
and smaller businesses, all of which are important to Bodycote.  
Much of the AGI business is locally oriented. 

Strategically we have focused on building customer relationships to 
enable our participation in long-term programmes. Not only do we 
have a competitive advantage as a result of our scale and capabilities, 
but our global reach allows customers to work with us on multiple 
projects simultaneously, making us a valued business partner.

The ADE business 

ADE revenue by market 
sector and geography
£m

Bodycote services all of the major 
manufacturers in the aerospace industry as 
well as a large portion of their supply chains. 

The following review reflects constant currency growth rates  
unless stated otherwise. 

Revenue in 2023 was £355.5m, an increase of 14% (14% at actual 
exchange rates) with strong growth in civil aerospace, oil & gas  
and medical revenue.

Headline operating profit increased to £69.5m (2022: £50.8m), 
and headline operating margin increased to 19.5% (2022: 16.2%)  
and 21.0% excluding the revenue effect of energy-related  
surcharges (2022: 16.9%), reflecting higher aerospace volumes  
as well as improved pricing and operational performance in our  
Surface Technology business. Statutory operating profit increased  
to £63.1m (2022: £44.0m). 

We spent £13.4m on expansionary capital expenditure, with  
significant investment in capacity growth for the North American 
Specialist Technologies business. 

Return on capital employed increased to 15.5% (2022: 11.9%) 
as a result of the improved profitability.

Market sector 

Aerospace and Defence 

Automotive

General Industrial (including energy)

Total

Geography

Western Europe

North America

Emerging Markets  

Total

197.9

13.2

144.4

355.5

185.1

162.8

7.6

355.5

22

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
The AGI business 

AGI revenue by market 
sector and geography
£m

Market sector 

Aerospace and Defence

Automotive

General Industrial (including energy)

Total

Geography

Western Europe

North America

Emerging Markets

Total

16.0

181.4

249.6

447.0

254.6

102.4

90.0

447.0

Bodycote has a long and successful history 
of servicing its wide-ranging customer base. 

Our extensive network of facilities enables the business to offer 
customers the broadest range of capability and security of supply. 
Each of our AGI facilities works with customers to respond with the 
expertise and appropriate service level required, no matter the size  
of the customer’s demand. 

The following review reflects constant currency growth rates  
unless stated otherwise. 

Revenue was £447.0m, an increase of 4% on the prior year 
(4% at actual exchange rates). There was good growth in the first  
half of the year, led by automotive sales in Eastern Europe, with a 
softening in the second half due to weaker industrial end-markets. 

Headline operating profit was £79.3m (2022: £80.8m), and headline 
operating margin declined slightly to 17.7% (2022: 18.7%) and  
19.6% excluding the revenue effect of energy-related surcharges 
(2022: 20.4%), impacted by the low volume levels in the second  
half of the year. Statutory operating profit declined to £77.6m 
(2022: £78.2m).

We spent £14.4m on expansionary capital expenditure,  
with ongoing expansion in Emerging Markets, particularly in  
Eastern Europe and China.

Return on capital employed was broadly stable at 17.8% 
(2022: 18.2%).

23

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
 
Strategic report

Governance

Financial statements

Additional information

A component journey
Rock solid – Drill bits

Erosion in drill bits presents a serious challenge in mining when productivity is crucial. Rotary blasthole 
drills operate in variable ground formations. Bodycote’s carburising treatment increases the wear resistance 
of the drill bit parts, thus extending product life and operating efficiencies. 

The drill bit components begin life 
as casehardening steel forgings.

 The bit legs and 
rollers are machined to 
achieve the design required 
for best performance 
through difficult terrain. 

The parts undergo a painting 
operation to prevent hardening 
the sections which require 
better ductility. 

A 3D printed insert is applied 
as masking to ensure that 
only the unpainted areas  
will be treated in the  
carburising process. 

Carburising increases 
the surface hardness, 
or wear resistance, 
in the drill bit. Oil quench 
immediately follows. 

Before returning the 
parts, Bodycote inspects 
and performs quality checks 
for hardness.

End application, 
rotary blasthole 
drilling rigs.

 Denotes the parts of the component journey undertaken by Bodycote

24
24

Bodycote plc Annual Report 2023

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
 
 
 
 
Chief Financial Officer’s report

 A year of improved margins 

and strong cash generation, 
which further strengthened 
the Group’s financial position.

B. Fidler
Chief Financial Officer

Financial overview

Revenue

Headline operating profit
Amortisation of acquired intangible assets
Acquisition costs
Operating profit 
Net finance charge
Profit before taxation
Taxation charge
Profit for the year

2023
£m

802.5

127.6
(8.1)
(0.3)
119.2
(7.5)
111.7
(24.9)
86.8

 2022 
£m

743.6

112.2
(9.3)
(0.9)
102.0
(6.7)
95.3
(21.0)
74.3

Group revenue increased to £802.5m, growth of 7.9% at actual exchange rates and 8.3% at constant currency. 

Headline operating profit for the year increased 13.7% to £127.6m (2022: £112.2m), representing growth of 16.7% at constant currency. 
This saw the Group deliver further improvement in headline operating margin to 15.9% (2022: 15.1%) reflecting the benefit of increased 
volumes, pricing and improved operational efficiencies. Statutory operating profit increased to £119.2m (2022: £102.0m).

The Group continued to recover cost inflation during the year through a combination of pass through energy surcharges and sustainable price 
increases. Excluding the revenue impact of energy surcharges, headline operating margins rose by 120 bps to 17.3% (2022: 16.1%). 

25

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Chief Financial Officer’s report continued

Net finance charge
The net finance charge increased modestly to £7.5m (2022: £6.7m), 
analysed in the table below:

Interest on loans and bank overdrafts
Interest on lease and pension liabilities
Financing and bank charges
Total finance charge
Interest received
Net finance charge

2023 
£m
(2.7)
(2.7)
(2.9)
(8.3)
0.8
(7.5)

2022 
£m
(2.3)
(1.8)
(3.0)
(7.1)
0.4
(6.7)

The increase in interest charges during the year was driven primarily 
by higher underlying interest rates on the Revolving Credit Facility 
drawings and on leases. These were partly offset by an increase in 
interest received on cash deposits during the year. 

Profit before taxation

Headline profit before taxation
Amortisation of acquired intangibles
Acquisition costs
Profit before taxation

2023 
£m
120.1
(8.1)
(0.3)
111.7

2022 
£m
105.5
(9.3)
(0.9)
95.3

Headline profit before tax increased by 13.8% to £120.1m 
(2022: £105.5m), growth of 17.2% at constant currency. Statutory  
profit before taxation increased to £111.7m (2022: £95.3m).

Taxation
The tax charge for the year was £24.9m (2022: £21.0m). The headline 
tax rate for the Group was 22.5% (2022: 22.3%), before accounting 
for amortisation of acquired intangibles, acquisition costs and 
exceptional items. This was in line with our expectations. The Group’s 
overall tax rate reflects the blended average of the tax rates in the 
jurisdictions around the world in which the Group trades and 
generates profit. Looking ahead, the headline tax rate is expected to 
moderately increase over the next few years mainly due to growth in 
the US business and an increase in the UK corporate tax rate.

The effective statutory tax rate was 22.3% (2022: 22.1%). 
Provisions of £26.4m (2022: £28.1m) are carried in respect of  
potential future additional tax assessments related to ‘open’  
historical tax years. Note 6 of the consolidated financial statements 
provides more information.

The OECD Pillar II proposals for a global minimum tax rate are 
applicable to the Group from 1 January 2024. The changes are not 
expected to have a material impact on the Group’s tax charge in 2024.

Earnings per share
Basic headline earnings per share rose 13.3% to 48.4p (2022: 42.7p) 
as a result of the higher headline operating profit. Basic earnings per 
share for the year increased to 45.1p (2022: 38.6p). Note 8 of the 
consolidated financial statements provides further details of the basis 
of these calculations.

Profit before taxation
Taxation charge
Profit for the year
Basic headline EPS 
Basic EPS

26

2023 
£m
111.7
(24.9)
86.8
48.4p
45.1p

2022 
£m
95.3
(21.0)
74.3
42.7p
38.6p

Return on capital employed
Return on capital employed rose by 150 bps in the year to 14.8%  
from 13.3% in 2022. The increase reflected improvement in headline 
operating profit together with the Group’s ongoing discipline over 
capital expenditure projects, focused on delivering the Group’s 
strategy and driving attractive returns.

Cash flow

Headline operating profit
Depreciation and amortisation
Other, including impairment and profit  
on disposal of PPE
Headline EBITDA1
Net maintenance capital expenditure
Net working capital movement
Headline operating cash flow
Restructuring
Financing costs, net
Tax, net
Free cash flow
Expansionary capital expenditure
Ordinary dividend
Acquisition spend
Own shares purchased less SBP and others
Reduction in net debt
Opening net debt
Foreign exchange movements
Closing net debt
Lease liabilities
Net cash/(debt) excluding lease liabilities 

2023 
£m
127.6
74.0

(2.7)
198.9
(57.7)
(1.7)
139.5
(1.6)
(6.4)
(9.0)
122.5
(27.8)
(40.6)
(0.1)
(8.1)
45.9
(99.4)
1.8
(51.7)
64.3
12.6

2022 
£m
112.2
74.9

3.0
190.1
(52.2)
(25.3)
112.6
(7.4)
(5.8)
(15.4)
84.0
(22.1)
(38.5)
(0.9)
1.7
24.2
(116.4)
(7.2)
(99.4)
66.0
(33.4)

1   Refer to page 153 of the Annual Report for a reconciliation of operating profit to 

Headline EBITDA.

Improving cash flow conversion has been a significant focus during 
2023 and reflecting this, cash generation improved materially in the 
year. Headline operating cash flow rose to £139.5m (2022: £112.6m), 
as a result of higher headline operating profit and improved working 
capital control through better receivables collection. Headline  
operating cash flow conversion improved to 109% (2022: 100%). 
The statutory measure, net cash from operating activities, rose to 
£191.6m (2022: £142.9m).

The Group generated a strong increase in free cash flow to  
£122.5m (2022: £84.0m) for the year with free cash flow conversion  
of 96% compared to 75% for 2022. Net tax payments in 2023 were 
£9.0m (2022: £15.4m) with the reduction reflecting receipt of tax 
refunds relating to prior years. 

Closing net debt was £51.7m (2022: £99.4m). Excluding lease 
liabilities, the Group moved from a net debt position in the prior year 
of £33.4m to a net cash position of £12.6m, an improvement of 
£46.0m. This improved balance sheet position was achieved after 
paying £40.6m of dividends to shareholders and deploying £13.2m  
for the purchase of 2 million shares for the Employee Benefit Trust to 
satisfy future share-based payments under the Group’s share incentive 
schemes (at an average price of £6.61).

Going forwards from 2024, the Group will amend its definition  
for both headline operating cash flow and free cash flow to  
include expansionary capital expenditure as well as maintenance 
capital expenditure. This will better align the Group with normal 
market practice. 

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Expansionary capital expenditure
The Group invested £27.8m (2022: £22.1m) in expansionary capital 
projects. Over 80% of the expansionary spend was deployed in our 
strategic focus areas of Specialist Technologies, Emerging Markets, 
civil aerospace and electric vehicles.

Total capital expenditure in the year (including both maintenance and 
expansionary) was £85.5m (2022: £74.3m). The Group remains 
committed to maintaining its assets to the highest standards of  
quality and safety.

Dividend and dividend policy
The Group has a long and stable track record of dividend growth and 
aims to pay ordinary dividends so that dividend cover will be at or 
above 2.0 times earnings on a ‘normalised’ multi-year basis. 

In line with this policy, the Board has recommended a final dividend  
of 16.0p (2022: 14.9p), bringing the full year dividend to 22.7p 
(2022: 21.3p). The interim dividend of 6.7p, approved by the Board on 
27 July 2023, was paid on 10 November 2023 to shareholders on the 
register at the close of business on 6 October 2023. Subject to 
shareholder approval at the 2024 AGM, the final dividend will be paid 
on 6 June 2024 to shareholders on the register at the close of 
business on 26 April 2024. 

Borrowing facilities
The Group is financed by a mix of cash flows from operations, 
short-term borrowings and leases. The Group’s funding policy aims  
to ensure continuity of financing at a reasonable cost, based on 
committed and uncommitted facilities and loans to be procured from 
several sources over a spread of maturities. The Group continues to 
have access to committed facilities at competitive rates and currently 
deems this to be the most effective means of long-term funding. 
At 31 December 2023, the facility was drawn as follows:

Facility
Revolving Credit 
Facility

Expiry 
date
27 May
2027

Facility 
£m

Facility 
utilisation 
£m

Facility 
headroom 
£m

250.9

32.1

218.8

Post balance sheet events – acquisition  
and share buyback
Bodycote announced completion of the acquisition of Lake City  
in January 2024 for total gross consideration of £52.2m on a cash  
and debt free basis, which was settled through the Group’s existing 
cash balances and borrowing facilities.

Reflecting the Group’s strong financial position and demonstrating a 
disciplined and balanced approach to capital allocation, Bodycote also 
announced in January 2024 its intention to launch a share buyback 
programme of up to £60m. This will commence on 15 March 2024.

Alternative performance measures
Bodycote uses alternative performance measures such as revenue 
excluding surcharges, organic revenue, headline operating profit, 
headline operating margin, headline operating margin excluding 
surcharge revenue, basic headline earnings per share, headline profit 
before taxation, headline operating cash flow, headline operating cash 
conversion, free cash flow, free cash flow conversion, net debt and 
return on capital employed together with current measures restated at 
constant currency. The Directors believe that these assist users of the 
financial statements to gain a clearer understanding of the trading 
performance of the business, allowing the impact of restructuring and 
reorganisation activities and amortisation of acquired intangible assets 
to be identified separately. These alternative performance measures 
can be found on page 152.

Going concern
As described on page 104 of the consolidated financial statements, 
the Directors have formed a judgement, at the time of approving the 
financial statements, that there are no material uncertainties that cast 
doubt on the Group’s going concern status and that it is a reasonable 
expectation that the Group has adequate resources to continue in 
operational existence for at least the next 12 months. In making this 
judgement, they have considered the impacts of potential severe but 
plausible consequences arising from the Group’s activities. For this 
reason, the Directors continue to adopt the going concern basis in 
preparing the consolidated financial statements. 

In addition to the Revolving Credit Facility, the Group also has access 
to an additional committed facility of £9.7m (£0.2m drawn) bringing 
total committed facility headroom to £228.3m at 31 December 2023 
(2022: £185.8m).

B. Fidler
Chief Financial Officer 
15 March 2024

27

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Principal risks and uncertainties

Emerging risk
Bodycote’s emerging risk identification process is based on horizon 
scanning. Each emerging risk is assessed based on its potential 
impact on the Group on a high, medium or low rating across three 
time horizons: 0-2 years; 2-5 years; and more than five years. 

This process takes place alongside the annual risk review, with 
emerging risks being considered in facilitated risk workshops 
conducted with the Executive Committee. This review helps to ensure 
that any new and emerging risks are appropriately identified and 
ensures close monitoring of any emerging risks to ensure appropriate 
mitigating actions are undertaken. 

The Board has highlighted geopolitical risk, specifically, the 
unpredictable geopolitical landscape and the uncertainty over future 
global events as an emerging risk. If tensions in the geopolitical 
landscape result in the implementation of aggressive trade barriers 
that reduce the movement of goods, this could result in customers 
shortening their supply chains and moving them closer to their main 
production locations. The emerging risk is mitigated by the fact that 
Bodycote has a global network of sites which allow us to service 
customers from multiple locations, such that the residual risk 
exposure is not considered significant. 

No additional emerging risks were identified in 2023. The risk of  
global pandemics and their impact on both supply chain issues and 
operations are no longer considered as either an emerging nor 
principal risk for the Group. Bodycote has demonstrated the ability to 
respond to and manage its cost base well through the COVID-19 
pandemic. Additionally, the following two risks are no longer 
considered as emerging and are now included in our principal risks:

1 the acceleration in the transition to electric vehicles  

(markets and customers); and 

2 continued environmental activism and increased focus  

from both regulators and the investment community around 
climate change (environment).

The following tables set out a description of the Group’s principal risks 
and related mitigation measures, as agreed by the Board, and describe 
how these principal risks may affect Bodycote’s ability to deliver its 
strategy. The risk rating sets out the direction of change from 2022. 
Refer to page 14 for further information on our strategic priorities. 

The Board is responsible for the Group’s risk management, 
determining the Group’s risk appetite and ensuring that the Group 
risk process and systems of internal control are robust, continuously 
monitored and evolve to address changing business conditions and 
threats. The Board also provides direction and sets the tone on the 
importance of risk management. The review of financial risk has been 
delegated to the Audit Committee. The Executive Committee has 
taken ownership of specific business risks. Each risk is evaluated 
based on its likelihood of occurrence and severity of impact on the 
Group‘s strategy. Risks are then assessed at both a gross and net 
level, i.e. before and after the effect of mitigation. This approach allows 
the identification and consistent evaluation of significant and principal 
risks, as well as consideration of the effect of current lines of defence 
in mitigation. Internal audit provides independent assurance to help 
ensure that the Group’s risk management, governance and internal 
control processes are operating effectively. The Executive Committee 
also assists in the identification and evaluation of principal risks and 
controls as part of the Group’s risk assessment and risk 
management processes.

An update is provided at every Executive and Audit Committee 
meeting on the Group’s risk activities. A comprehensive review 
of the Group’s current and emerging risks is also presented to, 
and discussed with, the Board in June and December. The Board 
is satisfied that an ongoing process of identifying, evaluating and 
managing the Group’s significant risks has been in place throughout 
2023 and a robust assessment of both the Group’s principal and 
emerging risks has been undertaken. 

Details of the Group’s financial risks (liquidity, credit, interest rate 
and currency), which are managed by the Group’s treasury function, 
are provided in note 18 to the consolidated financial statements. 
The mitigating activities described in this report will reduce the impact 
or likelihood of the major risk occurring, although the Board recognises 
that it will not be possible to eliminate these risks entirely. 

Key events in the year
Inflation has remained at a high level leading to further increases in 
certain of the Group’s input costs, which have been successfully 
recovered through pricing. The Ukraine war continues and geopolitical 
tensions intensified in certain regions of the Middle East during the 
second half of the year. Bodycote has no direct exposure to any of  
the countries involved and has no facilities, customers, or suppliers in 
these territories.

There has been a continued increase in interest rates following the 
aggressive rate rises implemented during 2022 by numerous central 
banks to curb inflation. In the last quarter of 2023, monetary policy 
interventions appear to have eased inflation rates, with many  
central banks indicating that further rate hikes may not be required. 
Bodycote has continued to manage inflationary cost pressures well 
through annual price increases to recover rising labour and other  
costs and the energy surcharge programme, implemented in 2022, 
which has enabled recovery of energy cost inflation in the year.

28

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Risk description

Risk rating 

Mitigation and control

Stable
The high proportion of short-term 
fixed costs in the business means 
that a movement in sales can  
have a significant impact on the 
Group’s profitability. 

High levels of cost inflation exert 
pressure on the Group’s profitability 
if it is not successfully passed on  
to customers. 

The Electric Vehicle market 
continues to grow strongly, driven 
by the general focus on reducing 
global GHG emissions resulting in  
a shift in consumer spending. 

Stable
A number of small and midsized 
HIP vessels have been installed 
by competitors, but investment in 
large HIP vessels has been limited 
to date.

The entrance of new competitors 
could result in the erosion of 
market share with a loss of 
revenue and profitability. 

Stable
Bodycote is committed to 
providing a safe work environment 
for its employees. 

Market and customer risks

Markets
Bodycote operates in 22 countries. 
There is a risk that changes in both 
macroeconomic trends and the 
economic environment will impact 
the end-markets that the Group 
serves, and, consequently, the amount 
of parts that need to be treated.

These events may result in supply 
chain disruptions, rising energy  
prices and labour shortages  
which can escalate inflationary 
pressure on earnings if not passed  
on to customers.

The rate of transition from ICE 
to Electric Vehicles presents both 
a market risk and opportunity to 
the Group. Bodycote needs to 
maintain progress in building 
a strong market position in the 
Electric Vehicle supply chain.

Competitor action
The threat of new and existing 
competitors into one or more of 
the Group’s Specialist Technologies.

Corporate and community risks

Health and safety
The inherent nature of Bodycote’s 
activities and the equipment operated 
presents safety and health risks. 
Bodycote’s operations, if not properly 
managed, could have a significant 
impact on individual employees. 
Furthermore, poor safety and health 
practices could lead to disruption of 
business, financial penalties and loss 
of reputation.

 – Bodycote’s presence in 22 countries servicing 
more than 40,000 customers across a wide 
variety of end-markets acts as a natural hedge 
to neutralise localised economic volatility and 
component life cycles. 

 – Bodycote has demonstrated the ability to 
manage its cost structure in response to 
revenue shocks, supply chain issues and 
significant cost inflation, protecting 
profitability and returns. 

 – Restructuring activities in prior years have 
been aimed at successfully adapting the 
Group’s facilities footprint to respond to 
trends in end-markets in order to mitigate 
pressure on earnings. Bodycote has a long 
track record of passing on cost inflation to its 
customers and has acted quickly in the past 
to ensure that the surge in cost inflation is 
offset by energy surcharges and price 
increases to our customers.

 – Bodycote continues to focus on increasing 

its market share in the Electric Vehicle market 
with further new contract awards during  
the year.

 – The close control of proprietary knowledge. 

 – Expansion in the Group’s offerings to maintain 

the position as supplier of choice.

 – A focus on customer service to ensure that 
satisfied customers have no cause to seek 
alternative suppliers.

 – There are high financial barriers to entry.

 – Well established Group-wide health and safety 
policies ensure continuous improvement of 
safety standards, monitoring and investigation 
of all events.

 – ISO 45001 and ISO 14001 aligned EHS 

management systems overseen by the Group 
Head of EHS and implemented with support 
of divisional environment, safety and 
health teams.

 – Programme in place to focus on reduction 

of incidents which could have a high impact. 

 – Safety compliance audits at all plants at least 

every two years. 

Relevance 
to strategic 
priorities

3

1

4

2

5

2

1

1

Safety and 
Climate Change

2

Capitalising on and investing 
in our Specialist Technologies

3

Investing in  
Emerging Markets

4

Investing in structural  
growth opportunities

5

Driving operational  
improvement

6

Acquisitions

29

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Principal risks and uncertainties continued

Risk rating 

Mitigation and control

Relevance 
to strategic 
priorities

Risk description

Environment

Climate change
As a thermal processing company, 
the Group’s carbon reduction 
strategy is of particular importance 
to stakeholders, both as a potential 
risk and a commercial opportunity. 
Climate change poses a range of 
potential risks, arising from current 
and emerging regulation, technology, 
legal, market, reputational, and 
physical climate risk drivers, 
which could lead to business 
disruption, health risks, loss of 
reputation and financial costs. 

Increasing 
Climate change risk continues 
to rise in prominence in light of 
stakeholders’ expectations, 
changing regulations and reporting 
requirements, and potential 
physical weather-related impacts.

Operational risks

Service quality
The Bodycote brand is reliant on 
the repeatable delivery of parts 
to agreed specification within 
an agreed time period.

There is a risk that Bodycote fails 
to meet the needs of customers 
in terms of quality, delivery, 
innovation and problem-solving.

Stable
The risk of poor quality, poor 
service levels or non-compliance 
with agreed specifications can 
cause serious long-term damage 
to Bodycote’s reputation with 
financial consequences such as 
customer loss or the cost of 
damages or litigation

Contract review
There is risk that parts are not treated 
according to contractually agreed 
specification or additional customers’ 
amendments. 

Stable
Non-compliance with agreed 
specifications or failure to update 
the process at a plant to comply 
with specification changes 
requested by the customer may 
potentially lead to parts being 
rejected or failing, which could 
result in material claims against 
Bodycote with significant 
reputational damage, financial 
penalties and a loss of 
future revenue. 

 – Centre of expertise established to drive 

climate-related activity. Risk and Sustainability 
Committee supports execution of strategy. 

1

 – SBTi-validated Scope 1 and Scope 2 emissions 

reduction target – 28% reduction by 2030. 

 – A climate scenario process established to 
support the identification and mitigation of 
potential risks (see the TCFD report on  
pages 43 to 52). 

 – Climate-related stakeholder communications, 

in alignment with internationally 
recognised standards. 

 – Adherence to the ISO 14001 standard for 

environmental impact management (98%  
of the Group’s facilities are accredited). 
Remediation of contaminated sites continues.

 – Bodycote has stringent quality systems in 

place managed by qualified staff. 

5

 – Quality systems and processes are operated 
within our plants with strong oversight by our 
divisional quality teams. 

 – Where necessary, our plants maintain industry 

relevant accreditations, such as ISO 9001, 
Nadcap and IATF 16949. 

 – Each facility undergoes regular audits 
by quality staff, accreditation bodies 
and customers.

 – Each facility has a robust quality management 
system with regular audits by quality staff, 
accreditation bodies and customers. 

5

 – Bodycote carefully negotiates terms and 
conditions associated with the supply of 
services to its customers, carefully managing 
potential liabilities.

 – Certain potential damages resulting from this 
risk are fully or partially covered through the 
Group’s various insurance policies.

1

Safety and 
Climate Change

2

Capitalising on and investing 
in our Specialist Technologies

3

Investing in  
Emerging Markets

4

Investing in structural  
growth opportunities

5

Driving operational  
improvement

6

Acquisitions

30

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Risk description

Risk rating 

Mitigation and control

Relevance 
to strategic 
priorities

Stable
Should a number of facilities fail 
to maintain their accreditations, 
customers could potentially move 
work to a competitor resulting in 
a loss of revenue to Bodycote. 

Stable
Any significant incident at a site 
could result in the service to 
Bodycote’s customers from the 
affected site being disrupted. 

Stable
Significant periods of equipment 
downtime would impact customer 
service and revenue.

Operational risks continued

Loss of key accreditations
Bodycote is required to maintain 
specific accreditations in order to 
provide heat treatment and thermal 
processing services on parts for 
certain customers.

Failing to keep such accreditations 
would prevent Bodycote from 
delivering services to customers 
in these markets. 

Major disruption at a facility 
Bodycote’s facilities are subject to 
man-made and natural hazards that 
could lead to their potential closure. 
Some business processes are 
inherently risky and there is a 
possibility that a major incident, 
such as a fire or utility outage, 
could occur. In addition, some 
facilities are exposed to natural 
hazards, such as earthquakes, 
flooding and storms.

Machine downtime
Bodycote relies upon its operational 
equipment, across its network of 
plants, being available to meet the 
requirements of its customers. 
Therefore unexpected equipment 
downtime would potentially affect 
Bodycote’s ability to service its 
customers. Moreover, without 
an effective preventative maintenance 
programme there is a risk that 
equipment redundancy plans 
would need to be built into facility 
management in order to cope 
with equipment breakdowns.

 – Each facility has a robust quality management 
system with regular audits by quality staff, 
accreditation bodies and customers. 

5

 – Should a facility fail an accreditations audit 

a remediation plan to fix any non-conformities 
is implemented.

 – Bodycote has a global network of more than 
165 facilities enabling work to be transferred 
to another accredited facility. 

4

5

4

5

 – Business continuity plans are in place  

for all plants. 

 – Independent insurer physical inspections 
of facilities to assess hazard and business 
interruption risks have been conducted 
during the year.

 – Insurance cover, including business 

interruption cover. 

 – Scheduled equipment maintenance 

and inspections. 

 – Bodycote’s global network of more than 

165 facilities creates a framework to provide 
backup capability if required. 

 – Preventative maintenance programmes 

mitigate the risk of downtime occurrence 
associated with major breakdowns ensuring 
business continuity and customer satisfaction. 

 – Spare parts replenishment programme 

ensures efficient maintenance activities occur 
according to plan. 

 – Bodycote’s global network of facilities with 
robust business continuity plans help to 
minimise the impact of equipment downtime 
on customer service. If required, customer 
work can be transferred to another facility 
within the network.

1

Safety and 
Climate Change

2

Capitalising on and investing 
in our Specialist Technologies

3

Investing in  
Emerging Markets

4

Investing in structural  
growth opportunities

5

Driving operational  
improvement

6

Acquisitions

31

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
Principal risks and uncertainties continued

Risk description

Risk rating 

Mitigation and control

Relevance 
to strategic 
priorities

Information technology  
and cybersecurity
The Group relies upon its IT systems, 
including a range of ERP solutions, 
to manage its operations. IT systems 
interruptions could lead to business 
process disruption and interruption 
to key business services.

A cyber attack could result in 
compromised data, theft, manipulation 
or destruction of confidential and 
sensitive information and severely 
disrupt business operations.

Increasing 
There is an increasing global risk 
of sophisticated cyber attacks, 
including ransomware and phishing 
with the complexity of these 
attacks rising. 

A significant failure of IT systems 
as a result of external factors, 
such as a cyber attack, could 
disrupt service to our customers, 
and result in reputational and 
financial loss.

Regulatory risks

Regulatory and legislative 
compliance
The global nature of Bodycote’s 
operations means that the Group  
has to comply with a wide range of 
local and international legislative 
requirements, including modern 
slavery, anti-bribery and anti-
competition legislation, employment 
law and import and export controls. 

The Group also has to comply with 
taxation legislation and the advantages 
associated with the UK’s controlled 
foreign companies that the Group has 
employed in its financing structures. 

Stable
Failure to comply with current and 
new legislation could lead to 
substantial financial penalties, 
disruption to business, diversion 
of management time, personal 
and corporate liability and loss 
of reputation. 

5

5

 – The Group has robust governance processes 

to ensure that IT projects are adequately 
reviewed and approved to ensure that they 
are consistent with the Group’s IT strategy. 

 – Increased focus on IT security management 
processes, including regular testing and 
threat assessments.

 – Increased training and awareness programmes 

are provided for our users.

 – Bodycote maintains a focus on improving 

information security and has well-protected 
data centres supported by effective business 
recovery planning and data backup procedures. 

 – Business processes are supported by Human 
Resources policies and the Group Code of 
Conduct alongside training and 
awareness programmes. 

 – The ‘Open Door Line’ whistleblower facility 

operated by a third-party. 

 – Engagement of specialists (lawyers, 

accountants, tax specialists, trade compliance 
consultants and freight forwarders) to support 
Bodycote at local, divisional and Group levels. 

 – Regular audits of the effectiveness of 

implemented procedures.

 – Regular assessment of the changes required 
to comply with the UK Corporate Governance 
Code and related potential impacts on 
the Group.

1

Safety and 
Climate Change

2

Capitalising on and investing 
in our Specialist Technologies

3

Investing in  
Emerging Markets

4

Investing in structural  
growth opportunities

5

Driving operational  
improvement

6

Acquisitions

32

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
Viability statement

In preparing this statement of viability, the Directors have considered 
the prospects of the Group over the five-year period immediately 
following the 2023 financial year. This longer-term assessment process 
supports the Board’s statements on both viability, as set out below, 
and going concern (on page 27). The Directors have determined that a 
five-year period is an appropriate period over which the business could 
be restructured in the event that any material changes to demand for 
the Group’s services transpired. This period is also consistent with  
that used for the Group’s planning process. As a result, the Board 
determined that a period of longer than five years would not be 
meaningful for the purpose of concluding on longer term viability.

The base case forecasts which underpin this assessment are based  
on the Board approved 2024 budget and the Board approved five-year 
strategic plan. These reflect the acquisition of Lake City and the £60m 
share buy-back, which is assumed to be completed over a 12-month 
period ending March 2025. These projections reflect ongoing growth in 
the Group’s end markets over the forecast period. The performance of 
the Group over the period of the assessment has then been assessed 
against the covenants that exist in the Group’s Revolving Credit 
Facility, as explained on page 27, and the Group’s liquidity.

In conducting the review of the Group’s prospects, the Directors 
assessed the five-year plan alongside the Group’s current position,  
the Group’s strategy and the principal risks facing the Group  
(all of which are detailed in the Strategic Report on pages 1 to 52). 
This assessment included consideration of the principal risks on the 
business model and on future performance, liquidity and solvency and 
was mindful of the limited forward visibility that the Group has as it 
carries limited order backlog. The Directors’ viability assessment 
included a review of the sensitivity analysis performed on the five-year 
financial forecasts. The assessment included two scenarios designed 
to stress-test the Group’s base case forecasts, which were as follows:

 – A plausible downside scenario which assumes a slow-down in the 
global economy, resulting in a fall in 2024 revenues of 12% versus 
2023, and a limited revenue CAGR of only 2% over the five-year 
period, representing a 20% reduction in revenues versus the base 
case over this period. This downside takes account of short-term 
negative shock events which are intentionally more severe than  
those used in the Group‘s goodwill impairment assessment (set out 
on pages 120-122). 

 – A break-case scenario designed to establish the decline in revenues 
required to result in the Group’s liquidity being exhausted or loan 
covenants breached. This scenario shows that 2024 revenues would 
need to fall 30% below 2023 levels, and demonstrate zero growth 
thereafter, before the Group’s leverage ratio covenant is breached  
at the end of the five-year review period. Whilst this scenario is not 
considered remotely plausible, it was designed to stress-test the 
financial resilience of the Group.

In the plausible downside scenario, capital expenditure was  
reduced in 2024 versus the base case and dividends were  
maintained at the same level as 2023. In the break-case scenario 
capital expenditure was reduced in all years, reflecting the reduced 
maintenance capital expenditure required in that scenario due to 
sustained lower equipment utilisation, and the lower levels of  
growth capital expenditure that would be required in this scenario. 
In addition, dividends were reduced significantly. No mitigating  
actions such as restructuring were included.

In the base case and plausible downside scenario, there were  
no breaches to the Group’s covenants, and substantial headroom 
was maintained.

In making this viability statement the Directors considered the  
other mitigating actions (including, but not limited to, cost reduction 
initiatives, further discretionary capital expenditure reduction and the 
reduction of dividends) that may be taken by the Group in the event 
that the principal risks of the company become realised but note that 
none of these actions were modelled in performing the assessment 
since the Group maintained substantial headroom in both scenarios. 
The Directors also took into consideration the Group’s financial 
position at 31 December 2023, with available liquidity of £273.5m  
and a history of strong and resilient cash flow generation. 

Uncommitted facilities were not taken into account in performing the 
assessment. It is noted that the Group’s RCF matures in May 2027, 
before the end of the assessment period, however the Directors have 
a reasonable belief that, based on previous experience and ongoing 
supportive discussions with our lenders, should any debt facility be 
required, the RCF will be able to be refinanced or extended. 

The Directors have assessed the viability of the Group and, based  
on the procedures outlined above in addition to activities undertaken 
by the Board in its normal course of business, confirm that they have  
a reasonable expectation that the Group will be able to continue in 
operation and meet its liabilities as they fall due over the period to 
31 December 2028.

33

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Strategic report

Governance

Financial statements

Additional information

A component journey
Touch down – Landing gear

Safety critical landing gear must perform without fault every time the aircraft flies. A combination of thermal 
processing techniques is used to ensure the material properties are optimised and to protect it during its  
working life. Traditionally, the landing gear has been surface treated using hard chrome plate, but this is 
now being superseded by more environmentally friendly thermal spray processes, which provide extreme 
wear and corrosion resistance. 

Alloy Ti billet is forged 
to shape.

The part is heat treated 
to desired properties.

A thermally sprayed surface 
treatment is applied to replace hard 
chrome plate for improved wear and 
corrosion resistance.

The component is surface 
machined using diamond tools 
due to the extreme hardness 
of the surface finish. 

End application, 
aircraft.

 Denotes the parts of the component journey undertaken by Bodycote

34
34

Bodycote plc Annual Report 2023

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
 
 
Sustainability report

 Bodycote plays an important role in helping customers meet their 

sustainability goals. We are a major enabler of avoided emissions –  
CO2 can be reduced by up to 60% per part when processed by Bodycote. 
Outsourcing to Bodycote also directly reduces customers’ Scope 1  
and Scope 2 emissions. In 2023, we accelerated our work to develop 
digital tools to help customers see opportunities to decarbonise their 
processes, while also taking action to reduce the Group’s own  
carbon footprint in line with our 2030 science-based target.

Delivering our sustainability agenda
The Group has established a clear governance structure to deliver  
its sustainability priorities. The Group’s Executive Committee, led by 
the Group CEO, is ultimately responsible for the execution of the 
Group’s sustainability activity. During the year, the Group appointed  
a dedicated Chief Sustainability Officer to the Committee, who has 
functional responsibility for supporting the definition, execution and 
communication of the Group’s sustainability agenda. The Group CEO, 
and the Chief Sustainability Officer, provide regular updates to the 
Board on sustainability matters, including through dedicated sessions 
at least twice a year. The Group’s Risk and Sustainability Committee 
supports the Executive Committee in coordinating the delivery of 
sustainability goals. It meets at least three times a year.

Bodycote recognises the benefit of incorporating ESG measures in 
executive compensation. ESG metrics are included in the annual 
bonus scheme. 

Communications and ratings 
Bodycote is committed to transparent communication of our 
sustainability policies, actions, and results. Our disclosures align  
to our priority sustainability topics, and stakeholder and regulatory 
expectations and requirements. 

We have augmented our sustainability disclosures this year through 
the publication of a ‘2023 ESG Supplement’ document, available on 
our website. Disclosures within this are aligned with frameworks  
such as the Global Reporting Initiative (GRI) Index, SASB and other 
ESG ratings. 

S.C. Harris
Group Chief Executive

Our approach
Sustainability is integral to our corporate 
strategy and has long been part of our purpose 
through the contribution that our services  
make in reducing industry’s environmental 
impact. Indeed, the Group’s ability to provide 
sustainable, lower-carbon services that  
increase the lifespan of customer components 
is among its greatest opportunities to create 
shared value. 

The Group’s continued progress in managing its own environmental 
impact also delivers significant benefits to the Company itself,  
in lowering energy consumption, operating costs and exposure to 
financial risks.

Our approach to sustainability targets the areas where we have  
the greatest potential to create value for our stakeholders, and is 
underpinned by our emphasis on responsible and ethical business 
conduct. We prioritise the following areas: 

 – Our people: we are focused on fostering a safe, healthy  

environment in which colleagues can thrive and support in the 
delivery of our strategic priorities. 

 – Our customers: Bodycote offers some of the most energy-efficient 
processes available on the market. By using our services, customers 
can achieve significant carbon reductions.

 – Our environment: effective management of climate and 

environment-related issues is key to our operational performance. 
We have set a science-based carbon reduction target for 2030. 

 – Ethical business: we are committed to upholding strong  

governance standards, aligning our approach to key sustainability 
frameworks and standards, and meeting our legal obligations. 

This report provides a summary of the Group’s sustainability 
performance. Additional information is provided in the ‘2023 ESG 
Supplement’, published at the following address: www.bodycote.com. 
The Group’s Task Force on Climate-related Financial Disclosures 
(TCFD) report is on pages 43-52. 

35

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
Sustainability report continued

Our people

The Group’s people strategy is focused on nurturing our employees’ 
passion for their work, while ensuring a safe and healthy work 
environment, and providing opportunities for their ongoing professional 
development. Our culture is rooted in our core values, which apply 
across the Group. In keeping with our philosophy, our values are 
straightforward and focused on what matters most:

 – Honesty and transparency: Bodycote lives by a culture of honest 

and transparent behaviour. Our customers trust us to deliver what we 
say we will, our colleagues trust us to act in their best interests, and 
our suppliers trust us to conduct business according to agreed terms.

 – Respect and responsibility: We manage our business with respect, 
applying an ethical approach to all our dealings and being mindful  
of the impact of our actions. We show respect for our customers,  
our colleagues, our suppliers and the communities around us.

 – Creating value: Creating value is the very essence of our business 

and is the focus of our endeavours. We create value for our 
customers, our employees, and society more broadly. Ultimately,  
we create value for our shareholders, as the owners of our business. 

These values provide a framework for sustainable progress.  
They are reflected in our people policies and systems and in the 
Group’s Code of Conduct. 

Health and safety 
The safety of our colleagues, contractors and visitors is our  
utmost priority. We are committed to continuously improving  
our environmental, health and safety (EHS) performance. 

The Group manages potential hazards and minimises risks to 
employees through the deployment of robust safety management 
systems and procedures. We are committed to complying with all local 
legislative requirements as a minimum. We require all employees to 
accept their responsibility to work safety in line with our global 
Occupational Health and Safety Policy, which sets out our standards 
for safety rules and work procedures, use of safety equipment,  
and contribution to the maintenance of a safe working environment. 
We actively encourage the reporting of near misses, unsafe acts or 
conditions, and ongoing suggestions for improvement.

The Group’s health and safety performance is monitored at least 
monthly as a standing agenda item at Board and Executive Committee 
meetings. It is also the first agenda item for monthly Operations 
performance reviews, chaired by our Group Chief Executive.

Health and safety management 
Bodycote’s EHS management system is aligned with the  
ISO 45001 standard for occupational health and safety. It includes  
a comprehensive suite of EHS Standards that sets out expectations  
for health and safety target setting, procedures and practices  
across the Group.

The Group holds ISO 45001 certification covering 30% of its  
facilities in Europe. External EHS audits are undertaken through  
ISO accreditations at sites where we hold them in accordance with 
the re-certification process. Additional audits and site visits are 
undertaken by Group Internal Audit and members of the EHS team. 
Almost 70 plants in total were audited under the EHS management 
system during 2023 (around 43% of operational sites). All of the 
Group’s operational facilities undergo an internal EHS audit at least 
every two years.

The Group engages employees in health and safety through a range  
of activities. Employees working in our facilities participate in ‘Toolbox 
Talks’ at least twice a month. These cover a wide range of health and 
safety topics including manual handling, hazardous substance disposal 
and mental health management. Employee involvement in Toolbox 
Talks is monitored by the Executive Committee. 

We encourage employees to complete ‘T Cards’ in our facilities if they 
spot a potential health and safety risk or have a suggestion to improve 
safety. We also hold regular safety awareness events as part of our 
colleague engagement activities. Depending on their role, employees 
are required to undertake onsite and online learning courses to ensure 
they display good health and safety behaviours and remain alert to 
potential risks.

Measuring performance 
The Group monitors leading and lagging health and safety metrics  
to track performance and generate insights for improvement. 
We encourage the reporting of all incidents to foster a culture of 
transparency among employees. Performance reports are reviewed  
by management and the Board on a rolling basis, and include all 
incidents that result in injury, as well as incidents that are considered 
to have had the potential to cause a serious impact but where no one 
has been injured. 

36

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Lagging indicators 

The total reportable incident rate (TRIR)1 and lost time injury rate (LTIR) 
are the two key lagging indicators used to track the effectiveness of 
our health and safety practices. TRIR and LTIR rates are calculated in 
line with OSHA (Occupational Safety and Health Administration) 
standards. The TRIR includes all incidents (comprising of injuries and 
illnesses) where there is:

 – Lost time: a worker is not able to work the following day or shift,  

after the day of the incident;

 – Restricted work: a worker is not able to do their usual work due  

to the incident; and/or

 – Medical treatment: a worker requires specialist medical treatment 

(not first aid).

In 2023, the Group recorded a TRIR of 2.8 (2022: 2.5). The LTIR was 
1.5 for 2023, compared to 1.2 in 2022. There was an increase in the 
number of incidents relating to the manual handling of parts, slips, 
trips and falls, and lifting operations, particularly following holiday 
periods after colleagues had been away from the workplace. 
Delivering targeted and timely employee engagement activities 
remains a key area of focus to tackle the occurrence of these sorts  
of incidents. The Group also continued to make investments in manual 
handling and material handling improvements. In 2023, there were  
no fatalities from work-related accidents or ill health among  
Bodycote employees or contractors (nor in any of the last five years). 
See the ‘2023 ESG Supplement’ publication for more information 
about the Group’s EHS management plans. 

Total Reportable Incident Rate1
(TRIR)

0
9
2

.

2
8
2

.

2
5
2

.

7
7
2

.

0
3
2

.

’19

’20

’21

’22

’23

Leading indicators 

Leading indicators are used to measure employee engagement  
and identify opportunities for improvement in health and safety 
performance and compliance. Among these, the Group tracks near 
miss incidents to address risks before they result in accidents. 
There were 356 near misses reported in 2023 (2022: 362). 
Colleagues also identified 2,454 opportunities for improvement in 
2023 (2022: 1,871), showing an encouraging trend in the rate of 
awareness and reporting. 

1  The Group has re-named the ‘TRC rate’, which has historically been reported, as ‘TRIR’ for 

communication purposes only; the calculation of the rate and the basis of preparation of the 
data remains unchanged. TRIR represents the number of reportable cases per 200,000 hours 
worked. Bodycote includes all workers within the tracking and reporting of incidents, whether 
employees or contractors. The LTIR represents the number of lost time injury incidents per 
200,000 hours worked.

Supporting employee health
Bodycote promotes an environment that encourages line management 
to support the health and well-being of all employees. We recognise 
that individuals work best and can achieve high performance over time 
when they are healthy and feel valued.

The Group engages occupational health service providers across all 
locations. These service providers vary by region but typically provide 
health checks; monitoring for employees who may be exposed to  
risks such as noise or hazardous materials; and employee assistance 
programmes (EAPs).

The Group also has a range of initiatives in place to support 
employees’ wellbeing, including through Company-wide fitness 
initiatives that keep employees active. In addition, the Group  
promotes wellbeing through regular internal communications on  
topics such as managing stress and mental wellbeing.

People management 
Bodycote seeks to be a fair employer and promote opportunity and 
equality for all in our efforts to attract, develop and retain a diverse 
range of people. In so doing, we are committed to fostering an 
inclusive and open culture, in which colleagues can thrive and support 
the delivery of our strategic objectives.

Employee engagement 
The Group follows a regular, formal internal communications 
programme to ensure colleagues are kept abreast of important topics. 
We use several channels to support communications, including a 
bi-monthly group-wide newsletter, and weekly news updates on our 
intranet. The Group also publishes important updates via email across 
the Group.

Every year, the Group conducts employee feedback sessions with 
colleagues, hosted by our designated Non-Executive Director for 
workforce engagement. In 2023, around 100 colleagues were 
engaged in feedback sessions, including operational and management-
level employees representing the Group’s key functions and locations 
around the world. See page 56 for further information.

Developing our people 
We are committed to providing the appropriate skills and training to 
allow our employees to operate safely and effectively in their roles and 
deliver results. Bodycote invests in the training and development of  
its people at local and Group levels. Employee training is delivered 
through a variety of means, including through interactive online 
training modules, face-to-face workshops, and hands-on training  
in facilities. The Group also encourages cross-functional and cross-
divisional information sharing to support peer-to-peer learning.

Colleagues joining the business in office-based Group functions and 
plant-based managerial functions typically undertake at least five  
hours of induction training, including on a core set of mandatory 
compliance topics. During the year other colleagues are required to 
undertake refresher training in mandatory topics such as those  
related to compliance and security and cyber awareness, for example. 
Training completion rates for employees in-scope are reported  
to the Executive Committee, with appropriate escalation for any 
training not completed on time.

The Group recognises the importance of supporting employees  
in maintaining a good work-life balance, as part of our talent 
management strategy. As part of this, in 2022 the Group introduced a 
Remote Working Policy. All eligible office-based employees can work 
from the office three days a week, and from home for the remainder 
of the week. The policy applies across the Group’s offices globally. 

37

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
Sustainability report continued

Ethnic diversity 
Bodycote meets the Parker Review target for all FTSE 250 boards to 
have at least one member from an ethnic minority, with two members 
who meet the ONS classification of Asian/British Asian and mixed/
multiple ethnic groups, respectively. Further information regarding  
the gender balance and ethnic backgrounds of the Group’s Board  
and executive management team in accordance with LR 9.8.6 R(9) 
and (10) is provided on page 63. 

Employment practices 
Bodycote believes all colleagues should be appropriately rewarded for 
contributing to our success. We review wage levels and employment 
practices against local standards and conduct a pay review process 
annually, providing a regular opportunity to consider awards of pay 
increases. Bodycote is committed to complying with all applicable 
local and national minimum wage regulations at a minimum. 

The vast majority of our people are employed by permanent or 
fixed-term contracts. As at 31 December 2023, 92% of our workers 
were permanently employed by the Company, with the remainder 
employed on temporary contracts. The Group typically employs 
temporary workers to supplement our permanently employed 
workforce during busy periods in the operation, when there is a 
requirement for flexible resource to fill vacancies, or to support 
special projects.

Our permanently employed staff are provided with a range of benefits, 
including paid holiday and life insurance, normally immediately upon 
joining but in some cases after a certain time. We also offer tuition 
reimbursement schemes for colleagues participating in professional 
development courses. 

Freedom of association 
Bodycote upholds employees’ freedom of association and  
recognises their right to collective bargaining. We are committed  
to open and constructive engagement with our employees and  
their representatives. Around 36% of the Group’s employees are 
represented by unions and works councils. Where collective 
bargaining agreements are in place, they cover topics such as holiday 
entitlement, working hours, paid and unpaid absence, grievances,  
and local workplace changes. 

See the ‘2023 ESG Supplement’ publication for more information 
about the Group’s workplace practices at: www.bodycote.com.

Diversity, equity and inclusion 
Bodycote recognises the value of a diverse and skilled workforce and 
is committed to creating and maintaining an inclusive and collaborative 
workplace culture. We regularly review our recruitment and working 
practices to identify how we can continue to attract and retain a 
diverse workforce. 

Our Equality, Diversity and Inclusion Policy outlines our stance on 
maintaining equal opportunities and giving full, fair and impartial 
consideration to all employment applicants. Recruitment, training, 
reward and career progression are based purely on merit. We embrace 
a culture of acceptance and inclusion, accommodating part-time,  
agile and flexible working requests where appropriate. As set out in 
the Group’s Equality, Diversity and Inclusion Policy, harassment of  
any kind is not tolerated.

Bodycote supports employees with policies that fortify our culture  
and Core Values. Our policies comply with all current legislation to 
engender equal opportunity irrespective of age, race, gender,  
ethnic origin, nationality, religion, health, disability, marital status, 
sexual orientation, political or philosophical opinions or trade union 
membership as well as military and veteran status in North America. 

Gender diversity
As at the end of October 2023, female representation on the Board 
was 37.5%, up from 33% in 2022, and 38.5% of the Group’s executive 
management were female. Among the Group’s population of senior 
managers, 31% are female (2022: 33%). Across the workforce, 
women represent 21% of employees (2022: 21%). 

The Group’s 2022/23 Gender Pay Gap report showed that the UK 
mean gender pay gap is -8.6% in favour of women, while the median 
gender pay gap is also in favour of women (-6.5%). This compares to  
a UK national median gender pay gap of 14.3%.

2023

Male

Female

2022

Male

plc Board 

5 (62.5%)

3 (37.5%)

6 (67%)

Female

3 (33%)

Executive 
Committee

Senior 
managers 
(Executive 
Committee plus 
direct reports)

8 (61.5%) 5 (38.5%)

5 (56%)

4 (44%)

44 (69%)

20 (31%)

33 (67%)

16 (33%)

Other  
employees

3,793 (80%) 968 (20%) 3,851 (79%) 1,024 (21%)

Total

3,842 (79%) 991 (21%) 3,890 (79%) 1,043 (21%)

38

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
Our customers

Bodycote has an opportunity, and responsibility, to help industry 
disconnect growth from carbon emissions through its services and 
expertise. With increasing pressure on companies to decarbonise 
their activities to meet emissions targets and align with emerging 
legislation, Bodycote plays an important role in helping customers 
to reduce emissions across the entire manufacturing process – 
from services that reduce their direct (Scope 1 & Scope 2) emissions, 
indirect emissions (Scope 3) and solutions that avoid emissions 
entirely (Scope 4). 

Efficient thermal processes for reduced carbon 
Sustainability considerations – and carbon reduction in particular –  
are continuing to increase in importance to our customers. 
By outsourcing to Bodycote, customers can reduce the carbon 
footprint of the products they manufacture. Bodycote’s optimised  
thermal processing services typically uses less energy compared with 
customers’ in-house processes. This enables a significant reduction 
in emissions associated with energy consumption, as well as process 
gases and other consumables. 

Bodycote recently demonstrated the positive impact of our services 
on carbon reduction for one of our large customers. Bodycote  
processes the customer’s parts in over 40 facilities around the world. 
Over the past few years, sales volumes to the customer have 
increased, yet carbon emissions have decreased – illustrating our 
success in disconnecting growth from carbon emissions. We were 
able to demonstrate that since 2019, we have been able to decrease 
CO2e emissions by 47% per part processed. Our ability to provide 
this data strengthens relationships with customers, while generating 
useful insights for the continued refinement of our service offerings 
for positive environmental impact. 

Digital tools for customer carbon calculations
The Group developed a digital carbon calculator in 2023, which 
quantifies the carbon footprint of customers’ thermal processing 
compared to Bodycote’s services for the same process. The tool uses 
a range of input data – such as the type of furnace, number of parts 
processed per cycle, processing time, and type of processing gas 
used – compared with ‘real world’ data inputs from Bodycote’s own 
operations, tailored to the Bodycote facility and equipment type that 
the customers’ parts would be processed in. The results show 
the difference in the carbon footprint of having parts processed 
in our facilities, compared with customers treating them in theirs. 
Bodycote can reduce emissions associated with thermal processing 
by up to 60%, compared with customers’ in-house processes. 

As customers increasingly request data from Bodycote to input into 
their product carbon footprint calculations and product lifecycle 
analyses, Bodycote is also developing a tool to automate these sorts 
of calculations. Our new digital tools will enable the Group to provide 
accurate input data for customers’ calculations for different services 
offered by the Group. 

up to 60%

Bodycote can reduce emissions 
associated with thermal processing 
by up to 60%, compared with 
customers’ in-house processes.

Driving the green energy transition
As set out on page 13, in 2023, Bodycote began work on a major  
new multi-year contract to provide low-carbon heat treatment for 
automotive parts destined for hybrid vehicles. Bodycote is providing 
heat treatment services for a number of parts in the vehicles’ driveline 
system. The win marked another key milestone in the Group’s efforts 
to transition customers into adopting newer, lower-carbon heat 
treatment technologies. 

Instead of quoting for services using traditional processing methods, 
Bodycote proposed low pressure carburising (LPC) for the customer’s 
parts. This technology uses electricity, as opposed to gas, to enable  
a continuous reduction in products’ carbon footprint as the grid 
becomes increasingly decarbonised over time.

Most significantly, LPC enables a vast reduction in the amount 
of energy required to achieve the same metallurgical properties for 
a product. It cuts processing time by around 20% and the amount 
of energy required by 50%. Process gas – needed to achieve 
carburisation – is also reduced by 99% in LPC technology.

Through the application of our specialist knowledge and expertise  
in this area, Bodycote successfully transitioned the customer to 
a process that will enable them to achieve significant emissions 
avoidance and provide low carbon revenue growth for Bodycote 
at the same time. 

Coatings with lower environmental impacts 
Bodycote’s Surface Technology business provides High-Velocity 
Oxygen Fuel (HVOF) coatings for materials such as metals, alloys, 
ceramics, plastics, and composites. HVOF is an advanced thermal 
spray coating technique that uses a high-speed stream of oxygen 
and fuel gas to propel molten particles onto a substrate surface 
to create a dense, tightly bonded coating with excellent adhesion 
and high-quality mechanical properties. 

Importantly, HVOF coatings provide a viable substitute for hexavalent 
chrome. Also known as chromium (VI), hexavalent chrome has been 
widely used in industry for corrosion resistance and durability. 
However, its toxicity poses significant risks to human health and the 
environment and it is therefore subject to strict restrictions under  
the EU’s Registration, Evaluation, Authorisation, and Restriction of 
Chemicals (REACH) regulation. 

HVOF coatings technology offers a REACH-compliant alternative  
while exceeding customers’ specified performance requirements and 
minimising environmental impacts in a wide range of applications, 
including aerospace, automotive, and other manufacturing industries. 
Bodycote is collaborating with customers to drive uptake of  
HVOF coatings, to enable them to enhance workplace safety,  
reduce environmental contamination, and contribute to a more 
sustainable future.

39

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Sustainability report continued

Our environment

Bodycote offers some of the most energy-efficient processes available 
on the market, delivering energy and emissions reductions to provide 
benefits to our customers, the Group, and the wider environment. 

As well as being integral to our commercial offering, effective 
management of climate and environment-related issues is key to  
the Group’s operational performance. Through this, the Group 
manages its costs and exposure to risks, while minimising its 
consumption of resources and environmental impacts.

Energy and GHG emissions performance 
Bodycote has set a target to reduce absolute Scope 1 and 2 GHG 
emissions by 28% by 2030, compared with 2019 (market-based). 
This target has been validated by the Science Based Targets initiative 
(SBTi). At the end of 2023, the Group’s emissions were 24% below 
2019 levels (market-based). Emissions reductions are driven through 
energy efficiency programmes and decarbonisation initiatives. 

The Group’s absolute Scope 1 and 2 emissions reduced by 2% 
year-on-year (location-based). This reduction was mainly driven by 
lower gas consumption compared with the prior year (4.7% lower). 
Electricity consumption also reduced, however electricity-related  
CO2e emissions (Scope 2 location-based) remained similar to the prior 
year due to an increase in the carbon intensity of electricity grids in 
most of the Group’s countries of operation. The Group also continued 
to improve its emissions intensity in 2023, which reduced by 7% 
compared with 2022.

Energy consumption (kWh) reduced by 4.1% in 2023 due to  
avoidance and efficiency measures. The Group’s energy intensity 
(kWh/£m revenue) reduced by 9% year-on-year, demonstrating 
significant progress in reducing energy consumption while growing 
revenues. We estimate that at least 20% of the Group’s electricity 
consumption comes from renewable sources. 

Emissions reduction programme
We are delivering a programme of energy saving and efficiency 
measures and climate-related investments in technology to achieve 
our SBTi target. Our capital investment programme is overseen by  
the Executive Committee. The Group’s portfolio of climate-related 
initiatives includes the following: 

 – Increasing furnace capacity

 – Optimising heat treatment cycles 

 – Improving furnace insulation

 – Minimising occurrence of air and process gas leaks 

 – Reducing energy consumption of lighting 

 – Reducing process gas consumption

 – Reducing furnace pumps’ energy consumption

 – Improving buildings’ heating and cooling systems

The Group also works to embed climate-related considerations within 
existing business processes. For example, all capital investment 
decisions include sustainability reviews to ensure alignment with  
the Group’s SBTi commitment. 

CO2e emissions intensity 
(tCO2e/£m)

Scope 1

2023

2022

 (£m sales 
at actual 
exchange 
 rate)

 (normalised
to constant
currency
 rate)

 (£m sales 
at actual 
exchange 
 rate)

 (normalised
to constant
currency
 rate)

182.6

184.2

201.2

202.9

Scope 2 (location-based)

178.1

179.7

187.1

188.7

Scope 1 + Scope 2 total 

360.7

363.9

388.3

391.6

Energy consumption 
(kWh)4

2023 

% change 
in 2023

2022

Scope 1 Natural gas 

604,863,999  634,423,226 

-4.7% 

Other (LPG, fuel 
oils, diesel, petrol)

31,384,309 

32,508,292 

-3.5% 

CO2e emissions (ktCO2e)2,3

2023 

2022

% change 
in 2023

2019

Scope 2 Electricity

481,577,516  498,776,796 

-3.4% 

Scope 1 CO2e emissions 

134.3 

140.3 

-4.3% 

170.2

131.0 

130.4 

+0.5% 

186.4 

145.5 

136.2 

+6.8% 

198.7 

265.3 

270.7 

-2.0% 

356.6

279.8 

276.5 

+1.2% 

368.9 

Scope 2 CO2e emissions 
(location-based)

Scope 2 CO2e emissions 
(market-based)

Total Scope 1 + Scope 2 
(location-based) 

Total Scope 1 + Scope 2 
(market-based) 

Total CO2 emissions (ktCO2e)

.

6
6
5
3

.

5
4
9
2

.

9
4
8
2

.

7
0
7
2

.

3
5
6
2

’19

’20

’21

’22

’23

40

Total energy  
consumption (kWh) 

1,117,825,824  1,165,708,314 

-4.1% 

Scope 3 emissions
The Group’s Scope 3 footprint does not currently meet the materiality 
threshold under the SBTi framework to require a science-based 
emissions reduction target (under SBTi criteria, if a company’s Scope 3 
emissions are 40% or more of total scope 1, 2, and 3 emissions,  
a Scope 3 target is required). As such, we are not currently reporting 
our full Scope 3 footprint. However, we continue to keep this under 
review. See page 51 in the TCFD report for further information. 

2  Statutory carbon reporting disclosures required by the Companies Act 2006. The boundary for 

reported data has changed materially once in the last five years, following the Group’s 
acquisition of Ellison Surface Technologies in 2020. Historical data reported at that time was 
also restated to incorporate Ellison Surface Technologies’ CO2e emissions to provide 
comparable data across reported years. In addition, as part of the Group’s preparations for 
setting an SBTi emissions reduction target, there were minor changes to the boundary in 
2022 to incorporate all relevant emissions from refrigerants, fuel oil and transportation and 
this was reflected in 2022 and all prior years’ data reported at that time. During 2023, the 
Group continued to refine the emissions calculation methodology in line with best practice. 
This methodology has been applied to reported data for 2023 and the prior four years 
presented here.

3  The Group’s emissions calculation methodology is provided in the document (‘2023 ESG 
Supplement’) published on our website at the following address: www.bodycote.com

4  Energy consumption data for prior years has been restated to reflect consumption as actual 

data has become available.

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
Long-term emissions strategy 
Bodycote supports the aims of the Paris Agreement and recognises 
the importance of aligning the Group’s emissions reduction strategy 
with global net zero goals. Our first step has been to set and drive 
progress towards a near-term science-based emissions reduction 
target. We recognise the requirement to develop a longer-term 
transition plan. See the TCFD report for more information about our 
climate strategy.

Environmental management
Bodycote’s Environmental Policy applies to all sites worldwide and 
sets out the Group’s minimum standards for environmental 
management. It is publicly available on our website and describes the 
steps taken by the Group to continuously improve performance and 
prevent adverse impacts. Bodycote holds all necessary and relevant 
environmental licences and permits in each of the countries in which 
we operate. We are committed to complying with legislative 
requirements at a minimum.

The Group’s environmental management system is aligned to the 
international ISO 14001 standard. As at the end of 2023, 98% of  
the Group’s operating facilities had achieved or maintained ISO 14001 
certification, covering 82% of the Group’s employees. 

The Group’s approach to energy management is aligned to the  
ISO 50001 Energy Management Systems Standard. The Group holds 
ISO 50001 certification in several countries, covering 18% of  
operating facilities. Through this, the Group drives a consistent energy 
management approach and meets the Energy Efficiency Directive 
2012/27/E.U. requirements. The Group’s UK operations are compliant 
with the directive through the Energy Savings Opportunity Scheme. 

Bodycote’s UK footprint
In accordance with the Streamlined Energy and Carbon Reporting 
(SECR) reporting requirements, emissions and energy consumption 
relating to the Group’s UK business operations are identified 
separately in the below table. 

Energy consumption in the Group’s UK operations was almost the 
same year-on-year up 0.3% in 2023; however related carbon emissions 
increased by 4.3% compared with 2022 due to a significant change in 
UK GHG conversion factors for electricity in 2023. 

Bodycote’s UK sites (facilities and offices)5 

2023

2022

 CO2e
emissions
(tonnes CO2e)

 Energy
consumption
(kWh)

 CO2e
emissions
(tonnes CO2e)

 Energy
consumption
(kWh)

4,250.0  19,988,786 

4,201.0  20,009,506 

7,768.0  37,664,091 

7,325.0  37,514,076 

13.2 

54,627 

9.7 

39,253 

12,031.2  57,707,504 

11,535.7  57,562,835 

Scope 1

Scope 2

Scope 3 

Total 

5  Electricity and fuel consumption information is collected from each facility on a monthly basis. 
Scope 3 includes business road travel in vehicles not owned by the Company. Scope 3 is 
calculated from mileage and vehicle type. The DEFRA conversion factors are then applied to 
calculate the total tonnage of CO2e produced.

6  Normalised water consumption is a thousand m3 per £m sales using closing exchange rates  
at 31 December 2023. Water consumption data for prior years has been restated to reflect 
consumption as actual data has become available.

Water use 
Although the Group’s processes are not water intensive by design,  
we recognise that water is a scarce resource and are determined to 
safeguard it wherever possible. In 2023, the Group withdrew around 
817,533m³ of water, 8% less than in 2022. Water intensity (water 
withdrawal m3/£m sales) reduced by 13% compared with 2023. 
While the vast majority of water withdrawn is subsequently 
discharged, some is lost through evaporation. This is an area of  
focus as part of our efforts to minimise water use.

During the year the Group completed improvements to the cooling 
process for heat treatment furnaces. Previously these furnaces were 
supplied with water from cooling towers, where water was lost 
through evaporation. These were replaced by new adiabatic cooling 
systems, which are a closed-loop technology that reduce water losses 
through evaporation, as well as the amount of energy required for the 
cooling process. We initiated installation of eight of these systems in 
2023 to reduce our environmental impacts and operational costs,  
and improve efficiency. 

All water is supplied by relevant municipal suppliers and re-used  
and recycled extensively within our operations. When water from  
our operations is discharged by the Group, it is controlled using 
interception tanks. These allow water to be checked for contaminants 
and ensure it is acceptable prior to final discharge. Audits confirm that 
the Group’s control methods are in line with ISO 14001:2015 to ensure 
compliance with legal obligations. 

Water use (m3)

Total water withdrawn

817,533 

884,027 

Water intensity (m3/£m)

1.12 

1.28 

2023 

2022

% change  
in 2023

-8%

-13%

Water intensity
(thousand m3/£m sales normalised6) 

7
4
.
0 1
3
.
1

6
3
.
1

8
2
.
1

2
1
.
1

’19

’20

’21

’22

’23

Waste management 
Bodycote seeks to minimise waste produced across its locations. 
The Group typically re-uses the same packaging or containers that 
customer parts arrive in when returning them to customers. 
This practice helps avoid unnecessary waste, while providing 
efficiency for our customers. As a result, Bodycote minimises the 
amount of operational waste produced. Any waste that is created is 
segregated into different waste streams as appropriate and disposed 
of in accordance with local legislation. Chemicals and hazardous waste 
are stored separately and handled in accordance with legislative 
requirements. All hazardous waste is disposed with special care by 
licensed and authorised contractors in accordance with the applicable 
environmental legislation. 

41

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
Sustainability report continued

Ethical business

The Group strives to meet high standards of ethical and responsible 
behaviour in the way we conduct business. We have a robust 
governance structure to support business ethics, and a series of 
policies that detail our Group wide commitments and standards. 

Our Code of Conduct sets out our policy on compliance with 
legislation, child labour, anti-slavery and human trafficking, trade 
sanctions and conditions of employment, health, safety, and the 
environment. The Group prohibits forced, compulsory and underage 
labour and any form of discrimination based on age, race, gender, 
ethnic origin, nationality, religion, health, disability, marital status, 
sexual orientation, gender reassignment, pregnancy, and maternity  
or paternity, political or philosophical opinions or trade union 
membership. Appropriate mechanisms are in place to minimise  
the potential for any contravention of these rules.

We require employees to undertake training in our key policies to 
reinforce our expectations and mitigate our exposure to risks. 
This training is refreshed every three years. 

Anti-bribery and corruption
The Group provides interactive online training courses on Bribery 
Prevention, Data Protection, Failure to Prevent Tax Evasion, the Group 
Authority Matrix, and Competition Law. As at 31 December 2023,  
the completion rate for all interactive courses was 97% among 
relevant employees. 

In line with our ethos, Bodycote aims to win business in a high-value 
manner. The Group does not employ unfair trading methods and it 
competes vigorously, but fairly, within the requirements of applicable 
laws. Employees are prohibited from giving or receiving any gifts or 
donations. Bodycote does not make political donations.

Responsible supplier management 
Bodycote’s Supplier Code of Conduct sets out the minimum 
sustainability, environmental and social standards the Group expects 
its suppliers to adhere to, including those relating to the protection 
and promotion of human rights. We stipulate that we expect suppliers 
to communicate Bodycote’s values and expectations to their 
employees, as well as their own suppliers. This policy is supplemented 
internally by our Sustainable Procurement Policy. This provides guiding 
principles on social, environmental and ethical topics for employees 
involved in procurement activities. 

The Group manages suppliers with respect, honesty and integrity,  
no matter the size of the transaction. We agree fair contracts with 
suppliers and pay them promptly and in accordance with our 
agreed terms. 

Human rights and modern slavery
Bodycote upholds and respects universal human rights. The Group’s 
Human Rights Policy is aligned with the Ten Principles of the UN 
Global Compact, incorporating the United Nations Universal 
Declaration of Human Rights and the International Labour Organization 
Fundamental Conventions. Our policy reaffirms the Group’s 
commitment to freedom of association, the abolition of forced or 
compulsory labour; the elimination of child labour; the elimination  
of discrimination; and a safe and healthy working environment. 
The Group’s Anti-Slavery and Human Trafficking Statement is published 
on our website and reviewed by the Board of Directors annually.

Colleagues working in senior management, human resources and 
purchasing roles are required to complete dedicated Modern Slavery 
Act training, and participate in refresher training, at least every three 
years. Since 2021 over 99% of those colleagues required to undertake 
the training have completed it. We plan to re-train all relevant 
colleagues during 2024. 

Encouraging colleagues to speak up 
The Group’s open and transparent culture encourages colleagues to 
speak up whenever they have a concern, without fear of reprisal. 
We offer a range of channels for colleagues to report suspected 
wrongdoing, including a third-party operated whistleblowing helpline. 
Our ‘Open Door Line’ is open to anyone who wants to report a 
concern in work-related context or in connection with the workplace, 
including employees, contractors, and former employees. We promote 
the helpline via posters in plants and offices, on our intranet 
homepage and on the Group’s website. 

The Board and Executive Committee receive reports about any issues 
raised via the helpline. All reports made in 2023 were investigated and 
resolved without any remedial action necessary.

Community engagement 
Bodycote seeks to play a positive role in the local communities in 
which it operates. We encourage community involvement through 
activities championed by our plants locally. 

In the aftermath of the devastating earthquake that struck in  
February 2023 along the border region of Turkey and Syria, Bodycote 
employees came together to support the Turkish Red Crescent 
Association earthquake appeal. Including Bodycote’s matched giving 
for employee fundraising, we donated more than €70,000 to the 
earthquake recovery efforts. The funds provided vital aid to those in 
communities affected by the earthquake, reflecting Bodycote’s core 
values of respect and responsibility and our employees’ eagerness to 
help the communities in which we operate.

S.C. Harris
Group Chief Executive  
15 March 2024

42

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023TCFD report

Task Force on Climate-related Financial Disclosures Report

Bodycote continued to implement the 
recommendations of the Task Force on  
Climate-related Financial Disclosures (TCFD)  
in 2023, with a particular focus on advancing  
its climate scenario analysis. We conducted 
both qualitative and quantitative scenario 
analysis, including modelling the potential 
financial impacts of climate-related risks and 
opportunities under different scenarios,  
to inform the continued development of our 
climate-related strategy. 

TCFD statement of compliance 
This report sets out Bodycote’s climate-related financial disclosures, 
consistent with the TCFD framework, and in compliance with the 
Financial Conduct Authority (FCA) Listing Rule 9.8.6R(8). The Group’s 
disclosures have been prepared to align with guidance published by 
the Financial Reporting Council (FRC) and FCA. The main disclosures 
are set out in this report, on pages 43-52. There are additional 
disclosures on pages 40 to 41. 

Governance
Climate-related responsibilities of the Board 
Climate-related matters are an integral component of Bodycote’s 
business model and strategy. The Board oversees the management  
of climate-related matters as part of its responsibility to support the 
development of the corporate strategy. The Group Chief Executive 
updates the Board about the Group’s climate strategy and related 
activity at least quarterly. In 2023 the Board agenda included reviews 
of the Group’s SBTi target, climate risk assessment, climate-related 

opportunities integral to the corporate strategy, internal controls  
for the measurement of carbon emissions and climate-
related disclosures. 

The Board monitors the Group’s performance against four financial  
and two non-financial key performance indicators. Non-financial 
indicators include the Group’s absolute Scope 1 and Scope 2 GHG 
emissions (see page 50). The Board and its Committees also consider 
climate-related issues when reviewing annual budgets and as part  
of other business processes, such as authorisation of capital 
expenditures for projects that reduce carbon emissions. 

The Audit Committee supports the Board in providing oversight of  
the Group’s risk management procedures, including how climate and 
environmental risks and opportunities are identified, measured and 
managed. The Audit Committee also oversees the Group’s compliance 
with climate-related reporting requirements. The Remuneration, 
Finance and Nomination Committees have additional responsibilities  
in relation to climate and sustainability topics, as described in the 
diagram below.

Board members’ sustainability experience 
Board members have diverse experience in climate-related issues. 
Examples include:

 – The Group Chief Executive has practical experience in the 

development of SBTi targets, and driving the development and 
implementation of energy and carbon reduction projects. He chaired 
Mondi’s Sustainability and Social and Ethics Committees during his 
tenure as a non-executive director of the company from 2011 to 2021. 

 – Non-Executive Director, Beatriz García-Cos Muntañola has gained 

climate-related experience working in renewable energy and mining 
industries and through her current role as Chief Financial Officer of 
Ferroglobe plc. This includes developing decarbonisation and capital 
expenditure plans, sustainability reporting, and climate regulation  
and risk management.

Governance framework for climate and sustainability topics

Oversight of the Group’s management of its climate agenda, 
as a component of the Group’s business strategy.

Group Chief Executive: responsible for the execution of 
the Group's climate strategy, supported by the Executive 
Committee and the Risk and Sustainability Committee.

PLC Board

Audit Committee
Provides oversight of the 
effectiveness of the risk 
management framework,  
including how climate and 
environmental risks are  
identified and managed.

Remuneration Committee
Responsible for ensuring  
climate-related targets 
are considered for 
appropriate integration into 
remuneration arrangements.

Finance Committee
Consideration of climate-
related issues when reviewing 
and authorising certain 
finance, treasury, tax and 
investment matters, including 
capital expenditure on carbon 
reduction projects.

Nomination Committee
Consideration of candidates’ 
climate-related knowledge  
and experience for new 
appointments to the Board.

Executive Committee
Management of climate risks and opportunities, climate-related target setting, and achievement of targets and objectives.  
Individual members of the Executive Committee also have specific climate-related responsibilities according to their functions.

Risk and Sustainability Committee
Supports the implementation of the strategy and action plans to reduce our carbon footprint, reporting to the Group CEO and Executive Committee.

43

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023TCFD report continued

Climate-related responsibilities of management 
The Group Chief Executive has overall responsibility for the Group’s 
climate strategy. The Chief Sustainability Officer, a member of the 
Executive Committee, supports the definition and coordination of  
the climate strategy. Other members of the Executive Committee  
are responsible for implementing the strategy within their 
respective functions. 

Climate-related topics are a standing agenda item at Executive 
Committee meetings. This now includes review of performance 
against the Group’s key climate-related metrics (see page 50 for 
details). Examples of topics discussed during 2023 include: 

 – Progress towards the Group’s SBTi target and opportunities 

to accelerate. 

 – New carbon-focused customer communications and carbon 

calculator tools.

 – Processes for monitoring customer engagement on climate and 

sustainability topics.

 – Validation of the Group’s processes for calculating GHG emissions.

 – Climate risk and opportunity assessment as part of the Principal Risks 

management process.

The Group’s actions in each of these areas during the year are 
described throughout this report and in the Sustainability Report  
on pages 39-41.

Processes for oversight of climate-related issues 
The Executive Committee oversees processes for climate risk and 
opportunity management. Climate-related issues are considered as 
part of strategy, business planning, risk management and budgeting 
processes. Examples are as follows: 

 – Group strategy – climate-related matters influence the development 
of the Group’s service offering and the formulation of initiatives that 
drive emissions reductions for customers. 

 – Capital investment – all capital investment decisions include 

sustainability reviews to ensure alignment with the achievement  
of the Group’s SBTi commitment.

 – Major plans of action – environmental impacts and opportunities are 

considered as part of decision-making related to our asset and 
property portfolio. 

 – Risk management – climate risk assessment is integrated into our 

formal risk management processes (see pages 30 and 50). 

 – Annual budgets, scenario planning and Going Concern assessments 

– the ability to seize opportunities and mitigate potential climate-
related risks is considered as part of the annual budget process and 
longer-term financial modelling. 

The Risk and Sustainability Committee supports the Executive 
Committee in directing and implementing climate-related initiatives, 
risk management and reporting; and ensuring the sustainability 
strategy is embedded across the Group. See page 50 for 
more information.

Management team responsibilities 
Responsibilities of individuals: 
 – Group Chief Executive: overall responsibility for the Group’s  

climate-related strategy. 

 – Chief Financial Officer: evaluating potential financial impacts of 

climate-related risks and opportunities, including those considered  
as part of scenario modelling and stress testing. 

 – Divisional Presidents: managing climate-related topics in the 

operations, including in relation to employees, assets and property, 
implementing carbon reduction projects; developing new business  
to support customers’ climate-related goals. 

 – Chief Sustainability Officer: developing the Group’s climate strategy 

and targets, and monitoring and communicating progress. 

 – Chief Marketing Officer: developing marketing materials to drive 

awareness of the Group’s services and tools to support customers’ 
emission reduction targets. 

 – Other members of the management team: supporting the delivery of 
the climate strategy within their respective areas of responsibility.

Responsibilities of teams: 
 – Group Finance: supporting the assessment of financial impacts of 

climate-related risks, opportunities and investments, and conducting 
scenario modelling. 

 – Group Sustainability: supporting the development and implementation 
of the climate strategy, developing emission reduction pathways and 
targets, and communicating progress. 

 – Group EHS: standardising and implementing data collection 

processes, including for the calculation of the Group’s operational 
GHG emissions and carbon calculator tools. 

 – Group Internal Audit: ensuring climate-related risks and opportunities 
are captured on the Group’s risk registers, and verifying the controls 
for the capture of climate-related data. 

 – Technical Services Operation (TSO): supporting facilities in 

implementing carbon reduction projects and new technologies  
that enable energy and other resource savings.

 – Sales and customer key account teams: engaging with customers 
about their climate-related expectations and goals, and facilitating 
efforts to reduce their emissions. 

 – General managers of sites: day-to-day management of facilities, 
furnaces and other equipment to optimise efficiency and energy 
consumption, with support from the TSO team. 

Climate-related incentives 
Bodycote recognises the benefit of incorporating ESG metrics in 
executive compensation. Climate-related objectives have been linked 
to executive directors’ remuneration for several years. ESG metrics  
are included in the annual bonus scheme. 

44

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023The Group has undertaken a qualitative assessment of all identified 
climate-related risks and opportunities under each of these scenarios. 
The potential impact of several risks has also been quantified where a 
suitable quantification model and data has been available. This has 
been done by estimating their potential impact on both the Group’s 
annual incremental capital outlay and operating expenditure, as well  
as potential annual impacts to revenue in at-risk operating locations. 
The management of risks and opportunities is then prioritised 
according to their potential impact. Risks and opportunities are 
considered to be material when they become sufficiently important 
they could significantly impact our strategy. The Group’s approach  
to climate risk and opportunity quantification is likely to evolve 
going forward.

Physical risks, such as the impact of heatwaves and flooding on 
operations, have been assessed using external data sources. 
These risks were chosen for assessment as they have been identified 
as the most relevant in the Group’s locations of operation. 
Heatwave risk has been assessed using data from the IPCC’s Sixth 
Assessment Report, available through the World Bank Climate 
Knowledge Portal (https://climateknowledgeportal.worldbank.org/). 
Flooding risk (coastal and riverine) has been assessed using the same 
IPCC data source, together with data from WRI Aqueduct Water Risk 
Atlas 4.0. Wildfire risk was also assessed using a combination of IPCC 
data and data from MODIS by NASA4 . Other indicators used were 
extracted from the IPCC’s Sixth Assessment Report. 

The results of the 2023 assessment, presented in the table on  
pages 46-49, indicate that the majority of climate-related risks and 
opportunities remain broadly unchanged from the 2022 assessment. 

Strategy
Climate change has been identified as one of Bodycote’s top strategic 
priorities (see page 14 for the Group’s strategy and objectives) and  
we take a proactive approach to sustainability and energy efficiency 
throughout our operations. Growing awareness of climate change and 
sustainability matters continues to be a catalyst for business growth 
as we provide services and solutions that decrease our customers’ 
energy use and carbon emissions. 

Our proactive energy and emissions reductions initiatives are 
implemented across the Group to improve operational efficiency and 
reduce costs. Importantly, the positive impact of our initiatives extends 
to our customers through our ability to offer lower carbon processing 
services. That is both through our ability to reduce carbon emissions 
when comparing like-for-like technology, and our capability to transition 
customers onto lower carbon technology for their processing needs, 
such as low pressure carburising (LPC), which delivers an even larger 
reduction in energy consumption and carbon emissions. Both of these 
levers reduce carbon for customers and provide a clear competitive 
advantage for the Group. 

Climate scenario analysis
The Group regularly re-assesses climate-related risks and opportunities 
to inform its strategy, financial planning and investments. Senior  
professionals from across the business support the assessment of 
risks and opportunities through dedicated workshops. This process is 
supported by internal and external subject matter experts. 
Outputs from these assessments enable the Group to continually 
adapt, refine and update risks and opportunities and associated 
mitigation or realisation measures.

In 2023 the Group evolved its climate scenario analysis process. 
The Group applied the same time horizons as those used for the 
Group’s Principal risks, where short-term refers to 0-2 years,  
medium-term refers to 2-5 years, and long-term refers to over 5 years. 
While we acknowledge that climate risks tend to present themselves 
in a longer timeframe than other risks evaluated in our Principal Risks, 
the Group has opted to use the same timeframes to integrate climate 
risk assessment more easily into our overall strategy and risk 
assessment. Climate-related impacts were assessed by referencing  
a wider range of scenarios, including a 2°C or lower scenario as 
required under TCFD. The scenarios were modelled based on the 
latest assessment of the Intergovernmental Panel on Climate Change 
(IPCC), as set out below. 

Scenario 1 
(<1.5ºC)1

S1

Scenario 2 
(<2ºC)2

S2

Scenario 3 
(<3ºC)3

S3

Net Zero emissions reached by 
2050 globally
 – Global temperatures are limited to a  
1.5°C increase by 2050 compared to 
pre-industrial levels.

Emissions peak and start falling 
around 2050
 – Policy action is late and disruptive and 

while some steps have been taken, it is 
largely business-as-usual. 

Emissions keep rising  
(2x by 2100)
 – Limited global action results in 

accelerated global warming and 
significant physical risks. 

 – Physical risks are limited, and there has 
been a substantial shift in behaviour and 
public policy (e.g. higher carbon taxes).

 – There are limited public policies before 

2025, temperatures continue to rise, and 
physical impacts intensify. 

 – Governments fail to introduce further 
policies to address climate change.

1  RCP1.9/SSP1-1.9, PRI IPR: 1.5°C Required Policy Scenario.
2  RCP3.4/SSP2-4.5, PRI IPR: Forecast Policy Scenario.
3  RCP6.0/SSP3-7.0.
4  Extracted through the World Environment Situation Room by the UNEP (2023).  

URL: https://wesr.unepgrid.ch/

45

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023TCFD report continued

Climate risk and opportunity assessment 
Time horizons: Short (0-2 years); Medium (2-5 years); and Long (5+ years)

Potential impact and mitigation measures

Scenario time frame

Description
Risk of disruption to the Group’s operations and value chain as a result of wildfires and 
coastal and riverine flooding, with impacts on the Group’s employees, property and 
equipment and surrounding public infrastructure.

Impact assessment 
Fewer than 5% of sites are currently assessed as being at high risk of wildfires and 
flooding under all three scenarios. The potential impact of operational disruption and cost 
of relocation if necessary has been assessed as negligible (see the table on page 49).

Mitigation measures 
 – Implementation of additional mitigation measures in higher risk sites  

(e.g. safety, maintenance, business continuity and shift planning, landscaping etc)
 – Automation and remote technologies for continuous operations during disruption
 – Regular assessment of climate science and scenarios to monitor risk exposure 

Description
Risk of increased frequency and intensity of heatwaves, impacting employees, facilities 
and equipment, affecting costs (for example, equipment maintenance) and productivity. 

Impact assessment 
Higher risk sites have been identified, with a maximum of 20% of sites being high  
risk under Scenario 3. The potential financial impact of disruption to operations and 
potential investments in cooling measures has been assessed as low. See page 49.  
The risk of cold wave/frost has been evaluated as not being relevant currently. 

Mitigation measures 
 – Investment in additional insulation and cooling measures for temperature control  

in at-risk sites 

 – Investment in increased automation in our operations 

Description
Increased demand for electricity globally could result in an increased likelihood and 
occurrence of power outages, potentially resulting in unplanned downtime. In Scenario 2, 
high demand for electricity could impact energy security; in Scenario 3 there could also 
be an increase in electricity demand and cost due to additional cooling requirements. 

Impact assessment 
The potential financial impact of this risk has not yet been assessed. The Group 
demonstrated in 2022 and 2023 the ability to recover energy cost inflation through its 
energy surcharge policy. 

Mitigation measures 
 – Reduction in energy consumption through energy saving and energy efficiency measures
 – Operation during off peak hours with lower energy prices
 – Implementation of measures to reduce reliance on grid electricity (e.g. solar panels) 

Description
A failure to reduce energy usage and new carbon taxes could increase operating costs. 
New regulation or pressure to reduce carbon emissions could accelerate the need to 
retrofit or replace technology, requiring additional capital investment. 

Impact assessment 
The potential financial impact of this risk has been assessed using the estimated cost  
of carbon in 2030; see the table on page 49. 

Mitigation measures 
 – Reduction in energy consumption and continued progress towards our SBTi target 
 – Further development of a decarbonisation roadmap and investment in lower carbon 

technology and energy 

 – The Group demonstrated in 2022 and 2023 the ability to recover energy cost inflation 

through its energy surcharge policy

S1

Medium- 
term

S2

Medium- 
term

S3

Medium- 
term

Long-term

Long-term

S1

S2

S3

Medium- 
term

S1

Not 
applicable

Long-term

Long-term

Long-term

Long-term

S2

S3

S1

S2

S3

Not 
applicable

Physical Risks

Extreme weather events

Risk Driver:
Acute physical
 – Wildfires
 – Flooding

Extreme temperatures

Risk Driver:
Chronic physical
 – Heatwaves and  

heat stress
 – Cold wave/frost

Transition Risks

Impacts to  
electricity supply

Risk Driver:
Market
 – Uncertainty in  
market signals

Technology
 – Transitioning to low 
emission technology

Increased pricing of 
carbon emissions

Risk Driver:
Emerging regulation
 – Carbon pricing  
mechanisms

Technology
 – Transitioning to low 
emission technology

46

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Transition Risks (continued)

Potential impact and mitigation measures

Scenario time frame

Reputational risk

Risk Driver:
Reputation
 – Stigmatisation of sector 
 – Increased 

stakeholder concern

Description
Ability to attract customers, employees and investors who want to work with and for 
companies that are taking action on climate issues and minimising their exposure to risk. 
This could impact talent attraction, new business development, investor sentiment and 
access to or cost of debt. 

Impact assessment 
The Group’s carbon reduction strategy positively impacts customer, employee and 
investor advocacy. The Group is the only major heat treatment company globally with  
an SBTi target, offering a competitive edge for securing new business and talent  
where climate action plays a role.

Mitigation measures 
 – Ongoing tracking of stakeholders’ expectations through direct engagement,  

best practice benchmarks and research

 – Clear communications about Bodycote’s climate action, alignment to international 

standards and its commercial offerings for carbon reduction

Increased regulation of 
GHG emissions

Risk Driver:
Emerging regulation
 – Mandates on and 

regulation 
of existing services

Description
Increased regulation of GHG emissions could be disruptive for the Group and its 
customers, leading to business disruption, increased costs or taxes, and penalties or 
litigation in the event of non-compliance. It could also accelerate the requirement to 
invest in lower GHG emissions technologies. 

Impact assessment 
The Group has evaluated the potential financial impact of increasing deployment of  
low emissions technologies and has determined this as being ‘low’. See page 49. 

Mitigation measures 
 – Continued deployment of lower emissions Specialist Technologies processes 
 – Energy reduction and decarbonisation measures
 – Monitoring of regulatory landscape to ensure timely action and compliance 

Opportunities

Increased outsourcing  
by customers to reach 
GHG targets

Opportunity Driver:
Resource efficiency
 – Use of more efficient 
production processes

Description
Increased revenues resulting from increased outsourcing by customers to Bodycote to  
i) reduce their Scope 1 and 2 emissions and decrease exposure to carbon taxes, etc.;  
and ii) enable emissions avoidance (Scope 4) – as emissions per part processed by 
Bodycote can be up to 60% lower (see page 40). 

Impact assessment 
The Group has opportunities to support customers in achieving their emissions targets 
across all its sectors and markets, leading to increased revenues. Cost reductions may 
also be achieved within the Group’s operations as a result of higher efficiencies and 
furnace fill rates/utilisation. 

Realisation measures 
 – Current operations are already geared towards the realisation of this opportunity and 

support GHG emissions reduction and avoidance

Low carbon 
technologies offering for 
customers

Opportunity Driver:
Services
 – Development and/or 
expansion of low 
emission services

Description
Offering processing and Specialist Technologies services that have a lower carbon 
footprint for competitive advantage: allowing the Group to meet new requirements  
from customers and regulations and positioning Bodycote’s services as higher value  
(with a premium). 

Impact assessment 
The Group’s low carbon processing services present opportunities for higher revenues 
and increased margins.

Realisation measures 
 – Monitoring customers’ climate plans and their expectations of suppliers
 – Increased revenues would offset capital investment for additional capacity

Short-term

S1

S2

Medium-
term

S3

Not 
applicable

Long-term

Long-term

S1

S2

S3

Not 
applicable

Short-term

S1

S2

Medium-
term

S3

Not 
applicable

Short-term

S1

S2

Medium-
term

S3

Not 
applicable

47

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023TCFD report continued

Potential impact and mitigation measures

Scenario time frame

Opportunities (continued)

New volumes for 
Bodycote related to low 
carbon transition

Opportunity Driver:
Products and services
 – Ability to diversify 
business activities

Markets
 – Access to new markets

Description
Revenue uplift related to increased business from heat treatment services from sectors 
that support the transition to a lower carbon world (e.g. ICE to EVs). These sectors 
become a more significant revenue stream for Bodycote as a result of higher and new 
demand for services.

Impact assessment 
Bodycote is able to realise this opportunity via current facilities and technologies.  
The Group’s global heat treatment capacity allows us to quickly adapt to customers’ 
requirements with low capital investment. 

S1

Medium-
term

S2

Medium-
term

Realisation measures 
 – No significant effort or investment is expected to be required to diversify our customer 

base due to Bodycote having flexibility to serve both existing and new industries

S3

Not 
applicable

Government and  
other incentives 

Opportunity Driver:
Resource efficiency
 – Use of more efficient 
production processes

Services
 – Development of low 

carbon service offering

Description
Positive impact of Government and other incentives, including revenue uplift as a result 
of increased customer demand for services that benefit from energy tax exemptions  
due to emissions avoidance, incentives for the faster adoption of lower carbon 
technologies, and incentives and revenue uplift from the adoption of low emissions 
Specialist Technologies. 

Impact assessment 
The impact of this opportunity has not yet been assessed. The Group will continue 
monitoring the opportunity and evaluate quantifying it as information becomes available 
that allows a reasonable approach.

Realisation measures 
 – Continued installation of low carbon technologies across the Group

S1

Medium-
term

Long-term

S2

S3

Not 
applicable

48

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Climate risks quantitative impact assessment 

 Negligible <£1m   Low £1m-£5m   Moderate £5m-£10m   Significant £10m-£20m   Severe >£20m

Risk

Value drivers assessed

Chronic  
physical risk:
Heatwaves

Acute physical risk:
Flooding, wildfire

Potential cost of mitigation of extreme 
heat in sites at risk of frequent and severe 
heat waves (installation and operation of 
cooling systems) and probability of 
potential production losses2.

Potential cost of mitigating flooding and 
wildfire risk through relocation, and 
potential disruption to production in at-risk 
sites3.

Transition risk:
Increased  
pricing of carbon  
emissions

Future costs of carbon applied to 
groupwide Scope 1 and Scope 2  
emissions using IPCC estimates for prices 
per tonne of carbon under different 
scenarios. (Tonnes CO2e x projected cost 
per tonne)4.

Transition risk:
Increased  
regulation of  
GHG emissions

Accelerated decarbonisation of 
operational processes through investment 
in LPC furnaces (electrically-powered,  
low consumption) and retrofitting gas 
heated furnaces to be powered by 
electricity. Assumed transition time:  
25 years to 2050.

1  Costs before current and planned mitigation measures. 

2  Site risk assessed using CMIP6 data from the World Bank Climate Knowledge Portal.

3  Probability of risk estimated using WRI Aqueduct, UNEP and NASA data.

Potential annual 
impact before 
mitigation1

















–



–

–

S1

S2

S3

S1

S2

S3

S1

S2

S3

S1

S2

S3

Time horizon Mitigation measures

Long-term

 – Investment in additional insulation  

Long-term

Medium-term

Medium-term

Medium-term

Medium-term

and cooling measures for temperature 
control in at-risk sites 

 – Investment in increased automation  

in our operations

 – Implementation of additional measures 
in at-risk sites (e.g. safety, business 
continuity, landscaping)

 – Investment in increased automation  

in our operations 

 – Monitoring risk using climate science 

and models

Long-term

 – Carbon cost inflation recovery  

Long-term

Not applicable

through pricing

 – Alignment to SBTi emission 

reduction pathways 

 – Continuous reduction in absolute  
energy consumption, decreasing 
carbon emissions

 – Investment in increased automation  

in our operations 

Long-term

 – Continued deployment of lower 

Not applicable

Not applicable

emissions specialist technologies 
(LPC furnaces)

 – Energy reduction and decarbonisation  

measures

 – Monitoring of regulatory landscape to 
ensure timely action and compliance

4  Cost of carbon based on Intergovernmental Panel on Climate Change (IPCC) projections for 2030 - £100 per tonne of CO2e in Scenario 1; £25 per tonne of CO2e in Scenario 2.

Organisational resilience to climate change 
The Group’s climate scenario analysis process supports the  
exploration of the Group’s resilience to climate-related issues and  
the identification and development of suitable mitigation plans. 
As detailed in the risk and opportunities table, mitigation or realisation 
measures have been identified for each of the key risks and 
opportunities for the Group. The Group’s global presence and the 
diversity of applications for its services further provides resilience to 
potential risks, as well as possibilities for growth in new areas. 

Bodycote operates an indispensable service, which cannot be 
substituted, and does so more efficiently than customers in-house  
and competitors. Bodycote is the only major heat treatment company 
globally to have set an SBTi-approved emissions reduction target. 
An increased cost of carbon would be recovered through pricing,  
in the same way that higher energy costs in 2022 and 2023 have been 
recovered through energy surcharges. At the same time, the Group’s 
initiatives to reduce operational energy consumption provides 

additional resilience in the event of an increased cost of carbon – 
potential exposure to carbon costs reduces in line with lower energy 
consumption. Low carbon processing technology also provides 
resilience in reducing energy consumption, as well as supporting  
the Group’s growth objectives. See page 40 for details about the 
Group’s operational initiatives to reduce energy consumption and 
carbon. Examples of ways in which the Group supports customers’ 
environmental sustainability goals are provided on pages 13 and 39.

The Group has determined that scenarios where global warming is 
limited to 1.5ºC or less than 2ºC would be most beneficial and  
would help the business thrive, even after considering the potential 
impact of an increased cost of carbon. This is due to climate-related 
opportunities presented in these scenarios – both commercial and 
operational – and a likely lower level of disruption to operations from 
physical climate-related impacts.

49

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023TCFD report continued

Risk management
Climate risk and opportunity identification and assessment 
Climate change is considered to be among the Group’s principal risks. 
The potential impacts of climate change include both physical risks to 
operations and supply chains as a result of global warming, as well  
as transition risks and opportunities related to regulatory and market 
developments arising from the shift to a low-carbon economy. 
Risk appetite is determined by the Board annually.

Climate-related risks and opportunities most relevant for the Group  
are identified through several processes, including benchmarking  
and desktop research, consultation with colleagues in key roles, and 
customer engagement. Regulatory changes are also considered  
as part of the Group’s process to identify and assess risks and 
opportunities. External climate data supports the assessment of 
identified risks. As described on page 45, the Group ran a series  
of climate scenario analysis workshops to refresh its understanding  
of climate-related risks and opportunities in 2023. Insights from  
these workshops have been incorporated within the Group’s principal 
risks register. 

The process for determining the potential impact of each of the 
climate risks and opportunities, and their relative importance,  
includes both qualitative and quantitative evaluation by the Group’s 
Sustainability and Finance functions. Members of the Risk and 
Sustainability Committee are also engaged to input into assessments 
and corroborate outcomes. 

Climate risk management 
Climate risk and opportunity management is led by the Group Chief 
Executive. The Chief Sustainability Officer supports the Group Chief 
Executive in ensuring climate-related strategy is aligned to key risks 
and opportunities. This involves maintaining the Group’s climate risk 
register, and advising on appropriate controls to mitigate climate  
risks arising from current and emerging regulation, technology, legal, 
market, reputational, and physical climate developments. 

Climate risks and opportunities are prioritised according to the 
potential strategic and financial impact, the likelihood of occurrence 
and the magnitude of potential impacts. Operational activity to 
manage priority climate risks and opportunities is overseen by the 
Executive Committee. Where necessary, additional human and 
financial resources are deployed to support risk mitigation,  
or opportunity realisation plans. 

The Group’s climate risk and opportunity management plans are being 
updated following the climate scenario analysis work undertaken 
during the year. Insights from this work will inform the Group’s climate 
transition planning and the advancement of efforts to further integrate 
climate-related opportunities into the Group’s commercial offering and 
operations management. Mitigation and realisation strategies for key 
climate risks and opportunities are described on pages 46-48.

Integration of climate risk into overall risk management
Climate risk is assessed alongside other business risks using the 
Group’s overall risk management framework. Executive Directors  
and Senior Executives are assigned ownership of risk management  
as appropriate to their roles, with climate risk sitting with the  
Chief Sustainability Officer. The Executive Committee evaluates all 
principal risks and their mitigations collectively twice a year. 
This process ensures that climate-related risks and opportunities  
are incorporated into the Group’s strategic and financial planning in  
a timely and appropriate way. 

An aggregated principal risk register, which includes climate risk,  
is maintained by the Head of Internal Audit at a Group level. 
The operational management of risks is facilitated through Group 
policies and procedures, training, internal controls, reporting reviews 
and approval processes, which are overseen by Group Internal Audit 
and the Audit Committee. 

Climate risks are monitored throughout the year to identify any 
changes in the risk profile. The Risk and Sustainability Committee 
supports the identification, assessment, and management of 
climate-related risks. Climate risk descriptions, risk scores and 
mitigating actions are assessed at least twice a year by the Executive 
Committee and reviewed annually by both the Audit Committee  
and the Board. 

Metrics and targets
Climate-related metrics 
Bodycote monitors a range of metrics to support its assessment of 
climate-related risks and opportunities, and tracks performance against 
targets. The following metrics are currently monitored: 

 – Scope 1 and Scope 2 emissions (CO2e)

 – CO2e emissions intensity (CO2e / £m)

 – Energy consumption (MWh)

 – Energy intensity (MWh / £m)

These metrics are monitored by the Executive Committee. 
Going forward, the Board will also receive a report on energy  
usage on a quarterly basis. ESG metrics are included in the  
annual bonus scheme. 

Climate-related metrics are tracked using an EHS management 
platform which is deployed groupwide to capture environmental and 
health and safety data. It provides a single, comprehensive source of 
EHS data, including energy and carbon data that is reported internally 
and externally. 

50

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Other climate-related metrics
Given the nature of our business, energy consumption is the Group’s 
most material environmental topic. Bodycote’s processes are not 
water intensive by design, and the Group does not produce products 
to which water is added. However some water is required for some 
operational processes and the Group therefore also monitors water 
consumption. See page 41 for water use data and performance.

Bodycote uses an operational control approach for reported emissions. 
The Group’s emissions calculation methodology is provided in the 
Group’s 2023 ESG Supplement published at www.bodycote.com. 
The Group’s internal audit function undertook an independent review 
of the Group’s GHG emissions calculation processes during the year 
and provided assurance to the Board over the operating effectiveness 
of the existing controls in place. 

Bodycote acknowledges the benefit of climate-related metrics to track 
performance and control exposure to risk. We plan to expand our suite 
of climate-related metrics in future.

Climate-related opportunity metrics
The Group’s climate strategy presents both commercial and 
operational opportunities: 

 – Commercial opportunities 

Bodycote has begun systematically tracking customers’ sustainability 
requirements and new business opportunities (particularly concerning 
carbon reduction) via our customer relationship management 
platform. This provides useful insights into the frequency with which 
we are engaging with customers on carbon reduction, and the role it 
plays in winning new business. 

Scope 3 emissions 
Due to the nature of our business and energy consumption of our 
operations, the large majority of our emissions are captured in  
Scopes 1 and 2. The Group’s Scope 3 footprint does not currently 
meet the materiality threshold under the SBTi framework to require a 
science-based emissions reduction target (under SBTi criteria, if a 
company’s Scope 3 emissions are 40% or more of total Scope 1, 2, 
and 3 emissions, a Scope 3 target is required). As such, we are not 
currently reporting our full Scope 3 footprint. However, we continue to 
keep this under review. Meanwhile, we are working to develop our 
measurement approach to support a better understanding of our 
influence over value chain emissions, and in preparation for future 
reporting. Our climate transition scenario analysis will be updated to 
include Scope 3 emissions as appropriate at that stage.

Bodycote has a significant opportunity to support customers in 
reducing the energy consumption of their manufacturing processes. 
As illustrated in the case study on page 13, Bodycote can reduce 
emissions associated with thermal processing by up to 60% 
per part. 

Climate-related targets 
Bodycote has set a science-based emissions reduction target that has 
been validated by SBTi. The Group commits to reduce absolute Scope 
1 and Scope 2 GHG emissions by 28% by 2030 from a 2019 base year. 
In 2023, the Group’s emissions were 24% below our base year. 

The Group works towards an annual goal of achieving a 2% reduction 
in emissions, in line with the emission reduction trajectory required to 
achieve the SBTi target. Our top priority continues to be energy 
reduction: improving the efficiency of our operations and reducing the 
amount of energy consumed. The Group has established a core 
programme of eight key emission reduction initiatives, which are being 
implemented across our facilities globally. See page 40. 

The Group’s energy efficiency initiatives also support decarbonisation 
more widely. By optimising thermal processing for manufacturers, 
Bodycote can prevent emissions that would otherwise be released 
into the atmosphere. As a result, Bodycote plays a major role in 
avoiding emissions and reducing industry’s impact on the climate 
overall. During the year, the Group developed a new software tool to 
automate the calculation of avoided emissions for customers by 
outsourcing work to Bodycote, compared with completing the work 
in-house. See page 39 for details.

The Group’s position on carbon offsets 
In line with the science-based approach to emissions reductions, 
Bodycote focuses on emissions reduction and decarbonisation. 
The Group intends to only make use of carbon removal or offsets as 
part of a residual emissions strategy if required in the future, or as  
part of an additional initiative to compensate for emissions or support 
the restoration of nature. 

 – Operational opportunities 

The benefit of the Group’s efforts to reduce carbon emissions is 
passed directly on to customers, in that it lowers the Scope 3 
emissions associated with the services we provide to them.  
At the same time, the Group itself benefits from reduced energy 
consumption, and lower operating costs and exposure to financial 
risks. See page 40 for details of the Group’s projects to reduce 
operational carbon emissions. 

GHG emissions and related risks 

GHG emissions

2023 CO2e (kt)  Associated risks

Scope 1

Scope 2

Total  
Scope 1 + 2

134.3

131.0

265.3

 – Price volatility of fossil fuels

 – Fluctuation in electricity costs

 – Increased cost of carbon 
 – Faster than expected growth 
resulting in an increase in 
emissions beyond 
planned mitigation

The Group’s Scope 1 and Scope 2 emissions decreased by 2% in 
2023. CO2e per £m revenue reduced by 7% compared with 2022. 
The above table displays location-based emissions. The Group also 
reports emissions data according to the market-based methodology 
(see page 40).

The majority of the Group’s energy use relates to the consumption of 
electricity and gas. A breakdown of the Group’s energy and fuel use by 
source is provided on page 40. Emissions decreased in 2023 as a 
result of reduced electricity and gas consumption and energy 
efficiency measures in our facilities. 

Scope 1 and Scope 2 emissions for the last five years are set out on 
page 40. Emissions and energy consumption relating to the Group’s 
UK operations are provided separately on page 41.

51

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023TCFD report continued

Task Force on Climate-related Financial Disclosures reference table
The table below is a summary of our TCFD reporting and where the relevant information can be found within this Annual Report.

Governance

Describe the Board’s oversight of climate-related risks and opportunities. 

TCFD report – page 43

Describe the management’s role in assessing and managing  
climate-related risks. 

TCFD report – page 44

Strategy

Describe the climate-related risks and opportunities the organisation has 
identified over the short-, medium- and long-term.

Describe the impact of climate-related risks on the organisations’ business, 
strategy and financial planning.

Describe the potential impact of different scenarios, including a 2°C scenario  
on the organisations’ business, strategy and financial planning.

Risk management

Describe the organisation’s processes for identifying and assessing  
climate-based risks.

TCFD report – pages 45-49

TCFD report – pages 46-49

TCFD report – pages 46-49

TCFD report – page 50

Principal risks and uncertainties report 
– page 28

Describe the organisation’s processes for managing climate-based risks.

TCFD report – page 50

Principal risks and uncertainties report 
– page 28

Describe how processes for identifying, assessing and managing climate-based 
risks are integrated into the organisation’s overall risk management.

TCFD report – page 50 and Principal risks  
and uncertainties report – page 28

Metrics and Targets

Disclose the metrics used by the organisation to assess climate-based risks 
and opportunities in line with its strategy and risk management processes.

TCFD report – pages 50-51

Disclose Scope 1, Scope 2 and, if appropriate, Scope 3 greenhouse  
gas emissions and the related risks.

Describe the targets used by the organisation to manage climate-related  
risks and opportunities and performance against targets.

TCFD report – page 51

TCFD report – page 51

complete

52

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Non-financial and Sustainability Information Statement 
The table below sets out where information relevant to the Non-Financial Reporting Directive can be found in our 2023 Annual Report and on 
our website.

Our Core Values, Code of Conduct and Group Policies underpin everything we do at Bodycote. Our Core Values and Code of Conduct ensure we 
comply with all applicable international and local rules and regulations. They provide guidance, including through real-life scenarios, to help 
colleagues address challenging and ethical issues they may encounter at work. The Core Values and Code of Conduct are available on our 
website, and our Group Policies support and enhance our behaviour in line with the principles set out in the Code of Conduct. A description of 
our business model can be found on page 15.

The Group’s climate-related disclosures consistent with the Task Force on Climate-related Financial Disclosures (TCFD) framework are on  
pages 43–52 of this report. In these disclosures, details are provided about the Group’s climate-related governance, strategy, risk management 
and metrics and targets. 

Environmental

Standards, policies and actions 
which govern our approach

 – Environmental Policy

 – Carbon footprint and water 
consumption statements

 – Initiatives to reduce energy 

consumption and greenhouse 
gas emissions

Social

For further information 
visit pages 37, 40-41

Visit bodycote.com

Key metrics 

Internal processes to  
monitor performance

 – Progress on reductions 
in carbon footprint and 
water consumption

Energy and greenhouse gas 
management is tracked per 
facility monthly.

Standards, policies and actions 
which govern our approach

For further information 
visit pages 36 to 38

Key metrics 

 – Performance Goal 

Management System

 – Occupational Health & Safety Policy

 – Succession Planning Process 

 – Equality, Diversity and 

Inclusion Policy

 – Data Protection Policy

 – Open Door Policy

Business Governance

Standards, policies and actions 
which govern our approach

 – Core Values

 – Code of Conduct

 – Anti-Slavery and Human 
Trafficking statement

 – Human Rights Policy 

 – Anti-Bribery and Corruption Policy

 – Competition and Anti-Trust Policy

 – Control and Compliance Statement

 – Supplier Code of Conduct

 – Tax Strategy

Visit bodycote.com

 – % of female 

representation in total 
workforce and on 
Executive Committee 
and Board of Directors

 – Lost work case 
incident rate

Internal processes to  
monitor performance

 – The Executive Committee 

monitors EHS performance 
on a monthly basis

 – The Executive Committee 

monitors employee turnover 
rate performance on a 
monthly basis

 – Recordable incident rate

 – Employee Engagement  

 – UK Gender Pay 

Gap Report

Groups

 – Regular Open Door incident 
update to the Board and 
Executive Committee

For further information 
visit page 42

Visit bodycote.com

Key metrics 

% of relevant employees 
trained on our policies

# of breaches

Internal processes to  
monitor performance

The implementation and 
effectiveness of training is 
overseen by the Group General 
Counsel and Group Company 
Secretary.

53

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Board of Directors

1

2

3

4

5

6

Executive Directors
 Stephen Harris
GROUP CHIEF EXECUTIVE

1

APPOINTED: November 2008 
and Group Chief Executive from  
January 2009  

External roles
Non-Executive Director and Chairman 
Designate of Videndum PLC. 

Past roles
Spent his early career in engineering with 
Courtaulds plc and then moved to the USA to 
join APV Inc. from 1984 until 1995, where he 
held several senior management positions. 
He was appointed to the Board of Powell 
Duffryn plc as an Executive Director in 1995 
and then went on to join Spectris plc as an 
Executive Director from 2003 to 2008. He was 
also a Non-Executive Director of Brixton plc 
from 2006 to 2009 and of Mondi from 2011 
to 2021. At Mondi he had been the Chair of 
the Sustainability Committee, the Chair of the 
Social and Ethics Committee and the Senior 
Independent Director.

Qualifications
Chartered Engineer, graduated from the 
University of Cambridge, Master’s degree in 
business administration from the University of 
Chicago, Booth School of Business.

Non-Executive Directors

3

 Daniel Dayan
NON-EXECUTIVE CHAIR

APPOINTED: January 2022  

External roles
Non-executive Chair of CellMark AB from 2021 
(not listed).
Non-executive Chair of Aquaspersions group 
from 2021 (not listed).
Non-executive Chair of Trend Networks group 
from 2023 (not listed).
Director of Nightingale Hammerson Trustee 
Company (not listed) and subsidiary.

Past roles
Chair of Portals International from 2020 to 
2022. Chair of Low & Bonar plc from 2018 to 
2020, Non-Executive Director and Chair of 
the Remuneration Committee of Chemring 
Group plc from 2016 to 2018 and Chair of 
Nonwovens Innovation & Research Institute 
from 2014 to 2015. CEO of Linpac Group and 
Klöckner Pentaplast Group from 2015 to 2019 
and CEO of Fiberweb plc from 2006 to 2013. 
Daniel spent his early career at Novar plc 
until 2005 and prior to that worked at ICI and 
management consultant, Arthur D Little.

Qualifications
Bachelor’s degree in Engineering from the 
University of Cambridge.

5

 Patrick Larmon
SENIOR INDEPENDENT DIRECTOR

APPOINTED: September 2016  

External roles
Non-Executive Director of Handgards Inc.,  
Box Partners LLC, DFS Inc. and Fresh Edge 
LLC, none of which are listed companies.

Past roles
Was Executive Vice President and owner of 
Packaging Products Corporation until 1990 
when the company was acquired by Bunzl plc. 
Held various senior management positions for 
over 13 years before becoming President of 
Bunzl’s North America business in 2003,  
then Chief Executive Officer, North America, 
of Bunzl plc in 2004, joining the Bunzl plc board 
in 2005. Retired from Bunzl plc in December 
2018 and retired from Huttig Building Products 
Inc. in 2022. 

Qualifications
Graduated from Illinois Benedictine University 
(major Economics & Business Economics),  
is a Certified Public Accountant, completed  
an MBA from Loyola University of Chicago  
and a Master of International Business from  
St. Louis University.

2

 Ben Fidler
CHIEF FINANCIAL OFFICER

4

 Kevin Boyd
NON-EXECUTIVE DIRECTOR

6

 Lili Chahbazi
NON-EXECUTIVE DIRECTOR

APPOINTED: February 2023  

APPOINTED: September 2020  

APPOINTED: January 2018 

External roles
Strategy consultant and a global partner in  
the London office of Bain & Company.

Past roles
Lili began her career as an actuary before 
joining Bain & Company. 

Qualifications
Graduated with a BSc in Mathematics from 
Concordia University, Montreal followed 
by an MBA from INSEAD, Fontainebleau. 
Associate of the Society of Actuaries.

External roles
None. 

Past roles
Began his career in strategy consulting 
working for the LEK Partnership. He moved 
to investment banking in 1997, as an equity 
research analyst covering the Aerospace & 
Defence sector at Kleinwort Benson and  
then Deutsche Bank. Joined Rolls-Royce 
Holdings plc in 2017 where he held a number 
of senior management positions including 
Director of Group FP&A, Vice President 
Business Performance and Deputy Group 
CFO. Was a Non-Executive director of ITP 
Aero engines in Spain and Rolls-Royce SMR.

Qualifications
Masters degree in Biochemistry from the 
University of Oxford.

External roles
Non-Executive Chair of Genuit Group plc.   
Non-Executive Director of Galliford Try 
Holdings plc from March 2024.

Past roles
Held the positions of Chief Financial Officer at 
Oxford Instruments plc, Radstone Technology 
plc and at Spirax-Sarco Engineering plc 
(stepped down in September 2020). He was 
Non-Executive Director of EMIS Group plc 
from 2014, Chair of the Audit Committee from 
2019 and Senior Independent Director from 
2022 until October 2023. 

Qualifications
Chartered Accountant, Chartered Engineer. 
Fellow of the Institute of Chartered 
Accountants and the Institute of Engineering 
and Technology. BEng, Electronic and 
Information Engineering from Queen’s 
University Belfast.

54

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023  
 
 
 
7

8

9

KEY TO COMMITTEES:

Executive

Nomination

Remuneration

Audit

Committee Chair

7

 Cynthia Gordon
NON-EXECUTIVE DIRECTOR

8

 Beatriz García-Cos Muntañola
NON-EXECUTIVE DIRECTOR

9 Alison Broughton 

GROUP COMPANY SECRETARY

APPOINTED: June 2022 

APPOINTED: September 2023 

APPOINTED: January 2024

External roles
Chair and Non-Executive Director of Global 
Fashion Group and Non-Executive Director  
of Eutelsat Communications SA.

External roles
Chief Financial Officer of Ferroglobe PLC 
(NASDAQ) and director of a number of 
its subsidiaries.

Past roles
Began her career at Unilever before moving  
to Lloyds Bank. Held the positions of VP 
Business Marketing and VP Partnerships 
& Emerging Markets at Orange – France 
Telecom, was Group Chief Commercial Officer 
at Ooredoo Group and former CEO of Millicom 
Cellular, Africa. 

Non-executive director of Kinnevik AB, 
BIMA Mobile, Tele 2 AB and Bayport 
Financial Services.

Qualifications
Graduated with a BA from the University of 
Brighton in Business Studies.

Past roles
Began her career at Audigest, Spain, before 
moving to PPG Industries. She spent several 
years at Vestas Wind Systems in Spain and 
then at Trafigura in Switzerland. She was Chief 
Financial Officer at Bekaert in Belgium, before 
being appointed as Chief Financial Officer of 
Ferroglobe plc in 2019, based in the UK.
She was also a Non-Executive Director of 
Bridon-Bekaert Ropes Group in the UK from 
2016 to 2018.

Qualifications
Graduated with a Master’s degree in 
Economics and Business Administration from 
the University of Barcelona.

Past roles
Began her company secretarial career 
with Enterprise Oil plc, before joining Shell 
Exploration & Production Limited, part of the 
Royal Dutch Shell group, following a takeover 
in 2002. She spent eight years with Wolseley 
plc (now Ferguson plc) as Deputy Company 
Secretary, before joining Petrofac Limited 
in 2011, where she was latterly the Head of 
Company Secretariat.

Qualifications
A fellow of the Chartered Governance Institute.

Registered office:  
Springwood Court 
Springwood Close 
Tytherington Business Park 
Macclesfield  
Cheshire SK10 2XF

Registered Number 519057  
England and Wales.

Tel: +44 1625 505300

Board skills and experience

Strategy 

M&A

International 

Recent and relevant financial experience

Corporate finance/treasury

Accounting

Customer

Sales and marketing

Service industry

Environmental, including climate change

Governance

Engineering

Leadership

Emerging markets

Manufacturing

Capital-intensive industries

D. Dayan

S. Harris

B. Fidler

P. Larmon

L. Chahbazi

K. Boyd

C. Gordon

B. García-Cos  
Muntañola

55

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate governance statement

Chair’s message
Dear shareholders

On behalf of the Board, I am pleased to present Bodycote’s Corporate 
Governance Statement for 2023.

During the year, the Board considered ongoing issues around  
energy costs, inflation and interest rates, macroeconomic 
uncertainties, climate change and major geopolitical events, as well 
as the development of Bodycote’s business. The Board, alongside 
management, sought to assess the risks and opportunities presented 
by these events and to manage their impact. My role has been to 
guide the debate at the Board and to ensure that our strategy  
remains appropriate and on-course. In addition, I led the Nomination 
Committee in the search for a new Group Chief Executive following 
the announcement in May 2023 of Stephen Harris’ intention to retire 
in 2024, which resulted in the appointment of Jim Fairbairn.

Regular, open and constructive dialogue with shareholders continued 
throughout 2023, consistent with the Group’s broader commitment  
to meaningful engagement with key stakeholders. I met several 
significant shareholders personally during the year to discuss 
shareholder views in relation predominantly to the recruitment of a 
successor to Stephen Harris. The Group’s key stakeholders and their 
various perspectives are identified and taken into account as part of 
the Board’s annual strategy and corporate planning discussions and 
also in project assessments and many general Board conversations. 
These discussions and assessments focus not only on delivering value 
for shareholders, but also address the impact of our decisions and 
strategies on all stakeholders and this broad approach is a key aspect 
of our culture. In relation to good governance, there is a clear 
emphasis on setting the tone from the top and leading by example.

In line with the Director’s Duties, the Board’s engagement in 2023 
with employees, shareholders, customers and communities is 
explained in our stakeholder section on page 18.

The Group’s sustainability agenda has continued to gather pace during 
the year, including the addition of further resource and investment. 
A detailed report of activities can be found on pages 35 to 42. 
The Board provides regular challenge and oversight of the Group’s 
sustainability agenda, with environmental, health and safety 
performance being reviewed at every meeting. Climate change is 
continuing to rise in importance for Bodycote and its stakeholders and 
as such, climate-related matters have been discussed in the context 
of both the Group’s strategy and risk management during the year. 
The Group continues to make good progress towards its science-
based emissions reduction target, having reduced Scope 1 and 2 
emissions by 24% since 2019. Bodycote’s greatest opportunity 
however lies in its ability to support customers to achieve their 
sustainability goals, amplifying its impact across a multitude of 
markets and sectors. Emissions per part can be up to 60% lower 
when processed with Bodycote, compared with customers’ in-house 
processes. The Group is augmenting its communications and 
marketing tools to enable emissions savings for customers and play 
its fullest role in the transition to a low-carbon economy. The case 
study on page 13 provides further details about the Group’s work 
to support customers’ sustainability agendas. 

Ensuring high standards of business conduct is critical to the success 
of the Group. In 2023, in response to employee suggestions, we 
moved to a divisional model of Employee Engagement Groups led by 
Non-Executive Director Patrick Larmon, with virtual meetings taking 
place during the year. The feedback from these forums was reported 
to the Board and the Executive Directors charged with addressing any 
particular items that arose. Further information is set out on page 62. 

Succession planning is a regular topic for Board discussion,  
although the outcome of these discussions is only visible when new 
appointments are made. For each appointment we look to appoint an 
outstanding candidate, with a diverse range of relevant experience, 
to maximise Board effectiveness. When considering diversity, 
we recognise that this can take many forms including gender, 
nationality, social, ethnic background, and cognitive and personal 
strengths. Diversity at Board level and throughout the Group is 
recognised by both the Board and management as a valuable strength.

The Board continued to ensure that effective Board succession plans 
are in place. Ben Fidler was appointed as Chief Financial Officer in 
February 2023 to replace Dominique Yates who retired from the Board 
in April 2023. Beatriz García-Cos Muntañola was appointed as a 
Non-Executive Director in September 2023, with her experience as a 
serving Chief Financial Officer of a multinational metals group being  
of particular value to Board discussions. Eva Lindqvist stepped down 
from the Board at the 2023 AGM after more than nine years of service 
and Ian Duncan retired in November 2023 following completion of  
nine years of service.

As announced in October 2023, Jim Fairbairn will succeed Stephen 
Harris as Group Chief Executive. Jim joined the business in March 
2024 and Stephen will retire and step down from the Board after the 
Annual General Meeting (AGM) in May 2024, following the  
completion of a comprehensive handover. Jim’s track record in  
leading and developing specialist global industrial businesses and 
teams is outstanding, and we look forward to working with him to 
drive the continuing development and growth of Bodycote.

All Directors plan to attend this year’s AGM, which will provide an 
opportunity for shareholders to ask questions to the Board. I look 
forward to meeting any shareholder who can join us and extend 
my thanks to you all for your continued support. 

Daniel Dayan
Chair

Governance framework 
In respect of the 2023 financial year, Bodycote’s obligation under the 
Disclosure and Transparency Rules (DTR) is to prepare a corporate 
governance statement with reference to the UK Corporate 
Governance Code issued by the FRC in July 2018 (‘the Code’). 
The Code underpins the corporate governance framework for  
premium listed companies and sets out principles and provisions of 
good governance with compliance with the Code resting with the 
Board. A copy of the Code is available at www.frc.org.uk. The Board 
acknowledges the changes introduced to the revised Code, which 
was reissued by the FRC in January 2024, and which will take  
effect for financial years beginning on or after 1 January 2025. 
During 2024, consideration will be given to determining what  
process improvements may be required to enable the Company to 
report on a comply or explain basis against this revised Code.

Compliance with the 2018 UK Corporate Governance Code
Bodycote is required to explain how the Company has complied with 
the Code and this report details how the Company has applied the 
principles and complied with the provisions. In respect of the year 
ended 31 December 2023, Bodycote has complied with all provisions 
of the Code.

During 2023, Bodycote has complied with all relevant requirements 
of the DTR, the UK Listing Rules and narrative reporting requirements. 
Taken together with the Reports of the Audit and Nomination 
Committees, and the Board Report on Remuneration presented on 
pages 67 to 91, this statement explains how Bodycote has applied the 
principles of good corporate governance as set out in the Code.

56

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Code principles – Board areas of focus

Area of focus

Board leadership and Company purpose
 – Regularly discussing strategy at Board meetings during 

Read more on pages 10-12, 25-27
 – Approving capital expenditure in excess of £4m

the year

 – Receiving presentations from operational management  

 – Approving the Group’s strategy, budget, tax policy 

on performance against the strategy

and dividend 

 – Considering and approving potential acquisition opportunities

 – Considering and approving strategic opportunities,  

e.g. acquisitions

Division of responsibilities

Read more on pages 35-53, 56-64

 – Review of Board roles and responsibilities

 – Modern Slavery review

 – Review of Group policies
 – Review of schedule of matters reserved for the Board

 – Review of corporate governance code and guidelines
 – Review of terms of reference of all committees

 – Convening the AGM, approval of shareholder materials

 – Review of environmental, health and safety updates 

at each meeting

 – Overview of stakeholder relationship/workforce engagement

 – Determining/maintaining the Group’s values and ensuring 

 – Implementation of sustainability strategy, specifically 

that these are reflected in business practice

including climate change

Strategic 
priorities

1

4

2

5

3

6

1

5

Composition, succession and evaluation
 – Considering proposals on succession planning, 

when required, for the Board

 – Considering the talent management programme and 
the need to develop the managers and executives for 
the future

 – Approving further terms as Non-Executive Directors for  
I.B. Duncan (to November 2023), P. Larmon, L. Chahbazi  
and K. Boyd 

Audit, risk and internal control

 – Approval of 2022 year end and 2023 half-year results

 – Recommending the final and interim dividends

Read more on pages 28-32, 67-71

 – Reviewing proposals on senior executive succession planning

5

 – Reviewing the size, composition and diversity of both 

the Board and its Committees

 – Ongoing Board training

 – Tailored induction, when required

 – Reviewing Board and Committee effectiveness and Directors’ 

conflicts

Read more on pages 72-76
 – Review future scenarios and other factors in relation to audit, 

risk and internal control

 – Review of viability statement

 – Annual review of principal and emerging risks, 

 – Consideration whether the Annual Report and Accounts are 

risk management and control systems

fair, balanced and understandable

Remuneration

Read more on pages 77-91

 – Remuneration policy review and approval (including 

 – Chair and independent Non-Executive Directors’ fees review

Executive Directors’ and Senior Management remuneration)

1

5

3

4

2

5

1

Safety and 
Climate Change

2

Capitalising on and investing 
in our Specialist Technologies

3

Investing in  
Emerging Markets

4

Investing in structural  
growth opportunities

5

Driving operational  
improvement

6

Acquisitions

Core Values

57

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
Corporate governance statement continued

Board responsibilities

Chair

Group Chief Executive

Chief Financial Officer

 – overall responsibility and leadership of 

 – maintains strong financial management 

 – leadership and governance of the Board 
and chairs the Nomination Committee

 – oversees the Board 

effectiveness programme

 – ensures Board members receive 

accurate, timely and clear information 
on Board issues

 – ensures, together with the Group 

Company Secretary, a comprehensive 
induction of new Directors

 – sets Board agenda, style and tone of 

Board discussions

Group performance

 – stewardship of Group assets

 – plans, implements and executes 

strategies to deliver agreed objectives

 – maintains a close working relationship 

with the Chair, ensuring effective 
dialogue with investors and stakeholders

 – ensures leadership and development 

frameworks are developed to generate 
a positive pipeline for future opportunities 
for the Group

 – ensures effective communication  

 – overall responsibility for the Group’s 

with stakeholders

sustainability performance, and 
communicates the vision and values of 
the Group

and implements effective 
financial controls

 – provides financial and commercial 

decision leadership, vision and support

 – ensures the appropriateness of risk 

management systems

 – oversees all aspects of accounting/ 

finance operations including accounting 
policies and integrity of financial data 
and external financial reporting

 – responsible for corporate finance 
functions, financial planning and  
budget management

 – supports and advises the Senior 

Management team

 – manages the Senior Management team

 – leads the development of investor 

 – ensures progress on ESG impact tracking 

and reporting

relations strategy and communications

 – maintains relationships with key external 
stakeholders, including key shareholders, 
lenders, banks and credit rating agencies

Senior Independent Director 

Non-Executive Directors

Group Company Secretary

 – acts as a sounding board for the Chair

 – provide support to executive 

 – secretary to the Board and 

 – serves as an intermediary for 

other Directors

 – is available to meet shareholders if 

they have concerns which they have 
not  been able to resolve through the  
normal channels

 – conducts an annual review of the 

performance of the Chair and convenes 
a meeting of the Non-Executive Directors 
to discuss the same

management while providing constructive 
challenge and rigour

 – monitor strategy and bring sound 

judgement and objectivity to the Board’s 
decision-making processes

its Committees

 – ensures efficient information flows 

within the Board and its committees 
and between Senior Management 
and Non-Executive Directors

 – monitor management’s processes to 

 – facilitates induction of new Directors 

ensure financial controls and systems  
of risk management are robust 
and defensible

 – monitor reporting of performance

 – scrutinise performance of management

 – share skills, experience and knowledge 
from other industries and environments

 – are available to meet with 

major shareholders

and assists with training and 
development needs as required

 – regularly updates the Board on 

governance matters, legislative changes 
and regulatory regimes affecting 
the Group

 – ensures compliance with 

Board procedures

 – coordinates external Board evaluation 
and conducts internal Board evaluation

Matters reserved for the Board
The Board has a formal schedule of matters reserved for its decision-making and approval. These were reviewed during the year and updated 
where required. Certain defined powers and issues reserved for the Board to decide are, inter alia:

 – strategy; 

 – investments; 

 – approval of financial statements and circulars; 

 – equity and bank financing; 

 – capital projects, acquisitions and disposals; 

 – internal control and risk management; 

 – annual budgets; 

 – Directors’ appointments, service agreements, remuneration and 
succession planning, policies for financial statements, treasury,  
safety, health and environment, donations;

 – Committees’ terms of reference; 

 – Board and Committee Chairs and membership; 

 – corporate governance; 

 – key external and internal appointments; 

 – employee share incentives and pension arrangements; 

 – whistleblowing and review of whistleblowing arrangements; and

 – environmental, social and governance topics.

58

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Governance framework 
Directors’ information and training sessions 2023 Board
January
May
June
July
September
October
December

SBTi update, ERP update, HR update 
IT security update
Insurance – market overview
Risk update
ERP update, strategy update including ESG and policy reviews
Economist briefing and regulatory and corporate governance updates
Health and safety update, risk review, sustainability update, environmental update and corporate 
governance review

Audit Committee

October
May and October
Remuneration Committee
September

BDO Internal Audit Perspectives
PwC updates on regulatory and accounting changes

Remuneration review – market update Deloitte

Accountability
Board information
In advance of Board meetings, Directors are supplied with up-to-date information regarding the trading performance of each operating division 
and subdivision, in addition to the Group’s overall financial position and its achievement against prior year results, budgets and forecasts (where 
appropriate). They are also supplied with the latest available information on environmental, health and safety and risk management issues and 
details of both the Group’s and each division’s health and safety performance, in terms of severity and frequency rates for accidents at work in 
addition to the regular briefings from operational and functional management about Group-specific matters such as reports at each Board 
meeting from the Group Chief Executive and Chief Financial Officer.

Cybersecurity is covered by annual briefings and ad hoc updates by the Chief Information Officer. The Board also has a programme of briefings 
from the Group’s external advisers on a range of topics. This enables current and future plans to be set in the wider context of the 
broader environment.

Decision

ERP programme 

Succession planning

Final dividend for 2022

Acquisition of Lake City

What happened

The Board conducted a deep dive review of the ERP programme to confirm the status and implementation 
progress. This enabled the Board to endorse management‘s recommendations in relation to the ERP 
programme, with consideration given to capital costs, deployment plans and implementation timelines. 

In May 2023, it was announced that Stephen Harris intended to retire from the Board and the Company in 
2024, following an orderly transition to his successor. The Board considered the necessary requirements for 
this role, delegating the remit and process to identify suitable candidates to the Nomination Committee. 

The Board understands the importance of paying dividends whilst taking a prudent view and assuring that 
the Group’s cash position is protected during uncertain times. 

During 2023, the Board considered the acquisition of two specialist technology-focused businesses in the 
US, which were complementary to existing operations and which would expand our geographic footprint  
and customer reach. The acquisition of Lake City Heat Treating, a leading HIP and vacuum heat treatment 
business was completed on 19 January 2024. The acquisition of the other business did not complete due  
to a failure to satisfy all closing conditions to the agreement. 

The Board’s areas of focus in 2024 are expected to include:
 – Reviewing the new Group Chief Executive’s proposals in relation to organisational structure, strategy and market communication;

 – Increased emphasis on the challenges and opportunities arising from climate change, and sustainability and ESG matters more broadly;

 – Group culture; 

 – Board dynamics, diversity and development, aided by an external Board evaluation process;

 – Execution of strategic priorities;

 – Continued monitoring of financial and operational performance; 

 – Continued overview of the ongoing ERP implementation programme;

 – Continued strong focus on safety improvements; 

 – Oversight of the share buyback programme, which will commence in March 2024; and

 – Principal and emerging risks review.

59

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Corporate governance statement continued

Governance Report 
Board and Board Committees meeting attendance 
Each year the Board has a full programme of scheduled meetings, which are supplemented with ad hoc meetings, as required. During 2023, 
the Board met on nine occasions and Director attendance for meetings held during 2023 is set out below. 

All Directors are encouraged to engage actively and effectively during meetings, with scrutiny and constructive debate encouraged. 
Non-executive Directors are able to seek clarification on any key points from management when required. 

Senior Management from across the Group and advisers are routinely invited to attend and present at meetings to provide updates and context. 
This exposure allows specific matters to be brought to the attention of the Board, and for the Board to gain awareness of specific nuances that 
may not always be obvious in written reports. The exposure to members of Senior Management from across the Group helps enhance the 
Board’s understanding of the business, the implementation of strategy and the changing dynamics of the markets in which the Group operates. 
It is also felt this provides the Directors with the opportunity to consider key individuals who have been identified through the succession 
planning process.

Meetings held during the year

Executive Directors
Stephen Harris
Ben Fidler1 (appointed 24 February 2023)

Non-Executive Directors
Daniel Dayan
Patrick Larmon2
Kevin Boyd
Lili Chahbazi3
Beatriz García-Cos Muntañola4 
Cynthia Gordon 

Former Directors
Dominique Yates5
Eva Lindqvist6
Ian Duncan7

Board
Formal meetings
9

Audit  
Committee
4 

Nomination  
Committee
8 

Remuneration  
Committee
5 

Meetings attended Meetings attended Meetings attended Meetings attended
n/a
n/a

n/a
n/a

n/a
n/a

9
8

Meetings attended Meetings attended Meetings attended Meetings attended
n/a
5
5
4
4
5

n/a
4
4
3
1
4

9
9
9
9
4
9

8
7
8
7
3
8

3
3
9

n/a
2
4

n/a
3
7

n/a
2
4

1  Ben Fidler was appointed to the Board with effect from 24 February 2023 and attended all meetings after his appointment. 

2  Patrick Larmon was unable to attend one Nominations Committee meeting due to a pre-existing commitment.

3  Lili Chahbazi was unable to attend the Committee meetings on one occasion due to a pre-existing commitment.

4  Beatriz García-Cos Muntañola was appointed to the Board with effect from 1 September 2023.

5  Dominique Yates stepped down from the Board on 30 April 2023.

6  Eva Lindqvist stepped down from the Board following the AGM on 31 May 2023.

7 

Ian Duncan stepped down from the Board on 17 November 2023.

The Chair and Executive Directors also attended, by invitation, some parts of the Audit, Nomination and Remuneration Committees meetings, 
when relevant. 

There were five Employee Engagement Group meetings held during 2023. These meetings are chaired by Patrick Larmon, and are supported 
by the Divisional Presidents and the Chief Human Resources Officer.

Role and responsibilities of the Board and its principal committees
The Board is responsible to shareholders for good corporate governance, setting the Group’s strategic objectives, values and standards, 
and ensuring the necessary resources are in place to achieve the objectives.

The Board comprised nine members for the majority of 2023 until the retirement of Ian Duncan in November, when the composition dropped to 
eight members. On 11 March 2024, the Board composition returned to nine members following the appointment of Jim Fairbairn as Group Chief 
Executive designate, now comprising six Non-Executive Directors and three Executive Directors, led by the Group’s Non-Executive Chair, 
Daniel Dayan, who also chairs the Nomination Committee. The outgoing Group Chief Executive is Stephen Harris, and the Senior Independent 
Non-Executive Director is Patrick Larmon, who took over the role from Ian Duncan from 31 May 2023. Kevin Boyd is Audit Committee Chair 
and Cynthia Gordon is Remuneration Committee Chair, having taken over this role from Eva Lindqvist from May 2023. Biographical details of 
all Directors in office at 31 December 2023 are given on pages 54 and 55. During the year the Board visited facilities in Surahammar, Sweden 
and Izmir, Turkey. Such events involve meeting with local management and the workforce to understand technical and operational performance 
more clearly in countries where Bodycote has a significant presence.

60

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Proposals for re-election
The Board has decided, in line with the Code, that all Directors will retire annually and, other than in the case of any Director who has decided 
to stand down from the Board, will offer themselves for re-election at each AGM. In accordance with the Articles of Association, all newly 
appointed Directors must submit themselves for election and accordingly, Beatriz García-Cos Muntañola and Jim Fairbairn will stand for election 
at the AGM to be held in May 2024 having been appointed in September 2023 and March 2024, respectively.

Non-Executive Directors, including the Chair, are appointed for fixed terms not exceeding three years from the date of first election by 
shareholders (maximum of two three-year terms), after which their appointment may be extended by mutual agreement on an annual basis.

The Board recommends to shareholders that they elect and re-elect all Directors. Following completion of the annual evaluation process, 
the Board remains satisfied that it continues to operate effectively and, following an assessment of their performance through individual 
reviews, the Chair also confirms in respect of each Director that their performance continues to be effective and that each continues to 
demonstrate commitment to his or her respective role. 

Board evaluation
The Board understands the benefits of annual performance evaluations, both for Directors on an individual basis, as well as for the Board as a 
whole. It continually strives to improve its effectiveness and believes these evaluations can provide a valuable opportunity to highlight strengths, 
identify any weaknesses and therefore drive continuous improvements.

The Code requires the Board to undertake a formal and rigorous annual evaluation of its performance and that of its Committees, with a 
provision requiring that this be externally facilitated every three years. The Board’s last external evaluation was completed in 2021, with the  
next scheduled to be undertaken during 2024.

In accordance with the Code and our three-year cycle, the Chair and the Group Company Secretary internally facilitated this year’s review of  
the Board’s effectiveness. To ensure that all aspects of good governance were covered by the review, a tailored questionnaire was distributed to 
each member of the Board. Questions were framed under the following seven topics:

 – remit and objectives;

 – composition, training and resources;

 – corporate governance/risk management;

 – stakeholder engagement;

 – Board meetings and visits;

 – Board procedures and administration; and

 – evaluation and effectiveness.

The process of the internal Board and Committee evaluation consisted of four steps: a) design and initiation; b) data collection; c) review by 
chairs; and d) discussion and actions. The Board evaluation covered the activities of the main Board and each of its Committees. At a meeting 
of the Nomination Committee in December 2023, the Directors assessed the conclusions reached and are in the process of implementing 
a number of recommendations. Additional emphasis will be placed on succession planning, reviewing longer-term strategy and developing  
a wider approach to ESG. 

Arising from this exercise, the Board concluded that its focus should remain on divisional growth strategies, risk and sustainability, as well as 
continued training. The overall conclusion was that the Board is performing well, with high governance standards adopted. The Executive 
Directors are strongly challenged by the Board when appropriate. 

Led by the Senior Independent Director, the Directors carried out an evaluation of the Chair’s performance in 2023. The Board was satisfied  
with the Chair’s commitment and performance.

Training
Training is provided to employees where and when required, and it is important that Directors continue to develop and refresh their 
understanding of the Group’s activities. Every year, the Board, as part of the organised site visits, meets local operational management, 
allowing the Directors to familiarise themselves with the technologies used, business dynamics, logistics, health and safety standards and 
customers served. Plant visits to Surahammar in Sweden and Izmir in Turkey were undertaken during 2023. The Board is kept informed of 
relevant developments in the Group by way of monthly management reports and the progress of capital projects. 

It is also essential that Directors regularly refresh and update their skills and knowledge with both external and internal training.  
Members of the Board individually attend seminars, conferences and training events to keep up to date on developments in key areas. 
Board meetings include presentations from Group experts to ensure the Directors have access to the wealth of knowledge within  
the Group, as well as presentations and briefings from external providers.

61

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Corporate governance statement continued

The Board structure

Shareholders

Key responsibilities

Chair 

 – Effective running of the Board

 – Monitors progress of strategy and objectives

 – Guidance to Executive Directors

 – Safeguards the interests of shareholders

Key responsibilities

 – Oversight of the Group’s strategy and the 
long-term success of the Group’s business

Board 

Audit  
Committee

Nomination  
Committee

Remuneration  
Committee

Finance 
Committee

Monitors the 
integrity and 
effectiveness of 
the Group’s 
financial reporting 
and performance 
of audits and 
assesses 
financial risks

Ensures an 
effective Board 
that consists of 
individuals with 
the right balance 
of skills, 
knowledge 
and experience

Determines 
remuneration 
policy and senior 
executives’ 
remuneration 
packages

Implementation  
of treasury and 
tax policies and, 
within limits 
defined by  
the Board, 
authorises capital  
expenditure  
and other 
financial activities 

Employee 
Engagement 
Groups

Assist the Board 
as a workforce 
engagement 
mechanism and 
in understanding 
the views 
of employees

Group CEO
 – Responsible for: Risk & 

Sustainability Committee 
and Executive Committee

Risk and  
Sustainability 
Committee

Monitors and 
provides insight  
on risk and 
sustainability 
issues, in particular, 
climate change

Executive  
Committee

Focuses on the 
development and  
implementation  
of the Group’s 
strategy, 
financial structure,  
organisational 
development and 
policies as well  
as reviewing  
financial  
performance

Finance Committee
In order that necessary actions can be taken promptly, a finance 
sub-committee, comprising the Chair, the Senior Independent Director, 
the Group Chief Executive and the Chief Financial Officer is authorised 
to make decisions, within limits defined by the Board, in respect of 
certain finance, treasury, tax or investment matters.

In addition, the Board and the Executive Committee each take every 
opportunity to meet with local employees when visiting different 
business locations. During 2023, the Board visited the Surahammar 
site in Sweden, the Executive Committee visited the Rodengo and 
Madone sites in Italy and the Board and Executive Committee both 
visited the Izmir site in Turkey.

The Employee Engagement Groups
We currently have five Divisional Employee Engagement Groups, 
organised along divisional lines in Europe and North America,  
which meet either in person or virtually at least annually. The Groups 
are chaired by Patrick Larmon, the designated Non-Executive  
Director, with meetings facilitated by Divisional Presidents. 
Representatives from across the business are members of the 
Groups, and participation is rotated at certain intervals to allow a 
variety of opinions and voices to be heard and to ensure continued 
effectiveness. The Board feels that these Employee Engagement 
Groups assist them in understanding the views of employees and 
act as a conduit of information from employees directly to the Board.

Main activities of the Employee Engagement Groups
Participants are encouraged to discuss all aspects of the business 
including views, motivations and conditions of employees of 
Bodycote. This applies to all levels and activities across the Group. 
However, individual grievances or employment conditions of  
individual employees are not part of the remit of the Employee 
Engagement Groups.

The minutes of meetings are submitted with Board meeting  
papers and are presented to the Board by the designated  
Non-Executive Director. 

As a global business with operations in over twenty countries, 
diversity is an integral part of our culture and how we do business. 
The Group recognises the benefits of diversity in its broadest sense 
in strengthening the Board and its decision-making, and appoints 
Directors on the basis of relevant skills, knowledge, personality, 
diversity, and experience. The Group’s intention is always to appoint 
the most suitably qualified candidate to complement and balance the 
current skills, knowledge, experience and diversity of the Board, and 
who will be best able to lead the Company in delivering its long-term 
strategy. The Nomination Committee also considers an individual’s 
capability and capacity to commit the necessary time to the role in 
its recommendations to the Board. 

Bodycote acknowledges the changes introduced by the FCA Listing 
Rules (LR 9.8.6R(9)) relating to diversity at board and executive 
management levels, which require enhanced information to be 
reported and disclosure against targets on the representation of 
women and ethnic minorities. These changes recommend that at  
least 40% of the board are women; at least one of the senior board 
positions of chair, chief executive, senior independent director or  
chief financial officer is held by a woman; and that at least one 
individual on the board is from an ethnic minority background. 
Bodycote has achieved the target of having at least one individual on 
the Board from a minority ethnic background but while representation 
of women on the Board increased from 33% in 2022 to 37.5% as 

62

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 202331 December 2023, the Company has yet not met the updated  
gender diversity targets. The Nomination Committee acknowledges 
the improvements achieved in our Board diversity figures to date and 
will continue to consider gender and ethnic diversity requirements  
as part of its succession planning discussions, especially in relation to 
any vacancies that arise in the senior Board positions over the 
coming years. 

Details of female representation at senior management level and 
across the workforce as a whole are provided in the Sustainability 
Report on page 38, where we also disclose further details about 
the Group’s approach to diversity, equity and inclusion. 

In accordance with LR 9.8.6(10) of the FCA’s Listing Rules,  
the following tables detail the diversity profile of the Board and  
the Executive Committee as at 31 December 2023:

Board and Executive Management diversity

Gender categories 

ONS gender category
Men (including those self-identifying as men)
Women (including those self-identifying as women)
Non-binary
Not specified/prefer not to say

Ethnicity categories

ONS ethnicity category
White British or White Other
Mixed/Multiple ethnic groups
Asian/Asian British
Black/African/Caribbean/Black British
Other ethnic group
Not specified/prefer not to say

No. of Board 
members
5
3
0
0

% of Board
62.5% 
37.5% 
n/a
n/a

No. of Board 
members
6 
1
1 
0
0
0 

% of Board
75.0% 
12.5%
12.5%
n/a
n/a
n/a

No. of senior 
positions on 
the Board 
(CEO/CFO, 
SID or Chair)
4 
0
0
0

No. of senior 
positions on 
the Board 
(CEO/CFO, 
SID or Chair)
4 
0
0
0
0
0

No. in
 executive 
management
8 
5
0
0

% of 
executive 
management
61.5%
38.5%
0
0

No. in 
executive 
management
12 
1
0
0
0
0

% of 
executive 
management
92%
8%
0%
0
0
0

The data was collected by asking the individuals concerned. The reference date used was 31 October 2023, in line with the reference date used 
for completion of the FTSE Women Leaders Review submission. Our Equality, Diversity and Inclusion Policy is available on our website at the 
following address: www.bodycote.com/investors/governance/our-policies.

Shareholder relations
Stakeholder engagement enables the Board to better understand what matters to each stakeholder group, and recognising their differing 
interests is integral to Board discussions and central to the execution of our strategy. The engagement with our stakeholder groups is discussed 
in more detail on pages 18 and 20.

The Group Chief Executive and Chief Financial Officer regularly talk with and meet institutional investors, both individually and collectively, and 
this has enabled institutional investors to increase their understanding of the Group’s strategy and operating performance. Additional sessions 
are also held with stakeholders following the publication of our full-year and half-year financial results. In addition, up-to-date news on the Group 
and its share price, including copies of recent announcements and results presentations, are available to all stakeholders at www.bodycote.com. 

Our Chair, Daniel Dayan, engaged with the top 10 shareholders during 2023 following the announcement of Stephen Harris’ retirement and  
again on the announcement of Jim Fairbairn’s appointment as Group Chief Executive designate. Where requested, meetings took place during 
June, July, October and November 2023. 

We have communicated with existing and potential shareholders in a number of different ways during the year:

March 2023

 – Full year results announcement and results presentations

 – UK shareholder roadshow

 – Annual Report and Accounts and Notice of AGM posted to shareholders and placed on the website

May 2023

 – Trading Update

 – Annual General Meeting

July 2023

 – Half-year results announcement and results presentation 

September 2023

 – UK shareholder roadshows

 – Update on Group Chief Executive appointment with major shareholders

November 2023

 – Trading Update

63

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Corporate governance statement continued

On a regular basis, Bodycote’s financial advisers, corporate brokers 
and financial public relations consultants provide the Directors with 
opinion surveys from analysts and investing institutions following visits 
and meetings with the Group Chief Executive and Chief Financial 
Officer, enabling them to better understand investor sentiment. 
The Chair and Senior Independent Director (SID) are also available  
to discuss any issues not able to be resolved by the Group Chief 
Executive and Chief Financial Officer. On specific issues, such as  
the review of remuneration packages or elevated levels of votes 
against a resolution, the Group has sought, and will continue to seek, 
the views of certain investors.

Director support
All Directors have access to Executive Management and to additional 
information, as is needed, to discharge their duties and responsibilities 
fully and effectively. In addition, the Company also has procedures in 
place for Directors to seek independent professional advice, the cost 
of which is reimbursed by the Group, where they judge it necessary to 
discharge their responsibilities. All Directors have access to the Group 
Company Secretary, and they may also address specific issues with 
the SID. A statement of the Directors’ responsibilities is set out on 
page 92. 

Business ethics and culture
A healthy culture is one in which the Group has a purpose, values  
and strategy that are respected by the Group’s stakeholders and an 
operating environment that is inclusive, diverse and engaging; 
encouraging employees to make a positive difference for stakeholders. 
Corporate culture is guided by the principles against which the Board 
monitors how the culture exists and is viewed by employees. 
These are:

 – Core Values as explained in the Sustainability section on  

pages 35 to 42

or indicate a need for more extensive monitoring. The Audit 
Committee assists the Board in discharging these responsibilities.

The emerging risk review, based around horizon scanning, has 
explored what the future might look like and seeks to identify early 
warning signals. Emerging risks are characterised by their high level 
of uncertainty both in terms of likelihood and potential impact and 
are therefore more difficult to manage or mitigate. The emerging 
risks that have been considered by the Board include geopolitical  
risk, more specifically, the unpredictable geopolitical landscape and 
uncertainty over future global events. More information on emerging  
risk reviews can be found on page 28. 

The Board is satisfied that the Group maintains an effective system 
of internal controls and that there were no significant failings or 
weaknesses in the system. The system was in operation throughout 
2023 and continues to operate up to the date of the approval of this 
report. The key elements of the Group’s system of internal control 
that is monitored by the Board include:

 – Key financial, legal and compliance policies that apply across the 

Group including: Detailed Financial Policies, Group Authority Matrix, 
Anti-Bribery and Anti-Corruption, Anti-Slavery and Human Trafficking, 
Core Values and Code of Conduct. There are also procedures 
in place for the identification, reporting and resolution of potentially 
fraudulent activities.

 – A comprehensive financial planning, accounting and 

reporting framework. 

 – Financial control self-assessments (CSAs) have been developed and 
implemented throughout the Group. The CSAs provide confirmation 
that key internal controls are operating effectively throughout the year. 
The CSAs are verified by IA on a periodic basis and the findings and 
any recommendations from IA are reported to the Executive and 
Audit Committees on a regular basis. 

 – Attitudes as summarised in the Group Policies 

 – An annual internal control self-assessment, with management 

 – Behaviours as stated in the Group’s Code of Conduct

The ongoing implementation of key messages and expectations is 
driven through initiatives overseen by the Executive Committee and 
the divisions. This includes targeted communications and mandatory 
training, with the output reported back to the Board. 

The role of the Board in relation to purpose, strategy, long-term goals 
and stakeholder engagement is key in supporting a healthy corporate 
culture. The Board’s Committees support this role and the Board 
recognises that this continues to be an evolving area.

Accountability
Internal control and risk management
In accordance with the FRC ‘Guidance on Risk Management, 
Internal Control and Related Financial Business Reporting’ the Board 
recognises that it is responsible for the Group’s risk management  
and internal control systems. These systems have been designed to 
manage rather than eliminate the risk of failure to achieve business 
objectives and can only provide reasonable and not absolute 
assurance against material misstatement or loss. The Audit Committee 
assists the Board in the effective discharge of its responsibilities  
for financial reporting, risk management and internal control, with  
the Audit Committee well-placed to challenge the performance of the 
Group‘s financial reporting, risk management and internal control 
systems to safeguard the interests of shareholders,

The Board has embedded a continuous process for identifying, 
evaluating and managing the Group’s significant risks, including 
risks arising out of Bodycote’s corporate and social engagement. 
The Board’s monitoring covers all significant strategic, financial, 
operational and compliance risks. It is based principally on reviewing 
reports from management and from Internal Audit (IA) to consider 
whether any significant failings or weaknesses are promptly remedied 

64

certification, are also undertaken at every Bodycote plant. 
The assessments cover the effectiveness of key financial, compliance 
and selected operational controls. The results are validated by IA 
through audit sampling and are reported to the Executive and 
Audit Committees. 

Bodycote has engaged BDO to monitor and assist in improving the 
Group’s internal control system. IA reviews are conducted on the  
basis of a risk-based plan approved annually by the Audit Committee. 

During 2023, in compliance with Provision 29 of the Code,  
the Executive Committee performed an assessment of its risk 
management processes by holding risk reviews which were 
conducted via an internally facilitated risk workshop and an externally 
facilitated workshop with BDO. Management’s assessment, which 
has been reviewed by the Board, included a review of the Group’s  
key strategic, operational and emerging risks. As a result of the risk 
reviews, it was concluded that there would be no changes to the 
principal risks as at December 2023. Refer to pages 28 to 32 for 
further information on principal risks and uncertainties affecting 
the Group. 

Annual General Meeting
The 2024 AGM will be held on 30 May 2024 in accordance with  
the notice being sent to shareholders under separate cover. 
All resolutions to be considered during the AGM will be conducted  
on a poll, with the results announced to the market as soon as 
practicable after the meeting.

By order of the Board:

A. Broughton
Group Company Secretary
15 March 2024

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Directors’ report

Directors’ report
The Directors are pleased to submit their report and the audited 
financial statements for the year ended 31 December 2023.

Capital structure
Details of the issued share capital are shown in note 22 of the 
consolidated financial statements.

The Chair’s statement, the Group Chief Executive’s review on pages 
10 to 12, the Chief Financial Officer’s report and all the information 
contained on pages 25 to 27, together comprise the Directors’ report 
for the year ended 31 December 2023. For going concern, please see 
the Chief Financial Officer’s statement on page 27 and pages 104  
and 105 of the consolidated financial statements.

Strategic report
The Strategic report is provided on pages 1 to 53 of this Annual 
Report. This is a review of the development of the Group’s businesses, 
the financial performance during the year ended 31 December 2023, 
key performance indicators and a description of the principal risks and 
uncertainties facing the Group.

The Strategic report has been prepared solely to assist the 
shareholders in assessing the Group’s strategies and the potential  
of those strategies. It should not be relied on by any other party for 
any other purpose. Forward-looking statements have been made by 
the Directors in good faith, using information available up to the date 
of this report. Such statements should be regarded with caution due 
to the inherent uncertainties in economic trends and business risks. 
Since the end of the financial year, no significant events affecting 
the business of the Group have occurred.

Dividends
The Board has recommended a final dividend of 16.0p (2022: 14.9p) 
bringing the full year dividend to 22.7p per share (2022: 21.3p). 
If approved by shareholders, the final dividend of 16.0p per share  
will be paid on 6 June 2024 to all shareholders on the register at 
the close of business on 26 April 2024.

Share capital
The Company’s issued ordinary share capital as at 31 December 2023 
was £33.1m. No shares were issued during the year. At the Annual 
General Meeting on 31 May 2023, the shareholders authorised  
the Company to purchase up to 19,145,617 of its own shares. 
This authority will expire at the conclusion of the forthcoming 
Annual General Meeting to be held on 30 May 2024, at which time 
a further authority will be sought from shareholders.

The Company has one class of ordinary shares, which carries no right 
to fixed income. Each share carries the right to one vote at general 
meetings of the Company. There are no specific restrictions on the 
size of a holding nor on the transfer of shares, both of which are 
governed by the general provisions of the Articles of Association and 
prevailing legislation. The Directors are not aware of any agreements 
between holders of the Company’s shares that may result in 
restrictions on the transfer of securities or on voting rights. Details  
of employee share schemes are set out in note 24 and shares held  
by the Bodycote Employee Benefit Trust abstain from voting and  
waive dividend rights. No person has any special rights of control  
over the Company’s share capital and all issued shares are fully paid. 
The appointment and replacement of Directors is governed by the 
Company’s Articles of Association, the UK Corporate Governance 
Code, the Companies Act 2006, and related legislation. The Articles 
of Association may be amended by a special resolution of 
shareholders. The powers of the Directors are described in the 
Corporate governance statement on pages 56 to 64. Under the 
Articles of Association, the Company has authority to issue ordinary 
shares with a nominal value of £11,023,234.

There are a number of other agreements that take effect, alter, 
crystallise, or terminate upon a change of control of the Company 
following a takeover bid such as commercial contracts, bank loan 
agreements, property lease agreements, employment contracts and 
employee share plans. None of these are considered to be significant 
in terms of their likely impact on the business of the Group as a 
whole, and the Directors are not aware of any agreements between 
the Company and themselves or employees that provide for 
compensation for loss of office or employment that occurs because 
of a takeover bid except where specifically mentioned in this report.

Directors
The Directors in office as at 31 December 2023 and their biographies 
are listed on pages 54 and 55 and all apart from Ben Fidler and  
Beatriz García-Cos Muntañola served throughout the year. In line with 
the UK Corporate Governance Code, all Directors retired at the Annual 
General Meeting (AGM) held in 2023 and, save for Eva Lindqvist, 
stood for re-election by the shareholders. All Directors who were in 
office at the year end will retire at the AGM to be held in 2024 and,  
if they wish to continue to serve as Directors of the Company, will 
stand for re-election by the shareholders. Stephen Harris announced 
his retirement on 31 May 2023 and will retire and step down from the 
Board on 30 May 2024. He will therefore not stand for re-election at 
the 2024 AGM. Beatriz García-Cos Muntañola having joined the Board 
on 1 September 2023 will stand for election, having been appointed  
to the Board since the last AGM.  Jim Fairbairn was appointed to  
the Board with effect from 11 March 2024 as Group Chief Executive 
designate, to succeed Stephen Harris from 31 May 2024.  
Jim will stand for election at the 2024 AGM.

Dominique Yates retired from the Board as Chief Financial Officer  
on 30 April 2023 and Eva Lindqvist and Ian Duncan each stepped 
down as Non-Executive Directors on 31 May 2023 and 17 November 
2023 respectively. 

65

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Employee and stakeholder engagement
Information relating to engagement with employees and other 
stakeholders, including customers and suppliers, can be found in  
the Strategic report on page 18 and in the Corporate Governance 
report on pages 62 and 63.

Greenhouse gas emissions
Details of greenhouse gas emissions and Streamlined Energy  
and Carbon Reporting (SECR) are included within the Sustainability 
section of this report on pages 40 and 41.

Donations
There were no political contributions made during 2022 or 2023.

Shareholders
An analysis of the Company’s shareholders and the shares in issue  
as at 29 February 2024 together with details of the interests of  
major shareholders in voting shares notified to the Company pursuant 
to chapter 5 of the Disclosure and Transparency Rules are given on  
page 159.

External auditor
In accordance with the provisions of section 489 of the  
Companies Act 2006, a resolution for the reappointment of 
PricewaterhouseCoopers LLP (PwC) as external auditor is to be 
proposed at the forthcoming Annual General Meeting. Each person 
who is a Director at the date of approval of this Annual Report 
confirms that:

 – as far as each Director is aware, there is no relevant audit information 

of which the Company’s auditor is unaware; and

 – each Director has taken all the steps that he or she ought to have 

taken as a Director to make himself or herself aware of any relevant 
audit information and to establish that the Company’s auditor is aware 
of that information.

This statement is given and should be interpreted in accordance  
with the provisions of section 418 of the Companies Act 2006.

Annual General Meeting
The 2024 Annual General Meeting will be held on 30 May 2024  
in accordance with the notice being sent to shareholders under 
separate cover.

By order of the Board:

A. Broughton
Group Company Secretary
15 March 2024

Springwood Court  
Springwood Close  
Tytherington Business Park  
Macclesfield 
Cheshire 
SK10 2XF

Directors’ report continued

Directors’ interests in contracts and shares
Details of the Executive Directors’ service contracts and details of the 
Directors’ interests in the Company’s shares and share incentive plans 
are shown within the Directors’ report on remuneration on pages 77 
to 91. No Director has had any dealings in any shares or options in  
the Company since 31 December 2023. None of the Directors had a 
material interest in any contract of significance in relation to the 
Company and its subsidiaries at any time during the financial year. 

Qualifying third-party indemnity provisions (as defined by section 234 
of the Companies Act 2006) have remained in force for the Directors 
for the year ended 31 December 2023 and, as at the date of this 
report, remain in force for the benefit of the current Directors in 
relation to certain losses and liabilities which they may incur (or have 
incurred) to third parties in the course of their duties. Apart from  
these exceptions, none of the Directors had a material interest in  
any contract of significance in relation to the Company and its 
subsidiaries at any time during the financial year.

Potential conflicts of interest
During 2008, the duties owed by Directors to a company were  
codified and extended by the Companies Act 2006 so that Directors 
not only had to declare actual conflicts of interest in transactions as 
they arose, but also had a duty to avoid such conflicts whether real  
or potential. Potential conflicts of interest could arise where a single 
Director owes a fiduciary duty to more than one organisation  
(a ‘Situational Conflict’) which typically will be the case where a 
Director holds directorships in more than one company. To ensure all 
Directors have complied with these duties, each Director provided the 
Company with a formal declaration to disclose what, if any, Situational 
Conflicts affected him or her. The Board reviewed these declarations 
and approved the existence of each declared Situational Conflict up to 
September 2024 and permitted each affected Director to attend and 
vote at Bodycote Directors’ meetings, on the basis that each Director 
continued to ensure Bodycote’s information remained confidential,  
and provided overall that such authorisation remained appropriate and 
in the interests of shareholders. Where such authorisation becomes 
inappropriate or are no longer in the interests of Bodycote’s 
shareholders, either the Chair or the Nomination Committee can 
revoke an authorisation. No such revocations have been made.

Employment
The Group recognises the value that can be added to its future 
profitability and strength through the efforts of its employees. 
The commitment of employees to excel is key to the Group’s 
continued success. Through their attendance at, or participation  
in, strategy, production, safety and health meetings at site level, 
employees are kept up to date on the performance and progress  
of the Group, the contribution to the Group made by their site, 
and are advised of any safety and health issues. Employees can  
voice any concerns through the Group’s anonymous and confidential 
Open Door Whistleblowing Helpline, a phone line that can be 
accessed in the local language.

Approximately 3,000 Bodycote employees are connected to  
the Bodycote intranet, which aims to improve knowledge of  
Group activities, and assists greatly with technology exchange 
and coordination.

It is the Group’s policy to give full and fair consideration to  
applications for employment from disabled persons, having regard  
to their particular aptitudes and abilities, and to encourage the training 
and career development of all personnel employed by the Group. 
Should an employee become disabled, the Group will endeavour to 
seek to continue the employment, arranging appropriate retraining  
and adjusting the employee’s work environment where practical. 
An equal opportunities policy is in operation across the Group.

66

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Report of the Nomination Committee

Committee membership

Chair

D. Dayan

Members

K. Boyd

L. Chahbazi1

B. García-Cos Muntañola  
(appointed 1 September 2023) 

C. Gordon 

P. Larmon1

Former  
Members

I.B. Duncan  
(resigned 17 November 2023)

E. Lindqvist  
(resigned 31 May 2023)

Dear Shareholders, 

Attendance 

Main committee responsibilities

8/8

8/8

7/8

3/3 

8/8

7/8

7/7 

3/3

 – Regularly review the structure, size and composition (including the skills, 

knowledge, experience, and diversity) of the Board and make 
recommendations to the Board with regard to any changes.

 – Give full consideration to succession planning for Directors and other 

senior executives.

 – Be responsible for identifying and nominating for the approval of the Board, 

candidates to fill Board vacancies as and when they arise.

1   Ms. Chahbazi and Mr. Larmon were each unable to attend one Nomination Committee meeting due to 

pre-existing appointments.

I am pleased to introduce the Nomination Committee report for 2023, which provides an overview of the work of the Committee and its 
activities during the year. 

Board composition is a key focus for the Committee, to ensure that the Board has the right skills and experience to direct the Company  
in the successful execution of its strategy.

Succession planning remained the focus for the Committee during the year, with the appointment of Jim Fairbairn as Group Chief Executive-
designate to succeed Stephen Harris being the most significant piece of work undertaken. Stephen Harris will step down from the Board at  
the 2024 AGM. On behalf of the Board, I would like to thank Stephen wholeheartedly for his remarkable stewardship of Bodycote over the past 
16 years, marked by his definition of new strategies, determined execution, drive for excellence and leadership of the senior management team, 
all of which have contributed to significant value creation over an extended period.

Ben Fidler was appointed as Chief Financial Officer designate in February 2023 to replace Dominique Yates, who retired from the Board in  
April 2023. Beatriz García-Cos Muntañola was appointed as a Non-Executive Director in September 2023 to succeed Ian Duncan, who stepped 
down from the Board in November 2023 after his nine years’ service as a Non-Executive Director. In May 2023, following the conclusion of the 
AGM, Eva Lindqvist also stepped down from the Board after more than nine years‘ service as a Non-Executive Director. We thank Eva, Ian and 
Dominique for their service and wise counsel. The Committee will continue to focus on ensuring that the composition of the Board remains 
appropriate and that all relevant UK Corporate Governance Code requirements continue to be met. 

I am pleased to confirm that, following an internal review of the effectiveness of our Board and its committees, the Committee continues  
to operate effectively.

Daniel Dayan
Chair of the Nomination Committee

67

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Report of the Nomination Committee continued

Role of the Nomination Committee
The Nomination Committee is a sub-committee of the Board, the principal purpose of which is to review the structure, size and composition  
of the Board, which includes advising on the appointment and, if necessary, removal of Directors. The Committee’s terms of reference,  
which can be found on the Group’s website, include all matters required by the UK Corporate Governance Code (‘the Code’). The terms of 
reference are reviewed annually, with any required changes referred to the Board for approval. No changes were made to the terms of  
reference during the year. 

Recruitment Process

Succession 
planning

Board 
composition

Recruitment

Selection

Interview

Balance 
of skills

 – Vacancy for a Director is identified when one of the existing Directors confirms his/her 

intention to resign or retire, or when it is decided to add another NED to the Board

 – The need for specific knowledge, skills and role behaviours is identified during  

discussions at Nomination Committee meetings

 – External search consultancies with international reach are appointed to assist  

with any search 

 – A sub-committee examines a long list of candidates against the role specifications 

and a shortlist of candidates is identified

 – Candidates are initially interviewed by the Chair and the Group Chief Executive for a 
Non-Executive Director role. The final candidates then meet with all other Directors

 – In order to maximise the effectiveness of the Board, candidates are carefully 

considered ensuring that the Board has the right skills and experiences

Appointment

 – The new Director is announced as joining the Board 

Induction

 – The Committee and the Group Company Secretary play an active part in an induction 
programme, which is tailored to the needs, skills and experiences of the new Director 

Key activities

Board composition/succession planning

Non-Executive Directors

 – Recruited a new Group Chief Executive during 2023, to join  

 – Reviewed continued independence of the Non-Executive Directors

the Board in March 2024

 – Reviewed the Non-Executive Director time commitments and risk 

 – Reviewed and updated succession plans for the Board and 

of over-boarding

Senior Management

 – Recruited a new Non-Executive Director in September 2023  

to succeed a Director retiring from the Board

Diversity

Governance and evaluation

 – Considered the updated diversity requirements required following  

 – Reviewed the Committee’s Terms of Reference

the changes to the UK Listing Rules 

 – Evaluated the Committee’s effectiveness

 – Reviewed the performance of Executive Directors

Director appointment policy
The Committee has developed a formal rigorous and transparent procedure for the appointment of new Directors. Prior to making any 
appointment, the Committee, having evaluated the skills, knowledge, experience and diversity of the Board, determines the qualities and 
experience they require and then prepares a detailed description of the role with a view to appointing the most appropriate candidate. 
The Committee uses open advertising and the services of independent external advisers to facilitate the search, as appropriate.

A long list of candidates is drawn up, from which an appropriate number will be selected for interview. Upon completion of the process, 
the Committee will recommend to the Board the appointment of the preferred candidate.

68

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Board tenure (years)

Board diversity

Board composition

3

2

2

<2

2-3

5-7

1

>10

Female

Male

White

BAME

3

5

6

2

Executive 
Directors

2

Non-executive 
Chair
1

Independent
Non-Executive 
Directors

5

Composition of the Nomination Committee
As recommended by the Code, the Chair of the Board acts as the Chair of the Committee whose members comprise our Non-Executive 
Directors. The Chair cannot chair the Committee when it is dealing with either the succession to the Chair of the Group or the review of his  
or her own performance. Only members of the Committee have the right to attend the Committee meetings. Other individuals and external 
advisers may be invited to attend for all or part of any meeting when it is appropriate. The quorum necessary for the transaction of business  
is two. The Group Company Secretary is secretary to the Committee.

The Committee has the authority to seek any information that is required, from any officer or employee of the Company or its subsidiaries. 
In connection with its duties, the Committee is authorised by the Board to take such independent advice (including legal or other professional 
advice, at the Group’s expense) as it considers necessary, including requests for information from, or commissioning investigations by,  
external advisers.

Board changes 
During 2023, we welcomed Ben Fidler, who joined the Board as Chief Financial Officer designate on 24 February 2023, succeeding Dominique 
Yates, who retired from the Board on 30 April 2023. Ben joined the Group from Rolls-Royce Holdings plc, where he had held a number of senior 
management positions, most recently as Deputy Chief Financial Officer. We also welcomed Beatriz García-Cos Muntañola, who joined the Board 
as an independent Non-Executive Director on 1 September 2023. Beatriz is an experienced Chief Financial Officer, with significant international 
and sector experience, including extensive experience in capital markets. The retirement of Stephen Harris was announced on 31 May 2023 and 
the appointment of his successor, Jim Fairbairn, who joined the Board on 11 March 2024, was announced on 18 October 2023. Stephen will 
retire from the Board on 30 May 2024 after the completion of Jim Fairbairn’s induction and the conclusion of a comprehensive handover process. 

Each of these recruitment processes was led by the Chair, who was advised by two international search consultancies. In relation to Ben Fidler‘s 
appointment, Russell Reynolds were appointed, and for the appointments of Beatriz García-Cos Muntañola and Jim Fairbairn, Egon Zehnder 
were appointed. As part of each search process, the respective search consultancies were instructed to identify candidates who met the skills, 
experience and leadership behaviours required for the relevant roles, recognising that the Committee remains committed to ensuring that any 
Board appointment is filled by the best available candidate, with complementary skills, capabilities, experience and background to address the 
Board’s needs, irrespective of any other consideration. Both Russell Reynolds and Egon Zender were briefed on our diversity policy and were 
required to reflect the policy in the long list submitted to the Committee. Neither Russell Reynolds nor Egon Zehnder have any other 
connections to Bodycote plc that extend beyond executive searches for the Board.

Directors’ induction and training
On appointment to the Board, all Directors undertake a tailored and comprehensive induction programme, which is intended to account  
for each individual’s differing requirements, concentrating on key focus areas. This ensures Directors are fully prepared for their new role,  
taking their background and experience into consideration. Each programme also considers existing expertise and any prospective Board  
or Committee roles.

69

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Report of the Nomination Committee continued

In advance of Jim Fairbairn’s appointment to the Board in March 2024, arrangements were made for him to gain a thorough understanding of  
the Group with plant visits, introductions and briefings organised to ensure he was provided with the opportunity to ask questions relating to 
strategic, financial and operational matters. 

Details of the Board induction programmes undertaken by the three newly appointed Directors are set out below: 

Board induction programme

Topic

Business strategy

Finance

Governance

Legal

IT

Operations

Facilities 

Ben Fidler 
undertaken during 2023

Meetings with Group Chair,  
Group Chief Executive and  
Senior Managers

Beatriz García-Cos Muntañola 
undertaken during 2023

Jim Fairbairn  
undertaken since December 2023

Meetings with Group Chair,  
Group Chief Executive and  
Senior Managers

Meetings with Group Chair,  
Group Chief Executive and  
Senior Managers

Meetings with Group Finance teams, 
including Head of Internal Audit, 
Director of Finance, Group Financial 
Controller and Head of Tax & Treasury.  
Meetings with top shareholders and 
house analysts

Meetings with Chief Financial Officer. 
Meetings with Head of Internal Audit, 
Director of Finance, Group Financial 
Controller and Head of Tax & Treasury 
to be arranged

Meetings with Chief Financial Officer, 
with top shareholders and house 
analysts. Meetings with key members 
of the Group Finance team to be 
arranged

Meeting with Group Chair,  
Company Secretary and the  
Non-Executive Directors

Meetings with the Group Chair  
and Company Secretary

Meeting with Group Chair,  
Company Secretary and the  
Non-Executive Directors

Meeting with General Counsel

Meeting with General Counsel

Meeting with General Counsel

Meeting with Chief Digital Officer

Meeting with Chief Digital Officer

Meeting with Chief Digital Officer

Meetings with the Group Chief 
Executive, Executive Committee 
members and Presidents

Meetings with the Group Chief 
Executive and Executive Committee 
members

Meetings with the Group Chief 
Executive, Executive Committee 
members and Presidents

11 visits have taken place – in the UK, 
US, Sweden and Turkey, with further 
site visits scheduled during 2024

Two visits have taken place, one in 
Turkey and one in Czech Republic, 
with further site visits scheduled 
during 2024

Nine visits have taken place – in the  
US, Czech Republic, Hungary and 
Slovakia. This also included working on 
the shop floor at a plant in California. 
Further site visits have already been 
scheduled during 2024

The Board believes that continuous training and development supports Board effectiveness. The Company is therefore committed to offering 
tailored training to provide each Director with the necessary resources to refresh, update and enhance their skills, knowledge, and capabilities. 
As part of the mandatory training programme, all Directors are required to complete courses which address areas most pertinent to  
Bodycote and their roles on the Board. This covers both statutory obligations and ethical considerations and includes topics such as the legal 
duties of a director, competition law, anti-bribery and corruption, anti-tax evasion, the share dealing code, data protection, IT security,  
and anti-slavery regulations.

Board succession planning
The Committee spent time throughout 2023 considering succession planning across the business. The Committee received papers on  
Executive Director and Senior Management succession, which includes members of the Executive Committee and all Senior Management  
roles within the business. The plans identify immediate successors for these roles as well as the candidates as potential successors to roles  
in the longer-term. The Committee was satisfied that these plans remain sufficiently robust to enable vacancies to be filled on a short- to 
medium-term basis while taking account of the continuing need to consider diversity in its widest form. The Committee acknowledges that  
in a business the size of Bodycote, it is not always possible to identify internal successors for all roles.

The Committee is confident that it has carried out its role effectively during the year and its work will help to ensure that a strong pipeline of 
talented individuals is available to support the Group and meet its future business objectives and fulfil its strategic goals.

70

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Nomination Committee – allocation of agenda time

Board composition and succession planning

Performance of Chairman and Group Chief Executive

Governance and reporting 

Independence and re-election

53%

25%

17%

5%

Main activities of the Nomination Committee
In 2023 the Committee met formally eight times, reviewing the composition and skills of the Board, with a view to considering the current  
and future experience that the Board might require.

During the year, and in accordance with Provision 23 of the Code, the Committee discussed Board diversity and the diversity pipeline and 
reviewed the performance of the Group Chief Executive and other senior executives. In particular, the Committee discussed the Board 
membership with consideration given to gender, ethnicity and age. The Committee has sought to ensure that appointments are of the best 
candidates to promote the success of the Company and are based on merit, with due regard for the benefits of diversity on the Board. 
Further information concerning Board diversity can be found on page 63 as part of the Corporate governance statement. At the date of the 
report, female representation on the Board was 33% due to the overlap of the retiring and incoming Group Chief Executives, however this  
will return to 37.5% following the 2024 AGM. 

Following the external Board evaluation undertaken in 2021, the Board evaluation process this year was internally facilitated. Further details  
on the actions arising from this review can be found on page 61 in the Corporate governance statement of the Annual Report. 

The Committee considered and authorised the potential conflicts of interest which might arise where a Director has fiduciary responsibilities  
in respect of other organisations. The Committee concluded that no inappropriate conflicts of interest exist. The Committee also assigned the 
Chair to review and agree with the Group Chief Executive his personal objectives for the forthcoming year.

In December 2023, the Nomination Committee reviewed the Board’s size and composition, the frequency of the process for Board and 
Committee meetings, and best practice for dealing with Board issues including drawing up training and induction programmes for the Directors. 
The terms of reference of the Committee were reviewed, with a copy available on the Company’s website. The biographical details of the 
Directors in office at 31 December 2023 can be found on pages 54 and 55. The Committee, having reviewed its independence and contribution 
to Board matters, confirms that the performance of each of the Directors standing for re-election at this year’s Annual General Meeting 
continues to be effective and demonstrates commitment to their roles, including independence of judgement and time commitment for  
Board and Committee meetings. Accordingly, the Committee has recommended to the Board that all current Directors of the Company with  
the exception of Stephen Harris who will retire from the Board in May 2024, be proposed for election and/or re-election at the forthcoming 
Annual General Meeting.

As Chair of the Committee, I will be available at the Annual General Meeting on 30 May 2024, to answer any question relating to the work  
of the Committee. Questions can be submitted in advance of the meeting either to the registered office address or to agm@bodycote.com. 
Representative answers will be published on the Company website in due course.

On behalf of the Nomination Committee:

D. Dayan
Chair of the Nomination Committee
15 March 2024

71

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
Report of the Audit Committee

Committee membership
K.J. Boyd
Chair
P. Larmon
Members

L. Chahbazi1

C. Gordon 

B. García-Cos Muntañola  
(appointed 1 September 2023)

Former  
Members

I.B. Duncan 
(retired 17 November 2023)

E. Lindqvist 
(retired 31 May 2023)

Attendance 
4/4
4/4

Main committee responsibilities
 – Encourage and safeguard the highest standards of integrity, financial 

reporting, financial risk management and internal controls.

3/4

4/4

1/1

4/4 

2/2

 – Monitor the integrity of the financial statements including annual and 

half- yearly reports, trading updates and any other formal announcements 
relating to financial performance. Review and report to the Board on 
significant financial reporting issues and judgements.

 – Review the content of the Annual Report and advise the Board whether, 
taken as a whole, it is fair, balanced and understandable and provides the 
information necessary for shareholders to assess the Group’s position  
and performance, business model and strategy. 

 – Monitor and review the adequacy and effectiveness of the Group’s internal 

financial control and risk management systems.

 – Monitor and review the effectiveness of the Group’s Internal Audit function 
and its key findings and trends arising, and the resolution of these matters.

 – Oversee the relationship with the external auditor including approving the 

remuneration, audit scoping and terms of engagement, reviewing outcomes 
of the external audits, ensuring compliance with the policy for the provision 
of non-audit services, conduct the tender process and make 
recommendations to the Board, subject to the approval by shareholders, 
on the appointment, reappointment or removal of the external auditor.

 – Monitor policy on the engagement of the external auditor to supply non-audit 
services, ensuring there is prior approval of non-audit services, considering 
the impact this may have on independence, taking into account the relevant 
regulations and ethical guidance in this regard and report to the Board on any 
improvement or action required.

 – Review and monitor the external auditor’s independence, effectiveness 

and objectivity.

1  Ms. Chahbazi was unable to attend one meeting due 

to a pre-existing commitment.

The full terms of reference for the Committee can be found on the  
Group’s website.

Chairman’s introduction
I am pleased to present the Audit Committee report for the year end 31 December 2023. This report provides an overview of the Committee’s 
key activities and focus areas during the year and the framework within which it operates. 

The Committee fulfils an important oversight role providing effective governance over the Group’s reporting, including the adequacy of related 
disclosures, the management and oversight of the Group’s systems of internal control, the management of financial risks, the performance  
of Internal Audit as well as the appointment and evaluation of the external auditor. During the year, the Committee continued to focus on the 
integrity of Bodycote’s financial reporting, financial risk management, internal controls and on the quality of the external and internal audit 
processes and will continue to keep its activities under review as the regulatory environment changes. 

Kevin Boyd
Chair of the Audit Committee

72

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Committee membership and meetings
The Committee is comprised entirely of independent Non-Executive Directors. Their biographical details are shown on pages 54 and 55,  
and their remuneration on page 86. The Group Company Secretary is the secretary to the Audit Committee. 

Kevin Boyd is Chairman of the Audit Committee. Mr. Boyd is a Chartered Accountant and a Chartered Engineer with substantial experience in 
senior finance roles. The Board considers that Mr Boyd has extensive recent and relevant financial, accounting and sector experience required  
to chair the Committee.

All Committee members have significant and widespread experience in executive and non-executive capacities from either multinational or 
industrial companies and are considered to have competencies relevant to their duties. The expertise the Committee utilises, together with  
their independence, provides good challenge to management as well as the internal and external auditors.

The Committee met four times during 2023 and in March 2024; all members, while in office, attended all of the meetings. The Committee 
Chairman also invited the Board Chair, Group Chief Executive, Chief Financial Officer, Group Director of Finance, Group Financial Controller and 
Group Head of Internal Audit to attend all regular meetings. Other Senior Management from the Group were also invited, as appropriate, to 
attend meetings to provide a deeper level of insight into key issues. Furthermore, the external auditor PricewaterhouseCoopers LLP (PwC) 
attended every meeting, and BDO LLP, which provides internal audit services, also attended one meeting. As part of the process of working  
with the Board to carry out its responsibilities and to maximise effectiveness, regular meetings of the Committee generally take place just prior 
to Board meetings.

Mr Boyd also held preparatory meetings separately with the external auditor, the Chief Financial Officer, the Group Director of Finance, Group 
Financial Controller and the Group Head of Internal Audit before regular Committee meetings to review their reports and discuss issues in detail. 
PwC, the Group Head of Internal Audit and the Internal Auditors (BDO LLP) also met with the Audit Committee without the executives present. 

Main activities of the Committee during the year
The Committee supports the Board in fulfilling its responsibilities regarding financial reporting and assessing the effectiveness of the Group‘s 
financial risk management and internal control systems. The Committee is also responsible for reviewing the Interim results for the half-year  
and the annual report and financial statements before recommending them to the Board for approval. At its meetings, the Committee focused 
on the following main areas:

Financial reporting 
The primary recurring role of the Committee in relation to financial reporting has been to review, with management and the external auditor,  
the appropriateness and integrity of the interim results for the half-year and annual report and financial statements concentrating on, amongst 
other matters:

 – the quality and acceptability of accounting policies and practices including interpretation of reporting standards and the adoption of policies; 

 – the application and impact of significant judgements, accounting estimates and matters where there was a significant discussion with the 

external auditor;

 – compliance with regulatory and governance requirements;

 – the clarity of disclosures and compliance with the relevant accounting standards for the consolidated financial statements;

 – the key points of disclosure and presentation to ensure the adequacy, clarity and completeness in the annual report and financial statements;

 – consideration of the appropriateness of alternative performance measures and the classification of certain costs and revenues as exceptional  

in the annual report and financial statements;

 – whether the annual report, taken as a whole, is fair, balanced and understandable and provides the information necessary for shareholders to 

assess the Group’s strategy, business model and performance; 

 – reviewing with both management and the external auditor to ensure audit scoping was appropriate and that the external auditor had applied  

the necessary level of professional scepticism in performing their work; 

 – reviewing various materials to support the statements on risk management and internal control and related disclosures made in the annual report 

and financial statements on this matter; and

 – considering progress over the Group’s readiness for any changes required by the revised UK Corporate Governance Code, which will include an 

annual declaration on the effectiveness of material internal controls.

Reports from management were reviewed on significant matters, including outstanding litigation and claims, accounting judgements and issues, 
UK and overseas pension reports, business combinations, treasury and tax matters and also reports from the external auditor on the outcome of 
their work. A summary of the areas of focus considered by the Committee in respect of the 2023 consolidated financial statements is set out in 
the table on pages 74 and 75. 

Going concern, viability statement and financial resilience
The Committee receives regular updates from management on the underlying performance of the business, the strength of the Group’s liquidity 
and its operational and financial resilience. The Committee has reviewed the 2023 going concern and viability statements and challenged the 
assumptions, risk assessments, forecasts for profits and cash generation, liquidity, available borrowing facilities and covenant compliance that 
were modelled as part of the scenarios and stress testing undertaken. 

The Committee challenged assumptions related to current and future inflation and changes in energy costs on cash flows ensuring that these 
cash flows include the cost of actions to be undertaken within the time frame under review consistent with the carbon reduction initiatives 
agreed with the Science Based Targets initiative. Sensitivity analyses were undertaken to understand the impact of changes to key variables and 
included severe but plausible downside scenarios and stress testing. The Committee was satisfied that these represented accurate 

73

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Report of the Audit Committee continued

assessments of the Group’s financial position at the date of the consolidated financial statements. For further detail on the going concern and 
viability statements please refer to pages 27 and 33, respectively.

Fair, balanced and understandable
The Committee has reviewed the form and content of the interim results for the half-year and the annual report and financial statements and a 
paper prepared by management setting out the approach taken in their preparation. The review included the consideration of oversight 
throughout the year based on review of regular financial results and reports from both Senior Management and PwC, consideration of regulatory 
and governance requirements for reporting, the process of planning and preparing the annual report and ensuring it contains complete, accurate 
and balanced information, a collaborative approach between all parties required to contribute to the report and the reviews performed to ensure 
feedback was appropriately reflected (including internal and external reviews). 

Based on the activities described above and on robust discussion with both management and the external auditor, the Committee was satisfied 
with the work performed and advised the Board that the annual report, taken as a whole, presents a fair, balanced and understandable view of 
the business and its performance for the year under review and that it provides the information necessary for shareholders to assess the 
Group’s strategy, business model, position and performance.

In addition to these matters, the Committee considered the following significant topics impacting the financial statements:

Area of focus

Actions

Valuation of assets
As set out in the accounting policies, the Group 
performs an impairment test over the carrying amounts 
of goodwill at least annually, whilst tangible and other 
intangible assets are considered for impairment 
indicators. Refer to note 9 of the consolidated 
financial statements.

Restructuring, reorganisation and 
environmental provisions
Assumptions and judgement are exercised in the 
development of restructuring, reorganisation, legal 
and environmental provisions.

Taxation
The Group operates in a number of tax jurisdictions 
and is subject to increasing reviews by different tax 
authorities across the Group in the ordinary course  
of business.

A number of judgements are involved in calculating tax 
provisions and the level of deferred tax assets/liabilities 
to be recognised. 

Provisions are made based on the tax laws in the 
relevant country and the expected outcomes of any 
negotiations or settlements. 

Recognition of deferred tax assets relating to  
future utilisation of accumulated tax losses and other  
tax assets is dependent on future profitability and 
performance of the underlying business.

Refer to notes 6 and 19 of the consolidated 
financial statements. 

The Committee considered reports from management describing potential 
impairment indicators for tangible and intangible assets and the outcome of related 
tests as performed at year end. The annual impairment test was performed for all cash 
generating units with a goodwill balance, as required by accounting standards.

The Committee reviewed these reports and challenged the results including the future 
forecasts underlying the value-in-use calculations, and the assumptions, particularly 
the discount rate and the assessment of future inflationary impacts and growth 
factors used in the discounted cash flow calculations for each cash generating unit 
and the sensitivity analysis applied. 

The Committee considered the adequacy of the disclosures provided. Details of 
sensitivity analysis applied to key assumptions used in the impairment review as 
well as conclusions are set out in note 9 to the consolidated financial statements. 

The Committee was satisfied with the carrying value of assets and goodwill and the 
related disclosures and that no impairment was required as of 31 December 2023.

The Committee received reports from management and reviewed provision utilisation, 
the basis and the completeness of the assumptions used to calculate the provisions 
and the appropriateness of disclosures in the financial statements and concluded that 
the basis of presentation was appropriate. The Committee discussed and challenged 
with management the key judgements behind the provisions, taking note of the range 
of possible outcomes, and was satisfied with the accounting treatment and 
corresponding disclosures on these matters.

The Committee receives regular reports from management about new legislative 
developments that may impact the Group’s tax positions as well as the results of  
both internal and external reviews.

The Committee has focused on reviewing, understanding and challenging the  
Group’s critical tax risks and management’s assessment and valuation of these risks. 

Regular reports have been reviewed from management outlining the Group’s most 
significant tax exposures, including ongoing tax audits and related tax provisions 
recognised by management. The Committee has supported transparency over the 
Group’s tax risks and strategy in external reporting. Key risks, notably in the internal 
cross-border funding arrangements, have been reviewed and challenged including 
management’s views on the future profitability of the relevant businesses. 

The Committee has received and challenged reports over the Group’s preparation for, 
and impact of, the introduction of the global minimum tax rate in 2024 and the work 
on assessing the impact.

The Committee was satisfied with the Group’s tax approach and with the accounting 
treatment and disclosure in respect of tax exposures.

74

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Area of focus

Actions

Retirement benefits schemes
There will often be a range of reasonable assumptions 
and judgements involved in determining pension 
liabilities in relation to the Group’s defined benefit 
schemes including discount rates, mortality and inflation 
(see note 26 of the consolidated financial statements). 
These variables can have a material impact in calculating 
the quantum of the defined benefit pension liability. 

Management obtained independent external specialist advice in determining pension 
liabilities. The Committee reviewed reports prepared by management and key 
assumptions used from external advisers and is comfortable that the fundamental 
assumptions are reasonable. 

The Committee agreed to the treatment and the corresponding disclosures on these 
matters. See note 26 of the consolidated financial statements.

External audit
The Committee is responsible for managing the relationship with the Group’s external auditor on behalf of the Board.

The Committee continues to review and make recommendations with regard to the reappointment of the external auditor each year.  
In making these recommendations, the Committee considers auditor effectiveness and independence, partner rotation and any other factors 
which may impact the external auditor’s reappointment. The Group last undertook a tender for external audit services during 2018 which led  
to the appointment of PwC at the May 2019 Annual General Meeting, replacing Deloitte LLP. 

The Group requires the lead partner to change every five years in order to protect independence and objectivity and provide a fresh challenge to 
the Group. The 2023 audit was Mr. Simon Morley’s fifth and final year as the lead audit partner. As Mr. Morley has reached his maximum tenure, 
he will rotate off the Bodycote audit after the 2023 audit in line with rotation requirements. A successor has been appointed and transition 
commenced during the 2023 audit.

At the October Committee meeting, PwC presented its audit plan for the year end audit. The Committee considered, challenged and agreed the 
scope and materiality to be applied to the Group audit and its components. The Committee considered the scope carefully in respect of smaller 
and more remote locations as well as emerging market locations and noted that the majority of the Group’s local audits are performed by PwC. 
Audit fees for the year were agreed at £2.3m.

Key audit matters and the audit approach to these matters are discussed in the Independent Auditors’ Report (pages 93 to 99), highlighting the 
other significant matters that PwC drew to the Committee’s attention.

Assessment of effectiveness 
The Committee has adopted a formal framework for the review of the effectiveness of the external audit process and audit quality which 
includes the following aspects:

 – assessment of the quality, technical skills and experience of the engagement partners and the audit team;

 – audit approach and scope, including identification of risk areas;

 – quality of reporting to the Committee, the level of challenge and professional scepticism and the understanding demonstrated by PwC  

of the business of the Group;

 – execution of the audit;

 – interaction with management;

 – communication with, and support to, the Committee;

 – insights, management letter points, added value and reports; and 

 – independence and objectivity.

An assessment questionnaire was completed by each member of the Committee, the Chief Financial Officer, the Group Director of Finance  
and the Group Financial Controller as well as other senior personnel involved in the audit at both the corporate and divisional levels. 
Senior management received answers and comments from all questionnaires and consolidated them into a report. The Committee used this 
report to assist in its assessment of the level of external audit effectiveness. Feedback from the process was discussed and considered by the 
Committee and provided to the external auditor and management. The key outputs of this assessment were:

 – No issues were raised concerning the quality of both the audit partner and team in the feedback received.

 – The audit had been well planned and delivered, with work completed and management comfortable that any key findings had been raised 

appropriately, there was active engagement on misstatements and appropriate judgements on materiality.

 – PwC’s reporting to the Committee was clear and included explanations supporting its conclusions.

 – It was considered that there was an appropriate level of challenge during the audit over management’s judgements and assertions of matters 

including critical accounting judgements and key sources of estimation uncertainty.

 – PwC demonstrated a good understanding of the Group and identified and focused on areas of greatest financial reporting risk.

The Committee assessed the effectiveness of management in the external audit process by considering timely identification and resolution of 
areas of accounting judgement, the quality and timeliness of papers analysing those judgements and other documents provided for review by 
the external auditor and the Committee.

The Committee considered the UK Financial Reporting Council’s (FRC) 2022/23 report on Audit Quality Inspections which included a review of 
audits carried out by PwC. If the Bodycote audit is selected for quality review, the Committee understands that any resulting reports will be sent 
to the Committee by the FRC – no such review occurred in 2023. After considering all of the relevant matters, the Committee concluded that the 
external audit had been effective and objective. During 2023, the Group complied with The Statutory Audit Services for Large Companies Market 
Investigation (Mandatory Use of Competitive Tender Processes and Audit Committee Responsibilities) Order 2014.

75

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Report of the Audit Committee continued

Safeguarding independence and objectivity
The Committee recognises that the independence of the external auditor is an essential part of the audit framework. The independence of the 
external auditor was formally confirmed by PwC at the March 2023 Audit Committee and was confirmed again in March 2024. The Committee 
considered PwC’s presentation and confirmed that it considered the auditor to be independent.

Non-audit services 
The external auditor may be invited to provide services where their position as auditor renders them best placed to undertake the work.  
In order to safeguard the auditor’s independence and objectivity, and in accordance with the FRC’s Ethical Standard, the Group does not engage 
PwC for any non-audit services except where the proposed services are permissible in the context of the Ethical Standard in the first instance,  
and where it is work that it must, or is clearly best suited to, perform. Non-audit services, regardless of scope, cannot be awarded to the 
external auditor without prior approval from the Committee Chairman, on behalf of the Committee. In addition to the Group’s policy, the auditor 
runs its own independence and compliance checks, prior to accepting any engagement, to ensure that all non-audit work is compliant with the 
FRC’s Ethical Standard and that there is no conflict of interest. The only non-audit fees paid to the auditor in 2023 were for the half-year interim 
review and a subscription to a generic accounting and reporting website and are shown in note 2 of the consolidated financial statements 
representing 5% (2022: 5%) of the audit fee.

Internal audit
The internal audit plan for 2023 was presented to the Committee in October 2022. The plan took into account the Group’s strategic objectives 
and risks and provided the degree of coverage deemed appropriate by the Committee. The Committee reviewed and accepted the plan following 
discussions and challenge as to the scope and areas of focus. The internal audit approach for 2023 was focused on providing assurance over the 
Group’s principal risks and key financial and operational controls. The 2023 plan included an audit of the key reporting controls for Group Finance. 
An internal audit and risk update was provided at each meeting during the year.

At each regular meeting, the Group Head of Internal Audit presented a report to the Committee on the status of the internal audit plan,  
points arising from audits completed and follow-up action plans to address areas of weakness. The status of these actions is monitored closely 
by the Committee until they are completed. The Committee also received reports on actual or suspected frauds and thefts by third parties and 
employees; none had any material financial impact on the Group.

The Group Head of Internal Audit provides independent assurance over the key financial processes and controls in operation across the Group. 
The Group engaged BDO LLP to provide co-sourced internal audit services. 

Internal Audit has provided additional financial control assurance through a number of control self-assessments. Internal auditors have received 
self-certification from every plant that internal controls have been complied with, or noting any non-compliance. The accuracy of returns was 
monitored by Internal Audit by verification visits to a sample of sites. A control self-assessment has also been obtained from each of the 
divisional finance teams, financial shared services, Group IT services and Group finance team. Internal Audit performed audits over a sample  
of returns to confirm their accuracy.

The effectiveness of Internal Audit is reviewed and discussed annually with the Group Head of Internal Audit and the BDO LLP engagement 
partner. Audit quality is assured through a detailed review of each report being carried out by the Group Head of Internal Audit, and a summary 
of each report’s findings being reviewed by the Audit Committee. The review confirmed that the Internal Audit function was independent and 
objective and remained an effective element of the Group’s corporate governance framework. 

Risk management
The Committee reviewed the Group’s financial risk management and internal control systems’ effectiveness through regular updates from the 
Group Head of Internal Audit who has responsibility for monitoring the Group’s risk management and internal controls framework. The Executive 
Committee is responsible for developing the risk framework. 

The Committee reviewed changes to the principal financial risks and mitigating actions identified by management and also monitored the 
emerging risk identification process and provided its support to the Board in concluding that a robust assessment of the principal and emerging 
risks has been undertaken in 2023. Refer to the Principal Risks and Uncertainties report on pages 28 to 32. 

Internal control
The Board has overall responsibility for the effectiveness of the Group’s internal controls framework and is satisfied that the Group maintains an 
effective system of internal controls in relation to the financial reporting process, and that there were no significant failings or weaknesses in the 
system. At each regular meeting, the Committee considered and challenged reports from the internal auditors on internal controls’ effectiveness 
and noted no significant failings or weaknesses. The Committee also performed an annual review of the Group’s internal control processes  
and remains satisfied that management places a strong focus on closing out internal audit actions and ensuring their timely completion. 
The Committee has concluded the internal control system to be effective and in accordance with the Guidance on Risk Management, Internal 
Control and Related Financial and Business Reporting as issued by the FRC (September 2014). Refer to page 64 for further information.

Committee evaluation
The Committee’s activities formed part of an internal review of Board effectiveness which was undertaken in October 2023 and approved by  
the Board in December 2023. The Committee considered it had operated effectively during the year and the Directors indicated a high level of 
satisfaction with the work of the Committee. Based on this, and as a result of the work done during the year, the Committee has concluded  
that it has acted in accordance with its terms of reference and carried out its responsibilities effectively.

On behalf of the Audit Committee:

Kevin Boyd
Chair of the Audit Committee 
15 March 2024

76

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Directors’ report on remuneration

Committee membership

Attendance 

Main committee responsibilities

Chair

C. Gordon (from 31 May 2023)  5/5

Members

K. Boyd

L. Chahbazi1

B. García-Cos Muntañola  
(appointed 1 September 2023)

P. Larmon 

Former  
Members

I.B. Duncan  
(retired 17 November 2023)

E. Lindqvist  
(retired 31 May 2023)

5/5

4/5

4/4 

5/5

4/4 

2/2

1   Ms. Chahbazi was unable to attend one 

meeting due to a pre-existing commitment.

 – Responsibility for setting and reviewing the remuneration policy for  
Executive Directors, Senior Management and the Company’s Chair.

 – Recommend and monitor the level and structure of remuneration for 

Senior Management.

 – Review workforce remuneration and related policies and the alignment  
of incentives and rewards with culture, taking these into account when 
setting the policy for Executive Directors’ remuneration.

 – Approve the design of and determine targets for Executive Directors’  

and other senior executives’ incentive arrangements.

 – Review the design of all share incentive plans for approval by the Board and 
shareholders. Determine whether awards will be made on an annual basis.

 – Appoint remuneration consultants.

Chair’s letter
On behalf of the Board of Directors, and as your new Chair of the Remuneration Committee (‘the Committee’), I am pleased to present our 
Directors’ remuneration report for 2023. Firstly, I would like to express sincere thanks to my predecessor, Eva Lindqvist, for her work with the 
Committee over the last 10 years. She led the Committee through a number of regulatory changes during her tenure and I now look forward  
to taking this position forward over the coming years.

This report is split into the following sections:

 – This letter, which provides an overview of the key decisions made on Directors’ remuneration during the year (pages 77 and 78).

 – The Annual Report on Remuneration, which describes how our Directors’ Remuneration Policy was applied during 2023 and the remuneration 

outcomes for the year (pages 79 to 91).

The Directors’ Remuneration Policy was approved by shareholders at the 2022 Annual General Meeting and became effective from that date. 
There are no proposals to amend the Policy at the Annual General Meeting to be held on 30 May 2024, however we intend to hold a policy 
review during 2024, where input from shareholders will be sought, ahead of submitting our Remuneration Policy for shareholder approval at  
the AGM to be held in 2025. The Committee has addressed the principles prescribed in Provision 40 of the 2018 UK Corporate Governance Code 
(UK Code) when determining the Policy (see page 90).

The full Policy is available on our website at www.bodycote.com/wp-content/uploads/2022/03/Bodycote-annual-report-2021.pdf on page 76.

Executive Director changes
Group Chief Executive
Stephen Harris will step down as Group Chief Executive and retire from the Board and the Company on 30 May 2024, following an orderly 
transition to his successor. The treatment of Stephen Harris’ remuneration arrangements, which have been agreed in accordance with our 
Remuneration Policy, are set out on page 85. 

Jim Fairbairn was appointed as Group Chief Executive designate and as a member of the Board with effect from 11 March 2024, and will take  
up the role as Group Chief Executive on 31 May 2024. Having consulted with our remuneration advisors to ensure the approach taken was in 
accordance with our Remuneration Policy, while being consistent with industry benchmarks and shareholder expectations, the Committee 
agreed the following remuneration arrangements for Jim Fairbairn:

 – An annual salary of £620,000. This has been positioned at the median compared with FTSE 250 companies and is competitively positioned 

compared to industry peers.

 – A one-off relocation allowance of £30,000.

 – A pension opportunity equal to 10% of base salary, which is in line with the level available to the majority of the UK workforce.

 – A maximum annual bonus opportunity of 175% of base salary and a maximum Bodycote Incentive Plan (‘BIP’) opportunity of 175% of base salary, 
which is in line with our Directors’ Remuneration Policy. The 2024 annual bonus will be pro-rated for time served during the year. The 2024 BIP 
award will be pro-rated for time served during the vesting period.

The Committee also agreed to buy out Jim Fairbairn’s in-flight long-term incentive awards, which were forfeited by him on leaving his previous 
employer. Details of the proposed buy-out awards are set on page 80. 

Chief Financial Officer
Dominique Yates stepped down as Chief Financial Officer and retired from the Board and the Company on 30 April 2023. The treatment of 
Dominique Yates’ remuneration arrangements were disclosed in the 2022 Directors’ Remuneration Report.

Ben Fidler was appointed as Chief Financial Officer designate and as a member of the Board on 24 February 2023. He assumed the role of  
Chief Financial Officer on 1 May 2023. As disclosed in the 2022 Directors’ Remuneration Report, the Committee agreed to buy-out Ben Fidler’s 
2022 annual bonus (deferred proportion) and in-flight share incentives, which had been forfeited by him on leaving his previous employer.  
The buy-out awards were granted on 31 March 2023 and details are set out on page 85. 

77

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Directors’ report on remuneration continued

Business performance and incentive outcomes for 2023
The Group delivered good growth in 2023, with further progress in our target end-markets and another year of outperformance in Specialist 
Technologies. Good revenue progress was delivered in the structural growth areas of civil aerospace and medical contributing to strong revenue 
performance. Significant operating profit margin improvement was delivered, helping to drive Group margins to 17.3%, excluding surcharges. 
Headline EPS increased by 13% to 48.4p and return on capital employed rose by 150 bps in the year to 14.8% from 13.3% in 2022.

Bodycote returned to the strong levels of cash conversion which are more typical for the business with headline operating cash flow of  
£139.5m (2022: £112.6m). The cash generation further strengthened the Group’s balance sheet, achieving a net cash position at year end. 
This provides flexibility for a balanced approach to capital allocation in order to drive growth and deliver shareholder value.

We believe that the incentive payouts we have made to our Executive Directors are aligned with the overall performance of the Group.  
As such, the Committee determined that no discretionary adjustments (either upward or downward) would be required from the formulaic 
outcomes of the annual bonus and BIP.

Annual bonus
Headline operating profit and cash flow are currently the key internal financial metrics and therefore form the core annual bonus metrics. 
The Group achieved headline operating profit at constant currency of £130.9m and headline operating cash flow at constant currency of 
£143.7m. The personal scorecard element of the bonus primarily reflects how Executive Directors have delivered on our strategic goals and 
specific critical initiatives. Further details on the outcomes of the personal scorecards are set out on page 83. 

Stephen Harris, Ben Fidler and Dominique Yates earned a bonus equal to 98.2%, 98.6% and 96.1% of maximum respectively. Dominique Yates’ 
bonus was pro-rated for the time served as Chief Financial Officer during 2023. See page 82 for details on the application of the bonus deferral. 

For 2024, the Committee has amended the annual bonus structure, by introducing a new ESG metric. This change recognises the importance 
placed by the Board on the Group’s long-term sustainability goals and takes into consideration the feedback received from stakeholders.

Bodycote Incentive Plan (BIP)
The 2021 BIP awards were based on performance against return on capital employed (ROCE) (50%) and headline earnings per share (EPS) 
(50%) targets over a three-year period ended 31 December 2023. This award vested at 26.9% of the maximum. Further details are set out on 
page 84.

Employee engagement
We operate Employee Engagement Groups (see page 62 of the Corporate Governance Statement), where a wide range of topics are  
actively discussed with employees, including the remuneration and employment conditions of all employees. Feedback from these  
Employee Engagement Groups, alongside information provided by the Human Resources function, on pay and conditions across the Group,  
in addition to employee satisfaction surveys, are considered by the Committee as part of its discussions and decision-making process in  
relation to executive remuneration.

Annual General Meeting (AGM)
Our Annual Report on Remuneration, which summarises the remuneration outcomes for 2023 and explains how we intend to apply the policy 
during 2024 and beyond, will be subject to an advisory shareholder vote at the AGM to be held on 30 May 2024. I will look forward to receiving 
your support at this meeting, where I will be pleased to answer any questions you may have on this report or any of the Committee’s activities.

Conclusion
I trust the information presented in this report enables our shareholders to understand both how we have operated our Directors’ Remuneration 
Policy over the year and the rationale for our decision-making. We believe that the Policy operated as intended and we consider that  
the remuneration received by Executive Directors during the year was appropriate, taking into account Group and personal performance, 
 and the experience of shareholders and employees. 

Cynthia Gordon 
Chair of the Remuneration Committee
15 March 2024 

78

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Annual Report on Remuneration

Implementation of the Policy in 2024
Set out below is a summary of the key elements of the Policy for Executive Directors, together with how the Policy is intended to be 
implemented in 2024.

Salary 

 – Base salaries are reviewed in January every year

 – Stephen Harris will receive a salary of £696,181, an increase  

Key features

Implementation for 2024

 – Salary reviews are based on role,  

experience, performance, internal increases  
and the external market

of 4.5% (2023: £665,245). 

 – Ben Fidler will receive a salary of £522,500, an increase of 4.5% 

(2023: £500,000).

 – In determining the salary increases for Stephen Harris and  

Ben Fidler, the Committee had regard to the average increases 
awarded to employees across the Czech Republic and United 
Kingdom (the respective countries where they each live and work) 
and Western Europe. The average budgeted increases awarded to 
employees was 5% across the Czech Republic, 4.5% across the UK 
and 4.14% across Western Europe. With these increases in mind, 
the Committee considered a 4.5% increase for Stephen Harris and 
Ben Fidler to be appropriate. The Committee also considered 
Stephen Harris’ commitment to ensure a successful transition of the 
Group Chief Executive role, including agreeing to stay in role until 
30 May 2024, when determining his salary increase.

 – Jim Fairbairn was appointed on a salary of £620,000.

Benefits

 – A range of cash benefits and benefits-in-kind

 – In line with benefits provided in 2023.

Pension

 – Contribution to the Company’s defined 
contribution scheme, or cash equivalent

Annual bonus

 – Maximum opportunity of 200%, 175% and 

150% of base salary for the current Group Chief 
Executive, the Group Chief Executive designate 
and Chief Financial Officer respectively

 – At least 70% of the bonus will be based on 

financial performance with the remainder based 
on non-financial strategic and/or 
personal metrics

 – 35% of any bonus earned is ordinarily deferred 

into shares for three years, conditional on 
continued employment

 – The annual bonus is subject to malus and 

clawback provisions as set out in more detail  
in our Remuneration Policy

 – Jim Fairbairn will receive a one-off relocation allowance of £30,000 

following his appointment.

 – Stephen Harris receives a cash equivalent equal to 23.5% of base 

salary. This is aligned with the Company pension contributions of the 
Czech Republic workforce, the country where he lives and works. 

 – Jim Fairbairn and Ben Fidler will receive a cash equivalent equal to 

10% of base salary. This is aligned with the Company pension 
contributions of the United Kingdom workforce, the country where 
they each live and work.

 – Maximum opportunity of 200% of base salary for Stephen Harris, 
pro-rated for the time served as Group Chief Executive Officer 
during the year.

 – Maximum opportunity of 175% of base salary for Jim Fairbairn 

pro-rated for the time served as Group Chief Executive (including as 
designate) during the year.

 – Maximum opportunity of 150% of base salary for Ben Fidler.

 – The annual bonus will be split 65% in respect of headline operating 

profit, 10% in respect of headline operating cash flow, 5% in 
respect of ESG targets and 20% on personal strategic objectives.

 – Performance targets are considered commercially sensitive and will 

be fully disclosed in the 2024 Directors’ Remuneration Report.

Bodycote Incentive 
Plan (BIP)

 – Annual grants up to 200% of base salary, 

 – Maximum opportunity of 175% of base salary for all Executive 

subject to a three-year performance period and 
two-year holding period

Directors. Stephen Harris’ and Jim Fairbairn’s opportunity will be 
pro-rated for time served as Group Chief Executive (including as 
designate) during the vesting period.

 – Awards are based on performance against ROCE (50%) and 
headline EPS (50%) targets over a three-year period ending 
31 December 2026. 

 – Performance targets are set out on page 84.

Shareholding 
requirement

 – Executive Directors are required to build up a 
holding of 200% of base salary over five years

 – Stephen Harris has met the shareholding requirement.

 – Jim Fairbairn and Ben Fidler will work towards building 

 – Post-employment shareholding requirements 

their shareholdings.

also apply

79

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Directors’ report on remuneration continued

2024 BIP awards
The targets for the 2024 BIP awards are disclosed below. The Committee considers the targets to be appropriately stretching taking into account 
internal and external forecasts, the challenging market conditions, and the continued level of uncertainty.

Threshold performance
Target performance
Maximum performance

ROCE for 20261

Headline EPS for 2026

Performance target
15%
19%
21%

Vesting of element 
(% of maximum)
25.0%
57.1%
100.0%

Performance  
target
61.0p
65.0p
69.0p

Vesting of element 
(% of maximum)
25.0%
57.1%
100.0%

1  For the purposes of the BIP, pre-tax ROCE is calculated using actual exchange rates. Capital Employed includes the goodwill existing as at the start of the performance period (1 January 2024) only. 

If headline EPS at the end of the performance period is below 51.8p, then no awards will vest. BIP awards are subject to malus and clawback 
provisions as set out in more detail in our Directors’ Remuneration Policy. Furthermore, the Committee has discretion to amend the vesting 
outcome where it considers that it is not a fair and accurate reflection of business performance, which will include consideration of any potential 
‘windfall gains’ at the point of vesting.

Buy-out awards to be granted to Jim Fairbairn
As noted on page 77, the Committee has agreed to buy out Jim Fairbairn’s in-flight long-term incentive awards which were forfeited by him  
on leaving his previous employer. The Committee, with the support of its remuneration advisors, carried out a detailed review of the in-flight 
long-term incentive awards which were forfeited, including obtaining award certificates and confirmation of values forfeited. Jim Fairbairn  
was due to receive a cash payment of over £1,000,000 in April 2024 from a proportion of his in-flight long-term incentive awards based on 
performance achieved against targets. The expected value of his remaining in-flight long-term incentive awards (based on expected performance 
against targets) was circa £400,000, which were scheduled to vest in April 2025 and April 2026. The Committee has agreed to grant the 
following buy-out award, which will be granted as conditional shares, to Jim Fairbairn:

Tranche 1
Tranche 2
Tranche 3
Total

Grant date face value of award
£620,000
£155,000
£155,000
£930,000

Vesting date of award
11 March 2025 (first anniversary of appointment)
11 March 2026 (second anniversary of appointment)
11 March 2027 (third anniversary of appointment)

The Committee considers that the value and structure of the buy-out award is appropriate and has been determined in accordance with the 
terms of the Directors’ Remuneration Policy (see page 82 of the 2021 Annual Report), noting that the grant date face value of the buy-out award 
is considerably less than the value of the in-flight long-term incentive awards forfeited and the vesting periods of the buy-out award are longer 
compared to the in-flight long-term incentive awards forfeited. This buy-out award will be made in March 2024, following his appointment and 
subject to the Company’s share dealing code restrictions.

Jim Fairbairn will be expected to retain the shares following vesting (net of tax) to support the build-up of his shareholding towards the 
Company’s shareholding requirement. The vesting of awards will be subject to his continued employment. No dividend equivalents will be 
payable in respect of those shares that vest.

80

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Auditable section
This section provides details of remuneration outcomes for Directors who served during the financial year ended 31 December 2023.

Total single figure table

Fixed pay

Variable pay

Financial 
year

Salary/ 
fees 
(£000)

Pension 
(£000)

Taxable 
benefits9 
(£000)

Subtotal 
(£000)

Annual 
bonus10 
(£000)

BIP  
(£000)

Buy-out 
award  
(£000)

Subtotal 
(£000)

Total 
(£000) 

Executive Directors
S.C. Harris

B. Fidler1

Non-Executive Directors
D. Dayan

P. Larmon2

K. Boyd3

L. Chahbazi

C. Gordon4

B. Muntañola5

Former Directors
D. Yates6

I.B. Duncan7

E. Lindqvist8

2023
2022
2023
2022

2023
2022
2023
2022
2023
2022
2023
2022
2023
2022
2023
2022

2023
2022
2023
2022
2023
2022

665
634
422
–

289
275
83
73
79
71
65
62
73
36
22
–

149
425
62
77
33
75

156
149
42
–

–
–
–
–
–
–
–
–
–
–
–
–

35
100
–
–
–
–

41
41
14
–

–
–
–
–
–
–
–
–
–
–
–
–

10
29
–
–
–
–

862
824
478
–

289
275
83
73
79
71
65
62
73
36
22
–

194
554
62
77
33
75

1,306
767
630
–

23111
1812
–
–

–
–
1,03613
–

1,537
785
1,666
–

2,399
1,609
2,144
–

–
–
–
–
–
–
–
–
–
–
–
–

212
374
–
–
–
–

–
–
–
–
–
–
–
–
–
–
–
–

12411
1312
–
–
–
–

–
–
–
–
–
–
–
–
–
–
–
–

–
–
–
–
–
–

–
–
–
–
–
–
–
–
–
–
–
–

336
387
–
–
–
–

289
275
83
73
79
71
65
62
73
36
22
–

530
941
62
77
33
75

Notes accompanying the total single figure table:

1  Ben Fidler was appointed as Chief Financial Officer designate and as a member of the Board on 24 February 2023. He became Chief Financial Officer on 1 May 2023.

2  Patrick Larmon was appointed as Senior Independent Director on 31 May 2023 in succession to Ian Duncan.

3  Kevin Boyd was appointed Chair of the Audit Committee on 25 May 2022 in succession to Ian Duncan.

4  Cynthia Gordon was appointed to the Board on 1 June 2022. She was appointed as Chair of the Remuneration Committee on 31 May 2023 in succession to Eva Lindqvist. 

5  Beatriz García-Cos Muntañola was appointed to the Board on 1 September 2023.

6  Dominique Yates stepped down as Chief Financial Officer on 30 April 2023.

7 

Ian Duncan stepped down from the Board on 17 November 2023.

8  Eva Lindqvist stepped down from the Board on 31 May 2023.

9  Taxable benefits consist of company car (or allowance), family level private medical insurance, life insurance cover and sick pay. 

10  See page 82 for the application of bonus deferral.

11  The BIP awards granted on 15 April 2021 with a performance period ending on 31 December 2023 will vest in March 2024 at 26.9% based on the outcome of the performance targets.  

The estimated value at vesting is based on the average share price from 1 October 2023 to 31 December 2023. Dividend equivalents are included in the estimated value at vesting (S.C. Harris: 
£22,621, D. Yates: £12,137). 

12  The value relating to the BIP awards granted on 23 March 2020 and which vested on 23 March 2023 have been revised from the figures included in the 2022 report from £16,000 to £18,000 in 
relation to the award granted to S.C. Harris, and from £12,000 to £13,000 in relation to the award granted to D. Yates, which are now based on the mid-market closing share price on the vesting 
date of £6.29. The share price at the grant date was £5.32, reflecting a share price increase of £0.97 between the grant date and vesting date. The proportion of value at vesting attributable to share 
price appreciation is therefore 15%. The Committee did not exercise discretion to adjust the vesting outcome in respect of the share price appreciation.

13  As disclosed on page 68 of the 2022 Directors’ Remuneration Report, the Committee agreed to buy out the deferred portion of Ben Fidler’s 2022 annual bonus and in-flight share incentives which 
were forfeited by him on leaving his previous employer. The value of his buy-out award was based on the number of shares subject to the buy-out award (162,417) multiplied by the three-day 
volume weighted average share price for 22, 23 and 24 February 2023 of £6.376. These shares will vest between March 2023 and March 2025.

81

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Directors’ report on remuneration continued

Pension
Stephen Harris and Dominique Yates received a pension contribution or salary supplement in lieu of pension at a rate of 23.5% of base salary. 
Ben Fidler received a pension contribution of 10% of base salary. This is aligned with the Company pension contributions of the workforce 
where the Executive Directors work and live. 

Taxable benefits
The Group provides other cash benefits and benefits-in-kind to Executive Directors as well as sick pay and life insurance. These include the 
provision of company car (or allowance) and family level private medical insurance.

Executive Director
S.C. Harris
B. Fidler
D. Yates

Car/car allowance
£13,600
£10,138
£4,000

Fuel
£2,400
£1,014
£400

Healthcare
£24,525
£2,516
£5,320

Incentive outcomes for 2023 
Annual bonus
The maximum annual bonus opportunity for Stephen Harris, Ben Fidler and Dominique Yates was 200% of salary, 150% of salary and 150% of 
salary, respectively. As disclosed in the 2022 Directors’ Remuneration Report, Dominique Yates was eligible to receive a bonus pro-rated for the 
time served as Chief Financial Officer during 2023.

The annual bonus for 2023 was split 77% in respect of headline operating profit, 10% in respect of headline operating cash flow and 13% on 
personal strategic objectives. These performance conditions and their respective weightings reflected the Committee’s belief that any incentive 
compensation should be linked both to the overall performance of the Group and to those areas of the business that the relevant individual can 
directly influence.

Stretching targets were set in the context of challenging market conditions. Following strong performance in 2023, Stephen Harris, Ben Fidler 
and Dominique Yates earned a bonus equal to 98.2%, 98.6% and 96.1% of maximum respectively. 

For Stephen Harris and Ben Fidler, 35% of the amount earned will be deferred into shares. Ben Fidler’s deferred share award will vest in three 
years subject to continued employment. Stephen Harris’ deferred share award will vest at the time he steps down as Group Chief Executive and 
retires from the Board (see page 85). 

Dominique Yates stepped down as Chief Financial Officer and retired from the Board on 30 April 2023. The Committee agreed to pay any bonus 
earned by him fully in cash at the usual time in 2024. 

The performance targets and actual performance are set out below.

% of  

award Threshold

Target Maximum

Actual 
performance 
achieved1

% of  
max

% of  
salary

% of  
max

% of  
salary

% of  
max

% of 
salary

S.C Harris

B. Fidler

D. Yates2

Headline  
operating profit
Headline operating  
cash flow
Personal  
score card
Total

77%

£107m £115m

£123m

£130.9m

100%

154%

100% 115.5%

100% 115.5%

10% £110.5m £118.5m

£118.5m

£143.7m

100%

20%

100%

15%

100%

15%

13%

see page 83

86% 22.4%
98.2% 196.4%

89%

17.4%
98.6% 147.9%

70% 13.7%
96.1% 144.2%

1  Figures quoted are at constant currency rates.

2  Payout is pro-rated between threshold, target and maximum as follows: Headline operating profit (threshold 0%, target 60%, maximum 100%) and Headline operating cash flow (threshold 0%, 

target and maximum 100%). 

82

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Personal scorecards 

S.C. Harris

Overview

Key achievements 
in the year

Rating

B. Fidler

Overview

For 2023, the Group Chief Executive’s objectives were set with focus on continuing to drive Group 
strategy implementation forward. He was also charged with the development and retention of the 
Group Executive team, including recruitment, on-boarding and training of executives. Leadership of 
the Enterprise Resource Planning (ERP) project was to continue, in addition to systematically 
improving asset management and capital investment implementation.

Following the announcement that he would be stepping down from the Board, the Group Chief 
Executive continued to ensure the management team remained focused throughout the year, 
resulting in the delivery of strong revenue and profitability growth in 2023. He continued to 
strengthen the executive management team, with recruitment of new members completed 
successfully and the new executives successfully onboarded during the year. The focus on driving 
the implementation of Group strategy resulted in expansionary capex increasing by 11% compared 
to 2022, with 80% of this capex focused on the strategic priorities of Emerging Markets, Specialist 
Technologies, Electric Vehicles and Aerospace. Substantial new Electric Vehicle projects were 
secured in the Emerging Markets. Double digit growth was achieved in Aerospace and Specialist 
Technologies. Progress was made on the ERP implementation programme. Overall, he achieved or 
made significant progress on all of his objectives. 

After reviewing his scorecard performance and, in particular taking into consideration the additional 
achievements completed during the year, the Chairman and the Committee agreed with an overall 
rating, which equated to a bonus outcome of 86%.

For 2023 the Chief Financial Officer’s objectives included the development of the Enterprise 
Resource Planning (ERP) project; the establishment of a new London based corporate office; the 
delivery of improvements in Group cash conversion year-on-year; the strengthening of the Group 
Finance function; and the establishment of a revised energy hedging policy.

Link to strategy

3

1

4

2

5

Key achievements 
in the year

The ERP programme was strengthened during 2023, with completion dates advanced, reductions  
in both capex and opex expenditure achieved and a new pilot programme well underway. A new 
London office has been established. Cash flow and cash conversion were substantially improved. 
The bench strength of the Group Finance function was improved and the implementation of a 
revised energy hedging policy framework that better suits increased volatility in the energy markets 
is well underway. 

4

5

Rating

D. Yates

Overview

Mr Fidler’s detailed scorecard was reviewed by the Group Chief Executive and the Committee, 
assessing the achievement of each scorecard objective. Following this review, the Committee 
agreed with the rating, which equated to a bonus outcome of 89%.

For 2023, prior to his departure, objectives set were for Mr Yates relating to the on-boarding of a 
successor which would result in a successful transition. He was charged with the continued 
leadership of the Group Finance function during the transition period and the ongoing leadership of 
the ERP programme, including progress on cost accounting and data warehousing.

Key achievements 
in the year

The new Chief Financial Officer designate joined the Company in February 2023 and following an 
orderly and successful transition process, formally took over the role on 1 May 2023. The ERP 
programme was strengthened during 2023, with implementation progressed. 

5

Rating

The Committee assessed achievement for all personal scorecard objectives, this equated to a bonus 
outcome of 70%.

1

Safety and 
Climate Change

2

Capitalising on and investing 
in our Specialist Technologies

3

Investing in  
Emerging Markets

4

Investing in structural  
growth opportunities

5

Driving operational  
improvement

6

Acquisitions

83

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Directors’ report on remuneration continued

Bodycote Incentive Plan (BIP)
BIP awards vesting during the financial year
BIP awards granted on 15 April 2021 had a three-year performance period ended 31 December 2023, with 50% of the award subject to ROCE 
targets and 50% subject to headline EPS targets. Furthermore, if headline EPS at the end of the performance period was below 36.0p, then no 
awards would vest. The underpin target of 36.0p together with the ROCE threshold target were achieved. The threshold, target and maximum 
targets along with performance achieved and the vesting outcome are set out in the table below. 

Threshold performance
Target performance
Maximum performance
Performance achieved

ROCE for 20231

Headline EPS for 2023

Performance 
target
13.0%
17.0%
19.5%
14.8%

Vesting of element  
(% of max)2
0%
57.1%
100%
12.9%

Performance  
target
42.00p
55.00p
64.00p
48.40p

Vesting of element 
(% of max)2
0%
57.1%
100%
14.1%

1  For the purposes of the BIP, pre-tax ROCE is calculated using actual exchange rates. Capital Employed includes the goodwill existing as at the start of the performance period (1 January 2021) only. 

2   Figures have been rounded to one decimal place. 

The table below sets out the 2021 BIP outcome for Stephen Harris and Dominique Yates.

S.C. Harris
D. Yates

Number  
of shares 
granted
131,106
70,3442

End of 
performance 
period
31 Dec 2023
31 Dec 2023

% award 
vesting
26.9%
26.9%

Number  
of shares 
vesting
35,297
18,938

Dividend 
equivalents
£22,621
£12,137

Total 
estimated 
value of 
awards on 
vesting

End of  
holding 
period
£231,1061 15 Mar 2024 March 2026
£123,9961 15 Mar 2024 March 2026

Vesting  
date

1  The estimated value at vesting is based on the average share price from 1 October 2023 to 31 December 2023 (£5.9066). The share price at the grant date was £7.972.

2  Dominique Yates’ award was pro-rated for time served as Chief Financial Officer during the vesting period.

BIP awards granted during the financial year
Awards consisting of conditional shares were granted to Stephen Harris, Ben Fidler and Dominique Yates on 23 March 2023 equivalent in value 
to 175% of their base salaries. The performance period will end on 31 December 2025. As disclosed in the 2022 Directors’ Remuneration 
Report, Dominique Yates award will be pro-rated for the time served as Chief Financial Officer during the vesting period. 

Awards are subject to continued employment and the achievement of ROCE and headline EPS growth performance targets, as summarised in 
the table below. The Committee considered the targets to be appropriately stretching taking into account internal and external forecasts at the 
time, the challenging market conditions and the continued level of uncertainty faced by the business over the next three years.

Threshold performance
Threshold performance
Maximum performance

ROCE for 20251

Performance target
14.0%
18.9%
20.0%

Vesting of element  
(% of maximum)
0.0%
57.1%
100.0%

Headline EPS for 2025

Performance  
target
56.0p
64.0p
70.0p

Vesting of element 
(% of maximum)
0.0%
57.1%
100.0%

1  For the purposes of the BIP, pre-tax ROCE is calculated using actual exchange rates. Capital Employed includes the goodwill existing as at the start of the performance period (1 January 2023) only. 

If headline EPS at the end of the performance period is below 47.5p, then no awards will vest. Furthermore, the Committee has discretion to 
amend the vesting outcome where it considers that it is not a fair and accurate reflection of business performance. 

Dividend equivalents are payable in respect of those shares that vest. Shares that vest are subject to a two-year post-vesting holding period.

The number of awards that were granted to the Executive Directors during the year is set out below:

S.C. Harris
B. Fidler
D. Yates2

Grant date
23 March 2023
23 March 2023
23 March 2023

Number of  
shares granted
177,625
140,179
119,235

Market price  
at grant date1
£6.242
£6.242
£6.242

Face value  
at grant date
£1,108,735
£874,997
£744,265

1  The three-day volume weighted average share price following the announcement of results for 2022 (20, 21 and 22 March 2023). 

2  Dominique Yates was granted a BIP award of 119,235 shares equivalent to 175% of his salary. This 2023 BIP award was pro-rated for time served as Chief Financial Officer. The number of shares 

granted after the application of the time pro-rating was 13,248, which will remain subject to the achievement of performance conditions. 

84

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Buy-out awards granted to Ben Fidler during the financial year
As disclosed in the 2022 Directors’ Remuneration Report, the Committee agreed to buy out Ben Fidler’s 2022 annual bonus (deferred proportion) 
and in-flight share incentives which had been forfeited by him on leaving his previous employer. The buy-out awards were granted on 31 March 
2023 and have been structured on a like-for-like basis to reflect the value and the remainder of the vesting periods for incentives which were 
forfeited, in accordance with the terms of the Directors’ Remuneration Policy (see page 82 of the 2021 Annual Report). The Committee carried 
out a detailed review of the incentives which had been forfeited, including obtaining award certificates and confirmation of values forfeited. 
Details of the buy-out are as follows: 

Forfeited remuneration
Deferred proportion of 2022 annual bonus that would have vested in  
March 2025 subject to continued employment
2017 performance shares that would have vested in March 2023 subject to  
continued employment
2017 restricted shares that would have vested in March 2023 subject to continued employment
2022 restricted shares that would have vested in March 2024 subject to continued employment
Total

Number of Bodycote 
shares subject  
to the award1

Vesting date  
of award6

63,9062

31 March 2025

2,4373
1,7064
94,3685
162,417

31 March 2023
31 March 2023
8 March 2024

1  The number of shares subject to award was calculated based on a share price of £6.376 being the three-day volume weighted average share price for 22, 23 and 24 February 2023. 

2  The grant date face value is £407,465, which reflects the value of the deferred proportion of the 2022 annual bonus forfeited.

3  The grant date face value is £15,538, which reflects the value (taking into account performance achieved against targets) of the 2017 performance shares forfeited.

4  The grant date face value is £10,877, which reflects the value of the 2017 restricted shares forfeited.

5  The grant date face value is £601,690, which reflects the value of the 2022 restricted shares forfeited. 

6  The vesting of awards is subject to continued employment. No dividend equivalents will be payable in respect of those shares that vest.

Ben Fidler will be expected to retain the shares following vesting (net of tax) to support the build-up of his shareholding towards achievement  
of the Company’s shareholding requirement.

Executive Director changes
Stephen Harris will step down as Group Chief Executive and retire from the Board and the Company on 30 May 2024, following an orderly 
transition to his successor. The treatment of Stephen Harris’ remuneration arrangements is set out in the table below. This has been agreed by 
the Committee, in accordance with the terms of the Directors’ Remuneration Policy (see page 84 of the 2021 Annual Report), taking into 
account his significant contribution to the Group over the last sixteen years and his commitment to ensure a successful transition of the Group 
Chief Executive role.

Element
Base salary, benefits and pension Will continue to receive his salary, benefits and pension until he steps down as Group Chief Executive.
Annual bonus

Agreed treatment

Deferred bonus awards

BIP awards

Other

Will be eligible to receive a bonus equal to 200% of salary for the year ended 31 December 2024 pro-rated 
for time served as Group Chief Executive during the year. Any bonus earned will be paid fully in cash at the 
usual time in 2025, following the assessment of the Group’s performance for the full 2024 year. 
Unvested deferred bonus awards will vest in full following him stepping down as Group Chief Executive on 
30 May 2024. 
Will be granted a BIP award in 2024 equal to 175% of salary pro-rated for time served as Group Chief 
Executive during the vesting period.

Unvested BIP awards will: 

 – continue to vest in accordance with their normal vesting timetable, subject to the achievement of the 

relevant performance metrics; and

 – be pro-rated for time served as Group Chief Executive during the relevant vesting periods.

Any shares that vest will be subject to a two-year post-vesting holding period.
Will be paid a contribution to his legal fees in respect of him stepping down as Group Chief Executive up to 
a maximum of £20,000.

The Committee considers that paying the 2024 annual bonus fully in cash and vesting deferred bonus awards in full following Stephen Harris 
stepping down as Group Chief Executive is appropriate, noting that he has agreed to hold shares equivalent to at least 200% of salary for two 
years following him stepping down as Group Chief Executive. This is in excess of the number of shares that he is required to hold under the 
post-employment shareholding requirement, as this requirement only applies to shares which have been acquired pursuant to deferred share 
awards or BIP awards granted on or after 1 January 2022.

Loss of office 
Dominique Yates stepped down as Chief Financial Officer and retired from the Board and the Company on 30 April 2023. The treatment of his 
remuneration arrangements were disclosed in the 2022 Directors’ Remuneration Report. As set out on page 84, Dominique Yates was granted  
a BIP award in March 2023 of 119,235 shares equivalent to 175% of his salary. This award was subsequently pro-rated for time served as Chief 
Financial Officer during 2023. The number of shares granted after the application of the time pro-rating was 13,248 shares, which will remain 
subject to the achievement of performance conditions. 

Payments to past Directors
No payments to past Directors were made during the year.

85

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Directors’ report on remuneration continued

Chair and Non-Executive Directors’ fees
Chair of the Board and other Non-Executive Directors fees were as follows:

Base fee for Non-Executive Chair
Base fee for Non-Executive Directors
Remuneration Committee Chair/Audit Committee Chair
Senior Independent Director
Chair of Employee Engagement Groups

Fee for 2023
£288,750
£65,477
£13,650
£10,805
£10,805

Fee for 2022
£275,000
£62,359
£13,000
£10,291
£10,291

% increase
5%
5%
5%
5%
5%

At 31 December 2023 the aggregate annual fees for all Non-Executive Directors, including the Chair, was £744,172, which is below the 
maximum aggregate fee allowed by the Company’s Articles of Association of £1,000,000 p.a.

Directors’ shareholdings and scheme interests
The Board operates a shareholding retention policy under which Executive Directors and other senior executives are expected, within five years 
of appointment, to build up a shareholding in the Company. For the purposes of this requirement, only beneficially owned shares and the net of 
tax value of unvested share awards which are not subject to performance conditions will be counted.

The shareholding requirement for the Executive Directors is 200% of salary.

The interests in ordinary shares of Directors and their connected persons as of 31 December 2023 (or date of stepping down from the Board  
if earlier), including any interests awarded under the annual bonus or BIP and buy-out awards granted to Ben Fidler, are presented below along 
with whether Executive Directors have met the shareholding guidelines.

Executive Directors
S.C. Harris (200% of salary min. holding 
requirement)
B. Fidler (200% of salary min. holding 
requirement)2
Non-Executive Directors
D. Dayan
P. Larmon
L. Chahbazi
K. Boyd
C. Gordon
B. Muntañola3
Former Directors
D. Yates (200% of salary min. holding 
requirement)4
I.B. Duncan5
E. Lindqvist6

Counted towards the  
shareholding requirement

Not counted towards the 
shareholding requirement

Beneficially 
owned

Deferred shares 
granted  
under the  
annual bonus1

Unvested  
buy-out  
awards1

Shares  
subject to  
performance  
conditions BIP2

Shareholding 
requirement  
met

485,085

102,0367

–

461,9299

–

61,500
15,000
– 
8,800
1,708
–

351,317
–
12,200

–

–
–
–
–
–
–

51,4747
–
–

158,2748

–
–
–
–
–
–

–
–
–

–

–
–
–
–
–
–

130,5629
–
–

Yes

No

n/a
n/a
n/a
n/a
n/a
n/a

Yes
n/a
n/a

1  Vesting of the deferred shares granted under the annual bonus and unvested buy-out awards are subject to continued employment only.

2  Ben Fidler was appointed as Chief Financial Officer designate and as a member of the Board on 24 February 2023 and became Chief Financial Officer on 1 May 2023.

3  Beatriz García-Cos Muntañola was appointed to the Board on 1 September 2023.

4  Dominique Yates stepped down as Chief Financial Officer on 30 April 2023.

5 

Ian Duncan stepped down from the Board on 17 November 2023.

6  Eva Lindqvist stepped down from the Board on 31 May 2023.

7  Figures relate to deferred shares granted in 2022 and 2023. 

8  Ben Fidler was granted 162,417 shares under a buy-out award (see page 85). 4,143 shares vested during 2023 and these are currently held by the Employee Benefit Trust. 158,274 shares 

remain unvested.

9  Figures relate to unvested awards granted under the BIP in 2021, 2022 and 2023. For Dominique Yates, the outstanding awards have been prorated to his date of leaving. The BIP awards granted 

on 15 April 2021 will vest at 26.9% of maximum in March 2024.

As at 15 March 2024, the Company has not been advised of any changes to the interests of Directors and their connected persons as set out  
in the above table.

86

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Summary of outstanding share awards, including share awards granted during the year – Executive Directors
The interests of the Executive Directors in the Company’s share plans as at 31 December 2023 (or date of stepping down from the Board if 
earlier) are as follows. 

BIP

Deferred  
bonus shares

Buy-out awards

S.C. Harris
B. Fidler1
D. Yates2
S.C. Harris
B. Fidler1
D. Yates2
B. Fidler1

Interests as at  
1 January 2023
467,915
–
328,610
96,077
–
50,196
–

Granted in 
year
177,625
140,179
119,235
42,9884
–
21,0064
162,417

Vested  
in year
2,623
–
1,892
37,029
–
19,728
4,143

Interests  
as at  
31 December 
2023
461,9293
140,179
130,5623
102,036
–
51,474
158,274

Lapsed  
in year
180,988
–
315,3912
–
–
–
–

1  Ben Fidler was appointed as Chief Financial Officer designate and as a member of the Board on 24 February 2023 and became Chief Financial Officer on 1 May 2023.

2  Dominique Yates stepped down as Chief Financial Officer on 30 April 2023. All outstanding BIP awards have been pro-rated for time served as Chief Financial Officer during the relevant  

vesting periods. The number of shares lapsed in the year included in the table is after the application of time pro-rating.

3  The BIP awards granted on 15 April 2021 will vest at 26.9% of maximum in March 2024.

4  The grant date face value of the deferred bonus shares granted on 23 March 2023 is £268,331 for Stephen Harris and £131,119 for Dominique Yates. This is based on a share price of £6.242,  

being the three-day volume weighted average share price following the announcement of the 2022 year-end results (20, 21 and 22 March 2023). 

End of auditable section

Comparison of overall performance and pay
The chart below shows the value over the last 10 financial years of £100 invested in Bodycote plc compared with that of £100 invested in the 
FTSE All Share Industrial index. The Committee has chosen this index as it is a broad market index of which Bodycote plc is a constituent and 
reflects the wider sector in which the Group operates. The points plotted represent the values at each financial year end.

Historical TSR performance
Growth in the value of a hypothetical £100 holding over 10 years 

£300

£250

£200

£150

£100

£50

£0

Dec 13 Dec 14

Dec 15

Dec 16

Dec 17

Dec 18

Dec 19

Dec 20

Dec 21

Dec 22

Dec 23

Bodycote TSR

FTSE All Share 
Industrial Index

The table below shows how total remuneration for the Group Chief Executive, Stephen Harris, developed over the last 10 years.

Single figure of remuneration (£000)
Annual bonus (% of max)
Long-term incentive (% of max)

2014
1,803
73%
44%

2015
771
20%
0%

2016
875
19%
0%

2017
2,280
98%
48%

2018
2,728
68%
89%

2019
1,862
50%
84%

2020
783
0%
0%

2021
1,969
96%
0%

2022
1,608
61%
1%

2023
2,399
98%
27%

87

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
Directors’ report on remuneration continued

Percentage change in remuneration
The table below sets out the annual percentage change in remuneration for each of the Directors compared to that for an average employee.

% change in salary/fees 

% change in benefits 
2019/20 2020/21 2021/22 2022/23 2019/20 2020/21 2021/22 2022/23 2019/20 2020/21 2021/22 2022/23

% change in annual bonus 

Executive Director
S.C. Harris
B. Fidler1
D. Yates2
Non-Executive Directors
D. Dayan3
P. Larmon4
L. Chahbazi
K. Boyd5
C. Gordon6
B. Muntañola7
I.B. Duncan8
E. Lindqvist9
Average employee10

7.0% 2.0% 4.0% 5.0%
–
1.2% (65%)

–
2.3% 2.0%

–

–

2.8% 0.1%
–
0.8% (0.5)%

–

1.6% 3.9% (100%)
–
(100%)

–
0% (65%)

–

100% (35%)
–
100% (35%)

–

70.4%
–
(43%)

–

–

–

–

–

–
5.0%
3.0% 2.0% 3.0% 14.0% (83.2%) 1,935% (100%)
19% (100%)
3.0% 2.0% 3.0% 5.0% (70.6%)
(100%)
2.0% 17.3% 11.0%
–
5.0%
–
–
–
–
–
–
(61.5%)
3.0% 2.0% (4.4%)
23.4% (100%)
(19%)
3.0% 2.0% 6.8% (56%)
(93.3%) 3,985% (100%)
5.7% 6.9%
4.1% 2.9%

–
–
–
–
–
–
–
–
10% 9.8% 10.8% (100%)

(8.3%)
–
–

–
–
–
–
–
–
–
–

2.4%

–
–
–

–
–

–
–
–
–
–
–
–
–

–
–
–
–
–
–
–
–
100% (9.2)% 6.9%

–
–
–
–
–
–
–
–

1  Ben Fidler was appointed as Chief Financial Officer designate and as a member of the Board on 24 February 2023 and became Chief Financial Officer on 1 May 2023.

2  Dominique Yates stepped down as Chief Financial Officer on 30 April 2023.

3  Daniel Dayan was appointed as Chair to the Board on 1 January 2022.

4  Patrick Larmon was appointed as Senior Independent Director on 31 May 2023 in succession to Ian Duncan.

5  Kevin Boyd was appointed to the Board on 1 September 2020. He was appointed as Chair of the Audit Committee on 25 May 2022 in succession to Ian Duncan.

6  Cynthia Gordon was appointed to the Board on 1 June 2022. She was appointed as Chair of the Remuneration Committee on 31 May 2023 in succession to Eva Lindqvist. 

7  Beatriz García-Cos Muntañola was appointed to the Board on 1 September 2023.

8 

Ian Duncan stepped down from the Board on 17 November 2023.

9  Eva Lindqvist stepped down from the Board on 31 May 2023.

10  The annual percentage change of the average remuneration of the listed parent entity employees (excluding Directors), calculated on a full-time equivalent basis.

11  Percentage change in Benefits is calculated on unrounded figures. 

12  No bonuses were paid to Executive Directors or the Company’s employees in respect of 2020.

Pay ratio of Group Chief Executive to UK average employee
The table below sets out the Group Chief Executive’s remuneration as a ratio against the full-time equivalent remuneration of the 25th, 50th 
(median) and 75th percentile UK employees.

Year
2023
2022
2021
2020
2019

Method
Option A
Option A
Option A
Option A
Option A

25th percentile 
pay ratio
71:1
52:1
69:1
28:1
70:1

Median 
pay ratio
56:1
41:1
52:1
21:1
55:1

75th percentile 
pay ratio
39:1
28:1
36:1
15:1
40:1

The Group Chief Executive’s remuneration is calculated on the same basis as the single figure of remuneration table set out on page 81.  
A substantial proportion of the Group Chief Executive’s total remuneration is performance-related and delivered in shares. The ratios will 
therefore depend significantly on the Group Chief Executive’s annual bonus and BIP outcomes, which may fluctuate year to year.  
The calculations for the representative employees were performed as at the final day of the relevant financial year.

Option A methodology was selected on the basis that it is considered to be a robust approach and is aligned with best practice and 
investor expectations. 

2023 pay ratios have increased from 2022, returning to a more normal level, due to an increase in the Group Chief Executive’s total 
remuneration. The increase in 2023 is primarily explained by the higher bonus outcome achievement of 98.2% of maximum opportunity 
(2022: 61%) and higher BIP outcome achievement of 26.9% of maximum opportunity (2022: 1%). In 2023 the proportion of the Group Chief 
Executive’s bonus and BIP was 64% of total remuneration, in 2022 the Group Chief Executive’s bonus and BIP remuneration equated to  
49% of total remuneration.

Our broad remuneration policy reflects the diversity of cultures, legislative environments and employment markets of our geographical spread. 
However, in line with the UK reporting regulations we have reported solely on the UK employee population. The Board believes that the median 
pay ratio is consistent with the pay, reward and progression policies for the UK employee population.

88

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Total pay and benefits used to calculate the ratios
The table below sets out the UK employee percentile pay and benefits used to determine the above pay ratios and the salary component for 
each figure.

2023

Total pay and benefits
Salary component

Group Chief 
Executive
(£)

2,399,484 
665,245

25th percentile1,2
(£)

Median1,2
(£)

75th percentile1,2
(£)

33,712
32,147

42,542
40,355

61,294
54,612

1  The UK employee percentile total pay and benefits has been calculated based on the amount paid or receivable for the relevant financial year. The calculations are on the same basis as required for 
the Group Chief Executive’s remuneration for single figure purposes. For pension-related benefits, employer pension costs have been estimated using the employer contribution rates applicable to 
the member’s pension scheme. No other estimates or adjustments have been used in the calculations and no remuneration components have been omitted.

2  For employees employed on a part-time basis, their remuneration has been annualised to reflect the full-time equivalent.

Relative importance of pay spend 
The table below sets out the total expenditure in relation to staff and employee costs and distributions to shareholders in 2022 and 2023.

Staff and employee costs
Distribution to shareholders

2023 
(£m)
307.5
40.6

2022 
(£m)
276.5
38.5

%  
change
 11.2%
5.5%

Committee membership
The Committee was chaired by Eva Lindqvist from 1 January to 31 May 2023. Cynthia Gordon was appointed Chair from 31 May 2023. 
The Committee also comprised Patrick Larmon, Kevin Boyd, Lili Chahbazi, Beatriz García-Cos Muntañola (from the date of her appointment  
to the Board on 1 September 2023) and Ian Duncan (to the date he stepped down from the Board on 17 November 2023). The Committee’s  
full terms of reference are available on the Group’s website. No Committee members have any personal financial interest (other than as a 
shareholder), conflict of interest, cross-directorships or day-to-day involvement in the running of the business. 

Committee activities
During 2023 the Committee met five times to consider, amongst other matters:

Theme
Best practice

Agenda items
 – Consideration of feedback from shareholders and proxy agencies following the 2023 AGM

Executive Directors’ and senior 
executives’ remuneration

CEO succession
Reporting

 – Update on market practice and corporate governance
 – Base salary increases

 – Granting annual bonus and BIP awards, including the setting of targets

 – Assessment of annual bonus and BIP outcomes
 – Remuneration decisions in relation to CEO succession
 – Consideration and approval of the Directors’ Remuneration Report

Service contracts and letters of appointment
Executive Directors are employed under service contracts of employment, the principal terms of these service contracts are set out below: 

Name 
B. Fidler

D. Yates

Position 
Chief Financial Officer 
(with effect 1 May 2023)

Chief Financial Officer 
(retired 30 April 2023)

Effective date  
of contract
28 October 2022

Notice period

From Company
12 months

From Director
12 months

1 November 2016

12 months

12 months

Termination 
Company has right to terminate on payment 
of a termination payment

Company has right to terminate on payment 
of a termination payment

89

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Directors’ report on remuneration continued

The Chair and Non-Executive Directors have letters of appointment that set out their duties and responsibilities. They do not have service 
contracts. The key terms of the appointments are set out below: 

Position 
Name
Chair
D. Dayan 
Senior Independent Director
P. Larmon
Non-Executive Director
K. Boyd
Non-Executive Director
L. Chahbazi
C. Gordon
Non-Executive Director
B. Muntañola Non-Executive Director

Date of original appointment
1 January 2022
13 September 2016
1 September 2020
1 January 2018
1 June 2022
1 September 2023

Date of last reappointment at AGM           Notice period
2023
2023
2023
2023
2023
–

6 months
6 months
6 months
6 months
6 months
6 months

In accordance with the Code, all Directors will seek annual reappointment by shareholders at each AGM. Service contracts and letters of 
appointment are available for inspection at the Company’s registered office during normal business hours.

Addressing the factors in Provision 40 of the 2018 UK Corporate Governance Code 
Our Policy is designed to support an effective pay-for-performance culture which enables the Company to attract, retain and motivate Executive 
Directors who have the necessary experience and expertise to execute our strategy and deliver value to shareholders. Below is an explanation 
of how the Committee has addressed the principles prescribed in Provision 40 of the UK Code when determining the Remuneration Policy.

Principle

How the Committee has addressed the principle

Clarity and simplicity

The Committee ensures that remuneration arrangements are transparent, comprising a simple incentive structure 
made up of fixed, short-term and long-term variable pay, that is commonplace in the market and best practice 
remuneration provisions. These elements provide a clear line of sight for both executives and shareholders with the 
variable pay elements providing stretching targets to drive the success of the business. 

Risk

Predictability

Proportionality

The Committee promotes long-term sustainable performance through sufficiently stretching performance targets, 
whilst ensuring that the incentive structure does not encourage Executive Directors to take inappropriate risks. 
Executive Directors are subject to within-employment and post-employment shareholding guidelines to further 
support sustainable decision-making. 

The Committee has recourse to recover incentive payments in certain circumstances.

The ‘illustration of application of remuneration policy’ charts included on page 80 of our 2021 Annual Report indicate 
the potential values that may be earned through the remuneration arrangements to provide transparency around 
overall opportunities.

The Committee believes that the Remuneration Policy table clearly sets out how each element of remuneration  
links to the delivery of strategy. The disclosure of BIP performance targets provides a clear link between incentives 
and the long-term performance of the Company and the shareholder value created. 

The Committee has discretion to adjust incentive outcomes so that they fairly and accurately reflect the performance 
of the Company over the relevant performance period.

Alignment to culture

The Committee believes that the incentive arrangements are consistent with the Company’s values:

Honesty and Transparency: The incentive arrangements are simple, transparent  
and in line with market practice, facilitating understanding by all stakeholders.

Respect and Responsibility: The Committee has recourse to recover incentive payments in certain circumstances. 

Creating Value: The incentives are calibrated to reward participants for delivering exceptional performance. 
The Committee reviews all outcomes for Executive Directors and has discretion to adjust outcomes 
where appropriate. 

90

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Advisers to the Committee
During the year, the Committee received independent advice on executive remuneration matters from Deloitte LLP (Deloitte), which was 
formally appointed as Committee advisers from 1 January 2020, following a competitive tender process. Deloitte is a founder member of the 
Remuneration Consultants Group and as such, voluntarily operates under its Code of Conduct in relation to executive remuneration in the UK. 

The Committee reviews the objectivity and independence of the advice it received from its remuneration consultants at a private meeting  
each year. The Committee is satisfied that the advice provided by Deloitte on executive remuneration is objective and independent, and that  
no conflict of interest arises as a result of these services. 

The fees paid to Deloitte for its services to the Committee during the year, based on time and expenses, amounted to £47,750 excluding VAT. 
Deloitte also provided employee share plan advisory services, business tax services and financial advisory services to the Company during  
the year. 

The Committee also received assistance from the Group Chief Executive and Group Company Secretary, although they do not participate  
in discussions relating to the setting of their own remuneration. The Committee consulted with the Group Chief Executive and received 
recommendations from him in respect of his direct reports.

Statement of shareholder voting and shareholder engagement
The table below sets out the voting results of the advisory vote of the 2022 Directors’ remuneration report received at the AGM held on 
31 May 2023.

Annual Report on Remuneration including within the Directors’ remuneration report

Number of votes cast (excluding abstentions)
163,835,669

For
97.1%

Against
2.9%

Abstentions
7,715

The table below sets out the voting results in respect of the resolution to approve the Directors’ Remuneration Policy at the 2022 AGM.

Remuneration Policy report 

Number of votes cast (excluding abstentions)
120,988,831

For
77%

Against
23%

Abstentions
11,802,612

The Committee recognises that more than 20% of votes were cast against this resolution at the AGM held in 2022. As a result, and in 
accordance with Provision 4 of the Code, engagement with key investors and proxy advisors was undertaken to better understand the views 
expressed. It was recognised that while the majority of shareholders were supportive of the key remuneration recommendations, the concerns 
raised primarily related to the Committee’s approach to enshrining localised salary increases and pension positioning for Executive Directors 
within the Remuneration Policy. The context and rationale taken by the Committee was explained and it was confirmed that the approach taken 
remained fully consistent with typical market practice, with all amounts made in accordance with policy and in line with the Code. 

As noted on page 77, ahead of submitting our Remuneration Policy for shareholder approval in 2025, a policy review will be undertaken,  
with input sought from shareholders during 2024.

Cynthia Gordon
Chair of the Remuneration Committee
15 March 2024

91

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Directors’ responsibilities statement

Statement of Directors’ responsibilities in respect of the financial statements
The Directors are responsible for preparing the Annual Report and the financial statements in accordance with applicable law and regulation.

Company law requires the Directors to prepare financial statements for each financial year. Under that law the Directors have prepared the 
Group financial statements in accordance with UK-adopted international accounting standards and the Company financial statements in 
accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards, comprising FRS 101 
‘Reduced Disclosure Framework’, and applicable law).

Under company law, Directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the  
state of affairs of the Group and Company and of the profit or loss of the Group for that period. In preparing the financial statements,  
the Directors are required to:

 – select suitable accounting policies and then apply them consistently;

 – state whether applicable UK-adopted international accounting standards have been followed for the Group financial statements and United 
Kingdom Accounting Standards, comprising FRS 101, have been followed for the Company financial statements, subject to any material 
departures disclosed and explained in the financial statements;

 – make judgements and accounting estimates that are reasonable and prudent; and

 – prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Group and Company will continue 

in business.

The Directors are responsible for safeguarding the assets of the Group and Company and hence for taking reasonable steps for the prevention 
and detection of fraud and other irregularities.

The Directors are also responsible for keeping adequate accounting records that are sufficient to show and explain the Group’s and Company’s 
transactions and disclose with reasonable accuracy at any time the financial position of the Group and Company and enable them to ensure that 
the financial statements and the Directors’ Remuneration Report comply with the Companies Act 2006.

The Directors are responsible for the maintenance and integrity of the Company’s website. Legislation in the United Kingdom governing the 
preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

Directors’ confirmations
The Directors consider that the Annual Report and accounts, taken as a whole, is fair, balanced and understandable and provides the information 
necessary for shareholders to assess the Group’s and Company’s position and performance, business model and strategy.

Each of the Directors, whose names and functions are listed in the Governance Report, confirm that, to the best of their knowledge:

 – the Group financial statements, which have been prepared in accordance with UK-adopted international accounting standards, give a true and  

fair view of the assets, liabilities, financial position and profit of the Group;

 – the Company financial statements, which have been prepared in accordance with United Kingdom Accounting Standards, comprising FRS 101, 

give a true and fair view of the assets, liabilities and financial position of the Company; and

 – the Strategic report includes a fair review of the development and performance of the business and the position of the Group and Company, 

together with a description of the principal risks and uncertainties that it faces.

In the case of each Director in office at the date the Directors’ report is approved:

 – so far as the Director is aware, there is no relevant audit information of which the Group’s and Company’s auditors are unaware; and

 – they have taken all the steps that they ought to have taken as a Director in order to make themselves aware of any relevant audit information  

and to establish that the Group’s and Company’s auditors are aware of that information.

92

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Independent auditors’ report to the members 
of Bodycote plc

Report on the audit of the financial statements
Opinion
In our opinion:

 – Bodycote plc’s Group financial statements and Company financial statements (the “financial statements”) give a true and fair view of the  

state of the Group’s and of the Company’s affairs as at 31 December 2023 and of the Group’s profit and the Group’s cash flows for the year 
then ended;

 – the Group financial statements have been properly prepared in accordance with UK-adopted international accounting standards as applied in 

accordance with the provisions of the Companies Act 2006;

 – the Company financial statements have been properly prepared in accordance with United Kingdom Generally Accepted Accounting  

Practice (United Kingdom Accounting Standards, including FRS 101 “Reduced Disclosure Framework”, and applicable law); and

 – the financial statements have been prepared in accordance with the requirements of the Companies Act 2006.

We have audited the financial statements, included within the Annual Report, which comprise: the Consolidated balance sheet and the 
Company balance sheet as at 31 December 2023; the Consolidated income statement and the Consolidated statement of comprehensive 
income, the Consolidated cash flow statement, and the Consolidated and the Company statements of changes in equity for the year then 
ended; the Group and the Company accounting policies; and the notes to the financial statements.

Our opinion is consistent with our reporting to the Audit Committee.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (“ISAs (UK)”) and applicable law. Our responsibilities 
under ISAs (UK) are further described in the Auditors’ responsibilities for the audit of the financial statements section of our report. We believe 
that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Independence
We remained independent of the Group in accordance with the ethical requirements that are relevant to our audit of the financial statements 
in the UK, which includes the FRC’s Ethical Standard, as applicable to listed public interest entities, and we have fulfilled our other ethical 
responsibilities in accordance with these requirements.

To the best of our knowledge and belief, we declare that non-audit services prohibited by the FRC’s Ethical Standard were not provided.

Other than those disclosed in note 2 to the consolidated financial statements, we have provided no non-audit services to the Company or  
its controlled undertakings in the period under audit.

Our audit approach
Context
Bodycote plc is a global business operating in the thermal processing sector. The business operates in a number of countries around the  
world and provides services primarily to the automotive, general industrial, aerospace, defence and energy markets.

Overview
Audit scope 
 – The Group’s financial statements are a consolidation of a number of reporting units (each of which were deemed to be components) 

representing the Group’s trading entities around the world, its centralised functions and consolidation adjustment reporting units. The reporting 
units vary in size, and our approach to scoping considers those entities which are of most significance to the Group as a whole, in particular in 
North America and Europe. We also requested certain component teams to perform full scope audit procedures over additional components  
to ensure we achieved an appropriate level of audit coverage.

Key audit matters 
 – Valuation of goodwill (Group)

 – Valuation of uncertain tax positions (Group)

 – Valuation of the UK defined benefit pension scheme (Group and Company)

Materiality 
 – Overall Group materiality: £6,200,000 (2022: £6,000,000) based on professional judgement considering a number of potential benchmarks 

(specifically revenue and profit based benchmarks, both for the current year and over a number of years).

 – Overall Company materiality: £4,300,000 (2022: £4,700,000) based on approximately 1% of total assets.

 – Performance materiality: £4,650,000 (2022: £4,500,000) (Group) and £3,200,000 (2022: £3,525,000) (Company).

93

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Independent auditors’ report to the members 
of Bodycote plc continued

The scope of our audit
As part of designing our audit, we determined materiality and assessed the risks of material misstatement in the financial statements.

Key audit matters
Key audit matters are those matters that, in the auditors’ professional judgement, were of most significance in the audit of the financial 
statements of the current period and include the most significant assessed risks of material misstatement (whether or not due to fraud) 
identified by the auditors, including those which had the greatest effect on: the overall audit strategy; the allocation of resources in the audit; 
and directing the efforts of the engagement team. These matters, and any comments we make on the results of our procedures thereon, 
were addressed in the context of our audit of the financial statements as a whole, and in forming our opinion thereon, and we do not provide  
a separate opinion on these matters.

This is not a complete list of all risks identified by our audit.

The key audit matters below are consistent with last year.

Key audit matter

Valuation of goodwill (Group)

Refer to note 9 of the consolidated financial statements and the  
areas of focus in the Report of the Audit Committee.

For the cash generating units (“CGUs”) to which goodwill relates 
(which require an annual impairment test), the determination of the 
recoverable amount, being the higher of value in use (“VIU”) and 
fair value less costs of disposal (“FVLCD”), requires judgement and 
estimation by management. This is because the determination of a 
recoverable amount includes management’s consideration of key 
internal inputs and external market conditions such as future market 
volumes and pricing trends in those industries in which its customers 
operate, which impacts future cash flows, and the determination of 
the most appropriate discount rate. Notwithstanding the apparent 
decline in the impact of the COVID-19 pandemic, there remains 
ongoing uncertainty around the timing of recovery for many key 
sectors in which the Group operates, in particular due to the 
uncertainty associated with the impact on global supply chains, 
energy availability and prices, and broader cost inflation following  
the Russian invasion of Ukraine. Therefore, given the resulting effect 
of this area on the overall audit strategy, the allocation of resources  
in the audit and directing the efforts of the engagement team,  
we considered the impairment assessment of goodwill to be a key 
audit matter.

Management’s assessment also included a “mid-term” growth 
period from years 6 to 10, reflecting their view that the business 
would not be at a steady state of growth by year 5 based on 
internal forecasts. 

Specifically, we identified the valuation of the North America ADE 
and North America AGI goodwill balances as significant audit risks 
due to their lower level of headroom relative to the carrying value of 
the CGUs and the material goodwill balances held in those CGUs.

How our audit addressed the key audit matter

We tested the integrity of management’s impairment calculation and 
corroborated the 2024 forecast to the Board approved budget and for 
2025 to 2028 inclusive to the Group’s latest Board approved Financial 
Plan. We also assessed the assumptions made by management in 
the budget and understood management’s process for forecasting 
longer term cash flows, in particular focusing on the assumptions 
used through to 2028, and the expected ongoing improvement in the 
Group’s revenues and operating margin performance.

We agreed the underlying carrying values of the CGUs to audited 
financial information.

We challenged management’s key assumptions for revenue, 
profit and cash flow forecasts by comparing them with third party 
industry market data, where available, and considered the allocation 
of central costs to the CGUs. We also performed look back 
testing to understand how accurate management has been in its 
forecasting historically.

We assessed management’s growth assumptions beyond year 5, 
using our valuations experts to compare management’s long-term 
growth rate with economic forecasts. We also used our valuations 
experts to assess the reasonableness of the discount rates used  
by management, by independently calculating a range for this rate, 
and considered whether the rate used by management was within  
a supportable range. We used this independently calculated discount 
rate and our estimate of the long-term growth rate, alongside our 
view of certain other assumptions, to calculate our view of the 
recoverable amount.

We specifically considered management’s application of a mid-
term growth rate to years 6 to 10 in its impairment assessment, 
and performed analysis by removing this assumption and applying 
a long-term growth rate to determine the terminal value from the 
fifth year of management’s cash flow forecasts. This did not result 
in a different conclusion to that of management. We obtained 
management’s sensitivity analyses, which showed the impact of 
its view of reasonably possible changes to key assumptions and 
performed our own sensitivity analyses. Our sensitivity analysis 
sought to cover the potential risks associated with climate change, 
inflationary pressures and geopolitical risks. Whilst we did not 
identify specific sensitivities for each item, we modelled what we 
considered to be suitably severe overall assumptions impacting 
margins and growth that took these factors into account.

We considered the appropriateness of the disclosures in note 9 to 
the consolidated financial statements. Based on the procedures 
performed, we noted no material issues from our work.

94

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Key audit matter

How our audit addressed the key audit matter

Valuation of uncertain tax positions (Group)

The Group has operations in a number of geographical locations 
and as such is subject to multiple tax jurisdictions, giving rise to 
complexity in accounting for the Group’s taxation. Refer to note 6 
and 19 of the consolidated financial statements and the areas of 
focus in the Report of the Audit Committee.

In particular, the interpretation of complex tax regulations and the 
unknown future outcome of pending rulings by the tax authorities 
results in the need to provide against a number of uncertain tax 
positions. The Group undertakes financing activities between 
jurisdictions and non-financing cross border transactions, which 
require judgement to determine the appropriate tax charge and any 
associated provisions. These transactions result in the recognition 
of material provisions for tax of £26.4 million (2022: £28.1 million), 
which have, therefore, been treated as a key audit matter.

Valuation of the UK defined benefit pension scheme  
(Group and Company)

The Group operates a number of defined benefit pension schemes 
across different territories. Accounting for these schemes can 
be complex, and necessitates a higher level of audit effort. 
See the Group’s accounting policies, note 26 of the consolidated 
financial statements and the areas of focus in the Report of the 
Audit Committee.

The Group’s net retirement benefit obligation is £11.1 million 
(2022: £10.9 million). This net position also includes the UK 
scheme, which had an accounting surplus of £4.9 million as 
at 31 December 2023, which (consistent with prior years) 
was unrecognised.

The assets of the UK scheme total £67.6 million. Auditing the 
valuation of assets can be complex given the scheme invests 
in Pooled Investment Vehicles (“PIVs”), which may not have 
coterminous year ends with the Group’s financial statements,  
or may contain underlying assets that are more complex to value.

The obligations of the UK scheme total £62.7 million. The Group 
relies on management’s experts to determine the valuation of the 
obligations, which involves estimation and judgement in selecting 
appropriate actuarial assumptions.

Whilst the UK surplus remains unrecognised, an immaterial 
misstatement could lead to this surplus being eroded and result in 
pension balances needing to be recognised on the consolidated 
balance sheet in respect of the UK scheme. 

On this basis we identified the risk in relation to the valuation of 
the associated obligations for the UK pension scheme as elevated 
for the audit. Since this audit area in relation to the UK pension 
scheme involves relatively high audit effort for both the Group and 
the Company we have included it as a Key Audit Matter.

Our audit work, which involved taxation audit specialists at the Group 
level, included the assessment of the Group’s uncertain tax positions.

Our assessment included considering the current status of new 
and historical tax assessments and investigations to monitor 
developments in ongoing disputes, in addition to reviewing 
correspondence with tax authorities. We considered external tax 
advice received by the Group where relevant, to satisfy ourselves 
that the tax provisions had been appropriately recorded or adjusted to 
reflect the latest tax legislative developments. Where no advice was 
available, we understood management’s rationale based on internal 
analysis and other supporting information. We also considered 
significant transactions to identify uncertain tax positions that may 
arise from those transactions.

In assessing the adequacy of the tax provisions, we considered 
interest that could be applied by the local tax authorities. We also 
determined whether the tax provisions were recognised and 
measured in accordance with the relevant accounting standards.

We considered the appropriateness of the related disclosures in 
notes 6 and 19 to the consolidated financial statements. Based on 
the procedures performed, we noted no material issues from 
our work.

With respect to the UK scheme, which is our elevated audit risk in 
relation to the valuation of the associated liabilities, the following 
procedures were performed.

We assessed the pension assumptions used to derive the scheme 
obligations, including discount rates, inflation and mortality, using 
our actuarial experts where necessary. We also considered and 
challenged the appropriateness of the actuarial assumptions against 
our internally developed benchmark ranges, finding them to be within 
an acceptable range.

We performed testing to ensure that the obligations were consistent 
with the most recent funding valuations and that the movement in 
the obligations during the year was reasonable.

While the valuation of the associated UK pension scheme assets was 
not part of our elevated audit risk, independent investment manager 
confirmations were obtained for all material PIVs and bank letters 
obtained for all scheme bank accounts. Where PIVs were determined 
to be more complex additional audit procedures were performed, 
including over year end transactions and assessing the latest internal 
controls report for the relevant investment manager. 

While also not part of our elevated risk, we assessed management’s 
rationale for not recognising the surplus on the UK scheme, in line 
with accounting standards. We ensured that there had been no 
changes since previous years when the appropriateness of this 
judgement had been confirmed with our internal actuarial and 
accounting experts.

We also considered the appropriateness of the related disclosures 
in note 26 of the consolidated financial statements. Based on the 
procedures performed, we noted no material issues from our work.

95

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
Independent auditors’ report to the members 
of Bodycote plc continued

How we tailored the audit scope
We tailored the scope of our audit to ensure that we performed enough work to be able to give an opinion on the financial statements as a 
whole, taking into account the structure of the Group and the Company, the accounting processes and controls, and the industry in which 
they operate.

In establishing the overall approach to the Group audit, we determined the type of work that needed to be performed at components by us,  
as the Group engagement team, or component auditors operating under our instruction.

We identified one component (2022: one) as financially significant (as defined within ISAs (UK)). We obtained full scope audit reporting 
from a further fifteen components (2022: twelve), where we concluded that the component engagement leader is a Key Audit Partner, and 
an additional seven (2022: seven) components where full scope audits were also performed. Together, these components were in twelve 
countries, representing the Group’s principal businesses, and provided audit coverage of 78% of the Group’s revenue (2022: 75%) and  
77% of consolidated absolute profit before tax (2022: 73%).

Specified procedures over specific financial statement line items were performed at one further component (2022: one) and central 
testing was performed on selected items, such as goodwill, uncertain tax positions and the consolidation, primarily to ensure appropriate 
audit coverage.

The components included within our audit scope were determined based on each individual components’ contribution to the Group’s key 
financial statement line items (in particular revenue and profit before tax), and considerations relating to aggregation risk within the Group. 
Where work was performed by component auditors, we determined the level of involvement we needed to have in the audit work at those 
components to be able to conclude on whether sufficient appropriate audit evidence had been obtained as a basis for our opinion on the 
Group financial statements as a whole.

We issued formal written instructions to all component auditors setting out the audit work to be performed by each of them and maintained 
regular communication with them throughout the audit cycle. The audit was conducted in a hybrid working environment, through remote 
working and virtual meetings, as well as in-person meetings with certain Key Audit Partners. The Group engagement team also reviewed 
selected audit working papers for certain in-scope component teams, including those where the engagement leader was determined to be a  
Key Audit Partner.

In addition, given the extent of testing performed by our Czech Republic team at the Group’s Prague Shared Services Centre, which supports 
the financial accounting for the majority of the Group’s European businesses, a working paper review was also conducted of this team’s work.

The impact of climate risk on our audit
In planning our work, including identifying areas of audit risk and determining an appropriate response, we were mindful of the increased focus 
on the impact of climate change risk on companies and their financial reporting, and also that the Group has identified climate change as a 
principal risk. Climate change risk is expected to have an impact on the Group’s business as the operations and strategy of the Group evolve 
to address the potential physical and transition risks that could arise and the opportunities associated with climate change, including from its 
customer base. Climate change-related initiatives and commitments impact the Group in a variety of ways, as described within the Annual 
Report. We challenged the completeness of management’s climate risk assessment by considering the appropriateness of extending the cash 
flows as modelled in the Group’s impairment assessment into perpetuity and assessing how management had considered the impact of the 
Group’s sustainability initiatives on the cash flows included in this assessment.

Materiality
The scope of our audit was influenced by our application of materiality. We set certain quantitative thresholds for materiality. These, together 
with qualitative considerations, helped us to determine the scope of our audit and the nature, timing and extent of our audit procedures on the 
individual financial statement line items and disclosures and in evaluating the effect of misstatements, both individually and in aggregate on 
the financial statements as a whole.

Based on our professional judgement, we determined materiality for the financial statements as a whole as follows:

Overall  
materiality

How we 
determined it

Rationale for 
benchmark 
applied

Financial statements – Group

Financial statements – Company

£6,200,000 (2022: £6,000,000).

£4,300,000 (2022: £4,700,000).

Professional judgement considering a number of potential 
benchmarks (specifically revenue and profit based benchmarks, 
both for the current year and over a number of years).

Approximately 1% of total assets.

We considered a range of acceptable benchmarks for 
determining materiality. We selected a level of materiality 
that was within the range of outcomes suggested by these 
alternative benchmarks and reflected an appropriate increase 
on the prior year materiality level given the increased level 
of revenue and profit before tax. The materiality selected is 
equivalent to approximately 6% of current year profit before  
tax (2022: 6%).

The Company holds the Group’s investments in 
subsidiary companies. The strength of the balance 
sheet is the key measure of financial health that is 
important to shareholders as this determines the 
Company’s ability to pay dividends.

For each component in the scope of our Group audit, we allocated a materiality that is less than our overall Group materiality. The range of 
materiality allocated across components was between £500,000 and £3,800,000.

96

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023We use performance materiality to reduce to an appropriately low level the probability that the aggregate of uncorrected and undetected 
misstatements exceeds overall materiality. Specifically, we use performance materiality in determining the scope of our audit and the 
nature and extent of our testing of account balances, classes of transactions and disclosures, for example in determining sample sizes. 
Our performance materiality was approximately 75% (2022: 75%) of overall materiality, amounting to £4,650,000 (2022: £4,500,000)  
for the Group financial statements and £3,200,000 (2022: £3,525,000) for the Company financial statements.

In determining the performance materiality, we considered a number of factors - the history of misstatements, risk assessment and 
aggregation risk and the effectiveness of controls - and concluded that an amount at the upper end of our normal range was appropriate.

We agreed with the Audit Committee that we would report to them misstatements identified during our audit above £310,000 (Group 
audit) (2022: £300,000) and £215,000 (Company audit) (2022: £235,000) as well as misstatements below those amounts that, in our view, 
warranted reporting for qualitative reasons.

Conclusions relating to going concern
Our evaluation of the directors’ assessment of the Group’s and the Company’s ability to continue to adopt the going concern basis of 
accounting included:

 – Obtaining the directors’ assessment and understanding the assumptions used in the base case scenario and the severe but plausible  

downside scenario over the next twelve months;

 – Agreeing the budget for 2024 used in the base case scenario to the Board approved budget and evaluating the appropriateness of key 

assumptions used in determining these cash flows. For the period of the assessment not covered by the budget, we agreed the forecasts to 
the Group’s latest Board-approved Financial Plan and analysed the forecasts projected by management and considered these in the context of 
wider market data; and

 – We assessed the appropriateness of the severe but plausible downside scenario adopted by management, including considering the relevant 

downside risks that the Group may face over the next twelve months.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or 
collectively, may cast significant doubt on the Group‘s and the Company’s ability to continue as a going concern for a period of at least twelve 
months from when the financial statements are authorised for issue.

In auditing the financial statements, we have concluded that the directors’ use of the going concern basis of accounting in the preparation of 
the financial statements is appropriate.

However, because not all future events or conditions can be predicted, this conclusion is not a guarantee as to the Group’s and the Company’s 
ability to continue as a going concern.

In relation to the directors’ reporting on how they have applied the UK Corporate Governance Code, we have nothing material to add or draw 
attention to in relation to the directors’ statement in the financial statements about whether the directors considered it appropriate to adopt 
the going concern basis of accounting.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Reporting on other information
The other information comprises all of the information in the Annual Report other than the financial statements and our auditors’ report 
thereon. The directors are responsible for the other information. Our opinion on the financial statements does not cover the other information 
and, accordingly, we do not express an audit opinion or, except to the extent otherwise explicitly stated in this report, any form of 
assurance thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether 
the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit, or otherwise appears to 
be materially misstated. If we identify an apparent material inconsistency or material misstatement, we are required to perform procedures to 
conclude whether there is a material misstatement of the financial statements or a material misstatement of the other information. If, based 
on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that 
fact. We have nothing to report based on these responsibilities.

With respect to the Strategic report and the Directors’ report, we also considered whether the disclosures required by the UK Companies Act 
2006 have been included.

Based on our work undertaken in the course of the audit, the Companies Act 2006 requires us also to report certain opinions and matters as 
described below.

Strategic report and the Directors’ report
In our opinion, based on the work undertaken in the course of the audit, the information given in the Strategic report and the Directors’ report 
for the year ended 31 December 2023 is consistent with the financial statements and has been prepared in accordance with applicable 
legal requirements.

In light of the knowledge and understanding of the Group and Company and their environment obtained in the course of the audit, we did not 
identify any material misstatements in the Strategic report and the Directors’ report.

Directors’ Remuneration
In our opinion, the part of the Directors’ report on remuneration to be audited has been properly prepared in accordance with the Companies 
Act 2006.

97

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Independent auditors’ report to the members 
of Bodycote plc continued

Corporate governance statement
The Listing Rules require us to review the directors’ statements in relation to going concern, longer-term viability and that part of the corporate 
governance statement relating to the Company’s compliance with the provisions of the UK Corporate Governance Code specified for our 
review. Our additional responsibilities with respect to the corporate governance statement as other information are described in the Reporting 
on other information section of this report.

Based on the work undertaken as part of our audit, we have concluded that each of the following elements of the corporate governance 
statement is materially consistent with the financial statements and our knowledge obtained during the audit, and we have nothing material  
to add or draw attention to in relation to:

 – The directors’ confirmation that they have carried out a robust assessment of the emerging and principal risks;

 – The disclosures in the Annual Report that describe those principal risks, what procedures are in place to identify emerging risks and  

an explanation of how these are being managed or mitigated;

 – The directors’ statement in the financial statements about whether they considered it appropriate to adopt the going concern basis of 

accounting in preparing them, and their identification of any material uncertainties to the Group’s and Company’s ability to continue to do so 
over a period of at least twelve months from the date of approval of the financial statements;

 – The directors’ explanation as to their assessment of the Group’s and Company’s prospects, the period this assessment covers and why the 

period is appropriate; and

 – The directors’ statement as to whether they have a reasonable expectation that the Company will be able to continue in operation and meet its 
liabilities as they fall due over the period of its assessment, including any related disclosures drawing attention to any necessary qualifications 
or assumptions.

Our review of the directors’ statement regarding the longer-term viability of the Group and Company was substantially less in scope than an 
audit and only consisted of making inquiries and considering the directors’ process supporting their statement; checking that the statement 
is in alignment with the relevant provisions of the UK Corporate Governance Code; and considering whether the statement is consistent with 
the financial statements and our knowledge and understanding of the Group and Company and their environment obtained in the course of 
the audit.

In addition, based on the work undertaken as part of our audit, we have concluded that each of the following elements of the corporate 
governance statement is materially consistent with the financial statements and our knowledge obtained during the audit:

 – The directors’ statement that they consider the Annual Report, taken as a whole, is fair, balanced and understandable, and provides the 
information necessary for the members to assess the Group’s and Company’s position, performance, business model and strategy;

 – The section of the Annual Report that describes the review of effectiveness of risk management and internal control systems; and

 – The section of the Annual Report describing the work of the Audit Committee.

We have nothing to report in respect of our responsibility to report when the directors’ statement relating to the Company’s compliance 
with the Code does not properly disclose a departure from a relevant provision of the Code specified under the Listing Rules for review by 
the auditors.

Responsibilities for the financial statements and the audit
Responsibilities of the directors for the financial statements
As explained more fully in the Statement of Directors’ responsibilities in respect of the financial statements, the directors are responsible 
for the preparation of the financial statements in accordance with the applicable framework and for being satisfied that they give a true and 
fair view. The directors are also responsible for such internal control as they determine is necessary to enable the preparation of financial 
statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the Group’s and the Company’s ability to continue as a going 
concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors 
either intend to liquidate the Group or the Company or to cease operations, or have no realistic alternative but to do so.

Auditors’ responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, 
whether due to fraud or error, and to issue an auditors’ report that includes our opinion. Reasonable assurance is a high level of assurance, 
but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. 
Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected 
to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our 
responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our 
procedures are capable of detecting irregularities, including fraud, is detailed below.

Based on our understanding of the Group and industry, we identified that the principal risks of non-compliance with laws and regulations 
related to breaches of environmental regulations and health and safety regulations, and we considered the extent to which non-compliance 
might have a material effect on the financial statements. We also considered those laws and regulations that have a direct impact on the 
financial statements such as the Companies Act 2006. We evaluated management’s incentives and opportunities for fraudulent manipulation 
of the financial statements (including the risk of override of controls), and determined that the principal risks were related to posting 
inappropriate journal entries and management bias in accounting estimates and judgements. The Group engagement team shared this risk 
assessment with the component auditors so that they could include appropriate audit procedures in response to such risks in their work. 
Audit procedures performed by the Group engagement team and/or component auditors included:

98

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 – Discussions with management, Internal Audit and the Group’s internal legal counsel, including consideration of potential instances of  

non-compliance with laws and regulation and fraud;

 – Assessment of matters reported through the Group’s whistleblowing helpline and the results of management’s investigation of such matters;

 – Substantive testing of journal entries which met a defined risk criteria, focusing on where and how fraud could arise; and

 – Challenging assumptions and judgements made by management in its accounting estimates or judgements, in particular in relation to the 

valuation of goodwill.

There are inherent limitations in the audit procedures described above. We are less likely to become aware of instances of non-compliance 
with laws and regulations that are not closely related to events and transactions reflected in the financial statements. Also, the risk of not 
detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate 
concealment by, for example, forgery or intentional misrepresentations, or through collusion.

Our audit testing might include testing complete populations of certain transactions and balances, possibly using data auditing techniques. 
However, it typically involves selecting a limited number of items for testing, rather than testing complete populations. We will often seek to 
target particular items for testing based on their size or risk characteristics. In other cases, we will use audit sampling to enable us to draw  
a conclusion about the population from which the sample is selected.

A further description of our responsibilities for the audit of the financial statements is located on the FRC’s website at: www.frc.org.uk/
auditorsresponsibilities. This description forms part of our auditors’ report.

Use of this report
This report, including the opinions, has been prepared for and only for the Company’s members as a body in accordance with Chapter 3 of 
Part 16 of the Companies Act 2006 and for no other purpose. We do not, in giving these opinions, accept or assume responsibility for any 
other purpose or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by our 
prior consent in writing.

Other required reporting
Companies Act 2006 exception reporting
Under the Companies Act 2006 we are required to report to you if, in our opinion:

 – we have not obtained all the information and explanations we require for our audit; or

 – adequate accounting records have not been kept by the Company, or returns adequate for our audit have not been received from branches  

not visited by us; or

 – certain disclosures of directors’ remuneration specified by law are not made; or

 – the Company financial statements and the part of the Directors’ report on remuneration to be audited are not in agreement with the accounting 

records and returns.

We have no exceptions to report arising from this responsibility.

Appointment
Following the recommendation of the Audit Committee, we were appointed by the members on 24 May 2019 to audit the financial  
statements for the year ended 31 December 2019 and subsequent financial periods. The period of total uninterrupted engagement is  
five years, covering the years ended 31 December 2019 to 31 December 2023.

Other matter
In due course, as required by the Financial Conduct Authority Disclosure Guidance and Transparency Rule 4.1.14R, these financial statements 
will form part of the ESEF-prepared annual financial report filed on the National Storage Mechanism of the Financial Conduct Authority in 
accordance with the ESEF Regulatory Technical Standard (‘ESEF RTS’). This auditors’ report provides no assurance over whether the annual 
financial report will be prepared using the single electronic format specified in the ESEF RTS.

Simon Morley (Senior Statutory Auditor)
for and on behalf of PricewaterhouseCoopers LLP 
Chartered Accountants and Statutory Auditors 
London

15 March 2024

99

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Consolidated income statement
For the year ended 31 December 2023

Revenue
Cost of sales and overheads1
Other operating income1
Other operating expenses1
Net impairment losses on financial assets
Operating profit prior to exceptional items
Exceptional items
Operating profit
Finance income
Finance charge
Profit before taxation
Taxation charge
Profit for the year
Attributable to:
Equity holders of the Parent
Non-controlling interests

Earnings per share

Basic
Diluted

1  Excludes exceptional items.

All activities have arisen from continuing operations. 

Note
1
2
2
2

1,2
4
2
5
5

6

8

2023
£m
802.5 
(694.4)
12.6 
(1.3)
(0.2)
119.2 
– 
119.2 
0.8 
(8.3)
111.7 
(24.9)
86.8 

85.6 
1.2 
86.8 

Pence
45.1 
44.8 

Consolidated statement of comprehensive income
For the year ended 31 December 2023

Profit for the year
Items that will not be reclassified to profit or loss:
Actuarial (losses)/gains on defined benefit pension schemes
Tax on retirement benefit obligations that will not be reclassified
Total items that will not be reclassified to profit or loss
Items that may be reclassified subsequently to profit or loss:
Exchange (losses)/gains on translation of overseas operations
Movements on hedges of net investments
Movements on cash flow hedges
Total items that may be reclassified subsequently to profit or loss
Other comprehensive (expense)/income for the year
Total comprehensive income for the year
Attributable to:
Equity holders of the parent
Non-controlling interests

Note

26
19

18

2023
£m
86.8 

(0.1)
– 
(0.1)

(29.7)
1.5 
0.4 
(27.8)
(27.9)
58.9 

58.5 
0.4 
58.9 

2022
£m
743.6 
(646.2)
9.2 
(4.5)
(0.1)
102.0 
– 
102.0 
0.4 
(7.1)
95.3 
(21.0)
74.3 

73.7 
0.6 
74.3 

Pence
38.6 
38.5 

2022
£m
74.3 

5.8 
(0.2)
5.6 

57.2 
(3.1)
(0.3)
53.8 
59.4 
133.7 

133.3 
0.4 
133.7 

100

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consolidated balance sheet
At 31 December 2023

Non-current assets
Goodwill
Other intangible assets
Property, plant and equipment
Right-of-use assets
Deferred tax assets
Trade and other receivables

Current assets
Inventories
Current tax assets
Trade and other receivables
Cash and bank balances
Assets held for sale

Total assets
Current liabilities
Trade and other payables
Current tax liabilities
Borrowings
Lease liabilities
Derivative financial instruments
Provisions

Net current assets/(liabilities)
Non-current liabilities
Lease liabilities
Retirement benefit obligations
Deferred tax liabilities
Provisions
Other payables

Total liabilities
Net assets
Equity
Share capital
Share premium account
Own shares
Other reserves
Translation reserves
Retained earnings
Equity attributable to equity holders of the parent
Non-controlling interests
Total equity

Note

9
10
11
12
19
14

13

14
15
16

20

17
12
18
21

12
26
19
21
20

22

2023
£m

221.5 
111.2 
504.9 
58.5 
2.6 
1.3 
900.0 

29.5 
13.1 
148.4 
45.2 
0.5 
236.7 
1,136.7 

122.7 
46.0 
32.6 
11.8 
– 
12.0 
225.1 
11.6 

52.5 
11.1 
51.8 
3.0 
0.9 
119.3 
344.4 
792.3 

33.1 
177.1 
(15.6)
139.9 
52.3 
404.0 
790.8 
1.5 
792.3 

2022
£m

227.8 
116.9 
516.3 
59.6 
1.5 
1.5 
923.6 

27.8 
24.4 
154.4 
37.2 
0.3 
244.1 
1,167.7 

124.9 
42.8 
70.6 
12.3 
0.3 
10.2 
 261.1 
(17.0)

53.7 
10.9 
51.0 
7.9 
1.1 
124.6 
385.7 
782.0 

33.1 
177.1 
(5.2)
134.9 
81.2 
359.8 
780.9 
1.1 
782.0 

The financial statements of Bodycote plc, registered number 519057, were approved by the Board of Directors and authorised for issue on 
15 March 2024. They were signed on its behalf by:

S.C. Harris  

B. Fidler

101

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
Consolidated cash flow statement
For the year ended 31 December 2023

Net cash from operating activities
Investing activities
Purchases of property, plant and equipment
Proceeds on disposal of property, plant and equipment, right-of-use and intangible 
assets
Purchases of other intangible assets
Interest received
Net cash used in investing activities
Financing activities
Interest paid
Dividends paid
Principal elements of lease payments
Drawdown of bank loans
Repayments of bank loans
Own shares purchased
Net cash used in financing activities
Net increase/(decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of year
Effect of foreign exchange rate changes
Cash and cash equivalents at end of year

Note
23

7

23

2023
£m
191.6 

(74.1)

10.4 
(8.3)
0.8 
(71.2)

(7.2)
(40.6)
(13.1)
25.7 
(61.8)
(13.2)
(110.2)
10.2 
36.2 
(1.7)
44.7 

2022
£m
142.9 

(57.2)

4.7 
(9.8)
0.4 
(61.9)

(6.2)
(38.5)
(13.8)
50.7 
(75.0)
– 
(82.8)
(1.8)
37.9 
0.1 
36.2 

102

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Consolidated statement of changes in equity
For the year ended 31 December 2023

Share 
capital
£m
33.1 
– 

Share 
premium 
account
£m
177.1 
– 

Own 
shares
£m
(6.2)
– 

Other 
reserves
£m
137.5 
– 

Translation 
reserves
£m
23.8 
– 

Retained 
earnings
£m
319.4 
73.7 

Equity 
attributable 
to equity 
holders of 
the parent
£m
684.7 
73.7 

Non-
controlling 
interests
£m
0.7 
0.6 

Total 
equity
£m
685.4 
74.3 

– 

– 
– 

– 

– 

– 
– 

– 

– 
– 

– 

– 

– 
– 

– 
– 
33.1 
– 

– 
– 
177.1 
– 

– 

– 
– 

– 

– 
– 
– 

– 

– 

– 
– 

– 

– 
– 
– 

– 

– 
– 
33.1 

– 
– 
177.1 

– 

– 
– 

– 

– 

1.0 
– 

– 
– 
(5.2)
– 

– 

– 
– 

– 

– 
(13.2)
2.8 

– 

– 
– 
(15.6)

– 

57.4 

(3.1)
(0.3)

– 

(3.4)

(0.9)
1.7 

– 
– 
134.9 
– 

– 
– 

– 

– 
– 

– 
– 
81.2 
– 

– 

(28.9)

1.5 
0.4 

– 

1.9 
– 
(2.0)

5.1 

– 
– 
139.9 

– 
– 

– 

(28.9)
– 
– 

– 

– 
– 
52.3 

– 

– 
– 

5.6 

57.4 

(0.2)

57.2 

(3.1)
(0.3)

5.6 

– 
– 

– 

(3.1)
(0.3)

5.6 

57.4 

79.3 

133.3 

0.4 

133.7 

(0.1)
– 

(0.3)
(38.5)
359.8 
85.6 

– 

– 
– 

(0.1)

85.5 
– 
(0.8)

– 

0.1 
(40.6)
404.0 

– 
1.7 

(0.3)
(38.5)
780.9 
85.6 

– 
– 

– 
– 
1.1 
1.2 

– 
1.7 

(0.3)
(38.5)
782.0 
86.8 

(28.9)

(0.8)

(29.7)

1.5 
0.4 

(0.1)

58.5 
(13.2)
– 

5.1 

0.1 
(40.6)
790.8 

– 
– 

– 

0.4 
– 
– 

– 

– 
– 
1.5 

1.5 
0.4 

(0.1)

58.9 
(13.2)
– 

5.1 

0.1 
(40.6)
792.3 

1 January 2022
Profit for the year
Exchange differences on translation  
of overseas operations
Movements on hedges of net 
investments
Movements on cash flow hedges
Actuarial gains on defined benefit 
pension schemes net of deferred tax
Total comprehensive income for  
the year
Acquired in the year/settlement of  
share awards
Share-based payments
Deferred tax on share-based  
payment transactions
Dividends
31 December 2022
Profit for the year
Exchange differences on translation  
of overseas operations
Movements on hedges of net 
investments
Movements on cash flow hedges
Actuarial losses on defined benefit 
pension schemes net of deferred tax
Total comprehensive income  
for the year
Shares acquired in the year
Settlement of share awards

Share-based payments
Deferred tax on share-based  
payment transactions
Dividends
31 December 2023

Included in other reserves is a capital redemption reserve of £129.8m (2022: £129.8m) and a share-based payments reserve of £9.7m 
(2022: £6.7m). The capital redemption reserve arose from B shares which were converted into deferred shares in 2008 and 2009, and as  
a result, £129.8m was transferred from retained earnings to a capital redemption reserve.

The own shares reserve represents the cost of shares in Bodycote plc purchased in the market. At 31 December 2023, 2,292,243 
(2022: 639,125) ordinary shares of 173/11p each were held by the Bodycote International Employee Benefit Trust to satisfy share-based 
payments under the Group’s incentive schemes (see note 24). In the period ending 31 December 2023, 2,000,000 shares were purchased  
for the Bodycote International Employee Benefit Trust to satisfy future share-based payments under the Group’s share incentive schemes,  
for an average price of £6.57 (excluding costs) at a cost of £13.1m plus purchase costs of £0.1m.

Certain subsidiaries in the UK have taken an exemption to be audited. Refer to page 148 for further information.

103

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
Group accounting policies
Year ended 31 December 2023

Basis of preparation
The financial statements of the Group have been prepared in accordance with UK-adopted international accounting standards and with  
the requirements of the Companies Act 2006 as applicable to companies reporting under these standards. 

The Group has adopted Standards and Interpretations issued by the IASB and the International Financial Reporting Interpretations Committee 
of the IASB (IFRS IC). Individual standards and interpretations have to be adopted by the UK Endorsement Board (UKEB) before being applied 
in the UK. International Financial Reporting Standards (IFRS) are subject to ongoing amendment by the IASB and subsequent endorsement  
by the UKEB and are therefore subject to change.

The financial statements have been prepared on the historical cost basis, except for items that are required by IFRS to be measured at fair 
value, principally certain financial instruments measured at fair value, and retirement benefit assets. Historical cost is generally based on the 
fair value of the consideration given up in exchange for the assets.

In preparing the consolidated financial statements, the Directors have considered the impact of climate change in the context of the 
disclosures included in the Sustainability section of the Strategic report. These considerations did not have a material impact on the financial 
reporting judgements and estimates, consistent with the conclusion that climate change is not expected to have a significant impact on the 
Group’s cash flows, including those considered in the going concern and viability assessments. 

Basis of consolidation
The consolidated financial statements incorporate the financial statements of Bodycote plc (‘the Company’) and entities controlled by the 
Company (its subsidiaries and together, ‘the Group’) made up to 31 December each year. A subsidiary is an entity controlled, directly or 
indirectly, by Bodycote plc. Control exists when the Group has power over the subsidiary, has exposure or rights to the variable returns  
from its involvement with a subsidiary and then holds ability to use its power to affect its returns.

The results of subsidiaries acquired or disposed during the year are included in the consolidated income statement from the effective date of 
acquisition or up to the effective date of disposal, as appropriate. Where necessary, adjustments are made to subsidiary financial statements 
to bring the accounting policies used in line with those used by the Group. All intra-group transactions, balances, income and expenses are 
eliminated on consolidation.

Non-controlling interests in subsidiaries are identified separately from the Group’s equity therein. Those interests of non-controlling 
shareholders that are present ownership interests entitling their holders to a proportionate share of net assets upon liquidation may initially 
be measured at fair value or at the non-controlling interests’ proportionate share of the fair value of the acquiree’s identifiable net assets. 
The choice of measurement is made on an acquisition-by-acquisition basis. Other non-controlling interests are initially measured at fair value. 
Subsequent to acquisition, the carrying amount of non-controlling interests is the amount of those interests at initial recognition plus the  
non-controlling interests’ share of profits and losses less any distributions made. 

Changes in the Group’s interests in subsidiaries that do not result in a loss of control are accounted for as equity transactions. The carrying 
amount of the Group’s interests and the non-controlling interests are adjusted to reflect the changes in their relative interests in the 
subsidiaries. Any difference between the amount by which the non controlling interests are adjusted and the fair value of the consideration 
paid or received is recognised directly in equity and attributed to the owners of the Company.

Going concern
In determining the basis of preparation for the consolidated financial statements, the Directors have considered the Group’s business 
activities, together with the factors likely to affect its future development, performance and position. The Chief Financial Officer’s report 
included in this Annual Report includes a summary of the Group’s financial position, cash flows, liquidity position and borrowings.

The current and plausible impact of macroeconomic factors, including the war in Ukraine, energy and price inflation, and global supply chain 
impacts on the Group’s activities, performance and revenue, in addition to other factors and risks, have been considered by the Directors in 
preparing its going concern assessment. The Group has modelled a base case, which reflects the Directors’ current expectations of future 
trading in addition to potential severe but plausible impacts on revenue, profits and cash flows in a downside scenario.

Management’s base case scenario is built upon the budgeting and forecasting processes for 2024 and extended up to June 2025. It includes 
the recent acquisition of Lake City and the £60m share buyback that were announced in January 2024. This model shows an improvement 
in performance in both revenue and profits compared to 2023. The Group’s recent record of cash conversion was used to estimate the cash 
generation and level of net debt over that period. The severe but plausible downside scenario assumes a significant decline in revenue of 
around 20% below the base case modelled through to the end of June 2025, giving a 12% year on year decline in 2024. This downside takes 
account of short-term negative shock events which are intentionally more severe that those used in the impairment analysis. In mitigation to 
this severe sales decline, a 5% decline to maintenance capex and a 50% decline to expansionary capex compared to the base case has been 
assumed, together with an assumption that there is no growth in dividends from 2023 across this period.

In performing the scenarios, the assessment has considered both liquidity and compliance with the Group’s covenants. The key covenants 
attached to the Group’s Revolving Credit Facility relate to financial gearing (net debt to EBITDA) and interest cover, which are measured on  
a pre-IFRS 16 basis. The maximum financial gearing ratio permitted under the covenants is 3.0x (with a one-time acquisition spike at 3.5x)  
and the minimum interest cover ratio permitted is 4.0x. In both the base case and the severe but plausible downside scenario modelled,  
the Group continues to maintain sufficient liquidity and meet its gearing and interest cover covenants under the Revolving Credit Facility  
with substantial headroom.

Management also performed a reverse stress test. This indicated that 2024 revenue would need to decline by over 35% compared to 2023 
levels and with no growth in 2025 before the Group’s loan covenants were breached at the June 2025 test date. In this scenario, minimum 
liquidity was over £47m throughout the entire period. This scenario included the same mitigations as the downside scenario, with the 
expansionary capex reduction increased to 80% in H1 2025.

104

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023The Group meets its working capital requirements through a combination of committed and uncommitted facilities and overdrafts.  
For the purposes of the going concern assessment, the Directors have only taken into account the capacity under existing committed 
facilities, being predominantly the Group’s Revolving Credit Facility. 

The Group has access to a £250.9m Revolving Credit Facility maturing in May 2027. The Group’s committed facilities at 31 December 2023 
totalled £260.6m while uncommitted facilities totalled £63.5m. At 31 December 2023, the Group’s committed facilities had drawings of 
£32.3m (2022: £69.6m) and the Group’s net cash (excluding lease liabilities) was £12.6m (2022: net debt (excluding lease liabilities)  
of £33.4m). The liquidity headroom was £273.5m at 31 December 2023 (2022: £223.0m), excluding uncommitted facilities. 

Following this assessment, the Directors have formed a judgement, at the time of approving the financial statements, that there are no 
material uncertainties that cast doubt on the Group’s going concern status and that it is a reasonable expectation that the Group has adequate 
resources to continue in operational existence for at least the next 12 months from the approval date of the consolidated financial statements. 
For this reason, the Directors continue to adopt the going concern basis in preparing the consolidated financial statements. 

Critical accounting judgements and significant accounting estimates 
In the course of preparing the consolidated financial statements certain estimates, assumptions and judgements have been made in the 
process of applying the Group’s accounting policies that have had a significant effect on the amounts recognised in the financial statements. 
Although the estimates and judgements are based on management’s best information about current circumstances and future events and 
actions, actual results may differ and result in material variances.

Critical accounting judgements 
 – The Group operates in a number of countries and is subject to taxes in numerous jurisdictions. The recognition of a provision for taxes is a 

significant judgement that is based upon the interpretation of applicable tax legislation on a country-by-country basis and an assessment of  
the likely outcome of any open tax computations. There can also be estimation involved in determining the quantum of any provision.  
Refer to notes 6, 19 and 27. 

 – In line with previous years the Group continues to take the decision not to recognise an asset in relation to the surplus on the UK defined 

benefit pension scheme, regardless of value. See note 26.

Significant accounting estimates
 – Accounting for retirement benefit schemes under IAS 19 requires an assessment of the future benefits payable in accordance with actuarial 

assumptions. The discount rate and the mortality rates applied in the calculation of scheme liabilities are a key source of estimation uncertainty 
for the Group. Details of the accounting policies applied in respect of retirement benefit schemes are set out in note 26.

Other areas of judgement and accounting estimates
 – The Group has considered whether the valuation of goodwill and the related value-in-use calculation assumptions used for the annual 

impairment testing were significant estimates and has concluded that there is no reasonably possible material change expected in the carrying 
amount of these balances due to a change in these assumptions in the next financial year. This estimate is therefore not considered a key 
source of estimation uncertainty. Refer to note 9. 

 – The economy in Turkey is subject to high inflation and has qualified as a hyperinflationary economy as of 1 April 2022 for accounting periods 
ending on or after 30 June 2022. The Group has concluded that applying IAS 29 (Financial Reporting in Hyperinflationary Economies) is not 
required as the impact of adopting this standard is not material, but will continue to assess the position going forward.

 – The Group recognises climate change as a principal risk. Growing awareness of climate change and customer sustainability targets will provide 
opportunities for growth as we provide services and solutions that increase efficiency and reduce energy use. The Group’s view is that climate 
change does not create any further key source of estimation uncertainty at this time. Refer to our principal risks and uncertainties and 
sustainability reports and to note 9 for more information.

Revenue recognition
The Group predominantly has one revenue stream relating to thermal processing services with either identifiable customer contracts 
or specific terms and conditions that constitute a contract. Revenue is recognised net of discounts, VAT and other sales-related taxes. 
The Group’s right to consideration equates to the value of the services provided, the transaction price of which is based upon pricing as 
agreed with the customer. In general, the services provided to the Group’s customers consist of one performance obligation, being the 
delivery of a service which happens either at a point in time or over a short time frame. Revenue is recognised on completion of the service 
rendered as any spreading of revenue over a short time frame during which some services are performed would not have a material impact  
on revenue recognition. Where multiple performance obligations are determined to exist in one transaction, the allocation of transaction price 
and delivery of services are considered on a case-by-case basis. The determination of the transaction price is based upon pricing as agreed 
with the customer. In general, there are limited instances of judgements made in assessing revenue recognition under IFRS 15 given the 
relative simplicity of the contracts, and that revenue is recognised at a point in time.

In certain cases, the Group will use third parties as part of delivering customer contracts. When a third party is involved in providing goods 
or services, the Group determines if there is a principal or an agency relationship with that third party. Due to the nature of the contractual 
arrangements, it is initially assumed that the Group enters into a principal relationship with third-party contractors and thus recognises  
the related revenue on a gross basis with related costs included in cost of sales and overheads in the consolidated income statement.  
In some circumstances, third party work arranged for a customer of the Group is considered as agency activity. In such cases, the revenue 
and direct costs of sale are recorded on a net basis in revenue in the consolidated income statement.

Other operating income
Other operating income represents asset sales, profit on disposal of investment in associates, government support, scrap sales and other 
items of operating income not generated in the normal course of business.

105

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Group accounting policies continued
Year ended 31 December 2023

Foreign currencies
Transactions in currencies other than the functional currency are recorded at the rates of exchange prevailing on the dates of the transactions. 
At each balance sheet date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing 
on the balance sheet date. Gains and losses arising on retranslation are included in net profit or loss for the period. Non-monetary items that 
are measured in terms of historical cost in a foreign currency are not retranslated.

Exchange differences are recognised in profit or loss in the period in which they arise except for:

 – Exchange differences on transactions entered into to hedge certain foreign currency risks (see page 131); and  

 – Exchange differences on monetary items receivable from or payable to a foreign operation for which settlement is neither planned nor likely  
to occur (therefore forming part of the net investment in the foreign operation). These exchange differences are recognised initially in the 
consolidated statement of comprehensive income and reclassified from equity to profit or loss on disposal or partial disposal of the 
net investment. 

On consolidation, the assets and liabilities of the Group’s overseas operations are translated at exchange rates prevailing on the balance sheet 
date. Income and expense items are translated at the average exchange rates for the period unless exchange rates fluctuate significantly. 
Exchange differences arising, if any, are classified as equity and transferred to the Group’s translation reserve. Such translation differences are 
recognised as income or as expenses in the period in which the operation is disposed of.

Goodwill and fair value adjustments arising on the acquisition of a foreign entity are treated as assets and liabilities of the foreign entity and 
translated at the closing rate. 

Government assistance 
Economic support provided to the Group as part of government and state initiatives to support local economies is recorded in the consolidated 
income statement on the date at which the conditions attached to the receipt of such assistance have been met, in the period it becomes 
receivable. General economic support is presented within other operating income in the consolidated income statement and where 
appropriate net against the applicable costs within cost of sales and overheads. 

Operating profit
Operating profit is stated after charging restructuring costs, goodwill impairment, impairment of tangible and intangible assets, amortisation of 
acquired intangible assets, support from government assistance and any gains or losses on disposal of investments in associates, but before 
finance income and finance costs.

Dividends
Interim dividend distributions to Bodycote plc’s ordinary shareholders are recognised when paid. Final dividends are accrued when approved 
by the ordinary shareholders at the Group’s Annual General Meeting.  

Borrowing costs
Borrowing costs are recognised in the consolidated income statement in the period in which they are incurred as finance costs. 
Borrowing costs directly attributable to the acquisition, construction or production of qualifying assets, which are assets that take a substantial 
period of time to get ready for their intended use, are added to the cost of those assets, until such time as the assets are substantially ready 
for their intended use. Interest costs on borrowings are expensed to the consolidated income statement as they fall due and accounted for as 
financing cash flows as they are settled.

Exceptional items
The Group considers exceptional items to be those which derive from events or transactions which are significant for separate disclosure 
by virtue of their collective size or incidence in order for the user to obtain a proper understanding of the Group’s financial performance. 
These items include, but are not limited to, costs associated with significant restructuring and reorganisation costs, impairment charges, 
significant profits and losses on disposal of subsidiaries and other one-off items which meet this definition. Subsequent adjustments to items 
previously recognised as exceptional will normally also be reflected as exceptional items in future periods.

Goodwill
Goodwill arising in a business combination is recognised as an asset at the date that control is acquired (the acquisition date). Goodwill is 
measured as the excess of the cost of acquisition over the Group’s interest in the net fair value of the identifiable assets, liabilities and 
contingent liabilities of a subsidiary or associate at the date of acquisition. If the Group’s interest in the net fair value of the acquiree’s 
identifiable assets, liabilities and contingent liabilities exceeds the cost of the business combination, the excess is recognised immediately in 
the consolidated income statement.

Goodwill is allocated to cash generating units and is not amortised but tested annually for impairment, or more frequently when there is an 
indication that the unit may be impaired. If the recoverable amount of the cash generating unit is less than the carrying amount of the unit, the 
impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to assets of the unit on a pro-rata 
basis. Any impairment loss recognised for goodwill cannot be reversed in a subsequent period.

On disposal of an associate or subsidiary, the attributable amount of goodwill is included in the determination of the profit or loss on disposal. 

Other intangible assets
Intangible assets with finite useful lives that are acquired separately are carried at cost less accumulated amortisation and accumulated 
impairment losses. Intangible assets under development are carried at cost (less any accumulated impairment losses) until available for use. 
Intangible assets acquired in a business combination and recognised separately from goodwill are initially recognised at fair value at the 
acquisition date (which is regarded as their cost). Subsequent to initial recognition, intangible assets acquired in a business combination are 
reported at cost less accumulated amortisation and accumulated impairment losses.

106

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Amortisation of these assets is recognised in the consolidated income statement on a straight-line basis over their estimated useful lives,  
on the following bases:

Software 

10%-33%

Non-compete agreements 

20%-33%

Customer relationships 

7%-10%

Amortisation is recognised within administration expenses, which is included in cost of sales and overheads.

Costs associated with maintaining software programmes are recognised as an expense as incurred. Development costs that are directly 
attributable to the design and testing of identifiable and unique software products controlled by the Group are recognised as intangible assets 
and are amortised from the month in which the asset is available for its intended use. Directly attributable costs that are capitalised as part of 
the software asset include third-party costs, employee costs and an appropriate portion of relevant overheads.

Annual licence agreements to use Cloud software are expensed and treated as a service agreement. Perpetual licences to use Cloud software 
are capitalised if the Group has both a contractual right to the software and the ability to run the software independently of the host vendor. 
Customisation and configuration costs related to the implementation of a Cloud-based solution is expensed unless it creates an asset that is 
separate and identifiable from the software.

Property, plant and equipment
Property, plant and equipment are stated at cost less accumulated depreciation and any recognised impairment loss.

Depreciation is charged to the income statement either to cost of sales or administrative expenses, depending on the use of the asset, 
on a straight-line basis at rates which write down the value of assets to their residual values over their estimated useful lives. Land is 
not depreciated. 

The principal rates are as follows:

Freehold buildings 

2%

Leasehold improvements 

over the projected life of the lease

Fixtures and fittings 

Plant and machinery 

Motor vehicles 

10%-20%

5%-20%

20%-33%

The gain or loss arising on the disposal or retirement of an asset is determined as the difference between the sales proceeds and the carrying 
amount of the asset and is recognised in other operating income in the consolidated income statement.

Assets in the course of construction are carried at cost, plus appropriate borrowing costs, less any recognised impairment loss. 
Depreciation commences when the assets are ready for their intended use and they have been transferred to the relevant asset class.

Business combinations
Acquisitions of subsidiaries and businesses are generally accounted for under IFRS 3, where appropriate. The consideration for each 
acquisition is measured at the aggregate of the fair values (at the date of exchange) of assets given, liabilities incurred or assumed, and equity 
instruments issued by the Group in exchange for control of the acquiree. Acquisition-related costs are recognised in the consolidated income 
statement as incurred.

Subsequent changes in such fair values are adjusted against the cost of acquisition where they qualify as measurement period adjustments. 
All other subsequent changes in the fair value of any contingent consideration classified as an asset or liability are accounted for in accordance 
with relevant IFRS standards.

The acquiree’s identifiable assets, liabilities and contingent liabilities that meet the conditions for recognition under IFRS 3 are recognised  
at their fair value at the acquisition date, except that:

 – deferred tax assets or liabilities and liabilities or assets related to employee benefit arrangements are recognised and measured in accordance 

with IAS 12 Income Taxes and IAS 19 Employee Benefits respectively; and 

 – liabilities or equity instruments related to the replacement by the Group of an acquiree’s share-based payment awards are measured in 

accordance with IFRS 2 Share-based Payments. 

Impairment of tangible and intangible assets excluding goodwill
At each balance sheet date, the Group reviews the carrying amounts of its tangible and intangible assets to determine whether there is any 
indication that those assets have suffered an impairment loss. If any such indication exists or an asset is not in use and therefore requires 
an annual test, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where the 
asset does not generate cash inflows that are largely independent from other assets, the Group estimates the recoverable amount of the cash 
generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to dispose and value-in-use. In assessing value-in-use, the estimated future nominal 
cash flows are discounted to their present value using a nominal discount rate that reflects current market assessments of the time value of 
money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

If the recoverable amount of an asset (or cash generating unit) is estimated to be less than its carrying amount, the carrying amount of 
the asset (cash generating unit) is reduced to its recoverable amount. An impairment loss is recognised as an expense immediately in the 
consolidated income statement.

Where an impairment loss subsequently reverses, the carrying amount of the asset (cash generating unit) is increased to the revised estimate 
of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined 
had no impairment loss been recognised for the asset (cash generating unit) in prior years. A reversal of an impairment loss is recognised as 
income in the consolidated income statement immediately.

107

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Group accounting policies continued
Year ended 31 December 2023

Retirement benefit schemes
Obligations for contributions to defined contribution pension plans are recognised as an expense in the consolidated income statement 
as incurred.

The cost of providing pensions under defined benefit schemes is calculated in accordance with a qualified actuarial evaluation and spread 
over the period during which the benefit is expected to be derived from the employees’ services. The Group’s net obligation or surplus in 
respect of defined benefit pension schemes is calculated separately for each scheme by a qualified actuary using the projected unit method 
by estimating the amount of future benefit that employees have earned in return for their service in the current and prior periods less the fair 
value of the scheme’s assets. Past service costs resulting from scheme amendments or curtailments and gains or losses on settlements are 
charged to the consolidated income statement. If the calculation results in a surplus, the recognised asset is limited, under the provisions of 
IFRIC 14, to the present value of benefits available in the form of future refunds from the plan or reductions to future contributions.

The average discount rate for the schemes’ liabilities is based on investment grade rated corporate bonds or similar government bonds of 
suitable duration and currency. Scheme assets are measured using market values at the end of the reporting period. Actuarial gains and 
losses, differences between the expected and actual returns, and the effect of changes in actuarial assumptions are recognised in the 
consolidated statement of comprehensive income in the year they arise. Any scheme surplus (to the extent it is considered recoverable  
under the provisions of IFRIC 14) or deficit is recognised in full in the consolidated balance sheet. 

On plan settlement, a gain or loss on settlement is calculated as the difference between the present value of the defined benefit obligation 
being settled as determined on the date of the settlement and the settlement price including any plan assets transferred, and any payments 
made directly by the Group in connection with the settlement. This gain or loss is recognised in the income statement or other comprehensive 
income at the time of settlement, depending on the nature of how the gain or loss arises.

Right-of-use assets and lease liabilities
To the extent that a right-of-control exists over an asset subject to a lease, with a lease term exceeding one year, a right-of-use asset, 
representing the Group’s right to use the underlying leased asset, and a lease liability, representing the Group’s obligation to make lease 
payments, are recognised in the Group’s balance sheet at the commencement of the lease.

The right-of-use asset is measured at cost and includes the amount of initial measurement of the lease liability and any direct costs incurred, 
including advance lease payments, and an estimate of the dismantling, removal and restoration costs required by the terms and conditions 
of the lease. Contracts may contain both lease and non lease components such as administrative charges and taxes. The Group allocates 
the consideration in the contract to the lease and non-lease components based on their relative stand-alone prices. They are subsequently 
measured at cost less accumulated depreciation and impairment losses.

Depreciation is charged to the consolidated income statement to depreciate the right-of-use asset from the commencement date until 
the earlier of the end of the useful life of the right-of-use asset or the end of the lease term. The lease term shall include the period of any 
extension option where it is reasonably certain that the option will be exercised. Where the lease contains a purchase option the asset is 
written off over the useful life of the asset when it is reasonably certain that the purchase option will be exercised.

The lease liability is measured at the present value of the future lease payments, including fixed payments less any lease incentives 
receivable, amounts expected to be payable by the Group under residual value guarantees and the exercise price of purchased options where 
it is reasonably certain that the option will be exercised, discounted using the interest rate implicit in the lease, if easily determinable.  
If the rate cannot be readily determined, the lessee’s incremental borrowing rate is used. Finance charges are recognised in the consolidated 
income statement over the period of the lease. 

Lease arrangements that are short-term in nature in relation to low value assets are charged directly to the consolidated income statement 
when incurred. Short-term leases are leases with a lease term of 12 months or less and low value assets are defined based on quantitative 
criteria as outlined in IFRS 16.

Where subleased the right-of-use asset is de-recognised and a receivable booked to the balance sheet representing the rental income 
receivable for the full sub-lease rental period. Rental income is credited against the lease liability in the consolidated balance sheet.

Assets held for sale
Assets are classified and presented as held for sale at the lower of carrying amount and fair value less cost to sell if their carrying amount  
will be recovered through a sale transaction rather than through continuing use. This condition is regarded as met only when the sale is highly 
probable and the asset (or disposal group) is available for immediate sale. Assets categorised as held for sale are not depreciated.

Inventories
Inventories are stated at the lower of cost and net realisable value and are accounted for on a first in, first out basis or, in some cases,  
a weighted-average basis, if deemed more appropriate for the business. For finished goods and work-in-progress, cost comprises direct 
materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present 
location and condition. Net realisable value represents the estimated selling price less all estimated costs of completion and costs to be 
incurred in marketing, selling and distribution.

Financial instruments
Financial assets and financial liabilities are recognised on the Group’s balance sheet when the Group becomes a party to the contractual 
provisions of the instrument. Financial liabilities are classified according to the substance of the contractual arrangements entered into. 
The Group derecognises financial liabilities when, and only when, the Group’s obligations are discharged, cancelled or they expire.  
With the exception of the Group’s borrowings, and certain tax provisions, financial liabilities are not generally interest-bearing.

Receivables
Trade receivables, loans and other receivables that have fixed or determinable payments that are not quoted in an active market are classified 
as ‘receivables’. Receivables are measured at original invoice amount (which is considered fair value) and are subsequently held at amortised 
cost using the effective interest method, less any impairment. Interest income is recognised by applying the effective interest rate where 
applicable, except for trade receivables which do not carry any interest and are stated at their nominal value as reduced by appropriate 
allowances for expected credit losses and estimated irrecoverable amounts.

108

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023For trade receivables initially recognised at fair value less allowance for impairments, a simplified lifetime Expected Credit Loss (ECL) model 
is used to assess trade receivables for impairment. ECL is the present value of all cash shortfalls over the expected life of a trade receivable. 
Expected credit losses are based on historical loss experience on trade receivables, adjusted to reflect information about current economic 
conditions and reasonable and supportable forecasts of future economic conditions. At the date of initial recognition, the credit losses 
expected to arise over the lifetime of a trade receivable are recognised as an impairment in the consolidated income statement.

Cash and bank balances
Cash and bank balances comprise cash in hand and demand deposits and other short-term highly liquid investments that are readily 
convertible to a known amount of cash and are subject to an insignificant risk of changes in value. Overdrafts are presented as gross or  
offset against cash and bank balances depending on whether the Group has the right and intention to settle the balances as net. 

Bank borrowings
Interest-bearing bank loans and overdrafts are recorded at fair value, net of transaction costs. Finance charges, including premiums payable 
on settlement or redemption and direct issue costs, are accounted for on an accrual’s basis to the consolidated income statement using the 
effective interest method and are added to the carrying amount of the instrument to the extent that they are not settled in the period in  
which they arise.

Derivative financial instruments
The use of financial derivatives is governed by the Group’s policies approved by the Board of Directors, which provide written principles on 
the use of derivative financial instruments. The Group uses derivative financial instruments, in particular foreign currency swaps, forward 
exchange contracts and cross-currency interest rate swaps to manage the financial risks arising from the business activities and the financing 
of those activities. The Group does not use derivative financial instruments for speculative purposes.

Derivative financial instruments are initially recognised as assets and liabilities measured at their fair value on the balance sheet date. 
Changes in the fair value of any derivative instruments that do not fulfil the criteria for hedge accounting contained in IFRS 9 Financial 
Instruments are recognised immediately in the consolidated income statement. A derivative is presented as a non-current asset or a  
non-current liability if the remaining maturity of the instrument is more than 12 months and it is not expected to be realised or settled within 
12 months.

Net investment hedge
The Group uses foreign currency denominated borrowings to hedge its exposure to changes in the underlying value of net assets (translation 
exposure) in certain of its overseas operations arising from foreign exchange rate movements. The Group maintains documentation of 
the relationship between the hedged item and the hedging instrument at the inception of a hedging transaction together with the risk 
management objective and the strategy underlying the designated hedge. The Group also documents its assessment, both at the inception 
of the hedging relationship and subsequently on an ongoing basis, of the effectiveness of the hedge in offsetting movements in the nominal 
value of the hedged items. 

To the extent the hedge is effective, changes in the fair value of the hedging instrument arising from the hedged risk are recognised in the 
consolidated statement of comprehensive income and accumulated in other reserves. The gain or loss relating to any ineffective portion is 
recognised immediately in the consolidated income statement and is included in other operating income and expenses. 

Cash flow hedge
The Group maintains documentation of the relationship between the hedged item and the hedging instrument at the inception of a hedging 
transaction together with the risk management objective and the strategy underlying the designated hedge. 

The Group also documents its assessment, both at the inception of the hedging relationship and subsequently on an ongoing basis, of the 
effectiveness of the hedge in offsetting movements in the fair values or cash flows of the hedged items. 

To the extent the hedge is effective, changes in the fair value of the hedging instrument arising from the hedged risk are recognised in the 
consolidated statement of comprehensive income and accumulated in other reserves. Any gain or loss relating to any ineffective portion is 
recognised immediately in the consolidated income statement and is included in other operating income and expenses. If the hedged item 
results in the recognition of a non financial asset, the accumulated gains or losses are included within the initial cost of the asset at the time 
that the asset is recognised.

Hedge accounting is discontinued when the instrument expires or is sold, exercised or if it no longer meets the criteria for hedge accounting. 
If a forecasted transaction subject to hedge accounting is no longer expected to occur, the accumulated gain or loss in the hedging and 
translation reserve is recognised immediately in the consolidated income statement. 

Trade and other payables 
Trade and other payables are recognised at the amounts expected to be paid to counterparties and subsequently held at amortised cost. 

Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.

The tax currently payable is based on taxable profit for the year or tax assessment adjustments made to prior years. Taxable profit differs from 
net profit as reported in the consolidated income statement because it excludes items of income or expense that are taxable or deductible in 
other years and it further excludes items that are never taxable or deductible. The Group’s asset and liability for current tax is calculated using 
tax rates that have been enacted or substantively enacted by the balance sheet date.

Deferred tax is the tax expected to be payable or recoverable on differences between the carrying amounts of assets and liabilities in the 
financial statements and the corresponding tax bases used in the computation of taxable profit and is accounted for using the balance sheet 
liability method. Deferred tax liabilities are generally recognised for all taxable temporary differences and deferred tax assets are recognised to 
the extent that it is probable that taxable profits will be available against which deductible temporary differences can be utilised. Such assets 
and liabilities are not recognised if the temporary difference arises from the initial recognition of goodwill or from the initial recognition (other 
than in a business combination) of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

109

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Group accounting policies continued
Year ended 31 December 2023

Deferred tax liabilities are recognised for taxable temporary differences arising on investments in subsidiaries and associates, except where 
the Group is able to control the reversal of the temporary difference and it is probable that the temporary difference will not reverse in the 
foreseeable future. Deferred tax assets arising from deductible temporary differences associated with such investments and interests are  
only recognised to the extent that it is probable that there will be sufficient taxable profits against which to utilise the benefits of the 
temporary differences and they are expected to reverse in the foreseeable future.

The carrying amount of deferred tax assets is reviewed at each balance sheet date and reduced to the extent that it is no longer probable that 
sufficient taxable profits will be available to allow all or part of the asset to be recovered.

Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised, based 
on tax laws and rates that have been enacted or substantively enacted at the balance sheet date. Deferred tax is charged or credited in the 
consolidated income statement, except when it relates to items charged or credited in other comprehensive income, in which case the 
deferred tax is also dealt with in other comprehensive income. 

The measurement of deferred tax liabilities and assets reflects the tax consequences that would follow from the manner in which the Group 
expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.

Current and deferred tax assets and liabilities are offset when they relate to income taxes levied by the same taxation authority and the Group 
intends to settle its current tax assets and liabilities on a net basis.

Provisions
Provisions are recognised when the Group has a present obligation (legal or constructive) as a result of a past event, when it is probable that 
the Group will be required to settle that obligation and when a reliable estimate can be made of the amount of the obligation. If the obligation 
is expected to be settled within 12 months of the reporting date the provisions are included within current liabilities and if expected to be 
settled after 12 months included in non-current liabilities.

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the balance sheet 
date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated 
to settle the present obligation, and the difference between the carrying amount and the present value of those cash flows is material to the 
financial statements, the carrying amount is the present value of those cash flows.

Share-based payments
The Group has applied the requirements of IFRS 2 Share-based Payments. The Group issues equity-settled share-based payments to certain 
employees. Equity-settled share-based payments are measured at fair value at the date of grant. The fair value determined at the grant date  
of the equity-settled share-based payments is expensed on a straight-line basis over the vesting period. At each balance sheet date, the 
Group revises its estimate of the number of equity instruments expected to vest as a result of the effect of non-market-based vesting 
conditions. The impact of the revision of the original estimates, if any, is recognised in the consolidated income statement such that the 
cumulative expense reflects the revised estimates with a corresponding adjustment to the equity-settled share-based payments reserve.

Adoption of new and revised standards and interpretations applied in the current year
Accounting standard IFRS 17 - Insurance contracts issued in May 2017 is applicable for annual reporting periods commencing on or after 
1 January 2023. This standard establishes the principles for the recognition, measurement, presentation and disclosure of insurance contracts 
within the scope of the standard. There is no impact on the Group from adopting this standard and the Group has not therefore changed its 
accounting policies or made retrospective adjustments as a result of adopting this standard.

A number of amended standards became applicable in 2023. The Group did not have to change its accounting policies or make retrospective 
adjustments as a result of adopting these amendments and they did not have a material impact. These amendments were:

Effective for annual reporting periods commencing on or after 1 January 2023:

 – Amendments to IAS 8 (Definition of Accounting Estimates). 

 – Amendments to IAS 12 (Income taxes) - Deferred Tax related to Assets and Liabilities arising from a Single Transaction.

Issued and effective from 23 May 2023:

 – Amendments to IAS 12 (Income taxes) - International Tax Reform, Pillar Two Model Rules.

New standards and interpretations not yet applied
At the date of authorisation of these consolidated financial statements, the Group has not applied the following new and revised IFRS 
Standards that have been issued but are not yet effective. They are not expected to have a material impact on the Group:

 – Amendment to IFRS 16 Leases on sale and leaseback, effective from 1 January 2024.

 – The International Sustainability Standards Board (ISSB) has issued amendments to the Sustainability Accounting Standards Board (SASB) 

standards effective for annual reporting periods beginning on or after 1 January 2025.

 – Amendments to IAS 1 classification of liabilities as current or non-current, effective 1 January 2024.

 – Amendments to IAS 7 and IFRS 7 relating to supplier finance arrangements effective 1 January 2024.

General information
Bodycote plc is a Company incorporated in the United Kingdom under the Companies Act 2006. The address of the registered office is given 
on page 55.

The nature of the Group’s operations and its principal activities, and information on the Group’s objectives, are included within the Group’s 
Strategic report.

Items included in the financial statements of each entity in the Group are measured using the currency of the primary economic environment 
in which the entity operates. The consolidated financial statements are presented in pounds sterling, which is the functional and presentation 
currency of the Company. Foreign operations are included in accordance with the policies set out in the Foreign Currencies accounting policy 
on pages 105 and 106.

110

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 Notes to the consolidated financial statements
Year ended 31 December 2023

1.  Business and geographical segments
The Group has more than 165 facilities across the world serving a range of market sectors with various thermal processing services. 
The range and type of services offered is common to all market sectors.

In accordance with IFRS 8 Operating Segments, the segmentation of Group activity reflects the way the Group is managed by the chief 
operating decision maker, being the Group Chief Executive, who regularly reviews the operating performance of six operating segments,  
split between the Aerospace, Defence & Energy (ADE) and Automotive & General Industrial (AGI) business areas, as follows:

 – ADE – Western Europe;

 – ADE – North America;

 – ADE – Emerging Markets;

 – AGI – Western Europe;

 – AGI – North America; and

 – AGI – Emerging Markets.

The split of operating segments by geography reflects the business reporting structure of the Group.

We have also presented combined results of our two key business areas, ADE and AGI, the split being driven by customer behaviour and 
requirements, geography and services provided. Customers in the ADE segment tend to operate and purchase more globally and have long 
supply chains, whilst customers in the AGI segment tend to purchase more locally and have shorter supply chains.

Bodycote plants do not exclusively supply services to customers of a given market sector. Allocations of plants between ADE and AGI are 
therefore derived by reference to the preponderance of markets served.

ADE
2023
£m

Central  
costs and  
eliminations
2023
£m

AGI
2023
£m

Consolidated
2023
£m

355.5 

447.0 

– 

802.5 

71.2 
(1.7)
– 
69.5 
(6.4)
– 
63.1 
– 
63.1 

80.8 
(1.5)
– 
79.3 
(1.7)
– 
77.6 
– 
77.6 

– 
(2.7)
(18.5)
(21.2)
– 
(0.3)
(21.5)
– 
(21.5)

Group
Revenue
Total revenue
Result
Headline operating profit prior to share-based payments  
and unallocated central costs
Share-based payments (including social charges)1
Unallocated central costs
Headline operating profit/(loss)
Amortisation of acquired intangible assets
Acquisition costs
Operating profit/(loss) prior to exceptional items
Exceptional items
Segment result
Finance income
Finance costs
Profit before taxation
Taxation
Profit for the year

1  Includes £0.8m social security charges (2022: £0.1m credit).

Inter-segment revenues are not material in either year.

The Group does not have any one customer that contributes more than 10% of revenue. 

152.0 
(5.9)
(18.5)
127.6 
(8.1)
(0.3)
119.2 
– 
119.2 
0.8 
(8.3)
111.7 
(24.9)
86.8 

111

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Notes to the consolidated financial statements continued
Year ended 31 December 2023

1.  Business and geographical segments continued

Aerospace, Defence & Energy
Revenue
Total revenue
Result
Headline operating profit prior to share-based payments 
Share-based payments (including social charges)
Headline operating profit/(loss)
Amortisation of acquired intangible assets
Segment result

Automotive & General Industrial
Revenue
Total revenue
Result
Headline operating profit prior to share-based payments 
Share-based payments (including social charges)
Headline operating profit
Amortisation of acquired intangible assets
Segment result

Western Europe
2023
£m

North America
2023
£m

Emerging 
markets
2023
£m

Total ADE
2023
£m

162.8 

185.1 

36.2 
(0.8)
35.4 
(0.4)
35.0 

35.2 
(0.9)
34.3 
(6.0)
28.3 

7.6 

(0.2)
– 
(0.2)
– 
(0.2)

355.5 

71.2 
(1.7)
69.5 
(6.4)
63.1 

Western Europe
2023
£m

North America
2023
£m

Emerging 
markets
2023
£m

Total AGI
2023
£m

254.6 

102.4 

54.7 
(1.0)
53.7 
(0.4)
53.3 

10.1 
(0.1)
10.0 
(0.9)
9.1 

90.0 

16.0 
(0.4)
15.6 
(0.4)
15.2 

447.0 

80.8 
(1.5)
79.3 
(1.7)
77.6 

112

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.  Business and geographical segments continued

Group
Revenue
Total revenue
Result
Headline operating profit prior to share-based payments and  
unallocated central costs
Share-based payments (including social charges)
Unallocated central costs
Headline operating profit/(loss)
Amortisation of acquired intangible assets
Acquisition costs
Operating profit/(loss) prior to exceptional items
Exceptional items
Segment result
Finance income
Finance costs
Profit before taxation
Taxation
Profit for the year

Aerospace, Defence & Energy
Revenue
Total revenue
Result
Headline operating profit prior to share-based payments 
Share-based payments (including social charges)
Headline operating profit
Amortisation of acquired intangible assets
Operating profit prior to exceptional items
Exceptional items
Segment result

Automotive & General Industrial
Revenue
Total revenue
Result
Headline operating profit prior to share-based payments 
Share-based payments (including social charges)
Headline operating profit
Amortisation of acquired intangible assets
Operating profit prior to exceptional items
Exceptional items
Segment result

ADE
2022
£m

Central costs and 
eliminations
2022
£m

AGI
2022
£m

Consolidated
2022
£m

312.7 

430.9 

– 

743.6 

52.1 
(1.3)
– 
50.8 
(6.9)
– 
43.9 
0.1 
44.0 

81.1 
(0.3)
– 
80.8 
(2.4)
– 
78.4 
(0.2)
78.2 

– 
– 
(19.4)
(19.4)
– 
(0.9)
(20.3)
0.1 
(20.2)

133.2 
(1.6)
(19.4)
112.2 
(9.3)
(0.9)
102.0 
– 
102.0 
0.4 
(7.1)
95.3 
(21.0)
74.3 

Western  
Europe
2022
£m

North  
America
2022
£m

Emerging  
markets
2022
£m

Total ADE
2022
£m

137.1 

168.6 

24.5 
(0.4)
24.1 
(0.4)
23.7 
0.7 
24.4 

27.4 
(0.9)
26.5 
(6.5)
20.0 
(0.6)
19.4 

7.0 

0.2 
– 
0.2 
– 
0.2 
– 
0.2 

312.7 

52.1 
(1.3)
50.8 
(6.9)
43.9 
0.1 
44.0 

Western  
Europe
2022
£m

North  
America
2022
£m

Emerging  
markets
2022
£m

Total AGI
2022
£m

241.6 

103.0 

86.3 

430.9 

51.6 
(0.6)
51.0 
(0.5)
50.5 
0.2 
50.7 

12.1 
0.2 
12.3 
(1.5)
10.8 
(0.3)
10.5 

17.4 
0.1 
17.5 
(0.4)
17.1 
(0.1)
17.0 

81.1 
(0.3)
80.8 
(2.4)
78.4 
(0.2)
78.2 

113

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
 
 
 
 
 
 Notes to the consolidated financial statements continued
Year ended 31 December 2023

1.  Business and geographical segments continued
Other information

ADE
2023
£m
35.9 
32.4 

530.0 
(95.9)
434.1 

Western  
Europe
2023
£m
12.0 
12.7 

178.6 
(39.8)
138.8 

Western  
Europe
2023
£m
21.0 
22.2 

241.9 
(93.9)
148.0 

ADE
2022
£m
30.8 
34.1 

526.9 
(96.0)
430.9 

Central costs 
and eliminations
2023
£m
10.1 
3.1 

AGI
2023
£m
48.5 
46.6 

Consolidated
2023
£m
94.5 
82.1 

551.9 
(145.7)
406.2 

North  
America
2023
£m
23.7 
19.1 

346.8 
(55.3)
291.5 

North  
America
2023
£m
10.2 
12.0 

161.2 
(20.6)
140.6 

AGI
2022
£m
38.2 
47.0 

569.8 
(134.9)
434.9 

54.8 
(102.8)
(48.0)

Emerging 
markets
2023
£m
0.2 
0.6 

4.6 
(0.8)
3.8 

Emerging 
markets
2023
£m
17.3 
12.4 

148.8 
(31.2)
117.6 

1,136.7 
(344.4)
792.3 

Total ADE
2023
£m
35.9 
32.4 

530.0 
(95.9)
434.1 

Total AGI
2023
£m
48.5 
46.6 

551.9 
(145.7)
406.2 

Central costs 
and eliminations
2022
£m
10.6 
3.2 

Consolidated
2022
£m
79.6 
84.3 

71.0 
(154.8)
(83.8)

1,167.7 
(385.7)
782.0 

Group
Gross capital additions
Depreciation and amortisation
Balance sheet 
Segment assets
Segment liabilities
Segment net assets/(liabilities)

Aerospace, Defence & Energy
Gross capital additions
Depreciation and amortisation
Balance sheet 
Segment assets
Segment liabilities
Segment net assets

Automotive & General Industrial
Gross capital additions
Depreciation and amortisation
Balance sheet 
Segment assets
Segment liabilities
Segment net assets

Group
Gross capital additions
Depreciation and amortisation
Balance sheet 
Segment assets
Segment liabilities
Segment net assets/(liabilities)

114

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
 
 
 
 
 
 
 
 
1.  Business and geographical segments continued

Aerospace, Defence & Energy
Gross capital additions
Depreciation and amortisation
Balance sheet 
Segment assets
Segment liabilities
Segment net assets

Automotive & General Industrial
Gross capital additions
Depreciation and amortisation
Balance sheet 
Segment assets
Segment liabilities
Segment net assets

Western  
Europe
2022
£m
10.2 
12.5 

183.1 
(51.6)
131.5 

Western  
Europe
2022
£m
20.1 
22.5 

248.4 
(79.4)
169.0 

North  
America
2022
£m
20.4 
20.9 

337.7 
(43.5)
294.2 

North  
America
2022
£m
10.0 
13.2 

177.4 
(21.2)
156.2 

Emerging 
 markets
2022
£m
0.2 
0.7 

6.1 
(0.9)
5.2 

Emerging  
markets
2022
£m
8.1 
11.3 

144.0 
(34.3)
109.7 

Total ADE
2022
£m
30.8 
34.1 

526.9 
(96.0)
430.9 

Total AGI
2022
£m
38.2 
47.0 

569.8 
(134.9)
434.9 

Geographical information
The Group’s revenue from external customers and information about its assets (non-current assets excluding financial instruments,  
deferred tax assets and other financial assets) by country are detailed below:

Revenue from 
external customers

Non-current assets

USA
France
Germany
UK
Sweden
Netherlands
Others

2.  Operating profit

Revenue
Cost of sales
Gross profit
Distribution costs
Administration expenses
Other operating income
Other operating expenses
Net impairment losses on financial assets
Operating profit prior to exceptional items
Exceptional items (see note 4)
Operating profit 

2023
£m
271.7 
116.9 
82.3 
66.3 
50.9 
34.9 
179.5 
802.5 

2022
£m
258.2 
90.8 
79.0 
55.6 
48.1 
32.8 
179.1 
743.6 

2023
£m 
426.1 
63.3 
69.2 
96.7 
34.7 
22.7 
183.4 
896.1 

2023
£m
802.5 
(500.6)
301.9 
(21.8)
(172.0)
12.6 
(1.3)
(0.2)
119.2 
– 
119.2

2022
£m
450.6 
64.4 
71.3 
88.1 
35.2 
23.1 
187.9 
920.6 

2022
£m
743.6 
(473.9)
269.7 
(21.1)
(151.2)
9.2 
(4.5)
(0.1)
102.0 
– 
102.0 

115

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 Notes to the consolidated financial statements continued
Year ended 31 December 2023

2.  Operating profit continued
Operating profit for the year has been arrived at after charging/(crediting): 

Net foreign exchange loss
Inventory expensed
Depreciation of property, plant and equipment
Depreciation of right-of-use assets
Amortisation of other intangible assets
Gain on disposal of property, plant and equipment recognised in operating profit
Gain on disposal of right-of-use assets
Repairs and maintenance
Employee costs (see note 3)
Pension scheme administration expenses
Utility costs
Government assistance support received1
Acquisition costs
Impairment loss on trade receivables
Impairment of property, plant and equipment and other assets - recognised in operating profit

2023
£m
0.2 
76.8 
59.4 
12.9 
9.8 
(3.4)
(0.2)
27.2 
307.5 
0.5 
98.3 
(6.4)
0.3 
0.2 
0.9 

1  Government assistance consists of support towards energy costs of £6.1m (2022: £1.7m), R&D support of £0.2m (2022: £0.7m) and £0.1m (2022: £0.2m) in respect of other 

support programmes.

The analysis of auditors’ remuneration on a worldwide basis is as follows:  

Fees payable to the auditor for the audit of the annual accounts
Fees payable to the auditor and its associates for other services:
The audit of the Group’s subsidiaries
Total audit fees
Audit related assurance services1
Total fees payable to the auditor

2023
£m
1.2 

1.2 
2.4 
0.1 
2.5 

2022
£m
0.1 
69.2 
60.2 
13.0 
11.1 
(1.7)
(0.1)
23.5 
276.5 
0.6 
95.6 
(2.6)
0.9 
0.1 
4.8 

2022
£m
0.9 

1.2 
2.1 
0.1 
2.2 

1  This includes £0.1m (2022: £0.1m) for the interim review of the half year report. Non-audit fees in 2023 also include a nominal amount for a subscription to a generic accounting and 

reporting website.

The audit fees disclosed for 2023 include £0.1m of fees in connection with the 2022 audit. The audit fees disclosed for 2022 include £0.1m  
of fees in connection with the 2021 audit.  

116

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
3.  Employees
The average monthly number of employees (including Executive Directors) was:

ADE:

Western Europe
North America
Emerging markets

AGI:

Western Europe
North America
Emerging markets

Shared services
Head office

Their aggregate remuneration comprised:
Wages and salaries
Social security costs
Pension costs

2023
Number

2022
Number

765 
910 
65 

1,469 
590 
808 
292 
45 
4,944 

2023
£m

262.8 
36.1 
8.6 
307.5 

740 
868 
73 

1,490 
626 
815 
278 
43 
4,933 

2022
£m

235.6 
32.6 
8.3 
276.5 

Included in wages and salaries are share-based payments (excluding social charges) of £5.1m (2022: £1.7m). 

Included in pension costs are £8.3m (2022: £7.8m) relating to defined contribution schemes and a £0.3m (2022: £0.5m) charge relating to 
defined benefit schemes. Pension administrative costs not included above were £0.5m (2022: £0.6m) and interest costs not included above 
were £0.4m (2022: £0.1m) – see notes 2 and 26.

Disclosure of individual Directors’ remuneration, share interests, share awards, long-term incentive schemes, pension contributions and 
pension entitlements are shown in the tables in the Directors’ remuneration report on pages 79 to 91. See also note 24 for information on 
share-based payments and note 26 for information on retirement benefit schemes.

4.  Exceptional items

Severance and redundancy provision release
Net impairment reversal
Site closure costs
Losses on sales of property, plant and equipment recognised in exceptional items
Environmental provisions credit
Total exceptional items1

2023
£m
– 
– 
– 
– 
– 
– 

2022
£m
(0.8)
(0.1)
1.0 
0.1 
(0.2)
– 

1  Non-exceptional costs relating to severance and redundancy, impairment charges and reversals, site closure costs and environmental provisions are booked to other operating expenses. 

Gains and losses on sales of property, plant and equipment are booked to other operating income.

In 2020, the Group announced an organisation restructuring initiative which was driven by a combination of both macroeconomic  
uncertainties and longer-term automobile and aerospace market structural shifts. A number of plants were closed as a result of these 
restructuring activities. The related costs in the prior year were recorded as exceptional items in line with the Group’s accounting policy  
for exceptional items. 

At 31 December 2023 £1.4m (2022: £3.0m) was held as exceptional provisions.

117

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
 
 
 
 
 
 Notes to the consolidated financial statements continued
Year ended 31 December 2023

5.  Net finance charge

Interest on bank loans and overdrafts
Interest on lease liabilities
Total interest expense
Net interest on the defined benefit pension liabilities
Other finance charges
Total finance charge
Interest received on bank deposits
Other interest receivable
Total finance income
Net finance charge

6.  Taxation charge

Current taxation – charge for the year
Current taxation – adjustments in respect of previous years
Deferred tax (see note 19)
Total taxation charge

2023
£m
2.7 
2.3 
5.0 
0.4 
2.9 
8.3 
0.5 
0.3 
0.8 
7.5 

2023
£m
26.0 
(2.7)
1.6 
24.9 

2022
£m
2.3 
1.8 
4.1 
0.1 
2.9 
7.1 
0.1 
0.3 
0.4 
6.7 

2022
£m
21.3 
(0.6)
0.3 
21.0 

The Group uses a weighted average country tax rate rather than the UK tax rate for the reconciliation of the charge for the year to the profit 
before taxation per the consolidated income statement. The Group operates in several jurisdictions, many of which have a tax rate in excess 
of the UK tax rate. As such, a weighted average country tax rate is believed to provide the most meaningful information to the users of the 
financial statements. 

The appropriate tax rate for this comparison in 2023 is 25.4% (2022: 24.8%). The UK tax rate was increased from 19.0% to 25.0% from  
1 April 2023 as per the Finance Act 2021 and consequently, the deferred tax balances on the consolidated balance sheet relating to the UK 
have been measured using these revised rates. 

During 2021, the OECD published a framework for the introduction of a global minimum effective tax rate of 15%, the Pillar II GloBE Rules, 
applicable to large multinational Groups. On 20 June 2023, the United Kingdom substantially enacted the Pillar II GloBE rules. The Group has 
performed an overall assessment of the impact and determined that the adoption of the Pillar II GloBE Rules by jurisdictions where Bodycote 
operates is not expected to have a material impact on the Group’s future tax charge. The Group has applied the exception provided for by 
the Pillar II GloBE Rules (Amendments to IAS 12) and has not recognised, or therefore disclosed, information about deferred tax assets and 
liabilities related to these Pillar II GloBE rules.

The charge for the year can be reconciled to the profit before taxation per the consolidated income statement as follows:

Profit before taxation
Tax at the weighted average country tax rate of 25.4% (2022: 24.8%)
Tax effect of expenses not deductible in determining taxable profit1
Impact of recognition or derecognition of deferred tax balances
Tax effect of other adjustments in respect of previous years:
    Current tax2
    Deferred tax2
Effect of financing activities between jurisdictions3
Impact of trade and minimum corporate taxes
Effect of changes in statutory tax rates on deferred tax assets and liabilities
Other tax risk provision movements4
Tax expense for the year

2023
£m
111.7 
28.4 
1.1 
0.5 

(2.7)
0.1 
0.3 
0.3 
0.3 
(3.4) 
24.9 

2022
£m
95.3 
23.6 
1.7 
(2.0)

(0.6)
(3.4)
(0.6)
0.5 
0.9 
0.9 
21.0 

Tax on retirement benefit obligations taken directly to equity was a credit of £0.1m (2022: charge of £0.5m).  

1  Those costs in various jurisdictions that are not deductible in calculating taxable profits.

2  2023 and 2022 adjustments in current and deferred tax in respect of previous years relate mainly to changes in assumptions and outcomes in UK and overseas tax positions.

3  The Group is externally financed by a mix of cash flows from operations and short-term borrowings. Internally, operating subsidiaries are predominantly financed via intercompany loans. 

The effect is net of provisions based on management’s estimation of tax risk relating to the potential disallowance of interest. 

4 

Includes provisions for local tax risks and cross-border transactions. 2023 includes a credit of £4.3m (2022: £nil) for the release of a provision for a tax risk which is no longer within an 
audit period. 

118

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
6.  Taxation charge continued
As part of the calculation of the tax charge, the Group recognises a number of tax risk provisions in respect of ongoing tax enquiries and 
in recognition of the multinational tax environment that Bodycote operates in where the nature of the tax positions that are taken is often 
complex and subject to change. Included within current tax liabilities on the consolidated balance sheet as at 31 December 2023 of  
£46.0m (2022: £42.8m) are tax provisions totalling £26.4m (2022: £28.1m), of which £4.2m (2022: £5.3m) are expected to crystallise within 
12 months, although if facts and circumstances change this amount could materially differ. The provisions are based on an assessment of a 
range of possible outcomes to determine reasonable estimates of the consequences of tax authority audits in the various tax jurisdictions 
in which the Group operates. The material provisions relate to the financing of the Group’s operations where management’s judgement is 
exercised to determine the quantum of the tax risk provisions based on an understanding of the appropriate local tax legislation, taking into 
consideration the differences of interpretation that can arise on a wide variety of issues including the nature of ongoing tax audits and the 
experience from earlier enquiries, and determining whether any possible liability is probable. The Group’s individual tax provisions vary in 
quantum from £3.4m to £8.8m.

7.  Dividends

Amounts recognised as distributions to equity holders in the year:
Final dividend for the year ended 31 December 2021 of 13.8p per share
Interim dividend for the year ended 31 December 2022 of 6.4p per share
Final dividend for the year ended 31 December 2022 of 14.9p per share
Interim dividend for the year ended 31 December 2023 of 6.7p per share

Proposed final dividend for the year ended 31 December 2023 of 16.0p per share

2023
£m

– 
– 
28.5 
12.7 
41.2 
30.3 

2022
£m

26.3 
12.2 
–
– 
38.5 
– 

A final dividend for 2022 of 14.9p was approved at the Annual General Meeting (AGM) on 25 May 2023 to shareholders on the register of 
Bodycote plc on 21 April 2023 and was paid on 2 June 2023. 

The Board approved the payment of an interim dividend for 2023 of 6.7p on 29 July 2023 to those shareholders on the register of Bodycote 
plc on 6 October 2023 and has proposed a final dividend of 16.0p per share to be paid on 6 June 2024 to shareholders on the register at close 
of business at 26 April 2024 subject to approval by shareholders at the AGM. The 2023 interim dividend was paid on 10 November 2023.

As the proposed final dividend is subject to shareholder approval in 2024, it is not included as a liability in these financial statements. 
The dividends are waived on shares held by the Bodycote International Employee Benefit Trust. 

Any dividend unclaimed after a period of 6 years from the date for payment of such dividend is forfeited and reverted back to the Group.  
In the year 2023 £0.6m (2022: £nil) was received from dividends forfeited.

119

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 Notes to the consolidated financial statements continued
Year ended 31 December 2023

8.  Earnings per share
The calculation of the basic and diluted earnings per share is based on the following data:

Earnings
Earnings for the purpose of basic earnings per share being net profit attributable  
to equity holders of the parent

Number of shares
Weighted average number of ordinary shares for the purpose of basic earnings per share
Effect of dilutive potential ordinary shares:

Shares subject to performance conditions1
Shares subject to vesting conditions

Weighted average number of ordinary shares for the purpose of diluted earnings per share

Earnings per share:
Basic
Diluted1

Headline earnings
Net profit attributable to equity holders of the parent
Add back:

Amortisation of acquired intangible assets (net of tax)
Acquisition costs (net of tax)

Headline earnings

Headline earnings per share:
Basic
Diluted1

2023
£m

2022
£m

85.6 

73.7 

Number

Number

189,877,099

190,779,615

661,721 
344,050 
190,882,870

384,848 
191,502 
191,355,965

Pence

Pence

45.1 
44.8 

2023
£m

85.6 

6.1 
0.2 
91.9 

38.6 
38.5 

2022
£m

73.7 

7.0 
0.7 
81.4 

Pence

Pence

48.4 
48.1 

42.7 
42.5 

1  As at 31 December 2023, in accordance with IAS 33, the related performance conditions for open plans have been met resulting in 0.3p dilution of earnings per share 

(2022: 0.1p dilution) and 0.3p dilution of headline earnings per share (2022: 0.2p).

9.  Goodwill

Cost
At 1 January
Exchange differences
Recognised on acquisition of businesses
At 31 December
Accumulated impairment
At 1 January
Exchange differences
At 31 December
Carrying amount

120

2023
£m

288.9 
(6.6)
– 
282.3 

61.1 
(0.3)
60.8 
221.5 

2022
£m

274.5 
14.1 
0.3 
288.9 

60.6 
0.5 
61.1 
227.8 

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9.  Goodwill continued
Goodwill acquired through business combinations is allocated to the cash generating units (CGUs) that are expected to benefit from the 
synergies of the combination. The recoverable amounts of these CGUs are the higher of fair value less costs to dispose and value-in-use. 
Goodwill is allocated across the Group’s segments as follows:

ADE:

Western Europe
North America

AGI:

Western Europe
North America
Emerging Markets

2023
£m

27.2 
97.2 

27.8 
57.1 
12.2 
221.5 

2022
£m

27.2 
100.9 

28.2 
59.4 
12.1 
227.8 

Goodwill is tested for impairment at least annually, or more frequently if there are indications that the carrying value may not be recoverable.

The recoverable amounts of the CGUs are determined from value-in-use calculations. In assessing value-in-use, estimated post-tax future 
cash flows for each CGU are discounted to their present value using a post-tax discount rate which reflects current market assessments of  
the time value of money and the risks specific to the CGUs, including country risk premium.

The cash flows for each CGU have been derived from the 2024 budget, and five-year financial plan up to and including 2028, both of which 
have been approved by the Board. They have then been extrapolated for a further five years (until the end of 2033) by applying a medium-term 
growth rate to EBITDA, before applying a long-term growth rate into perpetuity from 2034 onwards.

The key assumptions applied in determining the value-in-use of each CGU were as follows:

 – Revenue: Revenue for 2024–2028 was projected based on management’s growth expectations of the underlying market sectors served by 

each CGU. These were benchmarked against external projections for each market and also included approved growth initiatives. 
Expectations on pricing were based on recent experience in the market and forecast inflation expectations. 

 – Operational gearing: Operational gearing represents the correlation between movements in revenue and operating profits. The gearing levels 

assumed reflect management’s expectations of future business performance, and are informed by past performance.

 – Capital expenditure: The future cash flows include estimates of capital expenditure required to maintain the existing asset base of each CGU, 
and are based on historical experience. Expansionary capital expenditure, and the associated cash flows, are only included to the extent that 
the capital expenditure has been approved at the balance sheet date and work on the project is already underway.  

 – Medium-term growth rates: The EBITDA for each CGU has been extrapolated between 2028 (the final year of the five-year financial plan) 

and 2033 reflecting a market-based nominal GDP growth rate of 4%. A medium-term growth rate has been used as management believe that 
the current inflationary environment will lead to higher nominal growth in the medium term, before reverting to a more normalised long-term 
growth rate. 

 – Long-term growth rate: A long-term growth rate has been applied into perpetuity based on the long-term average GDP growth projections of 

the geographies relevant to each CGU, and are in the range of 2.0% to 2.2% (2022: 2.0% to 2.3%).

 – Discount rate: The discount rates have been derived from a weighted average cost of capital, adjusted for the geographies in which each CGU 
operates. The post-tax discount rates range between 9.6% and 10.4% (2022: 8.6% and 9.9%). The pre-tax discount rates are the rates which, 
when applied to the pre-tax cash flows, result in the same NPV as calculated by the post-tax discount rate applied to the post-tax cash flows. 
The pre-tax discount rates range from 11.9% to 13.0% (2022: 10.5% to 12.0%). 

The majority of goodwill is allocated to two of the CGUs, being North America ADE (NA ADE) and North America AGI (NA AGI).  
The long-term growth rates and the rates used to discount the projected cash flows for these CGUs are shown below:

Cash generating units
North America ADE
North America AGI

Goodwill 
carrying value
2023
£m

Long-term 
growth rate
2023
%

Post-tax 
discount rate
2023
%

Pre-tax  
discount rate
2023
%

97.2 
57.1 

2.2 
2.2 

10.4 
10.4 

13.0 
12.9 

121

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
 
 
 
 
 
 Notes to the consolidated financial statements continued
Year ended 31 December 2023

9.  Goodwill continued
Expected future cash flows are inherently uncertain and could change materially over time. They are affected by several factors, including 
market and production estimates, together with economic factors such as prices, discount rates, currency exchange rates, estimates of 
operational costs, and future maintenance capital expenditure. The Group has conducted sensitivity analysis on the key assumptions applied 
to the value-in-use calculations for each CGU. 

The key assumptions that were sensitised in a downside scenario included a reduction in sales growth, operating margin and the medium and 
long-term growth rates. The combined impact of these adjustments reduced the aggregated net present value (NPV) of the CGUs by 29%. 
With the exception of the NA AGI CGU, no reasonably possible downside reductions to any of these assumptions resulted in an impairment. 

For the NA AGI CGU, management modelled a downside scenario which reflected no volume growth over the next five years, followed by 
an assumed 25% reduction in the medium and long-term growth rate versus the base case. In addition, it was assumed in this scenario that 
headline operating margins were well below the base case, being restricted to 11.5%, reflecting the margin achieved in 2022 and substantially 
below their pre-COVID peak despite the cost reduction actions taken since then. This downside scenario, which management believes to 
be unlikely, but could be possible if market conditions and underlying performance do not recover, could result in an immaterial impairment. 
This scenario does not include the benefit of any cost reduction and other initiatives that would be undertaken in the unlikely event that no 
growth in volumes or recovery of margins in this CGU was achieved. This downward trend would have to continue into the longer term to 
result in an impairment. 

In determining the sensitivities to apply, consideration was given to the impact that climate change risks and opportunities may have on the 
Group’s businesses. Specific scenarios relating to the potential risks of climate change, as set out in our TCFD section of the Annual Report, 
were considered to determine if these should be included in the modelling performed and it was determined that none of these scenarios 
would have a material impact on the outcome. Furthermore the impact of the above sensitivities was deemed sufficiently severe to cover  
a range of potential risks, some of which could relate to these potential risks.

Based on current available information, the Directors do not consider that there are any reasonably possible scenarios that could arise that 
would result in a material impairment charge being recognised in the next 12 months, notwithstanding the potential risk around the NA AGI 
CGU as set out above. Accordingly, the Directors have concluded that no impairment charge is required as at 31 December 2023.

10.  Other intangible assets

Cost

At 1 January 2022
Exchange differences
Additions
Eliminated on disposals
At 1 January 2023
Exchange differences
Additions
Eliminated on disposals
At 31 December 2023

Amortisation

At 1 January 2022
Exchange differences
Charge for the year
Eliminated on disposals
At 1 January 2023
Exchange differences
Charge for the year
Eliminated on disposals
At 31 December 2023

Carrying amount 

At 31 December 2023
At 31 December 2022

Software
£m

Customer 
relationships
£m

Non-compete 
agreements
£m

46.6 
0.5 
9.8 
(3.3)
53.6 
(0.3)
8.3 
(0.7)
60.9 

25.4 
0.4 
1.7 
(3.3)
24.2 
(0.1)
1.7 
(0.7)
25.1 

35.8 
29.4 

138.2 
16.3 
– 
– 
154.5 
(7.6)
– 
– 
146.9 

52.0 
6.3 
9.3 
– 
67.6 
(3.6)
7.8 
– 
71.8 

75.1 
86.9 

3.8 
– 
– 
– 
3.8 
– 
– 
– 
3.8 

3.1 
– 
0.1 
– 
3.2 
– 
0.3 
– 
3.5 

0.3 
0.6 

Total
£m

188.6 
16.8 
9.8 
(3.3)
211.9 
(7.9)
8.3 
(0.7)
211.6 

80.5 
6.7 
11.1 
(3.3)
95.0 
(3.7)
9.8 
(0.7)
100.4 

111.2 
116.9 

Included in intangible software assets are carrying values related to the Group’s existing ERP software module totalling £2.5m (2022: £4.0m) 
which are currently being amortised over the remaining useful life.

The Group is currently developing and implementing a new ERP software solution, assets of which will be held centrally. During the year,  
the Group has capitalised £8.1m (2022: £9.6m), of which £5.1m (2022: £4.7m) relates to internal capital costs for the development of this ERP 
solution. Included in intangible assets are £32.2m (2022: £24.0m) that is not yet available for use and is therefore not yet being amortised.

Contractual commitments related to the ERP software development were £1.1m at 31 December 2023 (2022: £1.9m). These costs will be 
capitalised as incurred. 

122

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
 
 
 
 
 
11.  Property, plant and equipment

Land and buildings

Long 
leasehold 
improvements
£m

Short 
leasehold 
improvements 
£m

Plant  
and 
machinery
£m

Fixtures  
and  
fittings
£m

Assets  
under 
construction
£m

Freehold
£m

Cost or valuation

At 1 January 2022
Additions1
Exchange differences
Recategorisation
Eliminated on disposals
At 1 January 2023
Additions1
Exchange differences
Transfer to assets held for sale
Recategorisation
Eliminated on disposals
At 31 December 2023

248.4 
0.1 
17.5 
10.1 
(3.6)
272.5 
0.1 
(7.4)
(1.4)
(1.6)
(10.4)
251.8 
Accumulated depreciation and impairment 
119.9 
7.0 
1.2 
8.3 
(0.5)
(2.6)
133.3 
6.8 
0.1 
(3.4)
(0.9)
(5.7)
(4.1)
126.1 

At 1 January 2022
Charge for the year
Impairment losses incurred
Exchange differences
Recategorisation
Eliminated on disposals
At 1 January 2023
Charge for the year
Impairment losses incurred
Exchange differences
Transfer to assets held for sale
Recategorisation
Eliminated on disposals
At 31 December 2023

Carrying amount

At 31 December 2023
At 31 December 2022

125.7 
139.2 

1  For further information on capital payables and accruals see note 20.

10.0 
0.1 
0.2 
(0.5)
(0.4)
9.4 
1.3 
(0.3)
– 
7.0 
(0.6)
16.8 

6.0 
1.0 
– 
0.1 
0.2 
(0.4)
6.9 
0.9 
– 
(0.3)
– 
5.9 
(0.6)
12.8 

4.0 
2.5 

19.8 
0.1 
1.9 
0.8 
(1.2)
21.4 
0.3 
(0.9)
– 
0.3 
(0.1)
21.0 

10.1 
1.5 
0.1 
0.9 
– 
(1.2)
11.4 
1.4 
– 
(0.4)
– 
(1.2)
(0.1)
11.1 

9.9 
10.0 

989.4 
4.9 
71.2 
39.5 
(17.2)
1,087.8 
3.3 
(31.3)
– 
52.1 
(29.8)
1,082.1 

702.0 
49.1 
3.3 
49.9 
0.3 
(16.4)
788.2 
48.6 
0.8 
(22.5)
– 
6.3 
(29.9)
791.5 

290.6 
299.6 

26.8 
0.5 
1.9 
2.0 
(1.2)
30.0 
0.6 
(0.9)
– 
(5.7)
(2.8)
21.2 

22.0 
1.6 
0.1 
1.5 
– 
(1.2)
24.0 
1.7 
– 
(0.7)
– 
(5.3)
(2.7)
17.0 

4.2 
6.0 

55.0 
52.2 
5.0 
(51.9)
(1.2)
59.1 
66.1 
(2.4)
– 
(52.1)
(0.2)
70.5 

0.1 
– 
– 
– 
– 
– 
0.1 
– 
– 
(0.1)
– 
– 
– 
– 

70.5 
59.0 

Total
£m

1,349.4 
57.9 
97.7 
– 
(24.8)
1,480.2 
71.7 
(43.2)
(1.4)
– 
(43.9)
1,463.4 

860.1 
60.2 
4.7 
60.7 
– 
(21.8)
963.9 
59.4 
0.9 
(27.4)
(0.9)
– 
(37.4)
958.5 

504.9 
516.3 

At 31 December 2023 the Group had entered into contractual commitments for the acquisition of property, plant and equipment amounting  
to £21.1m (2022: £9.4m). 

123

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Notes to the consolidated financial statements continued
Year ended 31 December 2023

11.  Property, plant and equipment continued
Property, plant and equipment impairments of £0.9m were incurred in the year (2022: £4.8m) that relate to assets that were deemed to no 
longer be required. Net asset impairments incurred in 2022 of £4.7m include £0.1m asset impairment reversal. All impairments in 2023 and 
2022 were written to £nil carrying value. Net asset impairments broken down by business segment are shown in the table below: 

ADE:

Western Europe
North America
Emerging Markets

AGI:

Western Europe
North America

2023
£m

– 
0.2 
0.3 

– 
0.4 
0.9 

2022
£m

– 
0.1 
– 

– 
4.6 
4.7 

As at 31 December 2023 property assets with a net book value of £0.5m were classified as a current asset held for sale (2022: £0.3m)  
(see note 16 for details). The Group also disposed of certain property assets with net proceeds recorded of £9.4m (2022: £3.2m). A gain  
on sale was recorded in operating profit in the consolidated income statement of £3.4m (2022: £1.7m) and a loss on sale of certain assets 
related to the 2020 restructuring programme included in exceptional items of £nil (2022: £0.1m).

12. Right-of-use assets
As a lessee
Information about leases for which the Group is the lessee is presented below:

Land, buildings, 
fixtures and 
fittings
£m

Plant and 
machinery
£m

Vehicles
£m

125.3 
9.0 
(1.2)
9.3 
142.4 
9.2 
(10.0)
(3.7)
137.9 

76.2 
8.4 
(0.9)
6.1 
89.8 
9.0 
(9.4)
(2.2)
87.2 

50.7 
52.6 

20.6 
1.3 
(0.8)
1.5 
22.6 
1.9 
(2.7)
(0.7)
21.1 

16.2 
2.2 
(0.8)
1.3 
18.9 
1.7 
(2.7)
(0.5)
17.4 

3.7 
3.7 

17.8 
1.6 
(1.5)
1.2 
19.1 
3.4 
(3.4)
(0.8)
18.3 

13.7 
2.4 
(1.3)
1.0 
15.8 
2.2 
(3.2)
(0.6)
14.2 

4.1 
3.3 

Total
£m

163.7 
11.9 
(3.5)
12.0 
184.1 
14.5 
(16.1)
(5.2)
177.3 

106.1 
13.0 
(3.0)
8.4 
124.5 
12.9 
(15.3)
(3.3)
118.8 

58.5 
59.6 

Cost or valuation

At 1 January 2022
Additions
Eliminated on disposals
Exchange differences
At 1 January 2023
Additions
Eliminated on disposals
Exchange differences
At 31 December 2023
Accumulated depreciation

At 1 January 2022
Charge for the year
Eliminated on disposals
Exchange differences
At 1 January 2023
Charge for the year
Eliminated on disposals
Exchange differences
At 31 December 2023

Carrying amount

At 31 December 2023
At 31 December 2022

124

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
12. Right-of-use assets continued
Lease liabilities

Maturity analysis – contractual undiscounted cash flows
Less than one year
One to five years
More than five years
Total undiscounted cash flows

At 1 January 
Additions
Disposals
Principal and interest repayments
Exchange differences
At 31 December 
Current
Non-current

Amounts recognised in the consolidated income statement
Depreciation charge
Interest on lease liabilities
Expenses relating to short-term leases
Expenses relating to leases of low value assets
Gain on disposal of right-of-use assets

2023
£m
12.3 
33.4 
53.4 
99.1 

2023
£m
66.0 
14.6 
(0.8)
(13.1)
(2.4)
64.3 
11.8 
52.5 

2023
£m
12.9 
2.3 
0.9 
0.8 
(0.2)

2022
£m
14.3 
33.9 
55.7 
103.9 

2022
£m
64.5 
11.7 
(0.7)
(13.8)
4.3 
66.0 
12.3 
53.7 

2022
£m
13.0 
1.8 
1.1 
0.7 
(0.1)

Contracts may contain both lease and non-lease components such as administrative charges and taxes. The Group allocates the consideration 
in the contract to the lease and non-lease components based on their relative stand-alone prices.

Lease terms are negotiated on an individual basis and contain a wide range of different terms and conditions. The lease agreements do not 
impose any covenants other than the security interests in the leased assets that are held by the lessor.

As a lessor
The Group sub-leases a small number of properties. There were no material arrangements where the Group is the lessor.

13. Inventories

Raw materials
Work-in-progress
Finished goods and goods for resale
Less: obsolescence provision

Inventory expensed in the years ended 31 December 2023 and 2022 is disclosed in note 2. 

2023
£m
26.7 
2.6 
0.9 
(0.7)
29.5 

2022
£m
23.9 
4.1 
0.9 
(1.1)
27.8 

125

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 Notes to the consolidated financial statements continued
Year ended 31 December 2023

14. Trade and other receivables

Amounts falling due within one year:

Amounts receivable for the supply of services
Allowance for expected credit loss
Net trade receivables
Other receivables
Prepayments

Amounts falling due after more than one year:
Trade and other receivables

2023
£m

130.8 
(2.8)
128.0 
10.3 
10.1 
148.4 

1.3 

2022
£m

135.8 
(2.9)
132.9 
11.7 
9.8 
154.4 

1.5 

The credit period given to customers for the supply of services as at 31 December 2023 is 62 days (2022: 63 days). An allowance has 
been made for estimated irrecoverable amounts from the supply of services of £2.8m (2022: £2.9m). This allowance has been determined 
by reference to expected credit losses as set out in the Group’s accounting policies. The carrying amount of trade and other receivables 
approximates their fair value. Included in the Group’s trade receivables balance are specific debtor balances with a carrying amount of  
£30.1m (2022: £32.0m) which are past due but not impaired at the reporting date. 

The Group has assessed these balances for recoverability and considers the credit quality intact and that any impairment would be  
de minimis for recognition.

Ageing analysis of net trade receivables:

Trade receivables within terms
Ageing of past due but not impaired receivables:

31-60 days
61-90 days
91-120 days
Greater than 120 days

Movement in the allowance for expected credit loss:

At 1 January 
Impairment losses recognised
Amounts written off as uncollectable
Impairment losses reversed
Exchange differences
At 31 December

2023
£m
97.9 

15.1 
11.5 
2.3 
1.2 
128.0 

2023
£m
2.9 
1.0 
(0.2)
(0.8)
(0.1)
2.8 

2022
£m
100.9 

17.0 
10.3 
3.2 
1.5 
132.9 

2022
£m
2.8 
1.3 
(0.2)
(1.2)
0.2 
2.9 

In determining the recoverability of a trade receivable the Group considers any change in the quality of the trade receivable from the date 
credit was initially granted up to the reporting date. The Group uses judgement in making these assumptions and selecting the inputs to the 
impairment calculation, based on the Group’s recent history and existing market conditions, as well as forward-looking estimates at the  
end of each reporting period. The concentration of credit risk is limited due to the customer base being large and unrelated. Accordingly,  
the Directors believe that there is no further credit provision required in excess of the allowance for expected credit loss.

Included in the allowance for expected credit loss are impaired trade receivables with a gross balance of £5.8m (2022: £6.5m) which are 
carried net after the expected credit loss provision at £3.0m (2022: £3.6m). Impairments recognised represent the difference between 
the carrying amount of the trade receivables and the present value of the expected proceeds. The Group does not hold any collateral over 
these balances.

Ageing of impaired trade receivables:

Less than 3 months
3-12 months
Over 12 months

126

2023
£m
0.2 
1.8 
3.8 
5.8 

2022
£m
0.3 
2.2 
4.0 
6.5 

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
 
 
 
 
 
 
15. Cash and bank balances
Cash and bank balances comprise cash held by the Group and a breakdown of significant cash and bank balances by currency is as follows:

US dollar
Euro
Sterling
Chinese yuan
Swedish krona
Other
Total cash and bank balances1

1  Refer to note 17 for an analysis of overdraft by currency.

2023
£m
24.4 
3.5 
3.7 
11.0 
0.8 
1.8 
45.2 

2022
£m
10.6 
7.3 
3.1 
10.3 
1.9 
4.0 
37.2 

16. Assets held for sale
Included in assets held for sale are £0.5m (2022: £0.3m) of assets that are actively being marketed for sale. During the year assets of £0.3m 
previously recorded as held for sale as at 31 December 2022 were sold. Assets classified as held for sale are recorded at the lower of their 
carrying amount and fair value less costs to sell. Current assets held for sale are analysed between operating segments as follows:

AGI:

Western Europe

ADE:

Western Europe

17.  Borrowings

Revolving Credit Facility
Bank overdrafts
Total borrowings
Weighted average interest rate paid
Analysis of Revolving Credit Facility drawdowns by currency:

US dollar
Euro
Sterling

Analysis of bank overdrafts by currency:

US dollar
Euro
Swiss Franc

2023
£m

– 

0.5 
0.5 

2023
£m
32.1
0.5
32.6
5.3%

–
32.1 
– 
32.1 

– 
0.2 
0.3 
0.5 

2022
£m

0.3 

– 
0.3 

2022
£m
69.6 
1.0 
70.6 
4.2%

12.0 
34.6 
23.0 
69.6 

1.0 
– 
–
1.0 

The majority of bank overdrafts are repayable on demand. No overdrafts are secured.

The Group has a £250.9m Revolving Credit Facility which commenced on 27 May 2020 which is due to expire on 27 May 2027. 
At 31 December 2023, the Group’s Revolving Credit Facility had total drawings of £32.1m (2022: £69.6m). As at 31 December the RCF 
is drawn in euros only, but through the year was drawn down in sterling, US dollars (USD) and euros (EUR) and as such was subject to 
foreign exchange movements of EUR and USD amounting to a loss of £1.4m. See section (e) in note 18 for information on the related net 
investment hedge.

All borrowings are classified as financial liabilities measured at amortised cost. Given their short-term nature, the carrying amount of bank 
overdrafts approximate their fair value.

127

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
 
 
 
 
 
 
 Notes to the consolidated financial statements continued
Year ended 31 December 2023

17.  Borrowings continued
Other financial liabilities
The following table details the Group’s remaining contractual maturity for its financial liabilities. The table has been drawn up based on the 
undiscounted cash flows of financial liabilities based on the earliest date on which the Group can be required to pay or has the intention to pay. 
The table includes both interest and principal cash flows.

Non-interest bearing financial liabilities1
Bank loans and overdrafts
Lease liabilities

Non-interest-bearing financial liabilities1
Bank loans and overdrafts
Lease liabilities
Derivative financial instruments

Less than 
1 year 
2023 
£m
65.8 
32.6 
12.3 
110.7 

Less than
1 year
2022
£m
72.2 
70.6 
14.3 
0.3 
157.4 

1-2 years 
2023 
£m
0.1 
– 
10.6 
10.7 

1-2 years
2022
£m
0.2 
– 
11.6 
– 
11.8 

 2-5 years 
2023 
£m
– 
– 
22.8 
22.8 

2-5 years
2022
£m
– 
– 
22.3 
– 
22.3 

 5+ years 
2023 
£m
– 
– 
53.4 
53.4 

5+ years
2022
£m
–  
– 
55.7 
– 
55.7 

Total 
2023 
£m
65.9 
32.6 
99.1 
197.6 

Total
2022
£m
72.4 
70.6 
103.9 
0.3 
247.2 

1  Excludes payroll related accruals of £37.0m (2022: £31.9m) which are financial instruments held at amortised cost but are paid immediately after year end.

Of the £32.6m (2022: £70.6m) bank loans and overdrafts disclosed above, £32.1m (2022: £69.6m) of bank loans are drawn under the 
committed facility maturing on 27 May 2027. The overdrafts are predominantly repayable on demand and some are part of pooling 
arrangements, which include offsetting cash balances. The net impact on the balance sheet of derivative cash flows was £nil (2022: liability of 
£0.3m).

128

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
18.  Financial instruments
(a) Financial instruments by category
In accordance with IFRS 9, the Group categorises its financial instruments into those measured at ‘amortised cost’, ‘fair value through profit or 
loss’ and ‘fair value through other comprehensive income’.

Financial assets
Trade and other receivables
Cash and bank balances

Financial assets
Trade and other receivables
Cash and bank balances

Financial liabilities
Borrowings – loans and overdrafts
Lease liabilities
Trade and other payables1

Financial liabilities
Borrowings – loans and overdrafts
Lease liabilities
Trade and other payables1
Other non-current liabilities
Derivative financial instruments

Fair value 
hierarchy

Fair value 
hierarchy

Fair value 
hierarchy

Fair value 
hierarchy

Level 2/3
Level 2

At amortised 
cost
2023
£m
133.9 
45.2 
179.1 

At amortised 
cost
2022
£m
141.4 
37.2 
178.6 

At amortised 
cost
2023
£m
32.6 
64.3 
62.2 
159.1 

At amortised 
cost
2022
£m
70.6 
66.0 
69.0 
0.1 
– 
205.7 

At fair value 
through profit  
or loss
2023
£m
– 
– 
– 

At fair value 
through profit  
or loss
2022
£m
– 
– 
– 

At fair value 
through profit  
or loss
2023
£m
– 
– 
– 
– 

At fair value 
through profit  
or loss
2022
£m
– 
– 
– 
– 
– 
– 

At fair value 
through OCI
2023
£m
– 
– 
– 

At fair value 
through OCI
2022
£m
– 
– 
– 

At fair value 
through OCI
2023
£m
– 
– 
– 
– 

At fair value 
through OCI
2022
£m
– 
– 
– 
– 
0.3 
0.3 

Total
2023
£m
133.9 
45.2 
179.1 

Total
2022
£m
141.4 
37.2 
178.6 

Total
2023
£m
32.6 
64.3 
62.2 
159.1 

Total
2022
£m
70.6 
66.0 
69.0 
0.1 
0.3 
206.0 

1  Excludes payroll related accruals of £37.0m (2022: £31.9m) which are financial instruments held at amortised cost but are paid immediately after year end.

For information on the derivative financial instruments with a fair value of £nil (2022: liability £0.3m) refer to section (d) of note 18.

(b) Fair value measurement
There have been no transfers of assets or liabilities between levels of the fair value hierarchy during the year. The carrying values of financial 
instruments at amortised cost as presented in the consolidated financial statements approximate their fair values.

(c) Financial risk management
The Group’s multinational operations expose it to a variety of financial risks. In the course of its business, the Group may be exposed to 
foreign currency risk, interest rate risk, liquidity risk and credit risk. Financial risk management and treasury policies are set by the Board. 
The Group’s treasury function provides a centralised service to the Group for funding, foreign exchange, interest rate management and 
counterparty risk. Treasury activities have the objective of minimising risk and treasury operations are conducted within a framework of 
policies and guidelines reviewed and authorised by the Board. 

In accordance with its treasury policy, the Group does not use or hold derivative financial instruments for trading or speculative purposes. 
The Group may however use derivative instruments, for risk management purposes only, transacted by specialist treasury personnel. The use 
of financial instruments, including derivatives, is permitted when approved according to treasury policy, where the effect is to minimise risk for 
the Group. There has been no significant change during the financial year, or since the end of the year, to the types or scope of financial risks 
faced by the Group.

129

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
 
 
 
 
 
 
 Notes to the consolidated financial statements continued
Year ended 31 December 2023

18.  Financial instruments continued
Liquidity risk
Liquidity risk is defined as the risk that the Group might not be able to settle or meet its obligations on time or at a reasonable price. 
Liquidity risk arises as a result of mismatches between cash inflows and outflows from the business. This risk is monitored on a centralised 
basis through regular cash flow forecasting, strategic planning, annual budget agreed by the Board each year and re-forecasts undertaken 
during the financial year. To mitigate the risk, the resulting forecast net cash/(debt) is measured against the liquidity headroom policy which 
requires a minimum liquidity headroom of £75m.

As at 31 December 2023, the Group had £218.8m (2022: £181.3m) available on the committed Revolving Credit Facility of £250.9m which 
together with cash and cash equivalents of £45.2m (2022: £37.2m), and available committed overdraft facilities of £9.5m (2022: £4.5m), 
resulted in available liquidity headroom of £273.5m (2022: £223.0m). The Group also uses uncommitted short-term bank facilities to manage 
short-term liquidity but these facilities are excluded from the liquidity headroom policy. The Group manages longer-term liquidity through its 
committed bank facilities and will, if appropriate, raise funds on capital markets.

As at 31 December 2023 the Group’s principal committed bank facility of £250.9m had a maturity date of 27 May 2027 (3.4 years to maturity) 
and had drawings of £32.1m (2022: £69.6m). 

Cash management pooling, netting and concentration techniques are used to minimise borrowings. 

Credit risk
Credit risk primarily arises because a counterparty may fail to perform its obligations. The Group is exposed to credit risk on financial assets 
such as cash balances, derivative financial instruments and trade and other receivables.

The Group’s credit risk is primarily attributable to its trade receivables. The amounts presented in the balance sheet are net of appropriate 
allowances for expected credit losses based on a simplified lifetime Expected Credit Loss (ECL) model to assess trade receivables for 
impairment where ECL is the present value of all cash shortfalls over the expected life of a trade receivable. An allowance for impairment is 
made when one or more events have occurred that have a significant impact on the expected future cash flows of the financial asset such 
that there is sufficient evidence of a reduction in the recoverability of the asset. The quantitative analysis of credit risk relating to receivables is 
included in note 14.

Counterparty risk encompasses settlement risk on derivative financial instruments and credit risk on cash and term deposits. The Group 
monitors its credit exposure to its counterparties via their credit ratings (where applicable) and through its policy, thereby limiting its exposure 
to any one party to ensure there is no significant concentration of credit risk. The credit risk on liquid funds (cash balances) and derivative 
financial instruments is limited because the counterparties are banks with high credit ratings assigned by international credit-rating agencies 
and Group policy is to enter into such transactions with a preference with counterparties with an investment grade rating. However, acquired 
businesses occasionally have dealings with banks with lower credit ratings. Business with such banks is moved as soon as practicable.

The Group has no significant concentration of credit risk, with exposure spread over a large number of counterparties and customers. 

Interest rate risk
Interest rate risk arises on borrowings and cash balances (and derivative liabilities and assets) which are at floating interest rates. Changes in 
interest rates could have the effect of either increasing or decreasing the Group’s net profit. Under the Group’s interest rate management 
policy, the interest rates on each of the Group’s major currency monetary assets and liabilities are managed to achieve the desired mix of fixed 
and variable rates for each major net currency exposure. The major interest rate risk is to rates in the UK, Europe and the USA.

Interest rate sensitivity
To represent management’s best estimate of a reasonable range of potential outcomes, the Group has measured the estimated change to the 
income statement and equity of either an instantaneous increase or decrease of 1% (100 basis points) in market interest rates, which did not 
indicate any material impact on the financial statements. This analysis was for illustrative purposes only. The sensitivity analysis excludes the 
impact of market risks on net post-employment benefit obligations.

The interest rate sensitivity analysis is based on the following assumptions:

 – changes in market interest rates affect the interest income or expense of variable interest financial instruments; and 

 – changes in market interest rates affect the fair value of derivative financial instruments designated as hedging instruments. 

Under these assumptions, a one percentage point fall or rise in market interest rates for all currencies in which the Group has variable net 
cash or net borrowings at 31 December 2023 would increase or reduce profit before tax by approximately £0.1m (2022: £0.7m). There is no 
significant impact on equity in the current or previous year.

130

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 202318.  Financial instruments continued
Currency risk 
Bodycote has operations in 22 countries and is therefore exposed to foreign exchange translation risk when the profits/losses and net assets 
of these entities are consolidated into the Group’s financial statements.

Ninety-two per cent of the Group’s revenues are in currencies other than sterling (EUR 37%, USD 34% and SEK 6%, and others at or below 
3% individually, total 15%). Cumulatively over the year, sterling rates moved such that the revenue for the year was £3.0m lower than it would 
have been had the revenue been translated at the rates prevailing in 2022. 

It is Group policy not to hedge exposure for the translation of reported profits. Refer to section (e) for further disclosure of the Group’s financial 
instrument risk management activities. 

The Group’s balance sheet translation policy is not to actively hedge currency net assets but where appropriate the Group will still match 
centrally held currency borrowings to the net assets. The Group generally borrows in sterling, US dollars and euros, consistent with the 
locations where the majority of the Group’s cash flows are generated. The Group recognises foreign exchange movements in equity for the 
translation of net investment hedging instruments and balances (see section (e)). 

Transactional foreign exchange exposures arise when entities within the Group enter into contracts to pay or receive funds in a currency 
different from the functional currency of the entity concerned. It is Group policy to hedge exposure to cash transactions in foreign currencies 
when a commitment arises, usually through the use of foreign exchange forward contracts. Even though approximately 92% of the Group’s 
revenues are generated outside the UK, the nature of the business is such that cross-border sales and purchases are limited and immaterial 
for the Group.

Currency sensitivity 
Taking the 2023 revenue by currency, a 10% weakening/strengthening in the 2023 cumulative average rates for all currencies versus sterling 
would have given rise to a +£81.8m /-£66.9m movement in revenue respectively. The impact on headline operating profit is affected by the 
mix of losses and profits in the various currencies. However, taking the 2023 operating profit mix, a 10% weakening/strengthening in 2023 
cumulative average rates for all currencies would have given rise to a +£12.3m/-£10.0m movement in headline operating profit.

(d) Derivative financial instruments
The Group’s derivative financial instruments were considered to be classified as level 2 instruments. Fair value measurements are those 
derived from inputs other than quoted prices included within level 1 that are observable for the asset or liabilities, either directly (i.e. as prices) 
or indirectly (i.e. derived from prices).

In accordance with IFRS 7 Financial Instruments: Disclosures, fair value is determined using quoted forward exchange rates and yield curves 
derived from quoted interest rates matching maturities of the contracts.

The Group’s interest rate risk is primarily in relation to its floating rate borrowings (cash flow risk). From time to time the Group will use 
interest rate derivative contracts to manage its exposure to interest rate movements within Group policy. At the balance sheet date, the Group 
has no outstanding interest rate derivative.

(e) Net investment hedge
During the year the Group’s outstanding Revolving Credit Facility drawings were denominated in GBP, USD, and EUR. Certain EUR and USD 
amounts were designated as a net investment hedge through the year to the Group’s subsidiaries with a matching functional currency on a  
1:1 ratio. As at 31 December the Revolving Credit Facility was drawn only in EUR and consequently the USD net investment hedge was open 
but inactive. The effects and performance of the active net investment hedges as at 31 December 2023 are set out as follows:  

EUR Net investment hedge
Carrying amount of the hedging instruments
Carrying amount of the hedged items (net assets  
of subsidiaries) and denominations
Hedge ratio
Change in hedging instruments carrying amount as a result  
of foreign currency movements from 1 January 2023
Change in value of hedged item used to determine  
hedge effectiveness

2023
£m
32.1 

32.1 
1:1

0.9 

(0.9)

2023
€m
37.0 

37.0 
– 

– 

– 

2022
£m
43.5 

43.5 
1:1

(2.1)

2.1 

2022
€m
49.0 

49.0 
– 

– 

– 

The gain on the net investment hedge of £1.5m (2022: £3.1m loss), made up of £0.9m on the EUR hedge (2022: £2.1m loss) and £0.6m on 
the USD hedge (2022: £1.0m loss) has been recognised in other comprehensive income and accumulated in other reserves in shareholders’ 
equity. There was no ineffectiveness to be recorded from the net investment hedges.

131

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 Notes to the consolidated financial statements continued
Year ended 31 December 2023

19.  Deferred tax 
The following are the major deferred tax liabilities and (assets) recognised by the Group and movements thereon during the current and prior 
reporting periods:

Accelerated tax 
depreciation
£m
50.0 

Tax losses
£m
(1.8)

Retirement 
benefit 
obligations
£m
(3.2)

0.5 
– 
1.7 
4.3 

1.0 
57.5 

5.9 
– 
(2.3)

0.3 
61.4 

(0.1)
– 
(1.7)
(0.1)

– 
(3.7)

0.3 
– 
0.1 

– 
(3.3)

0.2 
0.2 
– 
(0.2)

– 
(3.0)

0.2 
– 
– 

– 
(2.8)

At 1 January 2022
Charge/(credit) to the consolidated income 
statement
Debit to equity
Transfers
Exchange differences
Effect of change in tax rate in the income 
statement
At 1 January 2023
Charge/(credit) to the consolidated  
income statement
Credit to equity
Exchange differences
Effect of change in tax rate in the income 
statement
At 31 December 2023

Deferred tax liabilities
Deferred tax assets

Other
£m
(0.2)

(1.2)
0.3 
– 
(0.1)

(0.1)
(1.3)

(5.1)
(0.1)
0.4 

– 
(6.1)

2023
£m
51.8 
(2.6)
49.2 

Total
£m
44.8 

(0.6)
0.5 
– 
3.9 

0.9 
49.5 

1.3 
(0.1)
(1.8)

0.3 
49.2 

2022
£m
51.0 
(1.5)
49.5 

Deferred tax assets and liabilities are offset when there is a legally enforceable right to set off current tax assets against current tax liabilities 
and when they relate to income taxes levied by the same taxation authority and the Group intends to settle its current tax assets and liabilities 
on a net basis.

Other deferred tax assets relate to provisions recognised in the financial statements that are not yet deductible for tax purposes, in particular 
in relation to restructuring charges, share-based payments and local profit differences that are expected to reverse over time.

At the balance sheet date, the Group has unused tax losses of £33.1m (2022: £37.6m) available for offset against future profits. A deferred tax 
asset has been recognised in respect of £13.6m (2022: £15.7m) of such losses, based on existing taxable temporary differences generating 
future taxable profits against which the assets can be recovered in the relevant jurisdictions. No deferred tax asset has been recognised in 
respect of the remaining £19.5m (2022: £21.9m) of the losses where the likelihood that sufficient taxable profits of the appropriate type is not 
probable. The majority of losses may be carried forward indefinitely. 

The Group has capital losses of £53.3m (2022: £52.4m) which are not recognised for deferred tax as future suitable profits against which the 
losses could be utilised are not probable. A deferred tax liability of £3.9m (2022: £3.1m) relating to the temporary differences on unremitted 
earnings of overseas subsidiaries has been recognised as the Group believes it is probable that these temporary differences will reverse in the 
foreseeable future. Temporary differences arising in connection with interests in associates and joint ventures are insignificant.

The majority of the deferred tax liability is expected to reverse in over 12 months.

132

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
20. Trade and other payables

Working capital amounts falling due within one year:

Trade payables
Other taxes and social security
Other payables
Trade accruals1

Other amounts falling due within one year:

Interest payable
Capital payables
Capital accruals

Total amounts falling due within one year:

Working capital amounts falling due after more than one year:
Other payables

1  Accruals include £37.0m (2022: £31.9m) of payroll-related accruals.

2023
£m

20.8 
19.8 
6.1 
64.7 
111.4 

2.7 
4.6 
4.0 
11.3 
122.7 

0.9 

2022
£m

30.8 
20.7 
4.9 
55.8 
112.2 

1.7 
5.6 
5.4 
12.7 
124.9 

1.1 

Trade payables and accruals principally comprise amounts outstanding for trade purchases and ongoing costs. The average credit period 
taken for trade purchases as at 31 December 2023 is 22 days (2022: 35 days). The Directors consider the carrying value of trade payables to 
approximate to their fair value.

21.  Provisions

At 1 January 2023
Increase in provision
Release of provision
Utilisation of provision
Exchange difference
At 31 December 2023
Included in current liabilities
Included in non-current liabilities

Restructuring
£m
1.6 
0.8 
(0.4)
(1.5)
– 
0.5 

Restructuring 
environmental
£m
2.4 
0.2 
(0.1)
(0.1)
(0.2)
2.2 

Environmental
£m
8.9 
1.1 
– 
(2.5)
(0.5)
7.0 

Legal and 
operational
£m
5.2 
3.4 
(0.5)
(2.8)
– 
5.3 

Total
£m
18.1 
5.5 
(1.0)
(6.9)
(0.7)
15.0 
12.0 
3.0 
15.0 

As at 31 December 2023 the Group held £1.4m (2022: £3.0m) of exceptional restructuring provisions relating to the 2020 exceptional 
restructuring programme. Refer to the 2020 Annual report for more information.

The Group provides for the costs of environmental remediation if there is a probable outflow of economic resources that has been identified 
at the time of plant closure, as part of acquisition due diligence or in other circumstances where remediation by the Group is required. 
This provision is reviewed annually to determine the best estimate of expenditure required to settle the identified obligations and where 
applicable external confirmations are obtained to determine the best estimate of future liabilities. Environmental provisions are separated 
into restructuring environmental and environmental provisions to identify separately those provisions relating to the restructuring from those 
arising in the ordinary course of business. The majority of cash outflows in respect of these liabilities are expected to occur within five years. 

Legal provisions include, but are not limited to, alleged breach of contract and alleged breach of environmental legislation. While the Group 
cannot predict the outcome of individual legal actions, where the exposure can be reliably measured and an outflow of economic benefits is 
considered probable, provisions are recognised following legal advice.

There were no individually material provisions as at 31 December 2023. 

The Group remains exposed to contingent liabilities in respect of environmental remediation liabilities. In particular, the Group could be 
subjected to regulatory or legislative requirements to remediate sites in the future. However, it is not possible at this time to determine 
whether and to what extent any liabilities exist, other than for those recognised above. Therefore no provision is recognised in relation to 
these items. 

133

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Notes to the consolidated financial statements continued
Year ended 31 December 2023

22. Share capital

Authorised: 248,947,368 (2022: 248,947,368) ordinary shares of 173/11p each 
Issued and fully paid: 191,456,172 (2022: 191,456,172) ordinary shares of  173/11p each 

23. Notes to the cash flow statement

Profit for the year
Adjustments for:

Finance income
Finance costs
Taxation charge

Operating profit
Adjustments for:

Depreciation of property, plant and equipment
Depreciation of right-of-use assets
Amortisation of other intangible assets
Profit on disposal of property, plant and equipment recognised in operating profit
Loss on disposal of property, plant and equipment recognised in exceptional items
Profit on disposal of right-of-use assets
Share-based payments
Impairment reversal of property, plant and equipment and other assets recognised  
in exceptional items
Impairment of property, plant and equipment and other assets recognised in operating profit

EBITDA (See APM definition on page 153)

Increase in inventories
Decrease/(increase) in receivables
(Decrease)/increase in payables
Decrease in provisions

Cash generated by operations

Net income taxes paid
Settlement of derivatives
Refund of post settlement pension surplus
Net exchange differences

Net cash from operating activities

Cash and cash equivalents comprise:

Cash and bank balances
Bank overdrafts (included in borrowings)

2023
£m
43.0 
33.1 

2023
£m
86.8 

(0.8)
8.3 
24.9 
119.2 

59.4 
12.9 
9.8 
(3.4)
 – 
(0.2)
5.1 

 – 
0.9 
203.7 
(1.7)
6.2 
(1.0)
(3.1)
204.1 
(9.0)
(0.3)
– 
(3.2)
191.6 

2023
£m

45.2 
(0.5)
44.7 

2022
£m
43.0 
33.1 

2022
£m
74.3 

(0.4)
7.1 
21.0 
102.0 

60.2 
13.0 
11.1 
(1.7)
0.1 
(0.1)
1.7 

(0.1)
4.8 
191.0 
(8.5)
(37.4)
12.6 
(3.7)
154.0 
(15.4)
0.8 
1.8 
1.7 
142.9 

2022
£m

37.2 
(1.0)
36.2 

The cash and cash equivalents disclosed above in the statement of cash flows includes £0.8m (2022: £0.8m) held in escrow relating to 
environmental provisions in the USA and £1.3m (2022: £1.8m) held in the USA related to the refund of a pension surplus. The Group intends 
to use this refund of pension surplus cash to fund future pension contributions for its USA employees, otherwise the full amount will become 
subject to regulatory restrictions in the USA. 

134

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
 
 
 
24. Share-based payments 
The Company operates the Bodycote Incentive Plan (BIP) under which Executive Directors and Senior Executives receive a conditional award 
of Bodycote shares up to a maximum of 175% of base salary. Vesting of awards are based upon two performance measures, over a three-
year period.

At 1 January 
Granted during the year
Exercised during the year
Expired during the year
At 31 December
Average fair value of share awards granted during the year at 
date of grant (pence)
Fair value of awards granted during the year (£)

BIP
2023
5,337,784 
2,867,954 
(206,935)
(1,996,812)
6,001,991 

BIP
2022
4,499,730 
2,086,698 
(75,460)
(1,173,184)
5,337,784 

Other Plans
2023
484,211 
298,682 
(139,947)
(18,041)
624,905 

Other Plans
2022
311,335 
242,384 
(61,377)
(8,131)
484,211 

555.1 
15,919,411 

549.5 
11,465,911 

608.3 
1,816,981 

583.8 
1,414,922 

Fifty percent of the award is subject to a return on capital employed (ROCE) performance condition and 50% of the award is subject to 
headline operating profit or headline earnings per share (EPS) performance conditions. In the event that an underpin headline EPS target is  
not achieved, no awards will vest. 

Other plans include buy-out awards, a restricted share programme and a deferred bonus plan whereby 35% of any bonus earned is deferred 
into shares. Buy-out award shares issued vest between 1 and 24 months from the grant date, other plans shares issued vest after three years 
from the grant date, and all are conditional only on continued employment.

More information on the BIP and the buy-out awards for Executive Directors can be found in the Directors' remuneration report on pages 
77 to 91.

The exercise price of shares exercised was £nil. As at 31 December 2023 of 84,387 exercisable shares outstanding, 70,610 were related 
to BIP and 25,548 related to other plans. The inputs to the Black-Scholes simulation model, used to determine the charge to the income 
statement for BIP, are as follows: 

Weighted average share price (pence)
Weighted average exercise price (pence)
Expected life (years)
Expected dividend yields (%)
Weighted average remaining contractual life of shares 
outstanding (years)
Average fair value of share awards granted during the year  
at date of grant (pence)
Fair value of awards granted during the year (£)

BIP
2023
608.3 
                nil
3.0 
3.0 

BIP
2022
592.7 
                nil
3.0 
2.5 

Other Plans
2023
634.3 
                nil
0.1-3.0
3.0 

Other Plans
2022
616.6 
                nil
3.0 
0.0-2.5

1.2 

1.0 

1.1 

1.7 

555.1 
15,919,411 

549.5 
11,465,911 

608.3 
1,816,981 

583.8 
1,414,922 

The Group recognised a total charge to the consolidated income statement of £5.1m (2022: £1.7m) related to equity-settled share-based 
payment transactions, excluding social charges.

25.  Related party transactions
Transactions between subsidiaries of the Group, which are related parties to each other, have been eliminated on consolidation and are not 
disclosed in this note. For information on defined benefit retirement pension schemes that the Group operates see note 26.

The remuneration of the Board of Directors, who are considered key management personnel of the Group, was as follows:

Short-term employee benefits
Share based payments
Pensions

2023
£m
3.5 
1.8 
0.2 
5.5 

2022
£m
2.5 
0.2 
0.2 
2.9 

Further information about the remuneration of the individual Directors is provided in the Directors' report on remuneration on pages 77 to 91.

135

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
 Notes to the consolidated financial statements continued
Year ended 31 December 2023

26. Retirement benefit schemes
Defined contribution schemes
The Group operates defined contribution retirement benefit schemes for employees in the UK, France, Belgium and Canada.  
The assets of the schemes are held separately from those of the Group in funds under the control of trustees. Where there are employees 
who leave the schemes prior to vesting fully in the contributions, the contributions payable by the Group are reduced by the amount of 
forfeited contributions.

The Group’s employees in Denmark, Finland, Sweden, Italy, Slovakia, Switzerland and the Netherlands are members of state-managed 
retirement benefit schemes operated by the governments of each country. 

The relevant subsidiaries are required to contribute a specified percentage of payroll costs to the retirement benefit schemes to fund the 
benefits. The only obligation of the Group with respect to these retirement benefit schemes is to make the specified contributions.

The total cost charged to the consolidated income statement of £8.3m (2022: £7.8m) represents contributions payable to these schemes  
by the Group at rates specified in the rules of the plans. As at 31 December 2023 contributions of £0.3m (2022: £0.4m) due in respect of the 
current reporting period had not been paid over to the schemes.

Defined benefit schemes
The Group operated a number of pension schemes and provided leaving service benefits to certain employees during the year. The defined 
benefit obligation less fair value of assets at the end of the year and total expense recognised in the income statement are summarised below 
as follows:

Defined benefit obligation less fair value of assets 

UK Scheme
Non-UK Schemes

Total expense recognised in the income statement 

UK Scheme1
Non-UK Schemes1

2023
£m
– 
11.1 
11.1 

2023
£m
0.4 
0.8 
1.2 

2022
£m
– 
10.9 
10.9 

2022
£m
0.5 
0.7 
1.2 

1  The UK Scheme is closed to new members and the accrual of benefits and the costs represent administrative and past service credits and costs. Costs associated with the non-UK schemes 

relate to employee service and related costs (see note 3) and administrative costs (see note 2).

UK Scheme
The Group sponsors the Bodycote UK Pension Scheme (‘the Scheme’) which is a funded defined benefit arrangement for certain former UK 
employees, and pays out pensions at retirement based on service, final pensionable pay and price inflation. The Scheme is funded by the 
Group. The scheme asset values are sensitive to market conditions and the scheme liabilities are sensitive to actuarial assumptions used to 
determine the scheme obligations, the main assumptions of which are the discount rate, the rate of price inflation and the life expectancy rate. 
The following table provides an estimate of the potential impact on the pension scheme of changing these assumptions. 

0.5% change in discount rate
0.5% change in price inflation (and associated assumptions)
One year change in life expectancy at age 65

2023 
Increase
£m
(3.6)
1.4 
2.6 

2023 
Decrease
£m
4.0 
(1.3)
(2.6)

2022 
Increase
£m
(4.1)
1.6 
2.2 

2022 
Decrease
£m
4.5 
(1.5)
(2.2)

The sensitivity analysis was performed by recalculating the defined benefit obligation with the following parameters (all other parameters  
were not modified). The sensitivity table is based on an illustrative 0.5% change, although the assumptions may vary by greater amounts. 
Therefore, the Group considers the retirement benefit obligations a key source of estimation uncertainty.

The Scheme operates under UK trust law and the trust is a separate legal entity from the Group. The Scheme is governed by a board of 
trustees, composed of two member representatives, two employer representatives and one independent trustee. The trustees are required  
by law to act in the best interests of scheme members and are responsible for setting certain policies (e.g. investment, funding) together  
with the Group.

Funding of the Scheme is based on a separate actuarial valuation for funding purposes for which the assumptions may differ from the 
assumptions above. Funding requirements are formally set out in the Statement of Funding Principles, Schedule of Contributions and Recovery 
Plan agreed between the Trustees and the Group in respect of the 6 April 2017 actuarial valuation. The preliminary actuarial valuation of the 
Scheme as at 6 April 2023 was completed by a qualified independent actuary and the results of this have been updated on an approximate 
basis to 31 December 2023.

136

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
26. Retirement benefit schemes continued
It is the policy of the Group to recognise all actuarial gains and losses in the year in which they occur outside of the consolidated income 
statement and in the consolidated statement of comprehensive income. The UK Scheme was closed to new entrants and future accrual 
in 2019.

In June 2023, the High Court judged that amendments made to the Virgin Media scheme were invalid because the scheme’s actuary did not 
provide the associated S37 certificate necessary. If upheld, the High Court’s decision could have wider ranging implications, affecting other 
schemes (such as the Bodycote UK Pension Scheme) that were contracted-out on a salary-related basis, and made amendments between 
April 1997 and April 2016. 

There remains uncertainty about the impact of this judgment with a Court of Appeal hearing for the case set for June 2024 as well as the 
potential for overriding government legislation to be introduced and consequently the Company and the Trustee of the Bodycote UK Pension 
Scheme are not yet in a position to be certain of the full potential implications in detail. The Company and the Trustee of the Scheme will 
continue to seek legal advice on the matter and act accordingly as the situation evolves.

The Group acknowledges that the recognition of a pension scheme surplus is an area of accounting judgement, which depends on the 
interpretation of the wording of the Scheme Rules and the relevant accounting standard, IFRIC 14. In the Group’s view there is uncertainty 
over whether the wording of the Scheme Rules provides the Group with an unconditional right to a refund of any surplus from the Scheme 
either on an ongoing basis or assuming the full settlement of Scheme liabilities. The Group’s interpretation of the Scheme Rules is that there 
is material uncertainty over whether the power to wind up the Scheme is wholly within the Group’s control as would be required under the 
terms of IFRIC 14 in order to recognise a surplus on the balance sheet. Consistent with previous years, given this uncertainty the Group has 
adopted the provisions of IFRIC 14 and the associated additional reporting requirements. As the Scheme is in surplus as at 31 December 2023 
a restriction has been applied to the balance sheet, and the net surplus recognised on the balance sheet has been restricted to £nil.

Reconciliation of opening and closing balances of the present value of the defined benefit obligation (UK Scheme)

Defined benefit obligation at start of year
Interest expense
Actuarial gains arising from changes in demographic assumptions
Actuarial losses/(gains) arising from changes in financial assumptions
Experience losses
Benefits paid, death in service insurance premiums and expenses
Past service (credit)/cost
Defined benefit obligation at end of year

Reconciliation of opening and closing balances of the fair value of the assets (UK Scheme)

Fair value of assets at start of year
Interest income
Return on scheme assets excluding interest income
Scheme administration expenses
Contributions by employer
Benefits paid, death in service insurance premiums and expenses
Fair value of assets at end of year

Total expense recognised in the income statement (UK Scheme)

Past service (credit)/cost
Scheme administration expenses

Assets (UK Scheme)

Bonds
Liability Driven Investment
Diversified credit funds
Cash and cash equivalents

2023
Quoted1
£m
13.6 
21.9 
15.4 
10.1 
61.0 

2023
Unquoted
£m
2.9 
– 
3.7 
– 
6.6 

2022
Quoted1
£m
12.8 
15.4 
12.0 
9.4 
49.6 

1  Quoted scheme assets include assets which have a quoted market price in active markets held within investment trusts.

2023
£m
64.4 
2.9 
(3.2)
1.5 
0.3 
(3.1)
(0.1)
62.7 

2023
£m
67.4 
3.1 
0.3 
(0.5)
0.4 
(3.1)
67.6 

2023
£m
(0.1)
0.5 
0.4 

2022
£m
101.9 
1.8 
(0.5)
(35.4)
3.3 
(6.8)
0.1 
64.4 

2022
£m
115.9 
2.0 
(43.7)
(0.4)
0.4 
(6.8)
67.4 

2022
£m
0.1 
0.4 
0.5 

2022
Unquoted
£m
6.0 
– 
11.8 
– 
17.8 

137

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
 
 
 Notes to the consolidated financial statements continued
Year ended 31 December 2023

26. Retirement benefit schemes continued
None of the fair value of the assets shown above include any of the Group’s own financial instruments or any property occupied by, or other 
assets used by the Group.

The Scheme’s current strategic target is to allocate 19% of the investment strategy to non-matching asset classes, predominantly longer-
term credit based investments and 81% to a liability-matching portfolio, comprising Liability Driven Investment (‘LDI’), money market and 
shorter-term credit based investments. The LDI portion of the strategy has been put in place to reduce interest and inflation risk. LDIs are 
held in pooled investment vehicles and include over the counter derivatives and quoted equities designated to move in line with the defined 
benefit liability.

Assumptions for 2023 (UK Scheme)

RPI inflation
CPI inflation
Salary increases
Rate of discount
Allowance for pension in payment increases of 3% or RPI if lower
Allowance for revaluation of deferred pensions

Mortality – current pensioners (UK Scheme)

Actuarial tables used
Life expectancy for members currently aged 65

Mortality – future pensioners (UK Scheme)

Actuarial tables used
Life expectancy at age 65 for members currently aged 45

Cash commutation:

2023
% per annum
3.20 
2.90 
n/a
4.50 
2.18 
2.90 

2022
% per annum
3.25
2.95
n/a
4.70
2.12
2.95

2023
S3PxA YoB 
CMI 2021 1.5% 
long-term trend
19.8

2022
S3PxA YoB 
CMI 2020 1.5% 
long-term trend
21.3

2023
S3PxA YoB 
CMI 2021 1.5% 
long-term trend
20.7

2022
S3PxA YoB 
CMI 2020 1.5% 
long-term trend
22.9

2023
All members 
commute 75% 
of maximum 
permitted

2022 
All members 
commute 75% 
of maximum 
permitted

The weighted average duration of the defined benefit obligation at 31 December 2023 is approximately 12 years (31 December 
2022: 15 years).

The defined benefit obligation at 31 December 2023 can be approximately attributed to the scheme members as follows:

 – Active members:   

0% (2022: 0%)  

 – Deferred members: 

41% (2022: 40%)  

 – Pensioner members: 

59% (2022: 60%)  

All benefits are vested at 31 December 2023 (unchanged from 2022).

Present value of defined benefit obligations, fair value of assets and deficit (UK Scheme)

Present value of defined benefit obligation
Fair value of plan assets
Scheme surplus
Adjustment relating to asset ceilings and minimum funding requirements
Net defined benefit asset before deferred tax

2023
£m
62.7 
(67.6)
(4.9)
4.9 
– 

2022
£m
64.4 
(67.4)
(3.0)
3.0 
–

138

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
26. Retirement benefit schemes continued
Reconciliation of asset ceiling (UK Scheme)

Restriction due to asset ceiling at beginning of period
Interest on asset restriction
Other changes in asset restriction
Restriction due to asset ceiling at end of period

The best estimate of contributions to be paid into the plan for the year ending 31 December 2024 is £0.4m.

Amounts recognised in other comprehensive income (UK Scheme)

Return on scheme assets excluding interest income
Actuarial (losses)/gains arising from changes in financial assumptions
Actuarial gains arising from changes in demographic assumptions
Experience losses on liabilities
(Loss)/gain due to change in asset restriction
Total gain recognised in other comprehensive income

Combined non-UK disclosures
The Group operates defined benefit schemes in continental Europe. 

2023
£m
3.0 
0.2 
1.7 
4.9 

2023
£m
0.3 
(1.5)
3.2 
(0.3)
(1.7)
– 

In Europe the Group operates defined benefit pension, post-retirement and long-service arrangements for certain employees in France, 
Germany, Italy, Turkey, Switzerland and Liechtenstein. 

Reconciliation of opening and closing balances of the present value of the defined benefit obligation (non-UK schemes) 

Defined benefit obligation at start of year
Current service cost
Interest expense
Actuarial losses arising from changes in demographic assumptions
Actuarial losses/(gains) arising from changes in financial assumptions
Experience losses/(gains) on liabilities
Benefits paid, death in service insurance premiums and expenses
Employee contributions
Settlements
Exchange rate loss
Defined benefit obligation at end of year

Reconciliation of opening and closing balances of the fair value of plan assets (non-UK schemes) 

Fair value of assets at start of year
Interest income
Return on scheme assets excluding interest income
Scheme administration expenses
Contributions by employer
Contributions by employees
Benefits paid, death in service insurance premiums and expenses
Settlements
Exchange rate gain
Fair value of assets at end of year

2023
£m
16.2 
0.4 
0.5 
– 
0.1 
0.4 
(0.6)
0.1 
– 
0.2 
17.3 

2023
£m
5.3 
0.1 
0.4 
– 
0.2 
0.1 
– 
– 
0.1 
6.2 

2022
£m
14.0 
0.2 
(11.2)
3.0 

2022
£m
(43.7)
35.4 
0.5 
(3.3)
11.2 
0.1 

2022
£m
24.0 
0.5 
0.2 
0.5 
(4.1)
(1.5)
(1.6)
0.1 
(3.8)
1.9 
16.2 

2022
£m
12.2 
0.1 
(1.7)
(0.2)
0.1 
0.1 
(0.9)
(5.4)
1.0 
5.3 

139

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
 Notes to the consolidated financial statements continued
Year ended 31 December 2023

26. Retirement benefit schemes continued
Total expense recognised in the income statement (non-UK schemes) 

Current service cost
Net interest on the defined benefit liability
Scheme administration expenses
Settlements
Total expense

Assets (non-UK schemes) 

Cash and cash equivalents
Collective Foundation receivables
Total

2023
£m
0.4 
0.4 
– 
– 
0.8 

2022 
Quoted1
£m
1.7 
– 
1.7 

2022
£m
0.5 
0.1 
0.2 
(0.1)
0.7 

2022
Unquoted
£m
– 
5.3 
5.3 

2023 
Quoted1
£m
– 
– 
– 

2023
Unquoted
£m
– 
6.2 
6.2 

1  Quoted scheme assets include assets which have a quoted market price in active markets held within investment trusts.

None of the fair values of the assets shown above include any of the Group’s own financial instruments or any property occupied by, or other 
assets used by, the Group. 

Assumptions for 2023 (non-UK schemes) 

USA
France
Germany
Italy
Turkey
Liechtenstein
Switzerland

Salary  
increases
% per annum
n/a
3.0 
2.5 
2.5 
21.0 
2.5 
n/a

Rate of  
discount
% per annum
n/a
4.0 
3.5 
3.3 
24.5 
1.5 
2.3 

Inflation
% per annum
n/a
2.0 
n/a
2.5-3.0
21.0 
n/a
n/a

Pension 
increases
% per annum
n/a
1.0 
2.3 
n/a
n/a
n/a
n/a

There were no significant movements compared to the prior year with the exception of Turkey where the rate of discount percentage per 
annum was increased by 9.5 ppts to 24.5% compared with 2022 and the inflation percentage changed by 10.5 ppts to 21%, both due to the 
country’s current and forecasted high inflation period. 

The assumption for the inflation rate % per annum for Italy decreases by 0.5 ppts from 3.0% in 2024 to 2.5% from the year 2025 onwards.

Duration
The weighted average durations of the defined benefit obligations of the overseas schemes at 31 December 2023 range from 9 years to  
18 years. The durations ranged from 8 years to 17 years as at 31 December 2022.

140

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
26. Retirement benefit schemes continued
Present value of defined benefit obligations, fair value of assets and deficit (non-UK schemes) 

Present value of defined benefit obligation
Fair value of plan assets
Deficit in the schemes
Adjustment relating to asset ceilings and minimum funding requirements
Net defined benefit liability, before deferred tax

2023
£m
17.3 
(6.2)
11.1 
– 
11.1 

As all actuarial gains and losses are recognised, the deficit shown above at 31 December 2023 is that recognised in the balance sheet.

Amounts recognised in other comprehensive income (non-UK schemes) 

Return on scheme assets excluding interest income
Actuarial (losses)/ gains arising from changes in financial assumptions
Actuarial loss arising from changes in demographic assumptions
Experience (losses)/gains on liabilities
Gain due to change in asset restriction
Total gain recognised in other comprehensive income

£m
0.4 
(0.1)
– 
(0.4)
– 
(0.1)

2022
£m
16.2 
(5.3)
10.9 
– 
10.9 

£m
(1.7)
4.1 
(0.5)
1.5 
2.3 
5.7 

The only funded plans are those operated in France, Switzerland and Liechtenstein. The best estimate of contributions to be paid into the 
plans for the year ending 31 December 2024 is £0.1m. 

Sensitivities (changes to total defined benefit obligations) (non-UK schemes)

0.25% change in discount rate
0.25% change in price inflation (and associated assumptions)

2023 

2022 

Increase
£m
(0.5)
0.3 

Decrease
£m
0.6 
(0.3)

Increase
£m
(0.5)
0.3 

Decrease
£m
0.5 
(0.3)

The sensitivity table is based on an illustrative 0.25% change, although the assumptions may vary by greater amounts. Therefore, the Group 
considers the retirement benefit obligations a key source of estimation uncertainty.

27.  Contingent liabilities
The Group is subject to certain legal proceedings, claims, complaints and investigations arising out of the ordinary course of business. 
Legal proceedings may include, but are not limited to, alleged breach of contract and alleged breach of environmental, competition, securities 
and health and safety laws. The Group may not be insured fully, or at all, in respect of such risks. The Group cannot predict the outcome 
of individual legal actions or claims or complaints or investigations. The Group may settle litigation or regulatory proceedings prior to a final 
judgment or determination of liability. The Group may do so to avoid the cost, management efforts or negative business, regulatory or 
reputational consequences of continuing to contest liability, even when it considers it has valid defences to liability. The Group considers that 
no material loss is expected to result from these legal proceedings, claims, complaints and investigations. Provision is made for all liabilities 
that are expected to materialise through legal and tax claims against the Group.

28. Post-balance sheet events 
Acquisition of Lake City Heat Treating 
On 19 January 2024 the Group acquired Lake City Heat Treating (Lake City) for a total gross consideration of £52.2m ($66.5m USD) on a cash 
and debt free basis which was settled through the Group’s existing cash and borrowing facilities. This will significantly increase Bodycote’s 
customer reach in the Medical market within the ADE business in North America.

Given the proximity to the year end date an initial accounting and fair value exercise will be completed in the first half of 2024 and the 
accounting impact of this acquisition and the results of the operations for Lake City will be included in the Group’s condensed consolidated 
interim financial statements for the half year of 2024.

Share repurchase programme
On 22 January 2024, the Company announced its intention to launch a share repurchase programme of up to £60.0m. This will commence on 
15 March 2024.

141

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
Company balance sheet
At 31 December 2023

Non-current assets

Intangible assets
Property, plant and equipment
Right-of-use assets
Investments in subsidiaries
Trade and other receivables

Current assets
Trade and other receivables

Total assets
Current liabilities
Trade and other payables
Lease liabilities

Net current liabilities
Non-current liabilities
Trade and other payables
Deferred tax liabilities
Lease liabilities

Total liabilities
Net assets
Equity
Share capital
Share premium account
Own shares
Other reserves
Profit for year
Retained earnings
Total equity

Note

3

4
5
6

6

7
4

7
8
4

9

2023
£m

 34.1 
 0.2 
 1.3 
 388.9 
 6.2 
 430.7 

 5.1 
 5.1 
 435.8 

 10.4 
 0.2 
 10.6 
 (5.5)

 6.5 
 2.3 
 1.3 
 10.1 
 20.7 
 415.1 

 33.1 
 177.1 
 (15.7)
 139.8 
 3.8 
 77.0 
 415.1 

2022
£m

 27.1 
 0.2 
 0.1 
 388.9 
 49.9 
 466.2 

 6.8 
 6.8 
 473.0 

 7.3 
 0.1 
 7.4 
 (0.6)

 4.8 
 1.3 
– 
 6.1 
 13.5 
 459.5 

 33.1 
 177.1 
 (5.2)
 136.6 
 10.6 
 107.3 
 459.5 

The financial statements of Bodycote plc, registered number 519057, were approved by the Board of Directors and authorised for issue on 
15 March 2024.

They were signed on its behalf by:

S.C. Harris  
Director    

B. Fidler
Director

142

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Company statement of changes in equity
Year ended 31 December 2023

1 January 2022

Profit for the year
Exchange differences on translation of overseas 
operations
Actuarial gain on defined benefit pension schemes 
net of deferred tax
Total comprehensive (expense)/income for the year
Dividends paid
Share-based payments
Settlement of share awards
31 December 2022

Profit for the year
Exchange differences on translation of overseas 
operations
Actuarial gain on defined benefit pension schemes 
net of deferred tax
Total comprehensive income for the year
Dividends paid
Shares acquired
Share-based payments
Settlement of share awards
31 December 2023

 Share 
 capital
£m 
 33.1 

 Share 
premium 
account 
£m 
 177.1 

 – 

 – 

 – 
 – 
 – 
 – 
 – 
 33.1 

 – 

 – 

 – 
 – 
 – 
 – 
 – 
 – 
 33.1 

 – 

 – 

 – 
 – 
 – 
 – 
 – 
 177.1 

 – 

 – 

 – 
 – 
 – 
 – 
 – 
 – 
 177.1 

Own
shares
£m
 (6.3)

 – 

 – 

 – 
 – 
 – 
 – 
 1.1 
 (5.2)

 – 

 – 

 – 
 – 
 – 
 (13.2)
 – 
 2.7 
 (15.7)

 Other 
reserves 
£m 
 136.3 

 Retained 
earnings 
£m
 145.9 

 – 

 10.6 

 Total 
£m 
 486.1 

 10.6 

 (0.4)

 – 

 (0.4)

 – 
 (0.4)
 – 
 1.7 
 (1.0)
 136.6 

 – 

 0.1 
 10.7 
 (38.5)
 – 
 (0.2)
 117.9 

 3.8 

 0.1 
 10.3 
 (38.5)
 1.7 
 (0.1)
 459.5 

 3.8 

 0.2 

 – 

 0.2 

 – 
 0.2 
 – 
 – 
 5.1 
 (2.1)
 139.8 

 0.1 
 3.9 
 (40.6)
 – 
 – 
 (0.4)
 80.8 

 0.1 
 4.1 
 (40.6)
 (13.2)
 5.1 
 0.2 
 415.1 

Details of dividends paid are set out in note 7 of the Group consolidated financial statements.

Details of share-based payment transactions are set out in note 24 of the Group consolidated financial statements.

Own shares are held in the Bodycote International Employee Benefit Trust. The Bodycote International Employee Benefit Trust holds 
Bodycote plc shares and satisfies awards made under various employee incentive schemes when issuance of new shares is not appropriate.

In the year ended 31 December 2023, 2,000,000 shares were purchased for the Bodycote International Employee Benefit Trust to satisfy 
future share-based payments under the Group’s share incentive schemes, for an average price of £6.57 at a cost of £13.1m plus purchase 
costs of £0.1m.

At 31 December 2023, 2,292,243 (2022: 639,125) ordinary shares of 173/11p each were held by the Bodycote International Employee Benefit 
Trust and, following recommendations by the employer, are provisionally allocated to satisfy awards under employee incentive schemes. 
The market value of these shares was £13.6m (2022: £3.6m).

Included in other reserves is £9.6m (2022: £6.6m) relating to a share award reserve and a capital redemption reserve of £129.8m 
(2022: £129.8m). The capital redemption reserve arose from B shares which were converted into deferred shares in 2008 and 2009,  
and as a result, £129.8m was transferred from retained earnings to a capital redemption reserve. 

143

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
Company accounting policies

Basis of accounting
The financial statements have been prepared in accordance with Financial Reporting Standard 101 Reduced Disclosure Framework (FRS 101) 
and in accordance with the Companies Act 2006 as applicable to companies using FRS 101. The financial statements have been prepared 
under the historical cost convention and in accordance with applicable law. The principal accounting policies are summarised below, and have 
been applied consistently. In accordance with Section 408 of the Companies Act 2006, a separate profit and loss account dealing with the 
results of the Company has not been presented.

As permitted by FRS 101, the Company has taken advantage of the disclosure exemptions available under that standard in relation to  
share-based payments, financial instruments, capital management, presentation of a cash flow statement, standards not yet effective and 
related party transactions. 

Where required, equivalent disclosures are given in the Group consolidated financial statements of Bodycote plc, which are publicly available.

Dividends
Interim dividend distributions (ordinary and special) to Bodycote plc’s ordinary shareholders are recognised when paid and final dividends 
are accrued when approved by the ordinary shareholders at the Group’s Annual General Meeting. Further detail is contained in note 7 of the 
Group consolidated financial statements.

Going concern
The Directors have at the time of approving the financial statements, a reasonable expectation that the Company has adequate resources to 
continue in operational existence for at least the next 12 months and continue to adopt the going concern basis of accounting in preparing the 
Company’s financial statements. Further detail is contained in the Group going concern statement in the Group accounting policies.

Investments
Investments are held at cost less provision for impairment. Any potential impairment is determined whereby the carrying value of the 
investment is not supported by the net assets of the investment, or discounted future cash flows in the form of expected dividend income.

Foreign currencies
Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing on the dates of the transactions.  
At each balance sheet date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing 
on the balance sheet date. Non-monetary items that are measured in terms of historical cost in a foreign currency are not retranslated. 
Gains and losses arising on retranslation are included in net profit or loss for the year.

Pension costs
The Company participates in a final salary defined benefit pension scheme in the United Kingdom which is funded by the payment 
of contributions to a separately administered trust fund. This is a defined benefit plan which shares the risks between entities under 
common control. 

There is no contractual arrangement or policy for charging the net benefit cost between the entities who participate in this scheme. 
The Company is considered to be the entity that is legally the sponsoring employer of this scheme. As such, the Company recognises the net 
defined benefit cost as per the requirements of IAS 19 Employee Benefits, as described in further detail in the accounting policies applied in 
the Group consolidated financial statements.

For defined contribution schemes, the amount charged to the profit and loss account in respect of pension costs is the contributions payable 
in the year.

Right-of-use assets
To the extent that a right-of-control exists over an asset subject to a lease, with a lease term exceeding one year, a right-of-use asset, 
representing the Company’s right to use the underlying leased asset, and a lease liability, representing the Company’s obligation to make 
lease payments, are recognised in the Company’s balance sheet at the commencement of the lease.

The right-of-use asset is initially measured at cost and includes the amount of initial measurement of the lease liability and any direct costs 
incurred, including advance lease payments and an estimate of the dismantling, removal and restoration costs required by the terms and 
conditions of the lease.

Depreciation is charged to the income statement to depreciate the right-of-use asset from the commencement date until the earlier of the end 
of the useful life of the right-of-use asset or the end of the lease term. The lease term includes the period of any extension option where it is 
reasonably certain that the option will be exercised. Where the lease contains a purchase option the asset is written off over the useful life of 
the asset when it is reasonably certain that the purchase option will be exercised.

The lease liability is measured at the present value of the future lease payments, including any variable lease payments where applicable that 
depend on an index and the exercise price of purchased options where it is reasonably certain that the option will be exercised, discounted 
using the interest rate implicit in the lease, if readily determinable. If the rate cannot be readily determined, the Company’s incremental 
borrowing rate is used. Finance charges are recognised in the income statement over the period of the lease.

Lease arrangements that are short-term in nature or low value are charged directly to the income statement when incurred.

144

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Property, plant and equipment
Property, plant and equipment are stated at cost net of depreciation and any provision for impairment. Depreciation is provided on a  
straight-line basis, to reduce the carrying value to the estimated residual value at the point of sale, at the following annual rates:

Fixtures and fittings 10% to 20%

Intangible assets
Intangible assets are stated at cost net of amortisation and any provision for impairment. Amortisation is provided on a straight-line basis over 
their estimated useful lives, at the following annual rates:

Software 10% to 33%

Impairment of tangible and intangible assets
At each balance sheet date, the Company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any 
indication that those assets have suffered an impairment loss. If any such indication exists or an asset is not in use and therefore requires an 
annual test, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

Recoverable amount is the higher of fair value less costs to dispose and value in use. If the recoverable amount of an asset is estimated to be 
less than its carrying amount, the carrying amount of the asset is reduced to its recoverable amount. An impairment loss is recognised as an 
expense immediately in the income statement.

Where an impairment loss subsequently reverses, the carrying amount of the asset is increased to the revised estimate of its recoverable 
amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment 
loss been recognised for the asset in prior years.

A reversal of an impairment loss is recognised as income immediately.

Receivables
Receivables are initially recognised at fair value. Trade receivables, loans, and other receivables that have fixed or determinable payments that 
are not quoted in an active market are classified as ‘loans and receivables’. Loans and receivables are measured at amortised cost using the 
effective interest method, less any impairment. 

In accordance with IFRS 9, a simplified 12-month Expected Credit Loss (ECL) model is used to assess receivables for impairment. 

Amounts owed by subsidiary undertakings falling due after more than one year are classified as such according to the loan agreement in place 
until 27 May 2027. The interest rate for such facility was at SONIA plus 1.95% margin in 2023. 

Payables
Financial liabilities are classified according to the substance of the contractual arrangements entered into.

Non-interest-bearing financial liabilities are stated at their nominal value. Trade payables are recognised at fair value. 

The Company derecognises financial liabilities when, and only when, the Company obligations are discharged, cancelled or they expire.

Amounts owed to subsidiary undertakings falling due after more than one year are classified as such according to the loan agreement in place 
until 27 May 2027. The interest rate for such facility was at SONIA plus 1.2% margin in 2023.

Taxation
Current UK corporation tax and foreign tax is provided at amounts expected to be paid (or recovered) using the tax rates and laws that have 
been enacted or substantively enacted by the balance sheet date.

Deferred tax is recognised in respect of all temporary differences that have originated but not reversed at the balance sheet date where 
transactions or events that result in an obligation to pay more tax in the future or a right to pay less tax in the future have occurred at the 
balance sheet date. Temporary differences are differences between the Company’s taxable profits and its results as stated in the financial 
statements that arise from the inclusion of gains and losses in tax assessments in periods different from those in which they are recognised  
in the financial statements.

A net deferred tax asset is regarded as recoverable and therefore recognised only when, on the basis of all available evidence, it can be 
regarded as more likely than not that there will be suitable taxable profits from which the future reversal of the underlying temporary 
differences can be deducted.

Deferred tax is measured at the average tax rates that are expected to apply in the periods in which the temporary differences are expected  
to reverse based on tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

145

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Company accounting policies continued

Share-based payments
The Company issues equity-settled share-based payments to certain employees. Equity-settled share-based payments are measured at 
fair value at the date of grant. The fair value determined at the grant date of the equity-settled share-based payments is expensed on a 
straight-line basis over the vesting period. At each balance sheet date, the Company revises its estimate of the number of equity instruments 
expected to vest as a result of the effect of non-market based vesting conditions. The impact of the revision of the original estimates, if any,  
is recognised in profit or loss such that the cumulative expense reflects the revised estimates with a corresponding adjustment to the  
equity-settled employee benefits reserve.

The Company recognises and maintains the share-based payment reserve for all eligible Group employees. Appropriate provisions for non-
Company employees vesting share awards are passed on to other Group companies in the form of a non-interest bearing loan payable to the 
Company. When share awards are exercised by non-Company employees the Company charges other Group companies for the weighted 
average cost to purchase the shares exercised. The Company reduces the loan receivable from the other Group company for the shares 
exercised, recognising the difference between grant and exercise price within retained earnings settlement of share awards.

Critical judgements in applying the Company’s accounting policies and key sources  
of estimation uncertainty
In the course of preparing the Company’s financial statements, accounting for retirement benefit schemes under IAS 19 requires an 
assessment of the future benefits payable in accordance with actuarial assumptions. The discount rate and the mortality rates applied in  
the calculation of scheme liabilities are a key source of estimation uncertainty for the Company. Details of the accounting policies applied  
in respect of retirement benefit schemes are set out in note 26 of the Group consolidated financial statements. 

In line with previous years, the Company continues to take the decision not to recognise an asset in relation to the surplus on the defined 
benefit pension scheme, regardless of value.

146

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
Notes to the company financial statements
Year ended 31 December 2023

1.  Profit for the year
Bodycote plc has made use of the exemption from presenting a profit and loss account, in accordance with Section 408 of the  
Companies Act 2006.

Bodycote plc reported a profit for the financial year ended 31 December 2023 of £3.8m (2022: £10.6m).

The auditor’s remuneration for audit and other services is disclosed in note 2 of the Group consolidated financial statements.

2.  Employees

Average monthly number of employees

Their aggregate remuneration comprised:
Wages and salaries
Social security costs
Pension costs

2023
Number
46

2022
Number
48

£m

 10.3 
 1.1 
 0.5 
 11.9 

£m

 6.3 
 1.0 
 0.5 
7.8

Included in wages and salaries are share-based payments (excluding social charges) resulting in a charge of £0.7m (2022: £0.4m).

All Directors of the Group are remunerated through the Company and these costs are reflected in the financial statements of the Company. 
Disclosure of individual Directors’ remuneration, share interests, share awards, long-term incentive schemes, pension contributions and 
pension entitlements required by the Companies Act 2006 are shown in the tables in the Directors’ report on remuneration on pages 79 to 91.

3. 

Intangible assets

Cost
At 1 January 2023
Additions
Disposals
At 31 December 2023
Amortisation
At 1 January 2023
Charge for the year
Disposals
At 31 December 2023
Net book value
At 31 December 2023
At 31 December 2022

Software
£m

 45.5 
 8.6 
 (0.6)
 53.5 

 18.4 
 1.6 
 (0.6)
 19.4 

 34.1 
 27.1 

Included in software assets are ongoing development costs related to the Group’s ERP solutions. £31.4m (2022: £22.9m) of these costs are 
related to assets that are not yet available for use and are therefore not amortised. As such solutions become available for use, they will be 
amortised according to Group policy.

Additions are for the ongoing ERP development which include £4.3m (2022: £4.3m) charged from other Group companies.

147

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
Notes to the company financial statements continued
For the year ended 31 December 2023

4.  Right-of-use assets

Cost
At 1 January 2023
Additions
Disposals
At 31 December 2023
Depreciation
At 1 January 2023
Charge for the year
Disposals
At 31 December 2023
Net book value
At 31 December 2023
At 31 December 2022

Lease liabilities
Maturity analysis – contractual undiscounted cash flows
Less than one year
One to five years
More than five years
Total undiscounted cash flows

Current
Non–current
Total lease liabilities

5. 

Investments in subsidiaries

Cost
At 1 January 2023 and 31 December 2023
Provision for impairment
At 1 January 2023 and 31 December 2023
Net book value
At 1 January 2023 and 31 December 2023

 Buildings  
and vehicles 
£m 

 2.3 
 1.4 
 (2.3)
 1.4 

 2.2 
 0.2 
 (2.3)
 0.1 

 1.3 
 0.1 

2022
£m

 0.1 
  – 
  – 
 0.1 

 0.1 
  – 
 0.1 

£m

 395.5 

 6.6 

 388.9 

2023
£m

 0.3 
 1.0 
 0.5 
 1.8 

 0.2 
 1.3 
 1.5 

The following subsidiaries in the UK have taken advantage of an exemption from audit under section 479A of the Companies Act 2006.  
As the ultimate parent, Bodycote plc has provided a statutory guarantee for any outstanding liabilities of these businesses. These subsidiaries 
have been included in the Group consolidated financial statements of Bodycote plc as at 31 December 2023.

Bodycote America Capital Limited
Bodycote America Finance Limited
Bodycote America Treasury Limited
Bodycote Finance Limited
Bodycote Finance UK Limited
Bodycote Heat Treatments Limited
Bodycote H.I.P. Limited
Bodycote HIP Germany Limited
Bodycote International Limited
Bodycote Investments
Bodycote Nominees No. 1 Limited
Bodycote Pension Trustees Limited
Bodycote Surface Technology Limited
Bodycote Thermal Processing Mexico Limited

A full list of directly and indirectly owned subsidiary undertakings can be found on page 155 and 156.

148

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 20236.  Trade and other receivables

Amounts falling due within one year:
Amounts owed by subsidiary undertakings1
Corporation tax
Other receivables and prepayments

Amounts falling due after more than one year:
Amounts owed by subsidiary undertakings1
Other receivables

2023 
£m

 3.5 
 0.5 
 1.1 
5.1 

 5.8 
 0.4 
6.2 
11.3 

2022 
£m

2.1 
 2.8 
1.9 
6.8 

 49.2 
 0.7 
49.9 
56.7 

1  An assessment regarding the expected credit losses (ECL) of these amounts has been made and no allowance for ECL has been recognised on the basis that the loans do not exceed the 

borrower’s liquid assets. The portion of the ‘Amounts owed from subsidiary undertakings’ balance that is expected to be settled within 12 months is classified as current. Loans owed from 
subsidiaries have a defined maturity date being predominantly in line with the Group’s Revolving Credit Facility, however parties have the ability to repay earlier.

7.  Trade and other payables

Amounts falling due within one year:
Trade payables
Amounts owed to subsidiary undertakings1
Other taxes and social security
Other payables
Accruals

Amounts falling due after more than one year:
Amounts owed to subsidiary undertakings1

2023 
£m

 0.3 
 0.2 
 0.7 
 4.9 
 4.3 
 10.4 

 6.5 
 6.5 

2022 
£m

 0.4 
 0.2 
 0.2 
 2.3 
 4.2 
 7.3 

 4.8 
 4.8 

1  The portion of the ‘Amounts owed to subsidiary undertakings’ balance that is expected to be settled within 12 months is classified as current. Loans owed to subsidiaries have a defined 

maturity date being predominantly in line with the Group’s Revolving Credit Facility, however parties have the ability to repay earlier.

8.  Deferred tax
The following are the deferred tax assets and liabilities recognised by the Company and movements thereon during the current and prior year.

At 1 January 2022 
Charge to profit or loss
At 1 January 2023
Charge to profit or loss
At 31 December 2023

Accelerated tax
depreciation
£m
(0.5)
(1.0)
(1.5)
(1.0)
(2.5)

 Retirement 
benefit 
obligations 
 £m 
 – 
 – 
 – 
 – 
 – 

 Other timing 
differences 
 £m 
0.5 
(0.3)
0.2 
 – 
0.2 

 Total 
 £m 
 – 
(1.3)
(1.3)
(1.0)
(2.3)

Deferred tax assets and liabilities are offset where the Company has a legally enforceable right to do so. The following is the analysis of the 
deferred tax balances (after offset) for financial reporting purposes:

Net deferred tax liability

2023
£m
 (2.3)

2022
£m
(1.3)

149

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Notes to the company financial statements continued
For the year ended 31 December 2023

9.  Share capital

Share capital:
Ordinary shares (allotted, called-up and fully paid)

At 1 January 2023
At 31 December 2023

Number of 
shares
191,456,172 
191,456,172 

£m
33.1 
33.1 

Details of share awards in issue on the Company’s share capital and share-based payments are set out in note 24 of the Group consolidated 
financial statements.

10.  Contingent liabilities
The Company has guaranteed bank overdrafts, loans and letters of credit of certain subsidiary undertakings amounting to £37.0m 
(2022: £74.4m). The likelihood of these guarantees being called is considered to be unlikely, therefore the estimated financial effect on  
the Company is £nil (2022: £nil) as no provision is required.

11.  Pension commitments
The Company participates in a final salary defined benefit scheme in the UK, the details of which are disclosed in note 26 of the Group 
consolidated financial statements. This is a defined benefit plan which shares the risks between entities under common control. There is no 
contractual agreement or policy for charging the net benefit cost between entities who participate in this scheme. The Company is considered 
to be the entity that is legally the sponsoring employer of this scheme. The net defined benefit costs are recognised as per the requirements 
of IAS 19 Employee Benefits.

The Company acknowledges that the recognition of the pension scheme surplus is an area of accounting judgement, which depends 
on the wording of the scheme rules and IFRIC 14. The pension surplus not recognised at 31 December 2023 was £4.9m (2022: £3.0m). 
Full disclosures concerning the scheme as required by IAS 19 are set out in note 26 of the Group consolidated financial statements and full 
disclosure concerning IFRIC 14 is set out in note 26 of the Group consolidated financial statements.

The contributions made by the Company over the financial year to the defined contribution scheme amounted to £0.5m (2022: £0.5m).  
As at 31 December 2023, contributions of £nil (2022: £nil) were due in respect of the current year had not been paid over to the scheme.

12. Related party transactions
Information on the retirement benefit schemes operated by the Company are set out in note 26 of the Group consolidated financial 
statements. The remuneration of the Directors is set out in note 25 of the Group consolidated financial statements and in the Directors'  
report on remuneration on pages 77 to 91. The Company has taken the exemption available under FRS 101 not to disclose transactions  
with wholly-owned subsidiary companies.

13. Post balance sheet event
On 22 January 2024, the Company announced its intention to launch a share repurchase programme of up to £60.0m. This will commence  
on 15 March 2024.

150

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Five-year summary (unaudited)

Revenue
Profit:
Headline operating profit
Amortisation of acquired intangible assets
Acquisition costs
Operating profit prior to exceptional items
Exceptional items
Operating profit
Net finance charge
Profit/(loss) before taxation
Taxation
Profit after taxation
Non-controlling interests
Profit attributable to the equity holders of the parent
Headline earnings per share (pence)
Full year dividend per share (pence)

Assets employed
Intangible assets
Property, plant and equipment
Other assets and liabilities

Financed by
Share capital
Reserves
Shareholders’ funds
Non-controlling interests
Lease liabilities
Net (cash)/debt
Capital employed
Net assets per share (pence)
Return on capital employed (%):
Headline operating profit divided by the average of  
opening and closing capital employed

2023
£m
802.5 

127.6 
(8.1)
(0.3)
119.2 
– 
119.2 
(7.5)
111.7 
(24.9)
86.8 
(1.2)
85.6 
48.4 
22.7

332.7 
504.9 
6.4 

844.0

33.1 
757.7 
790.8 
1.5 
64.3 
(12.6)
844.0 
413.0 

2022
£m
743.6 

112.2 
(9.3)
(0.9)
102.0 
– 
102.0 
(6.7)
95.3 
(21.0)
74.3 
(0.6)
73.7 
42.7 
21.3 

344.7 
516.3 
20.4 

881.4 

33.1 
747.8 
780.9 
1.1 
66.0 
33.4 
881.4 
407.9 

2021
£m
615.8 

94.8 
(10.3)
(0.7)
83.8 
– 
83.8 
(6.3)
77.5 
(17.5)
60.0 
(0.5)
59.5 
35.8 
20.0 

322.0 
489.3 
(9.5)

801.8 

33.1 
651.6 
684.7 
0.7 
64.5 
51.9 
801.8 
357.6 

2020
£m
598.0 

75.3 
(9.8)
(2.1)
63.4 
(58.4)
5.0 
(6.5)
(1.5)
2.3 
0.8 
(0.4)
0.4 
27.8 
19.4 

323.5 
522.6 
(66.6)

779.5 

33.1 
647.4 
680.5 
0.9 
75.6 
22.5 
779.5 
355.4 

2019
£m
719.7 

134.9 
(4.6)
(1.7)
128.6 
– 
128.6 
(4.7)
123.9 
(29.9)
94.0 
(0.2)
93.8 
52.1 
19.3 

212.4 
534.5 
17.4 

764.3 

33.1 
671.9 
705.0 
0.8 
79.4 
(20.9)
764.3 
368.2 

14.8

13.3 

12.0 

9.8 

17.7 

151

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
 
Alternative performance measures (APMs) – unaudited

Bodycote uses various APMs, in addition to those reported under International Financial Reporting Standards (IFRS), as management consider 
these measures enable users of the financial statements to assess the headline trading performance of the business. These APMs of financial 
performance, position or cash flows are not defined or specified according to IFRS and are defined below and, where relevant, are reconciled 
to IFRS measures. APMs are prepared on a consistent basis for all periods presented in this report.

The APMs used include organic revenue, revenue excluding surcharges, headline operating profit, headline operating margin, revenue and 
headline operating profit at constant exchange rates, headline operating margin excluding surcharge revenue, headline profit before taxation, 
EBITDA, headline EBITDA, headline operating cash flow, free cash flow, headline operating cash conversion, free cash flow conversion, 
headline tax charge, headline tax rate, headline earnings per share (EPS), net (debt)/cash, net (debt)/cash plus lease liabilities and return on 
capital employed (ROCE). These measures reflect the headline trading performance of the business as they exclude certain non-operational 
items, exceptional items, acquisition costs and the amortisation of acquired intangible assets. The Group also uses revenue growth 
percentages adjusted for the impact of foreign exchange movements, where appropriate, to better represent the trading performance of 
the Group. The measures described above are also used in the targeting process for executive and management annual bonuses (headline 
operating profit and headline operating cash flow) with headline EPS and ROCE also used in executive share schemes.

The constant exchange rate comparison uses the current year reported segmental information, stated in the relevant functional currency,  
and translates the results into its presentational currency using the prior year’s monthly exchange rates. Expansionary capital expenditure  
is defined as capital expenditure invested to grow the Group’s business.

Organic revenue
Excludes revenue from acquisitions in the current and comparative period to provide a like-for-like comparison, reconciled in the table below:

Total revenue
Less adjustments for revenue from acquisitions completed in the current or prior year
Total organic revenue

Revenue excluding surcharges

Total revenue
Less energy surcharges
Total revenue excluding surcharges

Headline operating profit

Operating profit
Add back:
Amortisation of acquired intangibles
Acquisition costs
Exceptional items
Headline operating profit

Revenue and headline operating profit at constant exchange rates
Reconciled to revenue and headline operating profit in the table below: 

2023
£m
802.5 
– 
802.5 

2023
£m
802.5 
(66.8)
735.7 

2023
£m
119.2 

8.1 
0.3 
– 
127.6 

2022
£m
743.6 
(8.6)
735.0 

2022
£m
743.6 
(46.6)
697.0 

2022
£m
102.0 

9.3 
0.9 
– 
112.2 

Year to 31 December 2023

Central 
cost and 
eliminations
£m
– 
– 
– 

Consolidated
£m
802.5 
3.0 
805.5 

(21.2)
0.5 
(20.7)

127.6 
3.3 
130.9 

AGI
£m
447.0 
1.3 
448.3 

79.3 
2.0 
81.3 

ADE
£m
355.5 
1.7 
357.2 

69.5 
0.8 
70.3 

Revenue
Constant exchange rates adjustment
Revenue at constant currency

Headline operating profit
Constant exchange rates adjustment
Headline operating profit at constant currency

152

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
 
 
Headline operating margin

Headline operating profit
Revenue
Headline operating margin

Headline operating margin excluding surcharge revenue

Headline operating profit
Revenue excluding surcharges
Headline operating margin excluding surcharge revenue

Headline profit before taxation

Profit before taxation
Add back:
Amortisation of acquired intangibles
Acquisition costs
Exceptional items
Headline profit before taxation

EBITDA and headline EBITDA (earnings before interest, taxation, depreciation and amortisation)

Operating profit
Depreciation and amortisation
Impairment reversal of property, plant and equipment and other assets –  
recognised in exceptional items
Impairment of property, plant and equipment and other assets – recognised in operating profit
Profit on disposal of property, plant and equipment –recognised in operating profit
Profit on disposal of right-of-use assets – recognised in operating profit
Loss on disposal of property, plant and equipment – recognised in exceptional items

Share-based payments
EBITDA
Acquisition costs
Exceptional items, excluding impairments
Share-based payments
Headline EBITDA
Headline EBITDA Margin

Headline operating cash flow 

Headline EBITDA
Less:
Net maintenance capital expenditure
Net working capital movement
Headline operating cash flow

Free cash flow

Headline operating cash flow
Less:
Restructuring cash flows
Net income taxes paid
Net Interest paid
Free cash flow

2023
£m
127.6 
802.5 
15.9%

2023
£m
127.6 
735.7 
17.3%

2023
£m
111.7 

8.1 
0.3 
– 
120.1 

2023
£m
119.2 
82.1 

– 
0.9 
(3.4)
(0.2)
– 

5.1 
203.7 
0.3 
– 
(5.1)
198.9 
24.8%

2023
£m
198.9 

(57.7)
(1.7)
139.5 

2023
£m
139.5 

(1.6)
(9.0)
(6.4)
122.5 

2022
£m
112.2 
743.6 
15.1%

2022
£m
112.2 
697.0 
16.1%

2022
£m
95.3 

9.3 
0.9 
– 
105.5 

2022
£m
102.0 
84.3 

(0.1)
4.8 
(1.7)
(0.1)
0.1 

1.7 
191.0 
0.9 
(0.1)
(1.7)
190.1 
25.6%

2022
£m
190.1 

(52.2)
(25.3)
112.6 

2022
£m
112.6 

(7.4)
(15.4)
(5.8)
84.0 

153

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
 
 
Alternative performance measures (APMs) – unaudited 
continued

2023
£m
139.5 
127.6 
109.3%

2023
£m
122.5 
127.6 
96.0%

2023
£m
24.9 
2.0 
0.1 
27.0 

2023
£m
27.0 
120.1 
22.5%

2023
£m
45.2 
(0.5)
(32.1)
12.6 
(64.3)
(51.7)

2022
£m
112.6 
112.2 
100.4%

2022
£m
84.0 
112.2 
74.9%

2022
£m
21.0 
2.3 
0.2 
23.5 

2022
£m
23.5 
105.5 
22.3%

2022
£m
37.2 
(1.0)
(69.6)
(33.4)
(66.0)
(99.4)

Year to 31 December 2023

Central  
cost and 
eliminations
£m
(21.2)
(31.6)
 n/a 

AGI
£m
79.3 
446.3 
17.8%

Consolidated
£m
127.6 
862.8 
14.8%

Year to 31 December 2022

Central  
cost and 
eliminations
£m
(19.4)
(27.6)
 n/a 

AGI
£m
80.8 
442.8 
18.2%

Consolidated
£m
112.2 
841.6 
13.3%

ADE
£m
69.5 
448.1 
15.5%

ADE
£m
50.8 
426.4 
11.9%

Headline operating cash conversion 

Headline operating cash flow
Headline operating profit
Headline operating cash conversion

Free cash flow conversion

Free cash flow
Headline operating profit
Free cash flow conversion

Headline tax charge 

Tax charge
Tax on amortisation of acquired intangibles
Tax charge on exceptional items and acquisition costs
Headline tax charge

Headline tax rate 

Headline tax charge
Headline profit before taxation
Headline tax rate

Headline earnings per share
A detailed reconciliation is provided in note 8 of the consolidated financial statements.

Net debt and net cash/(debt) plus lease liabilities

Cash and bank balances
Bank overdrafts (included in borrowings)
Bank loans (included in borrowings)
Net cash/(debt) excluding lease liabilities
Lease liabilities
Net debt

Return on capital employed (%)

Headline operating profit
Average capital employed1
Return on capital employed (%)

Headline operating profit
Average capital employed1
Return on capital employed (%)

1  Average capital employed is defined as the average opening and closing net assets adjusted for net (debt)/cash plus lease liabilities.

154

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Subsidiary undertakings

Incorporated in the UK
Springwood Court, Springwood Close, Tytherington Business Park, Macclesfield SK10 2XF 
Bodycote America Capital Limited6 
Bodycote America Finance Limited6 
Bodycote America Treasury Limited6 
Bodycote Developments Limited2,4 
Bodycote Finance Limited6 
Bodycote Finance UK Limited6 
Bodycote Heat Treatments Limited1 
Bodycote H.I.P. Limited1 
Bodycote HIP Germany Limited3 
Bodycote International Limited3 
Bodycote Investments6 
Bodycote K-Tech Limited2 
Bodycote Nominees No. 1 Limited3 
Bodycote Nominees No. 2 Limited2 
Bodycote Pension Trustees Limited5 
Bodycote Processing (Skelmersdale) Limited2,4 
Bodycote Surface Technology Limited1 
Bodycote Thermal Processing Limited2 
Bodycote Thermal Processing Mexico Limited1 
Expert Heat Treatments Limited2,4 
Taylor & Hartley Fabrics Limited2

Incorporated in Belgium
Font Saint Landry 11, 1120 Brussels, Belgium  
Bodycote Belgium SA1 

Industrie Park Noord 7, 9100 Sint-Niklaas, Belgium 
Bodycote Hot Isostatic Pressing NV1 

Incorporated in Canada
4211 Mainway, Burlington, Ontario, L7L 5N9, Canada  
Bodycote Heat Treatment Canada, Inc.1 
Bodycote Thermal Processing Canada, Inc1

1100-1959 ST Upper Water Halifax Nova Scotia B3J 3N2, Canada 
Bodycote Surface Technology Canada Ltd.1

30 de l’Aeroport Boulevard, Bromont Québec JSL 1S6, Canada 
Bodycote Surface Technology Canada Property, Inc.4

Incorporated in China
No. 68 Ningbo East Road, Taicang Economic Development Area, Taicang City, Jiangsu, China 
Bodycote Heat Treatments Technology (Taicang) Co., Limited1 

Building 4 in International Innovation Park Phase Two, No.1188 Feng Hua Road, Jiaxing City, Zhejiang Province, China  
Bodycote (Jiaxing) Heat Treat Co., Ltd.1

2012 Kehang Road, High Tech District, Jinan City, Shandong, China 
Bodycote (Jinan) Heat Treatments Technology Co., Ltd.1

No.12 Building, No. 78, Gu Cheng Zhong Road, Yu Shan Town, Kunshan City, Jiangsu Province, China  
Bodycote (Kunshan) Heat Treatments Technology Co., Ltd.1 

No.B2-A, Wuxi National Hi-New Tech Industrial Development Z, Wuxi City, Jiangsu Province, 214028, China  
Bodycote (Wuxi) Technology Co., Ltd.1 

Incorporated in Czech Republic
Liberec 30, Tanvaldska 345, PSC, 46311, Czech Republic  
Bodycote HT s.r.o.1 

Rohanske nabrezi 671/15, Karlin, 186 00, Praha 8, Czech Republic 
Bodycote SSC s.r.o.6

155

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Subsidiary undertakings continued

Incorporated in France
Ilena Park – Bât. B2, Parc Technologique de Lyon, 117, allée des Parcs, 69800 Saint Priest, France 
Bodycote Bourgogne SAS1  
Bodycote France Holdings SA3  
Bodycote Haute-Savoie SAS2  
Bodycote Lyon SNC6  
Bodycote Metz-Tessy SAS1  
Bodycote SAS1  
Bodycote Sud-Ouest SAS1  
HITEC SAS2  
Nitruvid SAS1 

Incorporated in Germany
Schiessstrasse 68, 40549 Düsseldorf, Germany 
Bodycote Deutschland GmbH6 
Bodycote European Holdings GmbH3 
Bodycote Hirzenhain GmbH1 
Bodycote Schmerbach GmbH1 
Bodycote Specialist Technologies GmbH1 
Bodycote Specialist Technologies Deutschland GmbH1 
Bodycote Wärmebehandlung GmbH1

Incorporated in Ireland
12 Merrion Square North, Dublin 2, Ireland 
Bodycote Ireland Finance DAC6 

Incorporated in Jersey
50 La Colomberie, St Helier, JE2 4QB, Jersey  
Bodycote Jersey Holdings Limited3 

Incorporated in Mexico
Avenida Conquistadores, Exterior No.: 105 Interior No.: PA 07, Calle Rio Lys and Calle Rios Mosa, Col. Mirasierra, San Pedro Garza 
Garcia, Nuevo León 66240, México 
Bodycote de SLP, S. de R.L. de C.V.1

Carretera Monterrey-Saltillo #3279 B, Privada de Santa Catarina, Nuevo León 66367, México 
Bodycote Testing de Mexico, S. de R.L. de C.V.2

Avenida Olmo, No. 100, Parque Industrial y de Negocios Las Colinas, Silao, Guanajuato 36270, México 
Bodycote Thermal Processing de Mexico, S. de R.L. de C.V.1

Avenida Industriales del Poniente Km. 19, Colonia Centro, Santa Catarina, Nuevo León 66350, México 
Bodycote Thermal Processing de Mexico Servicios, S. de R.L. de C.V.6

Incorporated in Sweden
Box 209, 735 23, Surahammar, Sweden 
Bodycote Hot Isostatic Pressing AB1 

Box 124, 424 23, Angered, Sweden 
Bodycote Sweden AB3 
Bodycote Thermotreat AB2 
Bodycote Värmebehandling AB1 
Bodycote Ytbehandling AB1

Incorporated in Switzerland
chemin du Pavillon 2, 1218 Le Grand-Saconnex, Switzerland 
Bodycote (Suisse) SA6 
BDC Enterprises SA3,6

Jurastrasse 59, 2503, Biel, Canton de Berne, Switzerland 
HTM Biel GmbH1

156

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Incorporated in USA
12750 Merit Drive, Suite 1400, Dallas, TX 75251, USA 
Bodycote Americas, Inc.3 – merged into Bodycote USA, Inc. 31.12.2023 
Bodycote IMT, Inc.1 
Bodycote K-Tech, Inc.1 
Bodycote Syracuse Heat Treating Corporation1 
Bodycote Thermal Processing, Inc.1 
Bodycote USA, Inc.3 

8118 Corporate Way Suite 201, Mason OH 45040, USA 
Bodycote Surface Technology Property LLC4 
Bodycote Surface Technology Mexico LLC1 
Bodycote Surface Technology, Inc.1 
Bodycote Surface Technology Group, Inc.6

1237 Knoxville Hwy, Wartburg TN 37887, USA 
Bodycote Surface Technology Wartburg, Inc.1

Incorporated in other overseas countries
Boehlerdurplatz 1, 8605 Kapfenberg, Austria 
Bodycote Austria GmbH1

Groethofstraat 27, 5916PA Venlo, Netherlands 
Bodycote Hardingscentrum BV1 
Bodycote Hardingscentrum No.2 BV3

ÁTI-Sziget Ipari Park, 23. Épület, 2310 Szigetszentmiklós, Hungary 
Bodycote Hungary Hökezelö KFT1

Kemalpasa OSB, Izmir Kemalpasa Asfalti No:17/1, 35730 Kemalpasa-IZMIR, Turkey 
Bodycote Istas Isil Islem Sanayi ve Ticaret AS (79.3% owned)1

Gesällvägen 7, 01730 Vantaa, Finland 
Bodycote Lämpökäsittely Oy1

Wilgowa 65D, Czestochowa, 42-271, Poland 
Bodycote Polska sp z.o.o.1

Im alten Riet 123, 9494 Schaan, Liechtenstein 
Bodycote Rheintal Wärmebehandlung AG1

Matuškova 48, Vlkanová, Banksá Bystrica, 976 31, Slovakia 
Bodycote Slovakia s.r.o.1

Via Moie 28, 25050, Rodengo Saiano, Italy 
Bodycote Trattamenti Termici SpA1

Brasov, str. Zizinului nr. 119, cod 500407, Romania 
Bodycote Tratamente Termice SRL1

Industribuen 16-18, 5592, Ejby, Denmark 
Bodycote Varmebehandling A/S1 

Incorporated in USA
13753 Otterson Court, Livonia, MI 48150, USA 
Thixomat Technologies, LLC (13.9% Investment)

Classifications Key
1.  Thermal processing company 
2.  Dormant 
3.  Holding company 
4.  Property holding company 
5.  Trustee 
6.  Provision of services to Group companies

Except where stated, these companies are wholly owned subsidiaries and have only one class of issued shares.

It is agreed that the five German subsidiaries Bodycote Hirzenhain GmbH, Bodycote Schmerbach GmbH, Bodycote Specialist Technologies 
Deutschland GmbH, Bodycote Specialist Technologies GmbH and Bodycote Wärmebehandlung GmbH make use of the exemption option 
under Sec. 264 para. 3 German Commercial Code for the fiscal year 2023, and will not publish their annual financial statements according to 
Sec. 325 et seq. German Commercial Code.

The financial data of the above German companies for 2023 will be included in the consolidated annual accounts of Bodycote European 
Holdings GmbH.

157

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Shareholder enquiries

Registrar 
The Company’s Registrar is Equiniti Limited. Equiniti provide a range of services to shareholders. Extensive information, including many 
answers to frequently answered questions can be found online at www.shareview.co.uk. Equiniti’s registered address is: Aspect House, 
Spencer Road, Lancing, West Sussex BN99 6DA.

Use the QR code to register for FREE at www.shareview.co.uk 

Share dealing service
For information on the share dealing service offered by Equiniti Limited, telephone 0345 603 7037 (+44 121 415 7560 if calling from outside 
the UK). Lines open 8.00am to 4.30pm (UK time), Monday to Friday excluding public holidays in England and Wales.  
Please either telephone Equiniti or check online at www.shareview.co.uk for up-to-date commission rates.

Dividend reinvestment plan (DRIP)
Equiniti’s DRIP offers a convenient way for shareholders to build up their shareholding by using dividend payments to purchase additional 
shares. The DRIP is provided by Equiniti Financial Services Limited, part of Equiniti Group, which is authorised and regulated by the Financial 
Conduct Authority. It is important to remember that the value of shares and dividend payments can fall as well as rise and you may not recover 
the amount of money that you invest. Past performance should not be seen as indicative of future performance.

For more information and an application pack, please call 0333 207 5951 (+44 121 415 0804 if calling from outside the UK).  
Lines open 8.30am to 5.30pm (UK time), Monday to Friday excluding public holidays in England and Wales. Alternatively go to 
shareview.co.uk/info/drip.

Overseas shareholders
Equiniti provides a service to overseas shareholders that will convert sterling dividends into local currency at a competitive rate. 
Dividend payments will then be made directly into your local bank account. For more information log on to www.shareview.co.uk/info/ops 
for answers to any queries you may have, as well as the full terms and conditions of the service. Alternatively, please call 0333 207 5951             
(+44 121 415 0804 if calling from outside the UK). Lines open 08.30am to 5.30pm (UK time), Monday to Friday excluding public holidays in 
England and Wales.

Duplicate share register accounts
If you are receiving more than one copy of our annual report, it may be that your shares are registered in two or more accounts on our register 
of members. If that was not your intention, you might consider merging your accounts into one single entry. Please contact Equiniti, who will 
be pleased to carry out your instructions.

Shareholder warning 
Shareholders should be very wary of any unsolicited advice, offers to buy shares at a discount or offers of free company reports on the 
Company. Fraudsters use persuasive and high-pressure tactics to lure investors into scams and they may offer to sell shares that often turn 
out to be worthless, overpriced or even non-existent. Whilst high returns are promised, those who invest usually end up losing their money. 

Please keep in mind that firms authorised by the Financial Conduct Authority (FCA) are unlikely to contact you out of the blue. If you receive 
any unsolicited investment advice: 

 – Make sure you get the correct name of the person and organisation and make a record of any other information they give you,  

e.g. telephone number, address, and ask for their ‘firm reference number’ (FRN) 

 – Check that they are properly authorised by the FCA before getting involved. You can check the FCA register at https://register.fca.org.uk  

or call +44 800 111 6768 

 – Report approaches to the FCA – a list of unauthorised firms who are targeting, or have targeted, UK investors is maintained.  

Reporting such organisations means the list can be kept up to date and appropriate action be considered 

 – Inform Equiniti Limited, our Registrars. They are not able to investigate such incidents themselves, but will record the details and pass them on 

to the Company and liaise with the FCA on your behalf 

 – Consider that if you deal with an unauthorised firm, you would not be eligible to receive payment under the Financial Services Compensation 

Scheme If you suspect you have been approached by fraudsters, please contact the FCA using the share fraud reporting form at  
fca.org.uk/scams 

You can also call the FCA Helpline on: 0800 111 6768 (UK freephone) or 0300 500 8082 (UK), or +44 207 066 1000 (from outside UK). 

If you have already paid money to share fraudsters, you should contact Action Fraud on 0300 123 2040 or online at actionfraud.police.uk.

158

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023Shareholder analysis
Analysis of share register as at 29 February 2024:

Holding range
1 to 1,000
1,001 to 10,000
10,001 to 100,000
100,001 to 500,000
500,001 and over

Type of shareholders
Directors’ interests
Major institutional and corporate holdings
Other shareholdings

Number of
shareholders
631
542
199
79
72
1,523

%
41.4
35.6
13.1
5.2
4.7
100.0

Number of
shares
255,702
1,744,528
7,005,686
17,436,818
165,013,438
191,456,172

% of
shareholders
0.3
31.4
68.3
100.0

As at 26 February 2024 the following voting rights in the Company had been notified in accordance with the Disclosure and 
Transparency Rules:

Name of shareholders
Martin Currie Investment Management Ltd.
Goldman Sachs Advisors BV
Fidelity Management & Research Company LLC
Artemis Investment Management
The Vanguard Group, Inc.
Baillie Gifford & Co.
Blackrock Investment Management (UK) Ltd. 

Number of 
shares
14,086,370
12,100,000
10,201,401
9,549,730
9,057,851
7,298,305
5,820,193

%
0.1
0.9
3.7
9.1
86.2
100.0

% of total
shares
0.3
98.6
1.1
100.0

%
7.4
6.3
5.3
5.0
4.7
3.8
3.0

159

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023 
Company information

Advisers
Auditors  
PricewaterhouseCoopers LLP

Principal bankers 
HSBC UK Bank plc, National Westminster Bank plc, Handelsbanken plc, UniCredit Bank AG, Wells Fargo Bank, N.A. and KBC Bank N.V.

Brokers 
HSBC Bank plc and Jefferies International Limited

Solicitors 
Herbert Smith Freehills LLP and DLA Piper UK LLP

Financial calendar 
Annual General Meeting
Final dividend for 2023
Interim results for 2024
Interim dividend for 2024
Results for 2024

30 May 2024
6 June 2024
July 2024
November 2024
March 2025

160

Strategic reportGovernanceFinancial statementsAdditional informationBodycote plc Annual Report 2023www.bodycote.com

For the online version of this report go to 
www.bodycote.com/investors

Bodycote plc 
Springwood Court 
Springwood Close 
Tytherington Business Park 
Macclesfield 
Cheshire 
United Kingdom 
SK10 2XF

Tel:  +44 (0)1625 505300 
Fax: +44 (0)1625 505313 
Email: info@bodycote.com

© Bodycote plc 2024 
Produced by Radley Yeldar 
www.ry.com